data_1fo5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fo5 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.25 103.28 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.47 123.7 31.21 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.839 0.856 . . . . 0.0 110.221 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.89 141.2 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -134.83 146.96 49.77 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.93 88.38 2.71 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.579 1.551 . . . . 0.0 106.968 -173.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.51 ' C ' ' HG1' ' A' ' 9' ' ' THR . 16.5 t80 -105.92 93.9 4.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.821 1.249 . . . . 0.0 107.869 -175.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.51 ' HG1' ' C ' ' A' ' 8' ' ' PHE . 2.4 m -177.72 156.84 1.16 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.588 2.355 . . . . 0.0 105.587 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 160.568 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.459 -0.511 0 CA-C-O 119.273 -0.386 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 46.88 -118.46 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.386 1.475 . . . . 0.0 110.159 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.54 65.09 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.648 -1.168 . . . . 0.0 111.981 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -62.29 -44.08 97.34 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.934 1.243 . . . . 0.0 110.431 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -66.07 -52.26 50.51 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.471 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.55 -41.53 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 117.827 -1.082 . . . . 0.0 109.452 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 p -62.5 -51.02 77.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.431 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -41.8 94.67 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.664 1.575 . . . . 0.0 110.08 -175.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.11 -50.6 71.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.776 1.23 . . . . 0.0 110.037 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.1 m -77.17 -29.66 17.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.85 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.13 64.36 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 120.292 1.405 . . . . 0.0 110.622 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.83 -44.29 90.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.855 0.752 . . . . 0.0 110.506 168.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.95 -55.01 9.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.734 2.014 . . . . 0.0 110.343 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.7 mmt -134.22 85.29 39.4 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 127.414 2.285 . . . . 0.0 109.265 -167.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.01 39.02 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.644 3.562 . . . . 0.0 111.747 -172.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -178.19 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.023 0.929 . . . . 0.0 110.709 -171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.7 48.02 0.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.746 0.703 . . . . 0.0 110.963 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.35 134.41 64.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -128.44 131.73 48.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.52 110.73 20.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.728 0.811 . . . . 0.0 109.225 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.33 102.38 15.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.56 96.56 10.13 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -112.35 85.12 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.05 116.44 2.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.13 99.86 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.824 0.821 . . . . 0.0 110.868 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.5 156.6 0.94 Allowed 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 134.129 4.972 . . . . 0.0 103.782 -178.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 36.69 54.56 1.13 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.914 2.086 . . . . 0.0 114.186 163.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.35 154.73 0.92 Allowed Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 127.469 2.308 . . . . 0.0 109.384 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.04 160.4 33.45 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 -170.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -78.96 25.72 0.27 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.01 1.324 . . . . 0.0 111.339 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -25.09 63.01 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.71 -36.56 13.52 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 167.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmm -73.2 -6.45 45.92 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.218 1.007 . . . . 0.0 113.151 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.29 -119.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.565 0.746 . . . . 0.0 109.023 158.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.8 m-30 60.59 -171.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.728 1.611 . . . . 0.0 110.309 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.71 -14.3 80.01 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.173 171.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.49 -49.97 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 109.16 -170.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.9 mtm 41.29 46.93 2.88 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.678 2.391 . . . . 0.0 111.365 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 106.89 1.64 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.515 1.126 . . . . 0.0 109.075 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.7 158.26 23.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.548 0.739 . . . . 0.0 111.804 168.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.33 118.49 5.15 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.245 0.766 . . . . 0.0 110.59 -6.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -86.63 116.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 107.4 -170.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.8 mm -134.11 140.85 45.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 121.031 -1.043 . . . . 0.0 108.592 -168.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.51 129.79 69.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.404 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -124.61 146.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 45.77 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 129.857 3.263 . . . . 0.0 116.877 -159.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 169.76 -10.29 0.05 OUTLIER Glycine 0 CA--C 1.542 1.72 1 C-N-CA 131.252 4.263 . . . . 0.0 110.906 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -91.07 132.68 35.88 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 120.218 2.009 . . . . 0.0 111.247 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.03 127.11 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.613 1.965 . . . . 0.0 108.727 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -161.22 -179.69 7.65 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 -171.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.75 129.32 6.05 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -140.17 92.82 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 118.541 0.61 . . . . 0.0 109.643 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.21 -177.4 17.26 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.541 1.067 . . . . 0.0 112.171 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.98 -50.06 33.73 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.976 -1.011 . . . . 0.0 111.104 161.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -68.38 178.52 3.66 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.171 1.454 . . . . 0.0 110.673 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 p -58.14 -173.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.878 2.471 . . . . 0.0 111.322 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 3.7 ttpt -70.41 39.65 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.281 1.832 . . . . 0.0 113.957 -163.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.81 -38.49 78.74 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.925 1.69 . . . . 0.0 111.697 -168.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.26 68.67 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.292 1.037 . . . . 0.0 113.085 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -26.6 26.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.532 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.1 -36.26 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 120.582 -1.324 . . . . 0.0 109.781 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -60.75 -6.57 1.8 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.235 2.614 . . . . 0.0 113.624 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.4 -36.13 2.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.537 1.535 . . . . 0.0 112.469 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pt -61.43 -30.99 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.568 1.531 . . . . 0.0 109.13 165.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -64.88 -22.15 66.94 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.699 1.136 . . . . 0.0 113.897 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -46.96 7.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.928 0.891 . . . . 0.0 110.244 -168.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.303 0 C-N-CA 127.184 2.194 . . . . 0.0 105.786 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.84 105.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 108.637 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -89.96 113.94 25.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.27 140.47 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.08 138.71 40.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.43 90.68 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.066 1.346 . . . . 0.0 107.75 -174.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.473 ' C ' ' HG1' ' A' ' 9' ' ' THR . 42.8 t80 -105.81 76.41 1.18 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.54 1.638 . . . . 0.0 107.004 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 8' ' ' PHE . 90.2 m -147.39 164.79 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 CA--C 1.538 0.696 0 CA-C-O 120.836 0.265 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.35 -74.84 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.909 1.684 . . . . 0.0 112.715 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -23.1 67.29 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.513 -0.742 . . . . 0.0 112.389 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -54.18 11.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -65.88 -34.97 79.36 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.612 -1.185 . . . . 0.0 111.054 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.49 -50.27 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.938 1.245 . . . . 0.0 109.512 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.34 -33.29 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 120.869 1.668 . . . . 0.0 112.341 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.54 -47.05 80.22 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.217 1.007 . . . . 0.0 109.385 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -57.99 -49.66 76.08 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.875 1.67 . . . . 0.0 110.192 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.0 m -79.88 -25.24 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.23 -25.41 67.67 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 120.631 1.559 . . . . 0.0 110.129 174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.28 -13.83 9.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.51 -57.53 1.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.331 1.852 . . . . 0.0 110.055 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.1 mtt -118.87 90.34 40.49 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 108.089 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.9 13.28 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.532 2.821 . . . . 0.0 115.32 -166.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -177.78 -26.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.89 1.677 . . . . 0.0 112.742 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.75 -9.1 17.74 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.28 1.855 . . . . 0.0 111.809 161.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.86 137.71 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.829 1.252 . . . . 0.0 110.942 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -136.68 98.63 3.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.41 99.43 8.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -78.64 117.89 20.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 118.77 30.1 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 84.62 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -60.41 119.52 8.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.221 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.62 110.52 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.5 mtm -140.84 -56.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.03 -16.04 60.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.309 1.444 . . . . 0.0 111.082 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.0 t30 35.98 58.71 3.1 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 127.888 2.475 . . . . 0.0 113.06 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.31 145.49 59.92 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.641 2.894 . . . . 0.0 112.737 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.45 -18.41 18.21 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.717 0.807 . . . . 0.0 112.771 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -39.4 63.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 112.857 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.58 -40.62 11.23 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.201 0.909 . . . . 0.0 112.423 163.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.5 mmm -64.38 -5.87 6.06 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -64.51 -24.04 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.5 1.52 . . . . 0.0 112.133 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -62.34 161.0 12.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.756 1.222 . . . . 0.0 111.563 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.68 -39.81 93.81 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.255 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 55' ' ' ALA . 4.7 tp -52.34 -58.14 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.088 0.944 . . . . 0.0 111.195 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.0 mtt 55.15 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.198 2.599 . . . . 0.0 116.496 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -73.13 -171.05 0.84 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.73 2.012 . . . . 0.0 111.966 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.74 136.98 19.11 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.9 159.33 72.61 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 C-N-CA 125.117 -0.785 . . . . 0.0 111.099 -8.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -122.08 128.9 51.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.14 162.83 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.84 136.85 55.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 165.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.453 ' CG1' ' HZ2' ' A' ' 73' ' ' LYS . 1.8 pp -127.17 146.82 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.822 1.192 . . . . 0.0 108.387 169.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.3 t30 51.61 -36.9 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 130.103 3.361 . . . . 0.0 117.267 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.34 -8.58 0.04 OUTLIER Glycine 0 CA--C 1.541 1.71 1 C-N-CA 131.158 4.218 . . . . 0.0 110.928 167.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -91.76 120.36 32.42 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 126.358 1.863 . . . . 0.0 112.465 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.03 143.36 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.945 1.298 . . . . 0.0 107.885 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -178.29 166.59 1.9 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.486 1.514 . . . . 0.0 109.743 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.91 148.92 44.22 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.682 1.193 . . . . 0.0 109.074 165.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.02 137.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -177.93 51.82 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.371 0.532 . . . . 0.0 113.743 168.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.01 -45.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.143 1.377 . . . . 0.0 112.616 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.09 -172.48 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.327 1.51 . . . . 0.0 109.59 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 p -65.33 -163.17 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.515 -0.741 . . . . 0.0 110.926 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HZ2' ' CG1' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -70.79 27.82 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -158.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -29.3 -53.3 0.12 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.157 3.783 . . . . 0.0 113.654 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.75 -54.6 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.302 1.041 . . . . 0.0 111.503 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -27.33 62.4 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.609 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -42.84 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 120.138 1.336 . . . . 0.0 109.327 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.91 -12.9 41.19 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.691 -0.63 . . . . 0.0 111.971 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.43 -39.0 8.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.201 1.401 . . . . 0.0 111.689 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -56.45 -41.28 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 121.395 1.907 . . . . 0.0 110.015 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -19.96 61.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -30.17 30.79 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.753 1.615 . . . . 0.0 109.406 173.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 125.388 1.475 . . . . 0.0 111.807 175.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.5 tptt . . . . . 0 C--O 1.235 0.337 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.2 t -87.21 149.69 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -128.8 115.74 18.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.95 144.02 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 163.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -142.08 157.25 45.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.33 88.29 2.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.403 1.481 . . . . 0.0 109.016 -167.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -109.51 105.72 15.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -178.93 169.02 1.61 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 109.84 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 127.253 2.221 . . . . 0.0 107.375 170.866 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 CA--C 1.54 0.81 0 CA-C-O 119.176 -0.427 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.37 -125.41 0.55 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.936 2.095 . . . . 0.0 110.87 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.17 -32.13 6.61 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.306 -1.33 . . . . 0.0 113.449 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -56.38 -47.33 79.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.087 2.221 . . . . 0.0 111.332 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.9 -36.09 37.01 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 116.178 -1.868 . . . . 0.0 112.426 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.35 -31.74 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 CA-C-N 120.088 1.313 . . . . 0.0 108.455 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.78 -55.9 20.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 119.668 -1.895 . . . . 0.0 110.538 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -54.9 -42.36 72.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.297 1.408 . . . . 0.0 110.966 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.09 -71.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.696 2.399 . . . . 0.0 109.679 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -21.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 118.386 -1.325 . . . . 0.0 113.338 -175.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.27 68.67 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -58.36 -28.41 65.1 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.445 1.02 . . . . 0.0 112.54 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -83.12 -64.45 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 108.967 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.1 mmt -131.05 85.73 53.82 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 124.743 1.217 . . . . 0.0 110.396 -166.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 69.44 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.3 2.666 . . . . 0.0 107.837 163.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -179.14 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.033 2.533 . . . . 0.0 106.941 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.16 4.27 46.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -160.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.91 114.98 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.585 -168.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -77.43 152.45 34.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.52 57.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.485 1.914 . . . . 0.0 108.024 -169.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -64.92 136.6 57.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -172.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -115.66 102.77 10.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 77.85 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.458 1.123 . . . . 0.0 108.928 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.18 147.24 48.35 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.486 -0.759 . . . . 0.0 112.479 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.15 93.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 ttp -153.01 -62.98 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.18 1.792 . . . . 0.0 107.331 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -145.19 11.18 1.33 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.664 0.786 . . . . 0.0 111.371 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -76.42 148.79 80.83 Favored Pre-proline 0 C--O 1.238 0.49 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.89 139.84 63.97 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.137 2.558 . . . . 0.0 110.337 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -69.25 19.26 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.977 1.711 . . . . 0.0 113.45 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -34.2 45.29 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.147 1.379 . . . . 0.0 114.594 -169.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.07 18.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -26.07 65.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.504 1.522 . . . . 0.0 112.578 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.32 -17.52 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.624 1.102 . . . . 0.0 113.565 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -66.87 145.36 55.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.739 1.616 . . . . 0.0 109.535 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.35 -29.77 31.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tp -54.11 -44.59 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.17 1.485 . . . . 0.0 111.221 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 45.6 mtm 41.61 32.74 0.26 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.677 2.391 . . . . 0.0 114.206 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.07 -178.26 3.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.736 1.615 . . . . 0.0 110.352 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.29 160.08 61.21 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.384 1.474 . . . . 0.0 109.96 -161.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.59 126.2 9.19 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 CA-C-N 119.406 0.823 . . . . 0.0 110.325 -12.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 m -78.01 80.99 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.634 1.974 . . . . 0.0 106.706 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.12 154.92 3.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.8 128.4 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.432 ' CG2' ' HE3' ' A' ' 73' ' ' LYS . 44.0 pt -128.13 143.01 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.225 1.01 . . . . 0.0 110.745 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.259 34.5 t30 47.23 -50.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.035 2.934 . . . . 0.0 115.982 -163.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.69 -14.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.562 1.553 . . . . 0.0 112.233 159.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.82 152.75 19.97 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 120.514 2.157 . . . . 0.0 112.483 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.43 161.35 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.053 0.541 . . . . 0.0 109.678 173.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -178.62 165.51 1.69 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.382 2.273 . . . . 0.0 108.135 160.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.96 154.48 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 166.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.0 mm -130.16 78.82 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.79 -163.71 35.23 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.73 7.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 116.642 -1.647 . . . . 0.0 115.208 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.14 177.67 7.93 Favored 'Trans proline' 0 C--N 1.355 0.87 0 CA-C-N 122.776 2.027 . . . . 0.0 109.946 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -60.93 -173.2 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.41 1.084 . . . . 0.0 109.654 160.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HE3' ' CG2' ' A' ' 61' ' ' ILE . 4.0 tppt? -74.81 19.85 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 119.657 -1.902 . . . . 0.0 113.996 -159.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -29.35 -49.57 0.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 130.55 3.54 . . . . 0.0 116.534 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.79 72.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.653 1.115 . . . . 0.0 110.907 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.04 -28.25 61.32 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.254 -1.355 . . . . 0.0 111.273 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.87 -53.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.899 1.227 . . . . 0.0 108.297 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -63.33 -28.57 70.1 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.889 -0.507 . . . . 0.0 111.745 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.17 -67.07 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.792 -0.568 . . . . 0.0 110.045 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -60.32 -25.99 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.585 1.084 . . . . 0.0 112.772 -167.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.6 -31.5 71.58 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.038 1.29 . . . . 0.0 113.949 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.68 47.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.343 1.429 . . . . 0.0 109.408 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 129.717 3.207 . . . . 0.0 103.402 -175.387 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 N-CA-C 116.502 1.693 . . . . 0.0 116.502 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 N-CA-C 116.502 1.693 . . . . 0.0 116.502 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 tttp . . . . . 0 C--O 1.234 0.274 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.51 112.79 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 130.59 36.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 159.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mt -123.68 145.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 158.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -136.69 152.18 50.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mp -126.95 79.84 1.91 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -76.82 85.08 3.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.4 p -136.5 166.2 24.07 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.537 -1.352 . . . . 0.0 109.745 -164.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.534 0.355 0 O-C-N 120.064 -1.648 . . . . 0.0 110.339 -178.493 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 N--CA 1.457 -0.664 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.83 -143.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 130.381 3.472 . . . . 0.0 103.223 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.22 -42.86 4.47 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.977 1.311 . . . . 0.0 112.895 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -49.83 72.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.949 0.795 . . . . 0.0 112.283 176.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -58.81 -60.6 3.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.32 -41.01 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 O-C-N 125.259 1.599 . . . . 0.0 108.936 -167.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.451 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -44.34 92.03 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 121.253 1.842 . . . . 0.0 110.146 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.91 -35.64 78.97 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.294 3.038 . . . . 0.0 111.849 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 m -105.72 -20.57 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -23.74 67.49 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 120.543 1.519 . . . . 0.0 110.173 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -47.95 -44.5 30.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.986 0.515 . . . . 0.0 112.03 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.06 -41.38 14.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.216 1.006 . . . . 0.0 111.304 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.5 mtm -139.19 75.39 34.29 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 110.457 -164.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.67 43.86 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.416 3.41 . . . . 0.0 113.441 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -178.27 -53.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.241 2.217 . . . . 0.0 108.897 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.05 67.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.072 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.35 154.79 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 158.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.16 110.89 15.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.53 104.75 17.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -80.87 106.88 13.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.88 88.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.28 123.27 19.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.704 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.18 113.34 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 125.7 1.6 . . . . 0.0 107.811 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 ttt -160.41 -113.14 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -68.75 -21.79 64.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.73 1.605 . . . . 0.0 111.129 166.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -52.48 111.46 2.58 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 125.379 1.472 . . . . 0.0 109.998 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 158.82 55.2 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 112.201 -163.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -64.62 19.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.216 2.206 . . . . 0.0 114.842 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -20.27 33.77 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.044 -1.66 . . . . 0.0 113.941 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.75 -35.4 14.16 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 121.122 -0.986 . . . . 0.0 112.155 166.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -8.67 55.18 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.846 -1.159 . . . . 0.0 112.441 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -61.4 -26.87 68.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.98 0.912 . . . . 0.0 111.219 167.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -70.46 132.18 45.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.363 0.665 . . . . 0.0 109.958 -176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.83 0.29 1.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 117.004 1.562 . . . . 0.0 117.004 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 55' ' ' ALA . 4.5 tp -64.54 -50.22 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.026 1.913 . . . . 0.0 109.258 161.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.8 mtt 51.25 -8.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 130.938 3.695 . . . . 0.0 117.164 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -69.84 -172.15 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 110.447 163.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -178.05 144.66 0.51 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.863 1.665 . . . . 0.0 106.942 -158.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.17 108.24 0.26 Allowed 'Cis proline' 0 C--N 1.355 0.902 0 CA-C-N 122.157 1.806 . . . . 0.0 114.844 6.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.7 m -79.67 113.43 17.82 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.734 1.614 . . . . 0.0 107.395 -168.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mm -117.77 114.46 45.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.7 t -83.53 134.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 164.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.432 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 1.9 pp -132.0 158.25 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.052 161.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.0 -77.52 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.441 1.497 . . . . 0.0 112.335 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.28 20.67 0.07 OUTLIER Glycine 0 CA--C 1.542 1.774 1 C-N-CA 131.245 4.26 . . . . 0.0 109.512 170.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.91 151.92 20.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 131.691 3.997 . . . . 0.0 107.386 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.03 110.55 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 108.606 -164.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.93 -177.7 6.06 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.883 . . . . 0.0 111.925 -159.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.32 115.44 2.57 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.963 0.905 . . . . 0.0 108.604 158.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.98 74.36 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.24 -160.27 42.07 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.904 1.28 . . . . 0.0 113.756 159.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.33 1.38 Allowed Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 115.594 -2.146 . . . . 0.0 116.581 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.63 -127.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 124.115 2.505 . . . . 0.0 109.707 170.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -115.84 -114.54 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 121.133 1.788 . . . . 0.0 107.64 167.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -91.07 5.23 49.72 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.802 1.637 . . . . 0.0 111.404 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.502 22.2 mt-10 -37.8 -49.07 1.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -158.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.98 78.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 123.337 2.789 . . . . 0.0 113.018 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.424 ' CD1' ' HZ1' ' A' ' 73' ' ' LYS . 3.0 tm? -86.55 -22.88 26.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.454 1.102 . . . . 0.0 109.316 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -34.08 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.286 -1.509 . . . . 0.0 110.266 172.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -57.11 -22.75 42.11 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.653 -0.654 . . . . 0.0 111.551 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.1 -48.34 8.15 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.93 1.292 . . . . 0.0 110.47 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -56.91 -35.34 46.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 119.869 1.213 . . . . 0.0 111.523 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -67.07 -32.83 74.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.312 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -50.07 10.86 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 118.969 0.804 . . . . 0.0 108.85 170.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 . . . . . 0 CA--C 1.529 0.158 0 C-N-CA 124.015 0.926 . . . . 0.0 110.734 173.781 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.8 tttt . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.64 113.31 33.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.73 138.41 37.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.87 137.4 50.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -137.01 147.13 46.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tp -137.64 80.45 1.81 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -173.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -91.43 96.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.471 1.108 . . . . 0.0 108.081 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 t -178.62 174.35 1.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.995 2.118 . . . . 0.0 106.908 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.538 0.492 0 C-N-CA 124.968 1.307 . . . . 0.0 107.614 169.92 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 N--CA 1.455 -0.749 0 CA-C-O 121.312 0.463 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.02 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.243 2.217 . . . . 0.0 112.645 -167.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.4 73.27 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-O 116.293 -1.813 . . . . 0.0 110.807 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -52.57 -50.67 62.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.272 1.851 . . . . 0.0 109.93 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -59.12 -57.67 12.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 117.304 -1.331 . . . . 0.0 111.503 171.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.54 -36.28 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 119.556 1.071 . . . . 0.0 110.852 -169.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.18 -30.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 O-C-N 120.3 -1.5 . . . . 0.0 111.966 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.49 -44.62 95.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.989 1.268 . . . . 0.0 108.712 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.77 -56.08 26.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.288 2.235 . . . . 0.0 109.839 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 m -72.44 -28.85 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 117.684 -1.151 . . . . 0.0 112.969 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.56 -24.58 67.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.99 1.723 . . . . 0.0 111.209 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 -16.77 29.05 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -31.69 1.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.385 1.074 . . . . 0.0 111.987 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 mmt -128.86 67.91 78.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 127.171 2.189 . . . . 0.0 108.365 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.52 32.69 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 126.085 4.523 . . . . 0.0 114.248 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -178.15 -57.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.03 -1.669 . . . . 0.0 109.184 -159.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.93 14.12 0.32 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.158 1.383 . . . . 0.0 113.925 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 p -90.64 91.37 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.696 1.998 . . . . 0.0 110.019 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 81.99 3.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.16 0.984 . . . . 0.0 108.711 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 m -95.52 139.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 127.063 2.145 . . . . 0.0 110.828 -172.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -129.12 106.45 8.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -80.64 120.86 25.11 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.407 HG21 ' HZ2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -130.16 91.9 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 122.794 1.283 . . . . 0.0 109.908 173.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -50.46 113.23 0.83 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.783 2.033 . . . . 0.0 110.751 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.69 110.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 163.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.5 mtp -178.97 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 129.075 2.95 . . . . 0.0 104.052 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -155.26 98.74 2.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 102.322 -3.214 . . . . 0.0 102.322 -163.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.99 155.98 31.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 121.416 -0.802 . . . . 0.0 111.59 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.67 164.15 16.68 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.845 2.364 . . . . 0.0 112.966 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -73.33 -7.29 50.98 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.977 1.311 . . . . 0.0 112.789 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HZ2' HG21 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -44.56 -37.05 3.31 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -172.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.55 -28.62 17.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.136 0.88 . . . . 0.0 113.073 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.93 -9.61 46.52 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.502 -0.749 . . . . 0.0 111.406 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.0 -25.9 67.29 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.633 1.106 . . . . 0.0 111.04 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CD2' HG21 ' A' ' 65' ' ' VAL . 23.0 m-85 -72.3 159.25 34.36 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.098 0.951 . . . . 0.0 111.913 -163.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 131.05 47.06 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.263 0.8 OUTLIER 60.33 -23.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.07 3.348 . . . . 0.0 115.885 -177.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.8 -62.1 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.439 2.696 . . . . 0.0 111.785 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.76 -68.84 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 131.079 3.752 . . . . 0.0 112.865 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.9 t 77.85 125.03 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 128.326 2.651 . . . . 0.0 108.281 -165.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.54 165.12 76.84 Favored 'Cis proline' 0 N--CA 1.454 -0.814 0 CA-C-N 119.702 0.929 . . . . 0.0 111.878 0.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.3 m -145.38 102.16 3.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 -164.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.8 133.37 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -166.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.9 t -100.0 132.11 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.484 ' CG1' ' HZ1' ' A' ' 73' ' ' LYS . 2.3 pp -120.96 142.65 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 161.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 52.63 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.702 3.201 . . . . 0.0 116.617 -169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.52 -11.51 0.74 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 129.65 3.5 . . . . 0.0 111.001 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -92.14 111.9 23.63 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.006 2.122 . . . . 0.0 111.785 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.5 p -68.37 130.96 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.316 1.046 . . . . 0.0 109.187 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.463 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -161.27 -176.09 5.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.352 1.861 . . . . 0.0 106.574 179.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -168.31 130.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.526 1.966 . . . . 0.0 109.396 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.278 1.4 mt -121.45 75.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-O 122.023 0.916 . . . . 0.0 109.824 -173.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.72 -165.96 16.67 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.327 168.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.59 11.22 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 116.968 -1.491 . . . . 0.0 114.03 167.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.25 176.54 9.04 Favored 'Trans proline' 0 C--N 1.354 0.84 0 CA-C-N 122.385 1.888 . . . . 0.0 109.932 170.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -177.47 0.42 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.873 0.869 . . . . 0.0 110.789 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HZ1' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -74.49 30.44 0.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.478 -1.389 . . . . 0.0 112.62 -161.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.314 4.0 mt-10 -64.63 -20.55 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.152 -1.593 . . . . 0.0 114.505 -161.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.2 -48.75 74.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.816 -1.178 . . . . 0.0 112.277 167.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -24.51 56.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.235 -0.916 . . . . 0.0 110.808 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -38.2 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.722 -1.236 . . . . 0.0 108.924 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.505 ' CD ' ' HZ3' ' A' ' 81' ' ' LYS . 26.4 mm-40 -54.23 -25.84 25.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.775 1.171 . . . . 0.0 111.312 170.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.28 -57.12 4.24 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.173 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . 0.257 2.6 pt -55.7 -35.35 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.733 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HZ3' ' CD ' ' A' ' 78' ' ' GLU . 1.4 ptmt -85.24 -17.22 37.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.509 -1.71 . . . . 0.0 115.453 172.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -32.41 73.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 122.814 2.552 . . . . 0.0 109.582 165.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 127.481 2.312 . . . . 0.0 108.175 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HB2' ' HZ1' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -75.48 111.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.38 61.8 6.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.494 1.118 . . . . 0.0 110.877 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.05 136.23 27.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.18 141.33 42.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.32 85.01 2.24 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -159.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.91 84.22 1.89 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 0.0 109.059 -165.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -138.79 -179.43 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 -167.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 120.974 1.715 . . . . 0.0 110.003 169.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo . . . . . 0 N--CA 1.452 -0.917 0 N-CA-C 106.529 -2.143 . . . . 0.0 106.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 -86.27 0.2 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.98 -40.96 59.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.91 170.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -52.23 -44.98 65.12 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -68.38 -43.54 77.13 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 120.074 1.306 . . . . 0.0 110.059 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 t -67.89 -32.38 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.43 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.5 t -53.13 -62.43 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.742 1.617 . . . . 0.0 107.815 164.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -64.25 -35.62 81.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.263 0.483 . . . . 0.0 111.358 -169.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -62.49 -53.0 61.28 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.334 1.053 . . . . 0.0 110.118 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -67.14 -36.16 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -25.28 68.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.816 1.189 . . . . 0.0 112.272 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -52.16 -37.85 55.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 168.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -105.15 -55.09 2.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.556 1.542 . . . . 0.0 109.348 -165.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.6 79.48 12.54 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 127.703 2.401 . . . . 0.0 108.588 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.63 26.68 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.422 3.415 . . . . 0.0 112.777 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.14 -57.11 0.2 Allowed 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.622 -1.299 . . . . 0.0 110.751 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.03 -1.98 4.83 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -80.97 87.76 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.439 2.295 . . . . 0.0 111.495 -165.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -92.85 125.68 37.58 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 t -136.18 105.35 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.439 1.018 . . . . 0.0 110.876 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -88.64 119.28 28.96 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -88.09 122.35 31.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 98.86 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 171.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -69.14 149.25 48.85 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 116.943 -1.903 . . . . 0.0 109.021 166.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.35 123.38 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.46 -94.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.535 1.534 . . . . 0.0 107.722 -163.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.4 -36.34 83.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.823 1.647 . . . . 0.0 110.526 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 53.91 78.88 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.44 1.896 . . . . 0.0 111.504 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.48 157.26 56.73 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.018 2.479 . . . . 0.0 111.276 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -65.43 -20.32 66.32 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.75 -0.594 . . . . 0.0 111.727 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -32.1 53.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.86 -1.067 . . . . 0.0 113.817 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.54 -40.79 11.17 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.077 1.308 . . . . 0.0 113.504 163.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.4 mtp -66.09 -12.3 54.6 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.48 -20.74 66.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.863 1.665 . . . . 0.0 112.242 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.38 172.1 13.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.473 1.033 . . . . 0.0 109.709 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.46 -67.78 1.55 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.05 74.72 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 123.286 1.517 . . . . 0.0 108.26 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.25 36.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.604 -1.635 . . . . 0.0 114.762 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.75 -81.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.461 1.105 . . . . 0.0 113.663 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -178.45 152.7 0.8 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.26 1.424 . . . . 0.0 109.176 -168.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.95 94.32 0.13 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.577 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -20.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.0 m -72.6 108.27 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.914 1.285 . . . . 0.0 107.638 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 mm -112.94 155.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.92 142.77 42.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 168.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.289 7.8 pt -107.76 -119.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 116.583 -1.675 . . . . 0.0 111.085 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -53.57 -33.13 53.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.854 2.57 . . . . 0.0 112.439 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.53 -28.21 0.02 OUTLIER Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.336 0.97 . . . . 0.0 111.428 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.19 157.68 37.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.921 0.86 . . . . 0.0 111.317 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 m -118.09 120.54 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.646 1.578 . . . . 0.0 108.18 -158.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.55 ' CB ' ' HZ2' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -161.3 159.53 28.64 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -159.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -155.49 132.47 10.72 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.6 mm -135.26 118.73 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.06 -164.7 54.94 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 -34.79 0.75 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 116.621 -1.657 . . . . 0.0 114.434 169.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.28 -158.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 CA-C-N 122.34 1.872 . . . . 0.0 109.831 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -66.2 -171.71 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.466 -1.396 . . . . 0.0 109.818 160.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.55 ' HZ2' ' CB ' ' A' ' 66' ' ' GLU . 4.5 ttpt -77.17 49.06 0.66 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -158.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.69 -41.21 63.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -158.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.33 -41.57 73.08 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.835 -1.166 . . . . 0.0 112.136 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.25 -25.81 51.88 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.938 0.79 . . . . 0.0 110.923 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.7 t -55.53 -48.03 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.863 1.665 . . . . 0.0 107.807 167.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.9 -8.25 10.62 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.98 -51.48 3.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.763 -1.211 . . . . 0.0 110.156 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.7 pt -59.57 -23.06 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 O-C-N 121.262 -0.899 . . . . 0.0 111.615 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -62.46 -32.37 73.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.665 1.121 . . . . 0.0 113.219 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -42.26 10.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.578 1.081 . . . . 0.0 112.259 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 131.234 3.814 . . . . 0.0 121.022 -171.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.406 0.622 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 t -58.73 140.71 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 160.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 147.06 36.08 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.7 mt -141.59 129.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 71.5 mt-10 -128.59 128.03 43.43 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.14 69.56 1.16 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.669 1.988 . . . . 0.0 106.029 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -81.63 83.35 7.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.6 p -128.77 179.09 5.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.94 -1.1 . . . . 0.0 108.508 -166.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 117.054 -1.45 . . . . 0.0 112.343 171.259 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 CA--C 1.544 0.976 0 N-CA-C 108.706 -1.306 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.25 -80.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.804 1.642 . . . . 0.0 114.128 -158.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.05 -26.37 68.22 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.959 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -62.18 -47.74 83.15 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.231 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -49.09 69.51 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 120.412 1.46 . . . . 0.0 108.974 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 18.2 t -63.32 -34.07 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 117.662 -1.615 . . . . 0.0 110.342 -169.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.44 -45.37 75.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.532 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -53.17 -48.22 68.19 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.98 1.718 . . . . 0.0 109.487 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.78 -54.24 47.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 129.191 2.996 . . . . 0.0 110.23 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.72 -38.89 45.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.758 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.36 -28.24 66.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 120.615 1.552 . . . . 0.0 110.655 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -57.19 -25.72 59.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.549 1.14 . . . . 0.0 112.587 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.01 -23.11 6.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.275 1.03 . . . . 0.0 111.895 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.8 mtp -133.93 75.61 66.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 127.277 2.231 . . . . 0.0 110.629 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.55 29.63 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.518 3.478 . . . . 0.0 114.178 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -178.31 -48.39 0.01 OUTLIER 'General case' 0 C--O 1.236 0.348 0 O-C-N 120.325 -1.485 . . . . 0.0 109.693 -164.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.43 54.51 1.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.349 0.66 . . . . 0.0 110.518 169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.02 136.31 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.36 138.05 51.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.98 127.0 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 124.172 0.989 . . . . 0.0 109.691 -168.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -127.61 110.97 13.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 167.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.74 106.5 9.6 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 166.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.3 90.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.94 108.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 161.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.7 t -44.35 110.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.324 1.85 . . . . 0.0 109.126 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 tpp -140.03 -67.68 0.43 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.9 86.54 2.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -139.42 148.53 56.89 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.59 137.92 67.0 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 N-CA-C 106.266 -2.244 . . . . 0.0 106.266 161.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -73.17 39.33 0.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -31.23 70.2 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 120.792 -1.193 . . . . 0.0 112.609 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.36 -31.77 15.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 111.551 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.9 mtt -65.75 -7.56 16.42 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.932 -1.105 . . . . 0.0 112.132 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.56 -30.46 64.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.411 1.084 . . . . 0.0 111.008 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.77 169.05 8.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.767 0.827 . . . . 0.0 110.306 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.45 -30.32 77.53 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.656 -1.636 . . . . 0.0 112.536 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -51.14 -66.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.803 1.802 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 31.5 mtt 59.08 -39.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.961 2.504 . . . . 0.0 114.719 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.21 99.97 0.21 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.92 1.688 . . . . 0.0 110.984 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.1 m -60.59 150.18 75.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 121.528 -0.732 . . . . 0.0 109.407 159.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.22 113.14 2.08 Favored 'Cis proline' 0 C--N 1.349 0.603 0 CA-C-N 120.666 1.273 . . . . 0.0 111.93 1.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -96.78 117.88 32.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.219 2.208 . . . . 0.0 106.294 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.01 119.04 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -167.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -102.05 131.25 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.7 pt -128.26 163.37 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 125.032 1.458 . . . . 0.0 108.717 168.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 t30 48.16 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 111.63 -159.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.93 -3.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.443 0 C-N-CA 128.155 2.788 . . . . 0.0 111.892 167.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -91.54 129.83 37.46 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.232 2.016 . . . . 0.0 111.7 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.27 140.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.612 0.765 . . . . 0.0 109.733 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.18 -178.17 6.55 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -164.61 115.58 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.79 81.02 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 119.532 1.06 . . . . 0.0 110.468 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 171.9 23.17 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.376 -1.284 . . . . 0.0 112.007 166.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.71 3.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 115.958 -1.973 . . . . 0.0 115.836 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.08 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.367 2.238 . . . . 0.0 111.047 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 p -134.95 -127.99 0.16 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.934 2.094 . . . . 0.0 108.435 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -91.91 20.62 5.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.208 -1.558 . . . . 0.0 114.923 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -41.98 -45.11 3.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.618 2.008 . . . . 0.0 113.299 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.23 -49.65 60.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.569 1.148 . . . . 0.0 113.302 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.37 -21.86 28.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.03 -40.53 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.37 -29.05 65.7 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.471 -0.768 . . . . 0.0 112.455 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.53 -50.08 13.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 111.226 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 pt -60.44 -37.51 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.164 -0.96 . . . . 0.0 111.585 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -36.61 84.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.636 1.107 . . . . 0.0 113.237 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -21.47 45.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.44 1.473 . . . . 0.0 113.006 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 126.126 1.771 . . . . 0.0 109.281 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.315 0.579 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.77 101.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.74 160.37 32.73 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.811 0.815 . . . . 0.0 110.129 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -147.99 138.98 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 129.181 2.992 . . . . 0.0 105.135 167.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -135.7 146.87 48.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.56 82.98 2.06 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.785 1.234 . . . . 0.0 109.379 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.6 89.82 2.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.094 1.358 . . . . 0.0 108.5 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -135.69 179.69 6.18 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.856 -1.153 . . . . 0.0 113.279 -161.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 127.385 2.274 . . . . 0.0 108.278 -173.835 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.455 -0.792 0 N-CA-C 109.314 -1.072 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.52 -94.42 0.32 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.19 -25.29 58.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.264 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -56.61 -54.66 43.39 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.814 0.846 . . . . 0.0 111.755 171.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.6 mtt-85 -60.71 -45.21 95.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 118.659 0.663 . . . . 0.0 109.594 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.9 t -68.69 -34.58 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.563 -170.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.44 -32.57 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 121.133 1.788 . . . . 0.0 110.885 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -60.54 -53.68 54.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.815 1.189 . . . . 0.0 109.043 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.38 -36.97 77.33 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 122.915 0.486 . . . . 0.0 111.595 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -74.7 -35.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.975 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.7 70.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.642 1.564 . . . . 0.0 111.169 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -57.72 -22.23 45.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.56 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -112.55 -31.52 6.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.974 1.261 . . . . 0.0 112.069 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -145.14 85.84 7.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.549 1.939 . . . . 0.0 110.338 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.88 45.47 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.176 3.251 . . . . 0.0 110.913 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -178.0 -66.77 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.711 1.604 . . . . 0.0 109.035 -166.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.87 1.11 4.74 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.27 141.33 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.267 1.427 . . . . 0.0 108.988 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.31 130.06 30.22 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 164.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.63 92.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.815 1.246 . . . . 0.0 110.52 -159.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 104.33 16.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -75.61 121.75 22.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 159.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.09 92.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.7 161.72 14.53 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.745 -1.222 . . . . 0.0 109.948 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.5 mtp -178.59 -87.05 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.586 2.354 . . . . 0.0 105.665 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -68.17 -19.06 64.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.721 1.208 . . . . 0.0 111.983 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.08 56.13 17.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.394 1.878 . . . . 0.0 111.606 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.35 140.78 65.43 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.934 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.76 -15.62 42.7 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.814 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -40.25 -45.37 2.06 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.378 1.471 . . . . 0.0 112.333 162.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.45 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.07 -46.01 8.0 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 168.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mtp -68.57 -5.47 20.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.42 -26.27 63.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.378 1.071 . . . . 0.0 111.317 164.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -76.33 118.48 19.08 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.269 1.028 . . . . 0.0 110.243 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.59 -5.5 23.87 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.437 -1.201 . . . . 0.0 114.878 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.449 ' C ' ' H ' ' A' ' 55' ' ' ALA . 5.3 pt -68.44 -46.55 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.875 1.838 . . . . 0.0 109.603 170.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.3 mtt 47.08 -11.42 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.632 3.173 . . . . 0.0 117.447 -169.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -65.16 -27.7 68.9 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.397 1.879 . . . . 0.0 115.735 -159.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.311 28.8 m 50.98 166.72 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 128.251 2.62 . . . . 0.0 113.625 -161.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -65.52 105.78 0.34 Allowed 'Cis proline' 0 C--N 1.356 0.948 0 CA-C-N 121.55 1.589 . . . . 0.0 109.99 -14.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 m -79.89 124.49 28.71 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.803 1.641 . . . . 0.0 107.066 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.82 166.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 t -142.94 134.16 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.404 ' CG2' ' HZ2' ' A' ' 73' ' ' LYS . 37.1 pt -101.42 -157.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.745 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -23.23 -51.34 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.495 2.318 . . . . 0.0 114.91 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.22 -27.2 0.22 Allowed Glycine 0 CA--C 1.533 1.215 0 O-C-N 124.163 0.914 . . . . 0.0 112.106 158.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.55 140.59 29.6 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.684 1.742 . . . . 0.0 112.585 -163.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.71 147.64 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.173 2.189 . . . . 0.0 108.478 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -178.57 160.13 1.2 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.555 1.542 . . . . 0.0 109.401 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 146.89 52.51 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 159.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 mm -124.78 88.44 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.38 -165.16 51.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 121.664 0.591 . . . . 0.0 112.418 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.76 -22.84 0.54 Allowed Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.65 177.17 2.96 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 123.67 2.346 . . . . 0.0 110.632 164.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.1 p -70.55 -159.77 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 159.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HZ2' ' CG2' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -77.29 23.26 0.2 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 119.199 -2.188 . . . . 0.0 112.746 -170.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -44.93 -37.92 4.31 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.84 2.456 . . . . 0.0 112.508 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.87 -66.47 0.38 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.481 1.112 . . . . 0.0 111.567 169.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -23.31 64.25 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.647 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -39.8 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.568 1.531 . . . . 0.0 108.559 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -62.34 -7.46 4.39 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.05 -37.83 7.19 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.204 1.366 . . . . 0.0 112.376 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -42.78 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.569 1.077 . . . . 0.0 108.598 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -15.25 60.92 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.394 -1.441 . . . . 0.0 113.927 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -52.73 9.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.59 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? . . . . . 0 N--CA 1.472 0.649 0 CA-C-N 119.827 1.194 . . . . 0.0 112.307 174.901 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt . . . . . 0 C--O 1.237 0.408 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.08 130.97 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.673 1.124 . . . . 0.0 108.507 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -106.2 147.04 29.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.261 -0.899 . . . . 0.0 109.224 170.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mm -133.29 134.61 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -130.06 143.86 51.03 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.44 78.67 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.457 ' C ' ' HG1' ' A' ' 9' ' ' THR . 16.0 t80 -88.97 80.14 7.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.457 ' HG1' ' C ' ' A' ' 8' ' ' PHE . 52.6 m -152.33 159.39 43.47 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.352 -1.468 . . . . 0.0 110.468 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 162.657 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 CA-C-O 117.925 -0.948 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 43.08 -117.0 0.44 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.201 1.4 . . . . 0.0 110.389 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.59 -32.75 29.83 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 116.15 -1.881 . . . . 0.0 114.246 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -59.1 -59.07 6.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 121.457 1.935 . . . . 0.0 109.639 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -61.63 -50.26 73.27 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.495 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.4 -40.59 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 117.017 -1.468 . . . . 0.0 108.577 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.87 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 120.479 1.49 . . . . 0.0 109.657 171.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -58.69 -43.14 89.92 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.905 1.23 . . . . 0.0 110.653 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.28 -54.62 34.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.646 1.178 . . . . 0.0 110.653 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.5 m -71.6 -29.2 33.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.793 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.93 64.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.691 1.132 . . . . 0.0 110.125 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.77 -40.05 78.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.189 0.45 . . . . 0.0 110.078 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -76.56 -51.69 11.16 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.329 1.051 . . . . 0.0 111.909 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.4 mtt -141.38 82.94 13.93 Favored Pre-proline 0 C--N 1.333 -0.152 0 C-N-CA 127.517 2.327 . . . . 0.0 108.755 -167.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -68.85 8.81 0.52 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.205 1.937 . . . . 0.0 114.147 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.7 -40.69 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.551 1.141 . . . . 0.0 112.376 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -6.4 19.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.519 1.054 . . . . 0.0 111.812 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.66 144.72 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 119.496 1.044 . . . . 0.0 109.319 170.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 141.62 51.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.171 2.188 . . . . 0.0 105.182 165.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.35 129.04 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 124.019 0.928 . . . . 0.0 109.725 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -121.15 97.54 5.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -85.91 93.06 8.84 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.276 0.2 OUTLIER -116.27 92.42 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 123.056 1.408 . . . . 0.0 107.815 -170.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.06 124.15 20.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.967 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.79 117.45 5.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.59 -63.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -143.67 51.35 1.34 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -160.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -139.5 151.18 66.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.857 0.863 . . . . 0.0 111.101 -165.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.98 134.76 32.95 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.295 2.663 . . . . 0.0 111.852 -172.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -70.68 7.03 1.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.344 -0.848 . . . . 0.0 112.779 173.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.7 -31.63 17.03 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.079 1.752 . . . . 0.0 113.311 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB2' ' CD2' ' A' ' 8' ' ' PHE . . . -92.35 -41.48 10.33 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.616 0.644 . . . . 0.0 111.103 164.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.14 -0.75 3.56 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.83 -143.44 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.196 1.398 . . . . 0.0 109.662 159.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 67.6 -168.03 0.2 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.563 1.545 . . . . 0.0 111.725 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.87 162.76 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 158.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.293 1.5 tp 41.79 63.99 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 123.225 1.488 . . . . 0.0 112.563 -165.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtt -67.87 -22.33 65.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.687 163.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.02 0.84 4.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.906 1.282 . . . . 0.0 113.926 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 70.31 164.07 0.14 Allowed Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.406 1.482 . . . . 0.0 110.49 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.15 125.94 10.61 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.674 1.276 . . . . 0.0 111.474 -9.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.1 m -95.4 98.09 10.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.5 mm -119.48 120.4 63.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -167.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.63 127.95 47.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.9 pt -123.91 142.17 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.83 0.741 . . . . 0.0 109.885 169.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.5 t30 48.08 -42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.288 3.035 . . . . 0.0 116.886 -159.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.96 -15.6 0.06 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 128.414 2.911 . . . . 0.0 111.255 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -91.06 160.61 15.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.413 1.606 . . . . 0.0 110.17 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.64 127.55 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.82 0.848 . . . . 0.0 109.209 -158.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.93 173.39 15.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.026 0.83 . . . . 0.0 111.015 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.92 155.51 48.94 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.782 1.633 . . . . 0.0 106.874 159.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.6 mm -141.06 136.17 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.01 -171.34 45.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.82 -30.97 0.64 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.374 -1.774 . . . . 0.0 114.209 164.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -85.41 -166.54 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 CA-C-N 123.005 2.109 . . . . 0.0 110.53 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -63.33 175.63 0.95 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.054 0.941 . . . . 0.0 111.661 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 21.5 0.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.518 1.527 . . . . 0.0 113.771 -160.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -35.45 -40.8 0.16 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.312 2.245 . . . . 0.0 114.654 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.48 -64.76 0.72 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.714 1.606 . . . . 0.0 111.703 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -28.15 66.87 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.042 0.537 . . . . 0.0 110.698 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.13 -34.65 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.25 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.45 -16.55 55.86 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.529 -1.357 . . . . 0.0 113.745 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.48 -47.81 7.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.351 1.432 . . . . 0.0 110.466 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.87 -24.84 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.024 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -64.01 -46.5 84.23 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.129 0.877 . . . . 0.0 111.282 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.85 -49.49 8.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -165.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 . . . . . 0 N--CA 1.463 0.18 0 C-N-CA 129.128 2.971 . . . . 0.0 114.629 -165.744 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? . . . . . 0 C--O 1.234 0.278 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -105.39 103.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 158.17 35.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -143.39 138.94 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 161.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -129.08 144.16 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 mt -138.37 89.62 2.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.404 1.082 . . . . 0.0 108.465 -170.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -113.63 97.25 6.31 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.211 1.805 . . . . 0.0 108.917 -164.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t -178.91 -177.25 0.48 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.989 1.716 . . . . 0.0 106.626 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 CA--C 1.539 0.558 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.285 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo . . . . . 0 CA--C 1.537 0.665 0 CA-C-O 118.21 -0.829 . . . . 0.0 114.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.73 -81.21 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.875 1.67 . . . . 0.0 113.496 -166.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.18 -25.35 68.04 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.491 -1.242 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -61.39 -59.29 5.5 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.203 0.91 . . . . 0.0 109.791 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -61.6 -43.15 99.39 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.762 -0.586 . . . . 0.0 111.005 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -66.36 -33.71 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.942 -173.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.24 -27.41 13.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 CA-C-N 120.368 1.44 . . . . 0.0 111.88 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -61.23 -57.58 11.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 108.252 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -49.27 -66.18 0.44 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.328 1.851 . . . . 0.0 107.688 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.47 -27.95 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.686 1.13 . . . . 0.0 112.872 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 -26.35 68.01 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.829 1.649 . . . . 0.0 111.249 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -53.72 -48.98 69.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.221 0.919 . . . . 0.0 111.466 167.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.51 -51.77 47.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.587 0.63 . . . . 0.0 109.978 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.59 88.48 8.69 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.668 1.587 . . . . 0.0 109.367 -169.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.41 27.27 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.021 3.147 . . . . 0.0 110.95 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -151.67 -68.33 0.17 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.152 1.381 . . . . 0.0 108.62 -158.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.21 -5.03 28.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.16 139.44 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 119.175 0.898 . . . . 0.0 110.294 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.28 123.31 24.02 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -117.02 140.02 41.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -116.97 100.6 7.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.57 115.68 17.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 160.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.266 0.2 OUTLIER -129.23 101.32 6.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.766 1.27 . . . . 0.0 107.876 177.406 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.1 129.03 38.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.244 1.418 . . . . 0.0 108.324 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.55 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -178.94 -72.26 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 128.458 2.703 . . . . 0.0 106.328 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.6 -41.8 59.81 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -58.86 142.79 84.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.061 0.944 . . . . 0.0 112.159 -167.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.01 136.45 32.37 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.911 1.741 . . . . 0.0 108.254 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.08 -12.88 2.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.542 1.537 . . . . 0.0 113.386 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -4.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.833 2.853 . . . . 0.0 118.468 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.42 -63.89 1.2 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 121.5 1.954 . . . . 0.0 107.546 158.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.83 -21.22 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 129.738 3.215 . . . . 0.0 115.254 174.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.91 -20.38 3.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.802 2.041 . . . . 0.0 114.84 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -52.58 175.39 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.019 2.928 . . . . 0.0 115.555 -164.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -43.42 127.41 5.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.822 1.201 . . . . 0.0 110.837 164.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.289 0.2 OUTLIER 60.12 -24.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 129.435 3.094 . . . . 0.0 115.895 -170.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtm 62.24 -73.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 128.628 2.771 . . . . 0.0 110.754 -172.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 36.27 -130.95 0.1 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.187 2.595 . . . . 0.0 110.965 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -179.32 154.28 0.74 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 128.937 2.895 . . . . 0.0 105.138 175.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.93 -179.87 8.81 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 119.483 0.851 . . . . 0.0 112.0 -14.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -128.69 127.19 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 168.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -129.56 163.71 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 t -138.75 130.93 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 102.907 -2.998 . . . . 0.0 102.907 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.0 pt -99.21 -161.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 117.005 -1.474 . . . . 0.0 108.9 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -20.17 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.823 2.449 . . . . 0.0 114.308 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.68 -13.61 1.42 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.869 -0.962 . . . . 0.0 112.668 158.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -91.32 113.86 26.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.331 1.566 . . . . 0.0 113.186 -159.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.42 135.35 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.421 1.489 . . . . 0.0 107.855 164.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -178.57 169.33 1.74 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.862 2.065 . . . . 0.0 107.842 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -158.93 139.63 12.61 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 119.907 -1.745 . . . . 0.0 106.662 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.89 133.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -174.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 175.37 49.82 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.127 0.892 . . . . 0.0 111.966 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.21 -42.62 2.11 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.735 1.214 . . . . 0.0 112.825 164.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.12 -176.66 1.95 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 CA-C-N 121.798 1.678 . . . . 0.0 109.354 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -62.85 -175.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.518 -0.739 . . . . 0.0 111.119 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.45 32.99 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.886 2.074 . . . . 0.0 114.64 -158.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.34 -34.63 64.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.236 -1.54 . . . . 0.0 112.017 -172.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.81 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.49 1.116 . . . . 0.0 111.7 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.51 -28.8 30.88 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.928 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.24 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 120.697 1.589 . . . . 0.0 109.97 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -12.5 23.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.18 -37.28 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.718 2.007 . . . . 0.0 111.418 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.29 -34.4 40.03 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 121.677 2.035 . . . . 0.0 110.251 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -53.81 -35.28 61.23 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -31.42 16.33 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 170.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.313 0 C-N-CA 124.834 1.253 . . . . 0.0 111.696 -169.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 t -65.12 130.06 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 168.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.14 141.5 33.94 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 165.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -138.43 85.38 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -172.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -93.71 128.67 40.04 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.21 87.12 3.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 164.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -91.05 95.64 10.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.971 0.891 . . . . 0.0 108.65 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -178.47 172.1 1.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.192 1.797 . . . . 0.0 108.136 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 164.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 CA--C 1.542 0.903 0 N-CA-C 109.586 -0.967 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.92 -77.5 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.68 1.992 . . . . 0.0 111.994 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.92 78.48 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 118.224 -0.893 . . . . 0.0 108.796 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -48.64 -46.08 39.41 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.278 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -68.04 -53.0 28.97 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 121.02 1.737 . . . . 0.0 111.085 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.72 -40.2 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.017 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 m -73.98 -32.68 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 126.113 1.765 . . . . 0.0 112.637 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.64 -49.31 62.52 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.632 1.106 . . . . 0.0 108.139 164.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -76.98 -44.43 31.12 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.074 0.949 . . . . 0.0 110.531 -164.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.5 m -72.57 -26.44 24.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.95 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.49 63.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.936 1.698 . . . . 0.0 110.328 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.24 -41.18 99.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.303 1.041 . . . . 0.0 109.878 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.7 -56.82 7.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.146 0.579 . . . . 0.0 110.63 171.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.0 mtt -146.86 86.83 6.48 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 125.355 1.462 . . . . 0.0 109.214 -159.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.25 41.4 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.437 2.758 . . . . 0.0 111.66 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -151.56 -66.36 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 127.198 2.199 . . . . 0.0 108.061 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 45.45 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.977 1.711 . . . . 0.0 111.775 -173.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.14 83.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.065 1.346 . . . . 0.0 109.928 -161.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -89.24 110.8 21.52 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.46 142.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.034 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -156.52 152.16 27.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.354 1.073 . . . . 0.0 112.068 158.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.58 90.57 4.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.386 2.274 . . . . 0.0 106.334 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.45 85.33 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 121.56 12.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 93.67 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 mmt -143.6 -52.99 0.35 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.94 1.696 . . . . 0.0 109.089 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 13.3 6.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.143 2.177 . . . . 0.0 110.845 -169.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.14 154.42 30.57 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.554 2.342 . . . . 0.0 115.594 -160.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.23 145.06 77.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.788 2.325 . . . . 0.0 110.592 170.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -66.33 -9.8 36.68 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.381 -0.824 . . . . 0.0 111.041 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -61.0 -18.02 55.3 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -175.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.24 -39.54 11.47 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 119.974 -1.704 . . . . 0.0 112.068 161.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.2 mtm -63.35 -12.98 34.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.121 -0.987 . . . . 0.0 112.543 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.14 -26.66 68.45 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.564 1.146 . . . . 0.0 110.902 168.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -66.6 114.65 5.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 108.953 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.69 8.14 3.48 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.576 1.39 . . . . 0.0 116.576 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -69.83 -52.59 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.937 1.869 . . . . 0.0 108.587 159.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . 0.279 0.1 OUTLIER 40.9 7.74 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.926 3.29 . . . . 0.0 117.815 -169.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -178.44 0.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 123.392 1.568 . . . . 0.0 109.354 159.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.04 158.56 48.33 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.194 -0.941 . . . . 0.0 108.922 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.21 128.76 13.6 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 -10.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -77.78 106.13 9.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.7 mm -118.93 121.54 67.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -111.81 111.28 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pp -101.07 167.75 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 169.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 30.33 -81.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.07 1.748 . . . . 0.0 114.501 -161.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.53 10.19 1.46 Allowed Glycine 0 CA--C 1.534 1.243 0 CA-C-N 120.241 1.382 . . . . 0.0 114.139 165.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -86.52 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.33 1.565 . . . . 0.0 113.358 -166.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 p 114.78 134.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 1 C-N-CA 133.766 4.826 . . . . 0.0 106.753 -163.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -178.72 167.08 1.73 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.738 2.415 . . . . 0.0 108.088 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.82 116.67 5.53 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.733 1.613 . . . . 0.0 107.831 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 150.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.51 172.36 47.7 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 124.339 1.025 . . . . 0.0 111.248 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' H ' ' HD2' ' A' ' 71' ' ' PRO . . . -83.98 -33.55 0.55 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.702 1.201 . . . . 0.0 111.459 158.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' ' H ' ' A' ' 70' ' ' ALA . 85.9 Cg_endo -71.15 -165.75 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.636 1.62 . . . . 0.0 110.001 160.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.8 p -64.23 -172.47 0.07 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.525 0.73 . . . . 0.0 109.858 162.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -71.59 47.34 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.393 2.277 . . . . 0.0 114.529 -158.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -58.31 -45.36 88.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.577 1.951 . . . . 0.0 110.923 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.86 61.4 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 112.867 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.94 -20.63 21.98 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.995 0.918 . . . . 0.0 110.476 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.92 -38.42 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.561 -1.337 . . . . 0.0 108.353 167.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.2 -0.64 10.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.444 0.698 . . . . 0.0 112.761 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.57 -51.11 3.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.592 1.557 . . . . 0.0 111.21 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pt -53.48 -40.51 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 119.967 1.258 . . . . 0.0 107.948 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -72.9 -29.09 62.87 Favored 'General case' 0 C--N 1.345 0.377 0 O-C-N 120.209 -1.557 . . . . 0.0 114.78 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.49 1.95 . . . . 0.0 109.291 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.994 1.318 . . . . 0.0 113.92 172.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.2 tttt . . . . . 0 C--O 1.232 0.161 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.9 110.26 3.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -91.13 144.75 25.31 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.77 138.57 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -124.72 133.0 53.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.14 92.09 3.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.049 1.34 . . . . 0.0 109.118 -172.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -112.61 104.09 12.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.027 0.931 . . . . 0.0 109.857 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 t -178.57 170.92 1.59 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 108.65 170.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.547 0.855 0 C-N-CA 124.603 1.161 . . . . 0.0 109.889 169.87 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 N--CA 1.456 -0.708 0 N-CA-C 107.967 -1.59 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 -100.21 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.44 51.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.58 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -51.4 -67.73 0.23 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.99 1.316 . . . . 0.0 111.466 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -65.17 -39.4 92.88 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.328 -0.858 . . . . 0.0 110.965 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.5 t -65.05 -43.13 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 120.202 1.364 . . . . 0.0 110.227 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.83 -45.39 86.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 110.568 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -58.66 -60.44 3.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.925 1.29 . . . . 0.0 110.246 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 p -73.75 -33.27 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.203 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.49 70.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 121.032 1.742 . . . . 0.0 111.373 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -61.2 -13.07 15.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.25 -20.08 1.67 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.2 mtp -138.72 78.25 31.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 127.791 2.437 . . . . 0.0 107.304 168.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -70.9 25.28 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 125.29 3.994 . . . . 0.0 115.053 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -178.02 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.11 -1.618 . . . . 0.0 110.488 -159.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.05 3.85 7.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.142 0.883 . . . . 0.0 111.639 169.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.1 136.92 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 109.329 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -128.54 125.41 38.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 159.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.47 102.42 9.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.393 -2.076 . . . . 0.0 105.393 173.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -92.05 130.66 37.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.79 104.64 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.94 1.696 . . . . 0.0 106.49 -168.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.69 67.22 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -58.8 144.14 45.02 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.581 0.705 . . . . 0.0 109.647 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.37 141.87 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.3 ttm -178.66 -70.01 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 128.394 2.677 . . . . 0.0 104.621 -173.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.27 0.941 . . . . 0.0 111.046 170.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t30 43.57 54.48 11.01 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.7 2.4 . . . . 0.0 112.513 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.5 151.49 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.087 1.858 . . . . 0.0 112.464 -169.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -63.95 -12.54 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -37.49 32.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 119.591 1.087 . . . . 0.0 113.755 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -37.78 12.61 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 165.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.7 mtp -65.78 -11.89 49.63 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.62 -22.83 64.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.623 1.169 . . . . 0.0 113.125 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -66.99 151.12 48.24 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.255 0.934 . . . . 0.0 112.498 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.07 -45.83 42.35 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 126.215 1.864 . . . . 0.0 112.487 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.265 4.2 tt -133.37 83.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.516 1.15 . . . . 0.0 108.263 158.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -33.93 58.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.165 169.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 28.66 -116.67 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.829 2.452 . . . . 0.0 112.215 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -179.07 160.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 130.661 3.585 . . . . 0.0 105.673 164.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.21 119.28 5.37 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 CA-C-N 120.581 1.243 . . . . 0.0 110.124 -14.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m -80.39 98.94 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.208 1.803 . . . . 0.0 108.077 -164.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mm -109.48 151.79 11.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -121.3 141.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.446 ' CD1' ' HE3' ' A' ' 73' ' ' LYS . 36.6 pt -135.98 145.81 30.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.808 0.843 . . . . 0.0 109.857 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.17 -62.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.066 2.146 . . . . 0.0 110.89 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.42 -5.38 0.04 OUTLIER Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.932 2.206 . . . . 0.0 112.556 158.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.69 154.55 18.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.328 2.064 . . . . 0.0 116.177 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.2 m -105.12 131.78 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.3 1.44 . . . . 0.0 109.005 -161.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 21.5 tt0 -178.36 167.06 1.89 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.04 -1.038 . . . . 0.0 109.13 -165.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -162.02 125.72 3.14 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -170.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.61 109.07 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.69 -177.28 17.82 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.843 1.211 . . . . 0.0 110.337 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' H ' ' HD2' ' A' ' 71' ' ' PRO . . . -89.55 -32.79 0.38 Allowed Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.297 161.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 70' ' ' ALA . 86.8 Cg_endo -73.46 -170.98 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.847 1.695 . . . . 0.0 109.255 160.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.1 p -60.67 -176.22 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.755 1.622 . . . . 0.0 111.499 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HZ3' ' HB3' ' A' ' 66' ' ' GLU . 6.4 ttpt -71.96 36.9 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.783 2.033 . . . . 0.0 113.142 -163.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -50.32 -44.81 54.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.492 1.917 . . . . 0.0 110.857 -164.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.67 65.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.779 1.631 . . . . 0.0 113.319 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.51 -26.94 19.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.0 0.52 . . . . 0.0 110.741 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . 0.266 22.4 t -61.81 -40.02 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 125.025 1.33 . . . . 0.0 108.294 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.0 -13.99 14.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.653 1.581 . . . . 0.0 112.542 170.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.39 -44.61 7.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 116.903 -1.522 . . . . 0.0 111.324 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pt -56.0 -29.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.882 1.674 . . . . 0.0 112.599 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -51.93 -64.27 0.87 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.131 165.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -59.74 3.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.058 -174.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 126.398 1.879 . . . . 0.0 109.844 178.67 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.767 0.794 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.2 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.01 116.59 16.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.98 86.96 4.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 21.2 m-85 -73.09 156.56 38.58 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.86 0.838 . . . . 0.0 111.618 -169.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.434 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.09 38.62 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.49 5.68 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.373 171.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.78 -40.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 120.41 1.459 . . . . 0.0 109.495 172.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -57.0 -23.17 44.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.928 0.785 . . . . 0.0 112.056 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.26 150.65 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.325 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -98.76 134.27 41.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.343 1.057 . . . . 0.0 109.032 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.9 149.61 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.14 146.26 42.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.47 96.64 4.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.111 0.965 . . . . 0.0 108.399 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.465 ' C ' ' HG1' ' A' ' 9' ' ' THR . 34.4 t80 -121.99 86.62 2.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.251 1.024 . . . . 0.0 110.385 -169.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 10' ' ' SER . 1.2 m -156.91 -157.51 0.7 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.451 1.9 . . . . 0.0 107.826 174.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.544 ' H ' HG22 ' A' ' 9' ' ' THR . 73.2 m . . . . . 0 CA--C 1.53 0.206 1 C-N-CA 133.345 4.658 . . . . 0.0 107.17 -175.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.459 -0.519 0 CA-C-O 118.92 -0.533 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.37 -92.71 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.186 1.794 . . . . 0.0 112.978 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.57 -29.36 36.92 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 124.933 1.293 . . . . 0.0 111.791 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.19 -43.44 87.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 119.67 1.123 . . . . 0.0 111.094 172.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -71.22 -42.51 68.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.332 0.969 . . . . 0.0 109.277 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 t -64.16 -44.05 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.549 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.64 -34.76 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 119.536 -1.977 . . . . 0.0 110.761 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.94 -51.19 70.34 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.88 0.872 . . . . 0.0 110.327 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.47 -61.72 2.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.527 1.931 . . . . 0.0 110.063 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -59.53 -44.96 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.3 67.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.548 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -58.46 -35.31 71.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.287 -1.34 . . . . 0.0 112.507 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -106.44 -38.13 6.29 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.469 1.94 . . . . 0.0 112.063 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.2 mtm -121.25 77.97 34.24 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 127.651 2.38 . . . . 0.0 107.037 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.92 11.62 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.941 3.761 . . . . 0.0 113.876 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.62 -59.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.611 1.565 . . . . 0.0 108.22 -159.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.93 50.6 0.47 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.16 2.584 . . . . 0.0 113.082 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.95 92.36 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.485 1.114 . . . . 0.0 109.78 -166.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -102.03 72.85 1.35 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.907 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -77.41 111.53 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.39 117.76 23.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -85.16 123.35 30.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 160.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 96.16 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 155.26 15.87 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.89 150.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.243 1.417 . . . . 0.0 112.922 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.482 ' C ' ' H ' ' A' ' 44' ' ' ASN 0.255 15.1 ptt? 54.35 -172.97 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.372 2.269 . . . . 0.0 111.496 -174.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 63.77 -17.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.899 2.08 . . . . 0.0 114.016 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 42' ' ' MET . 3.8 p-10 -68.65 149.75 97.86 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 127.804 2.442 . . . . 0.0 111.066 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.2 174.45 12.81 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.605 2.203 . . . . 0.0 108.859 160.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.69 0.45 4.21 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.089 -1.007 . . . . 0.0 113.449 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -29.82 3.84 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -175.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.5 -53.13 4.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.352 0.524 . . . . 0.0 112.298 171.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.8 mtp -66.73 -7.56 21.85 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -171.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.99 -22.96 58.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.364 1.466 . . . . 0.0 113.372 166.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 21.9 m-85 -64.91 154.66 36.73 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.777 0.831 . . . . 0.0 109.176 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -18.09 75.7 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.626 -0.672 . . . . 0.0 112.517 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.24 73.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 122.566 1.174 . . . . 0.0 108.802 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 93.9 mtp -73.76 24.9 0.07 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.932 0.893 . . . . 0.0 112.227 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.11 -45.74 71.93 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.102 1.361 . . . . 0.0 113.237 -164.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t 67.41 133.52 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.317 1.847 . . . . 0.0 109.137 -164.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -66.1 121.29 3.36 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.95 1.375 . . . . 0.0 111.243 -9.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.2 m -83.48 106.06 14.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.08 159.55 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.64 128.66 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 170.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -123.69 156.12 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 116.663 -1.637 . . . . 0.0 108.85 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 45.27 -67.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.767 2.427 . . . . 0.0 114.761 -167.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.69 -9.57 0.1 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.132 1.825 . . . . 0.0 113.112 160.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.62 125.31 35.6 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.367 2.083 . . . . 0.0 111.94 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 t -72.03 140.25 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.43 1.492 . . . . 0.0 107.617 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.402 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 4.0 tp10 -178.69 166.53 1.72 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.902 2.081 . . . . 0.0 107.905 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -126.17 152.84 45.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.177 1.791 . . . . 0.0 106.996 165.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.0 mm -129.86 79.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.24 -164.49 36.75 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.799 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.3 1.5 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.99 -162.72 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 CA-C-N 123.517 2.292 . . . . 0.0 109.822 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.4 p -78.2 -150.6 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.751 -1.843 . . . . 0.0 107.65 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 3.5 tppt? -79.06 34.37 0.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.076 -2.265 . . . . 0.0 110.848 -174.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.303 29.7 mt-10 -62.08 -25.55 67.77 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -158.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.21 88.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.775 1.17 . . . . 0.0 111.408 170.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -33.98 53.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.862 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.3 t -48.17 -50.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.846 1.659 . . . . 0.0 107.558 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.56 -10.9 13.56 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.24 -47.24 3.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.219 1.407 . . . . 0.0 112.097 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.2 pt -64.12 -33.09 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.414 1.461 . . . . 0.0 111.241 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -57.51 -24.78 57.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.028 1.286 . . . . 0.0 111.621 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.28 0.0 OUTLIER -91.4 -56.31 3.18 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 117.466 -1.254 . . . . 0.0 107.678 -171.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.469 0.483 0 CA-C-N 120.182 1.355 . . . . 0.0 110.401 167.129 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt . . . . . 0 C--O 1.235 0.327 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 t -80.89 154.54 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.34 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -106.51 96.91 5.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -103.1 139.85 38.09 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.23 101.34 5.34 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 123.36 0.664 . . . . 0.0 109.857 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.63 82.51 1.63 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.347 2.259 . . . . 0.0 106.741 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -161.13 -179.37 7.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.926 1.29 . . . . 0.0 107.722 166.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p . . . . . 0 C--O 1.235 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 167.725 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 N--CA 1.448 -1.172 0 CA-C-O 118.948 -0.522 . . . . 0.0 113.154 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.87 -104.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.116 1.766 . . . . 0.0 111.499 -169.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.01 68.31 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.879 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -38.14 -60.07 0.8 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.951 1.25 . . . . 0.0 111.271 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.78 -39.6 61.65 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.566 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -53.44 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.796 1.18 . . . . 0.0 108.089 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.4 t -51.66 -52.53 20.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 128.167 2.587 . . . . 0.0 109.889 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.5 -44.38 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.612 1.097 . . . . 0.0 111.059 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.68 -43.08 99.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.7 1.2 . . . . 0.0 111.062 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.1 m -78.58 -29.42 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.495 -0.753 . . . . 0.0 112.561 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.95 -25.21 60.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.329 1.052 . . . . 0.0 111.766 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.0 -24.43 58.16 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.79 -0.569 . . . . 0.0 110.526 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -89.5 -57.95 2.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.807 1.243 . . . . 0.0 110.088 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.6 mtm -129.63 89.04 47.95 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.495 1.118 . . . . 0.0 110.511 -171.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.76 34.21 0.52 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.375 3.383 . . . . 0.0 113.084 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -178.3 -51.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.984 1.314 . . . . 0.0 110.615 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.24 -24.63 66.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.406 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.12 98.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 164.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -83.69 135.71 34.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.551 1.941 . . . . 0.0 106.837 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 m -135.06 147.12 29.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 118.941 0.791 . . . . 0.0 112.571 -164.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -140.01 117.9 11.75 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.952 1.301 . . . . 0.0 108.043 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -99.84 84.43 2.9 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.68 75.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -60.51 92.05 0.02 OUTLIER 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.932 1.293 . . . . 0.0 109.457 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.255 9.6 p 39.25 -67.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 131.66 3.984 . . . . 0.0 116.346 -167.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.7 ttp -54.99 151.44 8.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.864 1.211 . . . . 0.0 112.931 -158.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 64.93 34.51 8.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.534 1.534 . . . . 0.0 109.52 -158.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.24 103.6 0.51 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.493 1.917 . . . . 0.0 110.771 -165.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -94.19 139.95 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.731 1.62 . . . . 0.0 111.474 -169.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -64.6 -7.01 8.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.608 -1.308 . . . . 0.0 112.392 170.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.93 -41.48 11.58 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.186 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.47 -27.89 17.16 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 172.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.0 mtt -63.25 -4.99 2.87 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.825 -1.172 . . . . 0.0 111.447 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.68 -25.68 67.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.237 1.415 . . . . 0.0 113.11 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.407 ' CE2' HG13 ' A' ' 65' ' ' VAL . 33.2 m-85 -80.74 -154.98 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.076 1.35 . . . . 0.0 110.821 -168.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.29 -170.12 0.71 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 158.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.262 18.6 tt -31.05 -67.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.895 1.678 . . . . 0.0 113.275 -159.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 14.1 mmt 36.99 35.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.263 2.625 . . . . 0.0 114.485 167.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.79 -68.49 0.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 171.13 6.78 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.745 1.618 . . . . 0.0 107.629 158.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.21 128.94 17.4 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 109.685 -0.929 . . . . 0.0 109.685 -20.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 m -106.45 114.3 28.33 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -164.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.3 mm -132.3 124.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -159.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.08 128.06 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 168.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.06 161.49 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.3 m120 45.69 -92.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.708 1.203 . . . . 0.0 111.306 -170.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.21 1.31 3.37 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.25 160.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.08 115.08 27.74 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.599 1.56 . . . . 0.0 111.503 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.407 HG13 ' CE2' ' A' ' 51' ' ' TYR . 8.0 p -57.36 141.09 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.001 1.32 . . . . 0.0 109.843 159.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -178.7 -178.68 0.59 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 106.395 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -139.13 -36.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.77 1.228 . . . . 0.0 112.217 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.274 31.9 mm 49.71 -74.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 127.398 2.279 . . . . 0.0 112.133 -160.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.92 -176.6 25.68 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.732 1.151 . . . . 0.0 114.142 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' H ' ' HD2' ' A' ' 71' ' ' PRO . . . -77.25 -47.44 2.59 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.909 1.284 . . . . 0.0 108.7 158.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD2' ' H ' ' A' ' 70' ' ' ALA . 72.6 Cg_endo -65.76 174.97 4.89 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 CA-C-N 120.756 1.306 . . . . 0.0 108.826 158.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.22 178.5 0.51 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.551 -0.718 . . . . 0.0 112.068 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -68.05 64.84 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.393 1.877 . . . . 0.0 113.776 -159.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.282 -0.886 . . . . 0.0 111.816 -160.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.7 79.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.946 0.794 . . . . 0.0 110.726 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -29.57 62.47 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.88 175.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.13 -46.56 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.818 1.645 . . . . 0.0 109.106 166.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -3.8 3.85 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.967 1.707 . . . . 0.0 112.538 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.46 -45.52 2.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.698 1.599 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 pt -61.65 -23.66 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.998 1.272 . . . . 0.0 110.881 171.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -43.03 74.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.269 0.941 . . . . 0.0 111.857 169.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.272 0.4 OUTLIER -81.97 -53.74 5.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.334 0.515 . . . . 0.0 110.736 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.218 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.767 0.794 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.03 116.53 16.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.94 86.96 4.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 21.3 m-85 -73.04 156.55 38.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.861 0.839 . . . . 0.0 111.631 -169.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.434 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.07 38.6 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.75 -31.47 5.62 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.36 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.75 -40.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.41 1.459 . . . . 0.0 109.518 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -56.99 -23.17 44.12 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.89 0.768 . . . . 0.0 112.056 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 pttt . . . . . 0 C--O 1.234 0.238 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.38 160.33 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.859 1.264 . . . . 0.0 109.56 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 154.84 46.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 167.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.12 149.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 108.636 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -135.12 150.65 50.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.662 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.08 91.56 3.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.889 2.476 . . . . 0.0 106.678 167.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -94.67 82.25 3.93 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.4 p -140.43 169.87 16.86 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.093 -1.004 . . . . 0.0 109.792 -175.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.355 176.625 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 CA--C 1.542 0.883 0 N-CA-C 110.643 -0.56 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 -81.45 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.792 . . . . 0.0 111.617 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -19.43 45.37 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.372 -0.83 . . . . 0.0 112.003 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -65.03 -59.95 3.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.889 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -54.73 -45.39 74.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.18 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.24 -37.27 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 118.271 -1.372 . . . . 0.0 110.061 -174.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.251 3.3 p -67.36 -33.6 63.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 O-C-N 119.565 -1.96 . . . . 0.0 110.843 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.05 -53.84 53.09 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 120.928 1.694 . . . . 0.0 110.185 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.98 -60.69 2.12 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.98 2.512 . . . . 0.0 109.566 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.2 -40.58 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -25.91 64.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.8 -0.619 . . . . 0.0 110.241 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -38.39 -54.85 1.43 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.368 0.667 . . . . 0.0 111.009 165.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.28 -24.68 16.09 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.414 1.085 . . . . 0.0 112.797 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 46.7 mtt -144.74 78.61 12.77 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.271 1.028 . . . . 0.0 109.416 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.13 34.77 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.981 3.12 . . . . 0.0 113.054 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.97 -48.83 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.132 0.973 . . . . 0.0 109.294 -175.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.49 14.7 0.12 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.9 -1.048 . . . . 0.0 113.046 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.3 t -111.84 103.14 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 120.725 1.602 . . . . 0.0 107.488 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -76.76 96.59 4.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.76 153.29 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.547 0.612 . . . . 0.0 110.285 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.15 146.94 39.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.242 0.474 . . . . 0.0 110.409 158.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -107.74 69.92 0.76 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.744 2.418 . . . . 0.0 107.521 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.89 84.86 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 128.03 34.29 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 110.664 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -74.3 120.3 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.7 mmt -177.98 -74.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 -166.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -132.96 92.91 3.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -144.58 133.01 10.88 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.031 -0.985 . . . . 0.0 108.963 -159.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.03 152.01 74.32 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.125 1.883 . . . . 0.0 111.424 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.91 5.8 0.2 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -11.27 8.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 121.169 1.804 . . . . 0.0 115.363 -171.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.534 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -92.85 -33.57 14.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.969 2.622 . . . . 0.0 115.778 159.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtt -69.0 -6.84 30.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -64.09 -25.49 68.12 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.165 0.986 . . . . 0.0 111.664 163.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 16.1 m-85 -84.13 153.44 23.71 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.664 0.786 . . . . 0.0 110.587 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.74 42.49 1.54 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.949 1.261 . . . . 0.0 113.111 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tp -138.87 -52.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.8 1.64 . . . . 0.0 108.243 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 32.2 mtt 58.51 -2.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.421 2.288 . . . . 0.0 115.782 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.29 -161.06 0.2 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.65 1.98 . . . . 0.0 111.796 -175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -155.58 159.36 31.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.388 2.275 . . . . 0.0 106.27 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.94 109.66 1.23 Allowed 'Cis proline' 0 C--N 1.35 0.617 0 CA-C-N 121.069 1.418 . . . . 0.0 110.829 -9.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -93.19 132.86 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.508 ' HB ' ' HE2' ' A' ' 73' ' ' LYS . 20.4 mm -134.91 146.32 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -168.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.63 121.09 66.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.572 HG13 ' HZ3' ' A' ' 73' ' ' LYS . 2.7 pp -109.36 145.24 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 125.155 1.535 . . . . 0.0 108.082 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 57.97 -45.96 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.036 2.135 . . . . 0.0 115.749 -169.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.69 -11.67 0.3 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 130.326 3.822 . . . . 0.0 109.982 -168.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -91.51 124.15 35.46 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.316 2.247 . . . . 0.0 113.173 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.4 HG23 ' CD2' ' A' ' 51' ' ' TYR . 12.3 p -75.18 149.92 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.573 0.749 . . . . 0.0 110.354 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.502 ' CB ' ' HZ1' ' A' ' 73' ' ' LYS . 3.6 tp10 -178.44 171.64 1.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.764 2.026 . . . . 0.0 108.471 173.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.33 139.03 40.58 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.365 1.066 . . . . 0.0 109.473 167.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 mm -121.54 71.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 122.495 1.14 . . . . 0.0 108.315 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.04 -164.26 26.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 122.456 1.031 . . . . 0.0 113.431 160.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.62 6.02 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 116.273 -1.822 . . . . 0.0 115.801 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.13 -111.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 CA-C-N 123.122 2.151 . . . . 0.0 108.769 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.6 p -126.0 -116.99 0.27 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 121.561 1.982 . . . . 0.0 107.794 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.572 ' HZ3' HG13 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -92.11 14.84 14.85 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.075 1.75 . . . . 0.0 113.49 172.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -30.36 -50.49 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.021 2.601 . . . . 0.0 118.021 -163.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.93 -43.62 78.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.464 1.029 . . . . 0.0 111.766 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 -34.11 68.65 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.333 0.653 . . . . 0.0 109.969 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -48.65 -53.87 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.908 1.683 . . . . 0.0 108.37 171.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -67.62 -16.19 64.04 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.745 -0.597 . . . . 0.0 112.293 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.58 -49.19 9.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.311 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -60.44 -35.23 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 120.221 1.373 . . . . 0.0 109.885 174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.15 -19.69 47.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.542 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.255 0.0 OUTLIER -91.15 -67.5 0.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 109.145 159.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 . . . . . 0 N--CA 1.463 0.192 0 C-N-CA 124.384 1.074 . . . . 0.0 108.876 -179.879 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.34 133.23 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -124.47 117.31 24.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.088 0.858 . . . . 0.0 109.559 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.42 150.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 125.963 1.705 . . . . 0.0 107.681 -172.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -140.02 139.05 35.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.21 78.18 1.13 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -80.26 88.38 5.51 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.673 1.225 . . . . 0.0 107.761 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.8 p -141.75 -149.22 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -166.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 128.857 2.863 . . . . 0.0 108.087 -179.365 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo . . . . . 0 CA--C 1.536 0.588 0 N-CA-C 117.791 2.189 . . . . 0.0 117.791 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 44.18 -100.1 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.813 2.045 . . . . 0.0 112.344 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.85 72.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.538 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -61.01 -37.07 81.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.437 1.471 . . . . 0.0 111.413 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -66.53 -51.74 53.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.685 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.35 -32.06 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 118.487 -1.285 . . . . 0.0 110.187 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -63.86 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 117.703 -1.142 . . . . 0.0 108.768 165.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -58.93 -38.5 79.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.81 1.186 . . . . 0.0 111.048 -170.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.75 -53.96 50.97 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 110.155 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.33 -39.35 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.63 68.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.56 1.544 . . . . 0.0 111.814 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.561 ' ND2' ' HZ3' ' A' ' 81' ' ' LYS . 25.4 t-20 -52.77 -39.88 62.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.918 0.887 . . . . 0.0 110.012 169.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -93.49 -46.93 7.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.899 1.28 . . . . 0.0 111.495 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.33 87.35 47.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 126.009 1.724 . . . . 0.0 108.099 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.59 13.0 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.889 2.393 . . . . 0.0 112.877 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -142.57 -55.02 0.42 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -162.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.23 48.46 1.49 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.611 -0.68 . . . . 0.0 110.991 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.36 83.43 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.563 1.145 . . . . 0.0 108.921 -164.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.38 128.88 35.52 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -146.59 97.15 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 125.551 1.54 . . . . 0.0 107.067 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -80.08 144.09 33.43 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 109.837 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.39 115.57 29.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.258 0.2 OUTLIER -129.26 86.45 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -54.86 127.14 27.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 159.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 p -50.85 143.23 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.674 1.59 . . . . 0.0 112.075 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 ttt -142.19 -82.23 0.2 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 173.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.13 -2.82 26.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.478 1.111 . . . . 0.0 112.595 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.1 t30 35.83 57.76 2.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 127.432 2.293 . . . . 0.0 112.398 -168.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.74 137.22 37.99 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.182 1.255 . . . . 0.0 109.841 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -59.87 -20.71 58.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 116.32 -1.8 . . . . 0.0 112.182 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.34 -47.76 0.86 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.045 1.293 . . . . 0.0 112.332 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.1 -33.47 15.45 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 117.233 2.309 . . . . 0.0 117.233 169.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.65 3.21 26.21 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.318 -0.864 . . . . 0.0 112.89 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.27 -143.67 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.929 2.091 . . . . 0.0 109.51 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CE2' HG21 ' A' ' 65' ' ' VAL . 10.0 m-85 68.86 -167.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 0.0 111.192 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 5.74 81.92 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.067 0.842 . . . . 0.0 113.458 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.96 -59.58 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.958 1.303 . . . . 0.0 107.912 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtm 49.7 13.27 0.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.703 1.601 . . . . 0.0 114.818 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.58 106.09 5.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.391 1.476 . . . . 0.0 109.638 -168.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 m -56.69 158.03 9.21 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.022 . . . . 0.0 111.596 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.33 112.71 1.76 Allowed 'Cis proline' 0 C--N 1.354 0.828 0 CA-C-N 121.024 1.401 . . . . 0.0 111.066 -0.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.6 m -86.94 110.67 20.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.232 1.413 . . . . 0.0 107.266 -169.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 mm -115.45 152.05 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.75 132.88 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 164.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.417 HG13 ' HE3' ' A' ' 73' ' ' LYS . 2.5 pp -122.48 153.69 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 161.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 47.35 -69.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.9 2.88 . . . . 0.0 113.259 -171.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.77 4.05 0.24 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.6 2.048 . . . . 0.0 113.78 162.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.95 120.25 31.81 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 126.753 2.021 . . . . 0.0 110.106 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.433 HG21 ' CE2' ' A' ' 51' ' ' TYR . 7.2 p -72.82 133.7 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.799 0.727 . . . . 0.0 109.298 166.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 4.0 tp10 -161.56 163.05 30.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.244 1.817 . . . . 0.0 108.403 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -126.25 153.63 44.48 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 159.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm -141.99 149.0 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.71 -167.13 30.13 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 122.291 0.939 . . . . 0.0 113.312 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.61 -34.18 0.98 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 116.761 -1.59 . . . . 0.0 115.14 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.93 -109.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.282 1.851 . . . . 0.0 110.757 -164.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.3 p -114.72 -146.72 0.41 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 159.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HZ2' ' HB3' ' A' ' 66' ' ' GLU . 4.8 ttpt -79.08 20.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.051 -1.656 . . . . 0.0 111.42 -169.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -61.62 -28.94 69.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -158.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -48.98 -48.52 43.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.41 1.084 . . . . 0.0 112.422 165.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.72 -33.83 40.59 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 117.014 -1.47 . . . . 0.0 109.913 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . 0.291 2.6 m -68.29 -37.92 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 122.724 2.511 . . . . 0.0 110.961 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.56 -19.54 3.95 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.245 2.218 . . . . 0.0 111.257 165.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.97 -46.0 7.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.788 166.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.0 pt -53.73 -28.99 17.13 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-N 122.266 2.303 . . . . 0.0 112.092 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.561 ' HZ3' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -62.0 -79.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.355 164.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -16.23 25.07 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -170.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.359 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.378 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.3 m -147.63 2.4 0.72 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.349 1.86 . . . . 0.0 111.15 -173.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.06 162.62 0.16 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.837 2.455 . . . . 0.0 111.907 -165.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.25 103.28 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.47 123.7 31.21 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.839 0.856 . . . . 0.0 110.221 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.89 141.2 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -134.83 146.96 49.77 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.93 88.38 2.71 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.579 1.551 . . . . 0.0 106.968 -173.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.51 ' C ' ' HG1' ' A' ' 9' ' ' THR . 16.5 t80 -105.92 93.9 4.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.821 1.249 . . . . 0.0 107.869 -175.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.51 ' HG1' ' C ' ' A' ' 8' ' ' PHE . 2.4 m -177.72 156.84 1.16 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.588 2.355 . . . . 0.0 105.587 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t -128.28 85.79 59.58 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 160.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.54 137.87 40.44 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.073 1.849 . . . . 0.0 107.493 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -134.62 -31.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.506 -163.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.0 m -77.25 -79.36 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 116.933 -1.508 . . . . 0.0 108.524 167.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.42 111.23 3.26 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 123.315 2.22 . . . . 0.0 109.283 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -72.82 72.43 1.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.478 -0.764 . . . . 0.0 109.529 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.4 m -62.97 153.06 81.99 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 124.651 1.181 . . . . 0.0 109.151 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.54 -21.54 72.96 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.039 2.493 . . . . 0.0 112.258 169.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 46.88 -118.46 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.386 1.475 . . . . 0.0 110.159 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.54 65.09 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.648 -1.168 . . . . 0.0 111.981 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -62.29 -44.08 97.34 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.934 1.243 . . . . 0.0 110.431 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -66.07 -52.26 50.51 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.471 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.55 -41.53 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 117.827 -1.082 . . . . 0.0 109.452 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 p -62.5 -51.02 77.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.431 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -41.8 94.67 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.664 1.575 . . . . 0.0 110.08 -175.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.11 -50.6 71.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.776 1.23 . . . . 0.0 110.037 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.1 m -77.17 -29.66 17.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.85 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.13 64.36 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 120.292 1.405 . . . . 0.0 110.622 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.83 -44.29 90.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.855 0.752 . . . . 0.0 110.506 168.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.95 -55.01 9.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.734 2.014 . . . . 0.0 110.343 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.7 mmt -134.22 85.29 39.4 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 127.414 2.285 . . . . 0.0 109.265 -167.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.01 39.02 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.644 3.562 . . . . 0.0 111.747 -172.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -178.19 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.023 0.929 . . . . 0.0 110.709 -171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.7 48.02 0.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.746 0.703 . . . . 0.0 110.963 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.35 134.41 64.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -128.44 131.73 48.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.52 110.73 20.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.728 0.811 . . . . 0.0 109.225 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.33 102.38 15.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.56 96.56 10.13 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -112.35 85.12 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.05 116.44 2.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.13 99.86 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.824 0.821 . . . . 0.0 110.868 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.5 156.6 0.94 Allowed 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 134.129 4.972 . . . . 0.0 103.782 -178.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 36.69 54.56 1.13 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.914 2.086 . . . . 0.0 114.186 163.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.35 154.73 0.92 Allowed Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 127.469 2.308 . . . . 0.0 109.384 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.04 160.4 33.45 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 -170.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -78.96 25.72 0.27 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.01 1.324 . . . . 0.0 111.339 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -25.09 63.01 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.71 -36.56 13.52 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 167.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmm -73.2 -6.45 45.92 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.218 1.007 . . . . 0.0 113.151 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.29 -119.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.565 0.746 . . . . 0.0 109.023 158.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.8 m-30 60.59 -171.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.728 1.611 . . . . 0.0 110.309 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.71 -14.3 80.01 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.173 171.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.49 -49.97 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 109.16 -170.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.9 mtm 41.29 46.93 2.88 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.678 2.391 . . . . 0.0 111.365 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 106.89 1.64 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.515 1.126 . . . . 0.0 109.075 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.7 158.26 23.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.548 0.739 . . . . 0.0 111.804 168.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.33 118.49 5.15 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.245 0.766 . . . . 0.0 110.59 -6.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -86.63 116.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 107.4 -170.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.8 mm -134.11 140.85 45.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 121.031 -1.043 . . . . 0.0 108.592 -168.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.51 129.79 69.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.404 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -124.61 146.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 45.77 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 129.857 3.263 . . . . 0.0 116.877 -159.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 169.76 -10.29 0.05 OUTLIER Glycine 0 CA--C 1.542 1.72 1 C-N-CA 131.252 4.263 . . . . 0.0 110.906 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -91.07 132.68 35.88 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 120.218 2.009 . . . . 0.0 111.247 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.03 127.11 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.613 1.965 . . . . 0.0 108.727 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -161.22 -179.69 7.65 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 -171.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.75 129.32 6.05 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -140.17 92.82 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 118.541 0.61 . . . . 0.0 109.643 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.21 -177.4 17.26 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.541 1.067 . . . . 0.0 112.171 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.98 -50.06 33.73 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.976 -1.011 . . . . 0.0 111.104 161.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -68.38 178.52 3.66 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.171 1.454 . . . . 0.0 110.673 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 p -58.14 -173.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.878 2.471 . . . . 0.0 111.322 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 3.7 ttpt -70.41 39.65 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.281 1.832 . . . . 0.0 113.957 -163.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.81 -38.49 78.74 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.925 1.69 . . . . 0.0 111.697 -168.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.26 68.67 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.292 1.037 . . . . 0.0 113.085 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -26.6 26.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.532 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.1 -36.26 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 120.582 -1.324 . . . . 0.0 109.781 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -60.75 -6.57 1.8 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.235 2.614 . . . . 0.0 113.624 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.4 -36.13 2.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.537 1.535 . . . . 0.0 112.469 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pt -61.43 -30.99 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.568 1.531 . . . . 0.0 109.13 165.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -64.88 -22.15 66.94 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.699 1.136 . . . . 0.0 113.897 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -46.96 7.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.928 0.891 . . . . 0.0 110.244 -168.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.53 81.43 0.02 OUTLIER 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.184 2.194 . . . . 0.0 105.786 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.25 1.127 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.5 178.541 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 42.9 mtt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.5 m -70.2 81.39 0.52 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.797 1.239 . . . . 0.0 112.333 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 164.43 36.4 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.937 1.695 . . . . 0.0 106.427 158.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.84 105.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 108.637 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -89.96 113.94 25.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.27 140.47 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.08 138.71 40.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.43 90.68 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.066 1.346 . . . . 0.0 107.75 -174.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.473 ' C ' ' HG1' ' A' ' 9' ' ' THR . 42.8 t80 -105.81 76.41 1.18 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.54 1.638 . . . . 0.0 107.004 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 8' ' ' PHE . 90.2 m -147.39 164.79 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.39 85.09 60.1 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.11 113.96 2.62 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.317 2.011 . . . . 0.0 108.156 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -122.57 -57.73 1.72 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.0 t -56.14 -57.9 19.67 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 116.971 -1.49 . . . . 0.0 110.798 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.68 -13.49 11.87 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.978 1.785 . . . . 0.0 112.625 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 46.98 15.51 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 129.254 3.022 . . . . 0.0 116.873 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.8 m -65.18 156.77 80.03 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -167.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.86 62.48 4.81 Favored 'Trans proline' 0 CA--C 1.538 0.696 1 C-N-CA 125.888 4.392 . . . . 0.0 111.84 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.35 -74.84 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.909 1.684 . . . . 0.0 112.715 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -23.1 67.29 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.513 -0.742 . . . . 0.0 112.389 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -54.18 11.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -65.88 -34.97 79.36 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.612 -1.185 . . . . 0.0 111.054 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.49 -50.27 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.938 1.245 . . . . 0.0 109.512 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.34 -33.29 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 120.869 1.668 . . . . 0.0 112.341 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.54 -47.05 80.22 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.217 1.007 . . . . 0.0 109.385 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -57.99 -49.66 76.08 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.875 1.67 . . . . 0.0 110.192 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.0 m -79.88 -25.24 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.23 -25.41 67.67 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 120.631 1.559 . . . . 0.0 110.129 174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.28 -13.83 9.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.51 -57.53 1.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.331 1.852 . . . . 0.0 110.055 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.1 mtt -118.87 90.34 40.49 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 108.089 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.9 13.28 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.532 2.821 . . . . 0.0 115.32 -166.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -177.78 -26.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.89 1.677 . . . . 0.0 112.742 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.75 -9.1 17.74 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.28 1.855 . . . . 0.0 111.809 161.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.86 137.71 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.829 1.252 . . . . 0.0 110.942 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -136.68 98.63 3.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.41 99.43 8.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -78.64 117.89 20.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 118.77 30.1 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 84.62 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -60.41 119.52 8.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.221 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.62 110.52 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.5 mtm -140.84 -56.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.03 -16.04 60.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.309 1.444 . . . . 0.0 111.082 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.0 t30 35.98 58.71 3.1 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 127.888 2.475 . . . . 0.0 113.06 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.31 145.49 59.92 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.641 2.894 . . . . 0.0 112.737 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.45 -18.41 18.21 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.717 0.807 . . . . 0.0 112.771 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -39.4 63.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 112.857 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.58 -40.62 11.23 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.201 0.909 . . . . 0.0 112.423 163.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.5 mmm -64.38 -5.87 6.06 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -64.51 -24.04 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.5 1.52 . . . . 0.0 112.133 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -62.34 161.0 12.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.756 1.222 . . . . 0.0 111.563 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.68 -39.81 93.81 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.255 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 55' ' ' ALA . 4.7 tp -52.34 -58.14 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.088 0.944 . . . . 0.0 111.195 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.0 mtt 55.15 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.198 2.599 . . . . 0.0 116.496 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -73.13 -171.05 0.84 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.73 2.012 . . . . 0.0 111.966 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.74 136.98 19.11 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.9 159.33 72.61 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 C-N-CA 125.117 -0.785 . . . . 0.0 111.099 -8.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -122.08 128.9 51.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.14 162.83 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.84 136.85 55.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 165.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.453 ' CG1' ' HZ2' ' A' ' 73' ' ' LYS . 1.8 pp -127.17 146.82 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.822 1.192 . . . . 0.0 108.387 169.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.3 t30 51.61 -36.9 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 130.103 3.361 . . . . 0.0 117.267 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.34 -8.58 0.04 OUTLIER Glycine 0 CA--C 1.541 1.71 1 C-N-CA 131.158 4.218 . . . . 0.0 110.928 167.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -91.76 120.36 32.42 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 126.358 1.863 . . . . 0.0 112.465 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.03 143.36 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.945 1.298 . . . . 0.0 107.885 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -178.29 166.59 1.9 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.486 1.514 . . . . 0.0 109.743 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.91 148.92 44.22 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.682 1.193 . . . . 0.0 109.074 165.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.02 137.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -177.93 51.82 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.371 0.532 . . . . 0.0 113.743 168.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.01 -45.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.143 1.377 . . . . 0.0 112.616 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.09 -172.48 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.327 1.51 . . . . 0.0 109.59 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 p -65.33 -163.17 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.515 -0.741 . . . . 0.0 110.926 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HZ2' ' CG1' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -70.79 27.82 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -158.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -29.3 -53.3 0.12 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.157 3.783 . . . . 0.0 113.654 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.75 -54.6 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.302 1.041 . . . . 0.0 111.503 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -27.33 62.4 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.609 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -42.84 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 120.138 1.336 . . . . 0.0 109.327 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.91 -12.9 41.19 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.691 -0.63 . . . . 0.0 111.971 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.43 -39.0 8.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.201 1.401 . . . . 0.0 111.689 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -56.45 -41.28 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 121.395 1.907 . . . . 0.0 110.015 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -19.96 61.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -30.17 30.79 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.753 1.615 . . . . 0.0 109.406 173.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 -55.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.388 1.475 . . . . 0.0 111.807 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.25 -1.357 . . . . 0.0 110.16 -163.821 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.138 0.494 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 m -156.91 62.48 0.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 126.126 1.771 . . . . 0.0 106.656 162.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -71.2 99.63 1.93 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.784 0.834 . . . . 0.0 109.004 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.2 t -87.21 149.69 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -128.8 115.74 18.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.95 144.02 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 163.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -142.08 157.25 45.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.33 88.29 2.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.403 1.481 . . . . 0.0 109.016 -167.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -109.51 105.72 15.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -178.93 169.02 1.61 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 109.84 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p -129.69 77.24 77.35 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 127.253 2.221 . . . . 0.0 107.375 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.04 69.63 6.96 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.881 2.387 . . . . 0.0 111.661 -170.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.2 ttt -55.48 -42.08 73.86 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.794 1.237 . . . . 0.0 112.092 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.8 m -80.22 -71.7 0.14 Allowed Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 117.289 -1.338 . . . . 0.0 111.041 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.89 -26.67 15.29 Favored 'Trans proline' 0 C--N 1.351 0.7 0 CA-C-N 122.241 1.836 . . . . 0.0 113.364 -170.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 57.82 -61.37 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.214 2.205 . . . . 0.0 113.312 -163.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.2 m 58.73 168.69 0.07 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.176 1.79 . . . . 0.0 110.341 -159.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.12 -14.29 42.79 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.267 1.978 . . . . 0.0 112.345 161.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.37 -125.41 0.55 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.936 2.095 . . . . 0.0 110.87 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.17 -32.13 6.61 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.306 -1.33 . . . . 0.0 113.449 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -56.38 -47.33 79.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.087 2.221 . . . . 0.0 111.332 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.9 -36.09 37.01 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 116.178 -1.868 . . . . 0.0 112.426 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.35 -31.74 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 CA-C-N 120.088 1.313 . . . . 0.0 108.455 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.78 -55.9 20.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 119.668 -1.895 . . . . 0.0 110.538 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -54.9 -42.36 72.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.297 1.408 . . . . 0.0 110.966 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.09 -71.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.696 2.399 . . . . 0.0 109.679 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -21.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 118.386 -1.325 . . . . 0.0 113.338 -175.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.27 68.67 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -58.36 -28.41 65.1 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.445 1.02 . . . . 0.0 112.54 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -83.12 -64.45 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 108.967 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.1 mmt -131.05 85.73 53.82 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 124.743 1.217 . . . . 0.0 110.396 -166.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 69.44 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.3 2.666 . . . . 0.0 107.837 163.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -179.14 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.033 2.533 . . . . 0.0 106.941 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.16 4.27 46.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -160.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.91 114.98 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.585 -168.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -77.43 152.45 34.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.52 57.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.485 1.914 . . . . 0.0 108.024 -169.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -64.92 136.6 57.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -172.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -115.66 102.77 10.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 77.85 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.458 1.123 . . . . 0.0 108.928 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.18 147.24 48.35 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.486 -0.759 . . . . 0.0 112.479 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.15 93.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 ttp -153.01 -62.98 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.18 1.792 . . . . 0.0 107.331 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -145.19 11.18 1.33 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.664 0.786 . . . . 0.0 111.371 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -76.42 148.79 80.83 Favored Pre-proline 0 C--O 1.238 0.49 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.89 139.84 63.97 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.137 2.558 . . . . 0.0 110.337 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -69.25 19.26 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.977 1.711 . . . . 0.0 113.45 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -34.2 45.29 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.147 1.379 . . . . 0.0 114.594 -169.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.07 18.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -26.07 65.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.504 1.522 . . . . 0.0 112.578 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.32 -17.52 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.624 1.102 . . . . 0.0 113.565 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -66.87 145.36 55.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.739 1.616 . . . . 0.0 109.535 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.35 -29.77 31.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tp -54.11 -44.59 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.17 1.485 . . . . 0.0 111.221 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 45.6 mtm 41.61 32.74 0.26 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.677 2.391 . . . . 0.0 114.206 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.07 -178.26 3.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.736 1.615 . . . . 0.0 110.352 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.29 160.08 61.21 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.384 1.474 . . . . 0.0 109.96 -161.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.59 126.2 9.19 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 CA-C-N 119.406 0.823 . . . . 0.0 110.325 -12.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 m -78.01 80.99 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.634 1.974 . . . . 0.0 106.706 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.12 154.92 3.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.8 128.4 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.432 ' CG2' ' HE3' ' A' ' 73' ' ' LYS . 44.0 pt -128.13 143.01 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.225 1.01 . . . . 0.0 110.745 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.259 34.5 t30 47.23 -50.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.035 2.934 . . . . 0.0 115.982 -163.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.69 -14.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.562 1.553 . . . . 0.0 112.233 159.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.82 152.75 19.97 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 120.514 2.157 . . . . 0.0 112.483 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.43 161.35 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.053 0.541 . . . . 0.0 109.678 173.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -178.62 165.51 1.69 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.382 2.273 . . . . 0.0 108.135 160.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.96 154.48 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 166.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.0 mm -130.16 78.82 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.79 -163.71 35.23 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.73 7.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 116.642 -1.647 . . . . 0.0 115.208 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.14 177.67 7.93 Favored 'Trans proline' 0 C--N 1.355 0.87 0 CA-C-N 122.776 2.027 . . . . 0.0 109.946 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -60.93 -173.2 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.41 1.084 . . . . 0.0 109.654 160.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HE3' ' CG2' ' A' ' 61' ' ' ILE . 4.0 tppt? -74.81 19.85 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 119.657 -1.902 . . . . 0.0 113.996 -159.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -29.35 -49.57 0.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 130.55 3.54 . . . . 0.0 116.534 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.79 72.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.653 1.115 . . . . 0.0 110.907 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.04 -28.25 61.32 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.254 -1.355 . . . . 0.0 111.273 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.87 -53.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.899 1.227 . . . . 0.0 108.297 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -63.33 -28.57 70.1 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.889 -0.507 . . . . 0.0 111.745 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.17 -67.07 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.792 -0.568 . . . . 0.0 110.045 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -60.32 -25.99 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.585 1.084 . . . . 0.0 112.772 -167.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.6 -31.5 71.58 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.038 1.29 . . . . 0.0 113.949 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.68 47.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.343 1.429 . . . . 0.0 109.408 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 171.25 133.41 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 129.717 3.207 . . . . 0.0 103.402 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.246 0.889 0 C-N-CA 127.214 2.206 . . . . 0.0 111.36 163.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.0 mtt . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 117.201 -1.38 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.1 m -143.28 -29.7 0.52 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -161.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp 36.54 50.28 0.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.197 1.799 . . . . 0.0 112.769 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p -132.33 153.84 81.38 Favored Pre-proline 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.92 94.11 1.01 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.647 2.232 . . . . 0.0 107.251 172.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 mtt -61.04 -31.37 71.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.87 -0.585 . . . . 0.0 111.225 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.6 m 132.89 -60.03 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 1 C-N-CA 132.323 4.249 . . . . 0.0 109.112 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.77 -73.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.818 1.679 . . . . 0.0 109.969 171.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -67.34 129.53 40.21 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 90.4 m -146.61 -49.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.488 1.515 . . . . 0.0 113.607 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.465 ' HD2' ' H ' ' A' ' 16' ' ' CYS . 10.4 Cg_endo -61.72 -18.84 62.66 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 122.027 1.76 . . . . 0.0 116.502 -166.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 -39.51 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.574 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.0 mtt . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 117.201 -1.38 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.1 m -143.28 -29.7 0.52 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -161.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp 36.54 50.28 0.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.197 1.799 . . . . 0.0 112.769 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p -132.33 153.84 81.38 Favored Pre-proline 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.92 94.11 1.01 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.647 2.232 . . . . 0.0 107.251 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 mtt -61.04 -31.37 71.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.87 -0.585 . . . . 0.0 111.225 -174.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.6 m 132.89 -60.03 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 1 C-N-CA 132.323 4.249 . . . . 0.0 109.112 -173.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.77 -73.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.818 1.679 . . . . 0.0 109.969 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -67.34 129.53 40.21 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 90.4 m -146.61 -49.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.488 1.515 . . . . 0.0 113.607 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.465 ' HD2' ' H ' ' A' ' 16' ' ' CYS . 10.4 Cg_endo -61.72 -18.84 62.66 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 122.027 1.76 . . . . 0.0 116.502 -166.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 -39.51 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.574 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.6 m 74.47 93.07 0.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.171 1.788 . . . . 0.0 107.72 -169.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -118.64 110.87 17.83 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.51 112.79 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 130.59 36.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 159.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mt -123.68 145.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 158.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -136.69 152.18 50.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mp -126.95 79.84 1.91 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -76.82 85.08 3.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.4 p -136.5 166.2 24.07 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.537 -1.352 . . . . 0.0 109.745 -164.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 t -165.09 -42.46 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 O-C-N 120.064 -1.648 . . . . 0.0 110.339 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.79 90.83 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 121.285 1.495 . . . . 0.0 109.814 163.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.54 176.73 8.18 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.609 2.764 . . . . 0.0 107.945 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.261 90.7 m 110.4 -63.56 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 131.162 3.785 . . . . 0.0 109.267 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.19 40.14 0.5 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.855 2.37 . . . . 0.0 111.474 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -139.68 82.14 1.86 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.365 2.666 . . . . 0.0 104.731 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.6 m -66.79 -52.41 33.41 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 118.339 -0.839 . . . . 0.0 109.451 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.92 157.63 61.1 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 120.757 1.306 . . . . 0.0 109.003 160.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.83 -143.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 130.381 3.472 . . . . 0.0 103.223 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.22 -42.86 4.47 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.977 1.311 . . . . 0.0 112.895 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -49.83 72.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.949 0.795 . . . . 0.0 112.283 176.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -58.81 -60.6 3.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.32 -41.01 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 O-C-N 125.259 1.599 . . . . 0.0 108.936 -167.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.451 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -44.34 92.03 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 121.253 1.842 . . . . 0.0 110.146 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.91 -35.64 78.97 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.294 3.038 . . . . 0.0 111.849 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 m -105.72 -20.57 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -23.74 67.49 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 120.543 1.519 . . . . 0.0 110.173 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -47.95 -44.5 30.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.986 0.515 . . . . 0.0 112.03 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.06 -41.38 14.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.216 1.006 . . . . 0.0 111.304 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.5 mtm -139.19 75.39 34.29 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 110.457 -164.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.67 43.86 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.416 3.41 . . . . 0.0 113.441 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -178.27 -53.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.241 2.217 . . . . 0.0 108.897 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.05 67.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.072 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.35 154.79 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 158.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.16 110.89 15.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.53 104.75 17.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -80.87 106.88 13.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.88 88.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.28 123.27 19.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.704 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.18 113.34 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 125.7 1.6 . . . . 0.0 107.811 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 ttt -160.41 -113.14 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -68.75 -21.79 64.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.73 1.605 . . . . 0.0 111.129 166.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -52.48 111.46 2.58 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 125.379 1.472 . . . . 0.0 109.998 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 158.82 55.2 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 112.201 -163.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -64.62 19.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.216 2.206 . . . . 0.0 114.842 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -20.27 33.77 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.044 -1.66 . . . . 0.0 113.941 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.75 -35.4 14.16 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 121.122 -0.986 . . . . 0.0 112.155 166.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -8.67 55.18 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.846 -1.159 . . . . 0.0 112.441 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -61.4 -26.87 68.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.98 0.912 . . . . 0.0 111.219 167.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -70.46 132.18 45.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.363 0.665 . . . . 0.0 109.958 -176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.83 0.29 1.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 117.004 1.562 . . . . 0.0 117.004 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 55' ' ' ALA . 4.5 tp -64.54 -50.22 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.026 1.913 . . . . 0.0 109.258 161.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.8 mtt 51.25 -8.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 130.938 3.695 . . . . 0.0 117.164 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -69.84 -172.15 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 110.447 163.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -178.05 144.66 0.51 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.863 1.665 . . . . 0.0 106.942 -158.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.17 108.24 0.26 Allowed 'Cis proline' 0 C--N 1.355 0.902 0 CA-C-N 122.157 1.806 . . . . 0.0 114.844 6.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.7 m -79.67 113.43 17.82 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.734 1.614 . . . . 0.0 107.395 -168.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mm -117.77 114.46 45.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.7 t -83.53 134.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 164.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.432 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 1.9 pp -132.0 158.25 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.052 161.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.0 -77.52 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.441 1.497 . . . . 0.0 112.335 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.28 20.67 0.07 OUTLIER Glycine 0 CA--C 1.542 1.774 1 C-N-CA 131.245 4.26 . . . . 0.0 109.512 170.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.91 151.92 20.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 131.691 3.997 . . . . 0.0 107.386 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.03 110.55 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 108.606 -164.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.93 -177.7 6.06 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.883 . . . . 0.0 111.925 -159.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.32 115.44 2.57 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.963 0.905 . . . . 0.0 108.604 158.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.98 74.36 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.24 -160.27 42.07 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.904 1.28 . . . . 0.0 113.756 159.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.33 1.38 Allowed Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 115.594 -2.146 . . . . 0.0 116.581 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.63 -127.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 124.115 2.505 . . . . 0.0 109.707 170.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -115.84 -114.54 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 121.133 1.788 . . . . 0.0 107.64 167.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -91.07 5.23 49.72 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.802 1.637 . . . . 0.0 111.404 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.502 22.2 mt-10 -37.8 -49.07 1.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -158.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.98 78.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 123.337 2.789 . . . . 0.0 113.018 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.424 ' CD1' ' HZ1' ' A' ' 73' ' ' LYS . 3.0 tm? -86.55 -22.88 26.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.454 1.102 . . . . 0.0 109.316 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -34.08 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.286 -1.509 . . . . 0.0 110.266 172.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -57.11 -22.75 42.11 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.653 -0.654 . . . . 0.0 111.551 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.1 -48.34 8.15 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.93 1.292 . . . . 0.0 110.47 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -56.91 -35.34 46.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 119.869 1.213 . . . . 0.0 111.523 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -67.07 -32.83 74.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.312 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -50.07 10.86 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 118.969 0.804 . . . . 0.0 108.85 170.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -160.98 -71.4 0.06 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.015 0.926 . . . . 0.0 110.734 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 C--O 1.249 1.039 0 C-N-CA 126.727 2.011 . . . . 0.0 106.668 -158.002 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 50.8 mtp . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.6 t -167.11 87.31 0.29 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 165.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -144.34 122.33 12.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.64 113.31 33.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.73 138.41 37.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.87 137.4 50.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -137.01 147.13 46.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tp -137.64 80.45 1.81 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -173.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -91.43 96.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.471 1.108 . . . . 0.0 108.081 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 t -178.62 174.35 1.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.995 2.118 . . . . 0.0 106.908 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m -138.89 62.95 29.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.968 1.307 . . . . 0.0 107.614 169.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.11 85.56 1.81 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.044 2.496 . . . . 0.0 108.642 -169.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.5 mpp? 55.72 41.28 30.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.551 0.74 . . . . 0.0 110.305 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 25.0 m -44.24 -53.55 13.71 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.74 38.98 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 122.917 2.412 . . . . 0.0 112.579 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.23 -48.81 0.13 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.498 2.719 . . . . 0.0 106.492 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.9 m -119.95 105.35 42.89 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.085 1.754 . . . . 0.0 107.813 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -77.86 75.7 4.67 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.848 2.365 . . . . 0.0 111.022 -176.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.02 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.243 2.217 . . . . 0.0 112.645 -167.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.4 73.27 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-O 116.293 -1.813 . . . . 0.0 110.807 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -52.57 -50.67 62.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.272 1.851 . . . . 0.0 109.93 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -59.12 -57.67 12.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 117.304 -1.331 . . . . 0.0 111.503 171.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.54 -36.28 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 119.556 1.071 . . . . 0.0 110.852 -169.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.18 -30.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 O-C-N 120.3 -1.5 . . . . 0.0 111.966 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.49 -44.62 95.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.989 1.268 . . . . 0.0 108.712 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.77 -56.08 26.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.288 2.235 . . . . 0.0 109.839 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 m -72.44 -28.85 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 117.684 -1.151 . . . . 0.0 112.969 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.56 -24.58 67.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.99 1.723 . . . . 0.0 111.209 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 -16.77 29.05 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -31.69 1.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.385 1.074 . . . . 0.0 111.987 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 mmt -128.86 67.91 78.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 127.171 2.189 . . . . 0.0 108.365 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.52 32.69 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 126.085 4.523 . . . . 0.0 114.248 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -178.15 -57.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.03 -1.669 . . . . 0.0 109.184 -159.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.93 14.12 0.32 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.158 1.383 . . . . 0.0 113.925 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 p -90.64 91.37 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.696 1.998 . . . . 0.0 110.019 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 81.99 3.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.16 0.984 . . . . 0.0 108.711 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 m -95.52 139.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 127.063 2.145 . . . . 0.0 110.828 -172.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -129.12 106.45 8.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -80.64 120.86 25.11 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.407 HG21 ' HZ2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -130.16 91.9 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 122.794 1.283 . . . . 0.0 109.908 173.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -50.46 113.23 0.83 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.783 2.033 . . . . 0.0 110.751 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.69 110.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 163.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.5 mtp -178.97 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 129.075 2.95 . . . . 0.0 104.052 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -155.26 98.74 2.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 102.322 -3.214 . . . . 0.0 102.322 -163.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.99 155.98 31.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 121.416 -0.802 . . . . 0.0 111.59 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.67 164.15 16.68 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.845 2.364 . . . . 0.0 112.966 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -73.33 -7.29 50.98 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.977 1.311 . . . . 0.0 112.789 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HZ2' HG21 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -44.56 -37.05 3.31 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -172.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.55 -28.62 17.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.136 0.88 . . . . 0.0 113.073 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.93 -9.61 46.52 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.502 -0.749 . . . . 0.0 111.406 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.0 -25.9 67.29 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.633 1.106 . . . . 0.0 111.04 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CD2' HG21 ' A' ' 65' ' ' VAL . 23.0 m-85 -72.3 159.25 34.36 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.098 0.951 . . . . 0.0 111.913 -163.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 131.05 47.06 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.263 0.8 OUTLIER 60.33 -23.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.07 3.348 . . . . 0.0 115.885 -177.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.8 -62.1 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.439 2.696 . . . . 0.0 111.785 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.76 -68.84 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 131.079 3.752 . . . . 0.0 112.865 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.9 t 77.85 125.03 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 128.326 2.651 . . . . 0.0 108.281 -165.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.54 165.12 76.84 Favored 'Cis proline' 0 N--CA 1.454 -0.814 0 CA-C-N 119.702 0.929 . . . . 0.0 111.878 0.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.3 m -145.38 102.16 3.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 -164.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.8 133.37 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -166.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.9 t -100.0 132.11 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.484 ' CG1' ' HZ1' ' A' ' 73' ' ' LYS . 2.3 pp -120.96 142.65 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 161.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 52.63 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.702 3.201 . . . . 0.0 116.617 -169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.52 -11.51 0.74 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 129.65 3.5 . . . . 0.0 111.001 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -92.14 111.9 23.63 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.006 2.122 . . . . 0.0 111.785 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.5 p -68.37 130.96 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.316 1.046 . . . . 0.0 109.187 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.463 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -161.27 -176.09 5.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.352 1.861 . . . . 0.0 106.574 179.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -168.31 130.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.526 1.966 . . . . 0.0 109.396 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.278 1.4 mt -121.45 75.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-O 122.023 0.916 . . . . 0.0 109.824 -173.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.72 -165.96 16.67 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.327 168.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.59 11.22 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 116.968 -1.491 . . . . 0.0 114.03 167.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.25 176.54 9.04 Favored 'Trans proline' 0 C--N 1.354 0.84 0 CA-C-N 122.385 1.888 . . . . 0.0 109.932 170.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -177.47 0.42 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.873 0.869 . . . . 0.0 110.789 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HZ1' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -74.49 30.44 0.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.478 -1.389 . . . . 0.0 112.62 -161.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.314 4.0 mt-10 -64.63 -20.55 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.152 -1.593 . . . . 0.0 114.505 -161.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.2 -48.75 74.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.816 -1.178 . . . . 0.0 112.277 167.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -24.51 56.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.235 -0.916 . . . . 0.0 110.808 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -38.2 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.722 -1.236 . . . . 0.0 108.924 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.505 ' CD ' ' HZ3' ' A' ' 81' ' ' LYS . 26.4 mm-40 -54.23 -25.84 25.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.775 1.171 . . . . 0.0 111.312 170.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.28 -57.12 4.24 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.173 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . 0.257 2.6 pt -55.7 -35.35 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.733 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HZ3' ' CD ' ' A' ' 78' ' ' GLU . 1.4 ptmt -85.24 -17.22 37.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.509 -1.71 . . . . 0.0 115.453 172.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -32.41 73.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 122.814 2.552 . . . . 0.0 109.582 165.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 147.96 107.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.481 2.312 . . . . 0.0 108.175 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.252 1.216 0 C-N-CA 128.898 2.879 . . . . 0.0 113.654 173.396 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.5 mtp . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m -150.27 121.53 7.83 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 121.259 1.845 . . . . 0.0 110.279 169.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HB2' ' HZ1' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -159.88 108.54 1.75 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.523 1.529 . . . . 0.0 107.097 159.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -75.48 111.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.38 61.8 6.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.494 1.118 . . . . 0.0 110.877 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.05 136.23 27.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.18 141.33 42.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.32 85.01 2.24 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -159.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.91 84.22 1.89 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 0.0 109.059 -165.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -138.79 -179.43 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 -167.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -149.86 71.59 9.57 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 120.974 1.715 . . . . 0.0 110.003 169.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.05 135.95 28.51 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.904 1.736 . . . . 0.0 109.047 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 31.4 ttm -127.99 -23.63 3.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.77 0.828 . . . . 0.0 112.465 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.0 m -112.12 -45.53 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 117.431 -1.271 . . . . 0.0 112.53 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -86.16 69.8 4.61 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.446 2.097 . . . . 0.0 109.45 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -65.46 86.73 0.07 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.262 1.025 . . . . 0.0 108.432 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.1 m -111.44 162.21 21.98 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 125.989 1.716 . . . . 0.0 109.428 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -61.63 105.86 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 106.529 -2.143 . . . . 0.0 106.529 158.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 -86.27 0.2 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.98 -40.96 59.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.91 170.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -52.23 -44.98 65.12 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -68.38 -43.54 77.13 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 120.074 1.306 . . . . 0.0 110.059 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 t -67.89 -32.38 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.43 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.5 t -53.13 -62.43 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.742 1.617 . . . . 0.0 107.815 164.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -64.25 -35.62 81.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.263 0.483 . . . . 0.0 111.358 -169.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -62.49 -53.0 61.28 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.334 1.053 . . . . 0.0 110.118 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -67.14 -36.16 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -25.28 68.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.816 1.189 . . . . 0.0 112.272 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -52.16 -37.85 55.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 168.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -105.15 -55.09 2.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.556 1.542 . . . . 0.0 109.348 -165.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.6 79.48 12.54 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 127.703 2.401 . . . . 0.0 108.588 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.63 26.68 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.422 3.415 . . . . 0.0 112.777 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.14 -57.11 0.2 Allowed 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.622 -1.299 . . . . 0.0 110.751 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.03 -1.98 4.83 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -80.97 87.76 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.439 2.295 . . . . 0.0 111.495 -165.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -92.85 125.68 37.58 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 t -136.18 105.35 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.439 1.018 . . . . 0.0 110.876 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -88.64 119.28 28.96 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -88.09 122.35 31.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 98.86 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 171.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -69.14 149.25 48.85 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 116.943 -1.903 . . . . 0.0 109.021 166.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.35 123.38 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.46 -94.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.535 1.534 . . . . 0.0 107.722 -163.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.4 -36.34 83.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.823 1.647 . . . . 0.0 110.526 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 53.91 78.88 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.44 1.896 . . . . 0.0 111.504 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.48 157.26 56.73 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.018 2.479 . . . . 0.0 111.276 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -65.43 -20.32 66.32 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.75 -0.594 . . . . 0.0 111.727 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -32.1 53.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.86 -1.067 . . . . 0.0 113.817 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.54 -40.79 11.17 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.077 1.308 . . . . 0.0 113.504 163.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.4 mtp -66.09 -12.3 54.6 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.48 -20.74 66.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.863 1.665 . . . . 0.0 112.242 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.38 172.1 13.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.473 1.033 . . . . 0.0 109.709 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.46 -67.78 1.55 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.05 74.72 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 123.286 1.517 . . . . 0.0 108.26 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.25 36.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.604 -1.635 . . . . 0.0 114.762 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.75 -81.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.461 1.105 . . . . 0.0 113.663 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -178.45 152.7 0.8 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.26 1.424 . . . . 0.0 109.176 -168.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.95 94.32 0.13 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.577 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -20.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.0 m -72.6 108.27 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.914 1.285 . . . . 0.0 107.638 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 mm -112.94 155.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.92 142.77 42.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 168.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.289 7.8 pt -107.76 -119.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 116.583 -1.675 . . . . 0.0 111.085 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -53.57 -33.13 53.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.854 2.57 . . . . 0.0 112.439 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.53 -28.21 0.02 OUTLIER Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.336 0.97 . . . . 0.0 111.428 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.19 157.68 37.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.921 0.86 . . . . 0.0 111.317 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 m -118.09 120.54 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.646 1.578 . . . . 0.0 108.18 -158.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.55 ' CB ' ' HZ2' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -161.3 159.53 28.64 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -159.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -155.49 132.47 10.72 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.6 mm -135.26 118.73 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.06 -164.7 54.94 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 -34.79 0.75 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 116.621 -1.657 . . . . 0.0 114.434 169.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.28 -158.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 CA-C-N 122.34 1.872 . . . . 0.0 109.831 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -66.2 -171.71 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.466 -1.396 . . . . 0.0 109.818 160.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.55 ' HZ2' ' CB ' ' A' ' 66' ' ' GLU . 4.5 ttpt -77.17 49.06 0.66 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -158.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.69 -41.21 63.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -158.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.33 -41.57 73.08 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.835 -1.166 . . . . 0.0 112.136 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.25 -25.81 51.88 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.938 0.79 . . . . 0.0 110.923 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.7 t -55.53 -48.03 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.863 1.665 . . . . 0.0 107.807 167.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.9 -8.25 10.62 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.98 -51.48 3.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.763 -1.211 . . . . 0.0 110.156 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.7 pt -59.57 -23.06 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 O-C-N 121.262 -0.899 . . . . 0.0 111.615 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -62.46 -32.37 73.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.665 1.121 . . . . 0.0 113.219 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -42.26 10.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.578 1.081 . . . . 0.0 112.259 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 34.31 13.45 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 131.234 3.814 . . . . 0.0 121.022 -171.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.239 0 CA-C-N 121.494 1.952 . . . . 0.0 108.963 159.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.6 m -42.0 122.43 2.09 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.006 1.322 . . . . 0.0 110.786 165.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt 68.41 92.29 0.08 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 127.86 2.464 . . . . 0.0 111.478 -166.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 t -58.73 140.71 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 160.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 147.06 36.08 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.7 mt -141.59 129.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 71.5 mt-10 -128.59 128.03 43.43 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.14 69.56 1.16 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.669 1.988 . . . . 0.0 106.029 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -81.63 83.35 7.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.6 p -128.77 179.09 5.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.94 -1.1 . . . . 0.0 108.508 -166.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p 175.42 -63.81 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 CA-C-O 117.054 -1.45 . . . . 0.0 112.343 171.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.75 86.62 1.47 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.515 2.144 . . . . 0.0 111.882 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -166.19 149.97 7.62 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.683 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.3 m -69.76 168.58 16.64 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 158.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.26 46.16 0.7 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.232 2.621 . . . . 0.0 111.625 167.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -22.4 61.18 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.768 2.027 . . . . 0.0 113.769 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.4 m -133.32 149.83 73.54 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 167.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.85 72.8 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.922 2.415 . . . . 0.0 108.706 159.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.25 -80.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.804 1.642 . . . . 0.0 114.128 -158.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.05 -26.37 68.22 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.959 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -62.18 -47.74 83.15 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.231 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -49.09 69.51 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 120.412 1.46 . . . . 0.0 108.974 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 18.2 t -63.32 -34.07 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 117.662 -1.615 . . . . 0.0 110.342 -169.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.44 -45.37 75.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.532 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -53.17 -48.22 68.19 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.98 1.718 . . . . 0.0 109.487 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.78 -54.24 47.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 129.191 2.996 . . . . 0.0 110.23 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.72 -38.89 45.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.758 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.36 -28.24 66.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 120.615 1.552 . . . . 0.0 110.655 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -57.19 -25.72 59.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.549 1.14 . . . . 0.0 112.587 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.01 -23.11 6.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.275 1.03 . . . . 0.0 111.895 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.8 mtp -133.93 75.61 66.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 127.277 2.231 . . . . 0.0 110.629 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.55 29.63 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.518 3.478 . . . . 0.0 114.178 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -178.31 -48.39 0.01 OUTLIER 'General case' 0 C--O 1.236 0.348 0 O-C-N 120.325 -1.485 . . . . 0.0 109.693 -164.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.43 54.51 1.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.349 0.66 . . . . 0.0 110.518 169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.02 136.31 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.36 138.05 51.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.98 127.0 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 124.172 0.989 . . . . 0.0 109.691 -168.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -127.61 110.97 13.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 167.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.74 106.5 9.6 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 166.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.3 90.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.94 108.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 161.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.7 t -44.35 110.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.324 1.85 . . . . 0.0 109.126 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 tpp -140.03 -67.68 0.43 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.9 86.54 2.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -139.42 148.53 56.89 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.59 137.92 67.0 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 N-CA-C 106.266 -2.244 . . . . 0.0 106.266 161.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -73.17 39.33 0.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -31.23 70.2 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 120.792 -1.193 . . . . 0.0 112.609 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.36 -31.77 15.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 111.551 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.9 mtt -65.75 -7.56 16.42 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.932 -1.105 . . . . 0.0 112.132 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.56 -30.46 64.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.411 1.084 . . . . 0.0 111.008 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.77 169.05 8.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.767 0.827 . . . . 0.0 110.306 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.45 -30.32 77.53 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.656 -1.636 . . . . 0.0 112.536 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -51.14 -66.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.803 1.802 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 31.5 mtt 59.08 -39.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.961 2.504 . . . . 0.0 114.719 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.21 99.97 0.21 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.92 1.688 . . . . 0.0 110.984 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.1 m -60.59 150.18 75.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 121.528 -0.732 . . . . 0.0 109.407 159.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.22 113.14 2.08 Favored 'Cis proline' 0 C--N 1.349 0.603 0 CA-C-N 120.666 1.273 . . . . 0.0 111.93 1.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -96.78 117.88 32.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.219 2.208 . . . . 0.0 106.294 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.01 119.04 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -167.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -102.05 131.25 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.7 pt -128.26 163.37 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 125.032 1.458 . . . . 0.0 108.717 168.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 t30 48.16 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 111.63 -159.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.93 -3.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.443 0 C-N-CA 128.155 2.788 . . . . 0.0 111.892 167.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -91.54 129.83 37.46 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.232 2.016 . . . . 0.0 111.7 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.27 140.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.612 0.765 . . . . 0.0 109.733 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.18 -178.17 6.55 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -164.61 115.58 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.79 81.02 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 119.532 1.06 . . . . 0.0 110.468 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 171.9 23.17 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.376 -1.284 . . . . 0.0 112.007 166.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.71 3.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 115.958 -1.973 . . . . 0.0 115.836 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.08 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.367 2.238 . . . . 0.0 111.047 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 p -134.95 -127.99 0.16 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.934 2.094 . . . . 0.0 108.435 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -91.91 20.62 5.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.208 -1.558 . . . . 0.0 114.923 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -41.98 -45.11 3.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.618 2.008 . . . . 0.0 113.299 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.23 -49.65 60.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.569 1.148 . . . . 0.0 113.302 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.37 -21.86 28.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.03 -40.53 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.37 -29.05 65.7 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.471 -0.768 . . . . 0.0 112.455 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.53 -50.08 13.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 111.226 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 pt -60.44 -37.51 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.164 -0.96 . . . . 0.0 111.585 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -36.61 84.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.636 1.107 . . . . 0.0 113.237 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -21.47 45.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.44 1.473 . . . . 0.0 113.006 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.18 -73.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.126 1.771 . . . . 0.0 109.281 169.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.154 1.782 . . . . 0.0 107.268 -169.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.3 m 38.34 -123.84 0.28 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.256 2.222 . . . . 0.0 112.713 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? 27.72 73.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.976 2.51 . . . . 0.0 111.747 -165.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.77 101.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.74 160.37 32.73 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.811 0.815 . . . . 0.0 110.129 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -147.99 138.98 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 129.181 2.992 . . . . 0.0 105.135 167.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -135.7 146.87 48.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.56 82.98 2.06 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.785 1.234 . . . . 0.0 109.379 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.6 89.82 2.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.094 1.358 . . . . 0.0 108.5 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -135.69 179.69 6.18 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.856 -1.153 . . . . 0.0 113.279 -161.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t 178.75 -56.92 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.385 2.274 . . . . 0.0 108.278 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.38 93.4 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.407 2.071 . . . . 0.0 111.29 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 ttp -151.62 93.1 1.83 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.182 1.793 . . . . 0.0 107.094 -168.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.8 m -131.48 -72.59 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 117.186 -1.388 . . . . 0.0 110.355 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.79 -46.2 5.36 Favored 'Trans proline' 0 C--N 1.353 0.77 0 CA-C-N 122.251 1.84 . . . . 0.0 110.95 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -78.31 63.78 3.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 t -56.63 -56.14 35.59 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.481 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.14 118.99 6.0 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-N 121.38 1.529 . . . . 0.0 109.314 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.52 -94.42 0.32 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.19 -25.29 58.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.264 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -56.61 -54.66 43.39 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.814 0.846 . . . . 0.0 111.755 171.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.6 mtt-85 -60.71 -45.21 95.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 118.659 0.663 . . . . 0.0 109.594 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.9 t -68.69 -34.58 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.563 -170.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.44 -32.57 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 121.133 1.788 . . . . 0.0 110.885 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -60.54 -53.68 54.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.815 1.189 . . . . 0.0 109.043 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.38 -36.97 77.33 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 122.915 0.486 . . . . 0.0 111.595 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -74.7 -35.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.975 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.7 70.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.642 1.564 . . . . 0.0 111.169 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -57.72 -22.23 45.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.56 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -112.55 -31.52 6.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.974 1.261 . . . . 0.0 112.069 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -145.14 85.84 7.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.549 1.939 . . . . 0.0 110.338 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.88 45.47 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.176 3.251 . . . . 0.0 110.913 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -178.0 -66.77 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.711 1.604 . . . . 0.0 109.035 -166.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.87 1.11 4.74 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.27 141.33 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.267 1.427 . . . . 0.0 108.988 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.31 130.06 30.22 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 164.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.63 92.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.815 1.246 . . . . 0.0 110.52 -159.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 104.33 16.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -75.61 121.75 22.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 159.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.09 92.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.7 161.72 14.53 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.745 -1.222 . . . . 0.0 109.948 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.5 mtp -178.59 -87.05 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.586 2.354 . . . . 0.0 105.665 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -68.17 -19.06 64.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.721 1.208 . . . . 0.0 111.983 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.08 56.13 17.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.394 1.878 . . . . 0.0 111.606 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.35 140.78 65.43 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.934 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.76 -15.62 42.7 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.814 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -40.25 -45.37 2.06 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.378 1.471 . . . . 0.0 112.333 162.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.45 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.07 -46.01 8.0 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 168.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mtp -68.57 -5.47 20.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.42 -26.27 63.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.378 1.071 . . . . 0.0 111.317 164.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -76.33 118.48 19.08 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.269 1.028 . . . . 0.0 110.243 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.59 -5.5 23.87 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.437 -1.201 . . . . 0.0 114.878 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.449 ' C ' ' H ' ' A' ' 55' ' ' ALA . 5.3 pt -68.44 -46.55 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.875 1.838 . . . . 0.0 109.603 170.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.3 mtt 47.08 -11.42 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.632 3.173 . . . . 0.0 117.447 -169.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -65.16 -27.7 68.9 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.397 1.879 . . . . 0.0 115.735 -159.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.311 28.8 m 50.98 166.72 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 128.251 2.62 . . . . 0.0 113.625 -161.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -65.52 105.78 0.34 Allowed 'Cis proline' 0 C--N 1.356 0.948 0 CA-C-N 121.55 1.589 . . . . 0.0 109.99 -14.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 m -79.89 124.49 28.71 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.803 1.641 . . . . 0.0 107.066 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.82 166.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 t -142.94 134.16 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.404 ' CG2' ' HZ2' ' A' ' 73' ' ' LYS . 37.1 pt -101.42 -157.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.745 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -23.23 -51.34 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.495 2.318 . . . . 0.0 114.91 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.22 -27.2 0.22 Allowed Glycine 0 CA--C 1.533 1.215 0 O-C-N 124.163 0.914 . . . . 0.0 112.106 158.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.55 140.59 29.6 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.684 1.742 . . . . 0.0 112.585 -163.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.71 147.64 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.173 2.189 . . . . 0.0 108.478 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -178.57 160.13 1.2 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.555 1.542 . . . . 0.0 109.401 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 146.89 52.51 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 159.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 mm -124.78 88.44 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.38 -165.16 51.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 121.664 0.591 . . . . 0.0 112.418 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.76 -22.84 0.54 Allowed Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.65 177.17 2.96 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 123.67 2.346 . . . . 0.0 110.632 164.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.1 p -70.55 -159.77 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 159.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HZ2' ' CG2' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -77.29 23.26 0.2 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 119.199 -2.188 . . . . 0.0 112.746 -170.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -44.93 -37.92 4.31 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.84 2.456 . . . . 0.0 112.508 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.87 -66.47 0.38 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.481 1.112 . . . . 0.0 111.567 169.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -23.31 64.25 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.647 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -39.8 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.568 1.531 . . . . 0.0 108.559 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -62.34 -7.46 4.39 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.05 -37.83 7.19 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.204 1.366 . . . . 0.0 112.376 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -42.78 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.569 1.077 . . . . 0.0 108.598 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -15.25 60.92 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.394 -1.441 . . . . 0.0 113.927 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -52.73 9.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.59 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -159.54 49.24 0.31 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.827 1.194 . . . . 0.0 112.307 174.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.426 0.0 OUTLIER . . . . . 0 C--O 1.245 0.845 0 C-N-CA 126.738 2.015 . . . . 0.0 113.667 -162.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 42.1 tpp . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.5 m 48.3 46.53 20.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.484 1.114 . . . . 0.0 112.083 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -142.04 156.65 45.43 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.764 0.826 . . . . 0.0 110.086 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.08 130.97 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.673 1.124 . . . . 0.0 108.507 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -106.2 147.04 29.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.261 -0.899 . . . . 0.0 109.224 170.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mm -133.29 134.61 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -130.06 143.86 51.03 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.44 78.67 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.457 ' C ' ' HG1' ' A' ' 9' ' ' THR . 16.0 t80 -88.97 80.14 7.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.457 ' HG1' ' C ' ' A' ' 8' ' ' PHE . 52.6 m -152.33 159.39 43.47 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.352 -1.468 . . . . 0.0 110.468 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.9 t -145.61 105.04 4.27 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 162.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.53 122.5 6.03 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.966 1.777 . . . . 0.0 110.715 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 46.8 ttm -91.84 91.48 7.93 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.4 m 113.18 -58.42 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.302 0 C-N-CA 131.055 3.742 . . . . 0.0 111.045 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.59 58.58 7.07 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.803 2.335 . . . . 0.0 110.999 -173.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -61.7 111.03 1.68 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.8 m -121.43 162.71 34.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 125.701 1.6 . . . . 0.0 108.119 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.34 -21.25 71.27 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.764 1.643 . . . . 0.0 113.856 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 43.08 -117.0 0.44 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.201 1.4 . . . . 0.0 110.389 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.59 -32.75 29.83 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 116.15 -1.881 . . . . 0.0 114.246 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -59.1 -59.07 6.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 121.457 1.935 . . . . 0.0 109.639 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -61.63 -50.26 73.27 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.495 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.4 -40.59 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 117.017 -1.468 . . . . 0.0 108.577 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.87 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 120.479 1.49 . . . . 0.0 109.657 171.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -58.69 -43.14 89.92 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.905 1.23 . . . . 0.0 110.653 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.28 -54.62 34.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.646 1.178 . . . . 0.0 110.653 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.5 m -71.6 -29.2 33.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.793 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.93 64.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.691 1.132 . . . . 0.0 110.125 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.77 -40.05 78.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.189 0.45 . . . . 0.0 110.078 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -76.56 -51.69 11.16 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.329 1.051 . . . . 0.0 111.909 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.4 mtt -141.38 82.94 13.93 Favored Pre-proline 0 C--N 1.333 -0.152 0 C-N-CA 127.517 2.327 . . . . 0.0 108.755 -167.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -68.85 8.81 0.52 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.205 1.937 . . . . 0.0 114.147 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.7 -40.69 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.551 1.141 . . . . 0.0 112.376 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -6.4 19.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.519 1.054 . . . . 0.0 111.812 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.66 144.72 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 119.496 1.044 . . . . 0.0 109.319 170.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 141.62 51.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.171 2.188 . . . . 0.0 105.182 165.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.35 129.04 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 124.019 0.928 . . . . 0.0 109.725 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -121.15 97.54 5.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -85.91 93.06 8.84 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.276 0.2 OUTLIER -116.27 92.42 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 123.056 1.408 . . . . 0.0 107.815 -170.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.06 124.15 20.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.967 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.79 117.45 5.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.59 -63.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -143.67 51.35 1.34 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -160.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -139.5 151.18 66.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.857 0.863 . . . . 0.0 111.101 -165.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.98 134.76 32.95 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.295 2.663 . . . . 0.0 111.852 -172.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -70.68 7.03 1.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.344 -0.848 . . . . 0.0 112.779 173.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.7 -31.63 17.03 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.079 1.752 . . . . 0.0 113.311 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB2' ' CD2' ' A' ' 8' ' ' PHE . . . -92.35 -41.48 10.33 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.616 0.644 . . . . 0.0 111.103 164.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.14 -0.75 3.56 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.83 -143.44 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.196 1.398 . . . . 0.0 109.662 159.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 67.6 -168.03 0.2 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.563 1.545 . . . . 0.0 111.725 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.87 162.76 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 158.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.293 1.5 tp 41.79 63.99 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 123.225 1.488 . . . . 0.0 112.563 -165.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtt -67.87 -22.33 65.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.687 163.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.02 0.84 4.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.906 1.282 . . . . 0.0 113.926 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 70.31 164.07 0.14 Allowed Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.406 1.482 . . . . 0.0 110.49 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.15 125.94 10.61 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.674 1.276 . . . . 0.0 111.474 -9.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.1 m -95.4 98.09 10.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.5 mm -119.48 120.4 63.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -167.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.63 127.95 47.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.9 pt -123.91 142.17 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.83 0.741 . . . . 0.0 109.885 169.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.5 t30 48.08 -42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.288 3.035 . . . . 0.0 116.886 -159.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.96 -15.6 0.06 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 128.414 2.911 . . . . 0.0 111.255 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -91.06 160.61 15.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.413 1.606 . . . . 0.0 110.17 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.64 127.55 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.82 0.848 . . . . 0.0 109.209 -158.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.93 173.39 15.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.026 0.83 . . . . 0.0 111.015 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.92 155.51 48.94 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.782 1.633 . . . . 0.0 106.874 159.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.6 mm -141.06 136.17 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.01 -171.34 45.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.82 -30.97 0.64 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.374 -1.774 . . . . 0.0 114.209 164.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -85.41 -166.54 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 CA-C-N 123.005 2.109 . . . . 0.0 110.53 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -63.33 175.63 0.95 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.054 0.941 . . . . 0.0 111.661 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.26 21.5 0.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.518 1.527 . . . . 0.0 113.771 -160.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -35.45 -40.8 0.16 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.312 2.245 . . . . 0.0 114.654 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.48 -64.76 0.72 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.714 1.606 . . . . 0.0 111.703 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -28.15 66.87 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.042 0.537 . . . . 0.0 110.698 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.13 -34.65 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.25 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.45 -16.55 55.86 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.529 -1.357 . . . . 0.0 113.745 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.48 -47.81 7.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.351 1.432 . . . . 0.0 110.466 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.87 -24.84 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.024 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -64.01 -46.5 84.23 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.129 0.877 . . . . 0.0 111.282 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.85 -49.49 8.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -165.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 53.29 -58.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 129.128 2.971 . . . . 0.0 114.629 -165.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.479 1.912 . . . . 0.0 110.507 -169.574 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m -67.45 113.76 5.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.706 0.402 . . . . 0.0 110.285 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -144.05 126.21 15.57 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 168.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -105.39 103.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 158.17 35.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -143.39 138.94 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 161.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -129.08 144.16 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 mt -138.37 89.62 2.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.404 1.082 . . . . 0.0 108.465 -170.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -113.63 97.25 6.31 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.211 1.805 . . . . 0.0 108.917 -164.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t -178.91 -177.25 0.48 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.989 1.716 . . . . 0.0 106.626 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 t -158.23 69.71 3.86 Favored Pre-proline 0 CA--C 1.539 0.558 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.6 127.76 18.68 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.107 1.872 . . . . 0.0 109.26 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.6 ttt -55.88 105.89 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.765 1.226 . . . . 0.0 109.096 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.296 96.3 m 108.23 -76.11 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 131.352 3.861 . . . . 0.0 109.369 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.44 3.78 2.0 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 CA-C-N 123.346 2.231 . . . . 0.0 115.683 -172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.16 47.75 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.642 1.564 . . . . 0.0 113.396 163.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -138.46 -64.48 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 125.043 1.337 . . . . 0.0 109.629 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.85 -8.15 21.67 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.882 1.722 . . . . 0.0 114.235 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.73 -81.21 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.875 1.67 . . . . 0.0 113.496 -166.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.18 -25.35 68.04 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.491 -1.242 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -61.39 -59.29 5.5 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.203 0.91 . . . . 0.0 109.791 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -61.6 -43.15 99.39 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.762 -0.586 . . . . 0.0 111.005 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -66.36 -33.71 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.942 -173.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.24 -27.41 13.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 CA-C-N 120.368 1.44 . . . . 0.0 111.88 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -61.23 -57.58 11.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 108.252 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -49.27 -66.18 0.44 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.328 1.851 . . . . 0.0 107.688 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.47 -27.95 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.686 1.13 . . . . 0.0 112.872 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 -26.35 68.01 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.829 1.649 . . . . 0.0 111.249 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -53.72 -48.98 69.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.221 0.919 . . . . 0.0 111.466 167.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.51 -51.77 47.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.587 0.63 . . . . 0.0 109.978 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.59 88.48 8.69 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.668 1.587 . . . . 0.0 109.367 -169.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.41 27.27 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.021 3.147 . . . . 0.0 110.95 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -151.67 -68.33 0.17 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.152 1.381 . . . . 0.0 108.62 -158.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.21 -5.03 28.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.16 139.44 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 119.175 0.898 . . . . 0.0 110.294 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.28 123.31 24.02 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -117.02 140.02 41.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -116.97 100.6 7.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.57 115.68 17.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 160.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.266 0.2 OUTLIER -129.23 101.32 6.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.766 1.27 . . . . 0.0 107.876 177.406 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.1 129.03 38.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.244 1.418 . . . . 0.0 108.324 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.55 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -178.94 -72.26 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 128.458 2.703 . . . . 0.0 106.328 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.6 -41.8 59.81 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -58.86 142.79 84.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.061 0.944 . . . . 0.0 112.159 -167.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.01 136.45 32.37 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.911 1.741 . . . . 0.0 108.254 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.08 -12.88 2.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.542 1.537 . . . . 0.0 113.386 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -4.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.833 2.853 . . . . 0.0 118.468 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.42 -63.89 1.2 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 121.5 1.954 . . . . 0.0 107.546 158.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.83 -21.22 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 129.738 3.215 . . . . 0.0 115.254 174.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.91 -20.38 3.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.802 2.041 . . . . 0.0 114.84 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -52.58 175.39 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.019 2.928 . . . . 0.0 115.555 -164.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -43.42 127.41 5.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.822 1.201 . . . . 0.0 110.837 164.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.289 0.2 OUTLIER 60.12 -24.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 129.435 3.094 . . . . 0.0 115.895 -170.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtm 62.24 -73.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 128.628 2.771 . . . . 0.0 110.754 -172.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 36.27 -130.95 0.1 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.187 2.595 . . . . 0.0 110.965 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -179.32 154.28 0.74 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 128.937 2.895 . . . . 0.0 105.138 175.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.93 -179.87 8.81 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 119.483 0.851 . . . . 0.0 112.0 -14.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -128.69 127.19 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 168.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -129.56 163.71 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 t -138.75 130.93 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 102.907 -2.998 . . . . 0.0 102.907 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.0 pt -99.21 -161.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 117.005 -1.474 . . . . 0.0 108.9 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -20.17 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.823 2.449 . . . . 0.0 114.308 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.68 -13.61 1.42 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.869 -0.962 . . . . 0.0 112.668 158.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -91.32 113.86 26.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.331 1.566 . . . . 0.0 113.186 -159.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.42 135.35 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.421 1.489 . . . . 0.0 107.855 164.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -178.57 169.33 1.74 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.862 2.065 . . . . 0.0 107.842 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -158.93 139.63 12.61 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 119.907 -1.745 . . . . 0.0 106.662 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.89 133.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -174.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 175.37 49.82 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.127 0.892 . . . . 0.0 111.966 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.21 -42.62 2.11 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.735 1.214 . . . . 0.0 112.825 164.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.12 -176.66 1.95 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 CA-C-N 121.798 1.678 . . . . 0.0 109.354 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -62.85 -175.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.518 -0.739 . . . . 0.0 111.119 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.45 32.99 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.886 2.074 . . . . 0.0 114.64 -158.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.34 -34.63 64.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.236 -1.54 . . . . 0.0 112.017 -172.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.81 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.49 1.116 . . . . 0.0 111.7 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.51 -28.8 30.88 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.928 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.24 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 120.697 1.589 . . . . 0.0 109.97 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -12.5 23.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.18 -37.28 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.718 2.007 . . . . 0.0 111.418 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.29 -34.4 40.03 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 121.677 2.035 . . . . 0.0 110.251 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -53.81 -35.28 61.23 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -31.42 16.33 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 170.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.84 -66.32 0.4 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.834 1.253 . . . . 0.0 111.696 -169.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 C--O 1.255 1.343 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -178.294 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 58.0 mtp . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 p -151.73 169.95 20.95 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.104 0.562 . . . . 0.0 111.274 -164.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 108.86 104.61 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 131.046 3.738 . . . . 0.0 107.617 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 t -65.12 130.06 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 168.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.14 141.5 33.94 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 165.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -138.43 85.38 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -172.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -93.71 128.67 40.04 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.21 87.12 3.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 164.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -91.05 95.64 10.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.971 0.891 . . . . 0.0 108.65 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -178.47 172.1 1.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.192 1.797 . . . . 0.0 108.136 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 t -138.06 101.73 8.46 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 164.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.85 58.59 6.1 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.583 2.855 . . . . 0.0 110.914 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 39.9 ttm -62.42 -23.44 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.376 1.47 . . . . 0.0 111.835 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.2 m -79.11 -73.05 0.12 Allowed Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 116.736 -1.602 . . . . 0.0 110.659 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.48 -9.85 7.89 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 CA-C-N 122.982 2.101 . . . . 0.0 115.699 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 53.62 25.25 4.77 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 m -55.17 154.2 11.2 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.726 0.693 . . . . 0.0 112.336 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.37 57.22 3.44 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.429 3.42 . . . . 0.0 109.586 166.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.92 -77.5 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.68 1.992 . . . . 0.0 111.994 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.92 78.48 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 118.224 -0.893 . . . . 0.0 108.796 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -48.64 -46.08 39.41 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.278 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -68.04 -53.0 28.97 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 121.02 1.737 . . . . 0.0 111.085 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.72 -40.2 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.017 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 m -73.98 -32.68 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 126.113 1.765 . . . . 0.0 112.637 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.64 -49.31 62.52 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.632 1.106 . . . . 0.0 108.139 164.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -76.98 -44.43 31.12 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.074 0.949 . . . . 0.0 110.531 -164.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.5 m -72.57 -26.44 24.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.95 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.49 63.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.936 1.698 . . . . 0.0 110.328 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.24 -41.18 99.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.303 1.041 . . . . 0.0 109.878 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.7 -56.82 7.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.146 0.579 . . . . 0.0 110.63 171.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.0 mtt -146.86 86.83 6.48 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 125.355 1.462 . . . . 0.0 109.214 -159.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.25 41.4 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.437 2.758 . . . . 0.0 111.66 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -151.56 -66.36 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 127.198 2.199 . . . . 0.0 108.061 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 45.45 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.977 1.711 . . . . 0.0 111.775 -173.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.14 83.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.065 1.346 . . . . 0.0 109.928 -161.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -89.24 110.8 21.52 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.46 142.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.034 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -156.52 152.16 27.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.354 1.073 . . . . 0.0 112.068 158.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.58 90.57 4.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.386 2.274 . . . . 0.0 106.334 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.45 85.33 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 121.56 12.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 93.67 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 mmt -143.6 -52.99 0.35 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.94 1.696 . . . . 0.0 109.089 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 13.3 6.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.143 2.177 . . . . 0.0 110.845 -169.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.14 154.42 30.57 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.554 2.342 . . . . 0.0 115.594 -160.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.23 145.06 77.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.788 2.325 . . . . 0.0 110.592 170.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -66.33 -9.8 36.68 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.381 -0.824 . . . . 0.0 111.041 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -61.0 -18.02 55.3 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -175.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.24 -39.54 11.47 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 119.974 -1.704 . . . . 0.0 112.068 161.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.2 mtm -63.35 -12.98 34.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.121 -0.987 . . . . 0.0 112.543 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.14 -26.66 68.45 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.564 1.146 . . . . 0.0 110.902 168.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -66.6 114.65 5.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 108.953 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.69 8.14 3.48 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.576 1.39 . . . . 0.0 116.576 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -69.83 -52.59 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.937 1.869 . . . . 0.0 108.587 159.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . 0.279 0.1 OUTLIER 40.9 7.74 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.926 3.29 . . . . 0.0 117.815 -169.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -178.44 0.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 123.392 1.568 . . . . 0.0 109.354 159.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.04 158.56 48.33 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.194 -0.941 . . . . 0.0 108.922 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.21 128.76 13.6 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 -10.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -77.78 106.13 9.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.7 mm -118.93 121.54 67.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -111.81 111.28 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pp -101.07 167.75 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 169.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 30.33 -81.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.07 1.748 . . . . 0.0 114.501 -161.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.53 10.19 1.46 Allowed Glycine 0 CA--C 1.534 1.243 0 CA-C-N 120.241 1.382 . . . . 0.0 114.139 165.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -86.52 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.33 1.565 . . . . 0.0 113.358 -166.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 p 114.78 134.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 1 C-N-CA 133.766 4.826 . . . . 0.0 106.753 -163.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -178.72 167.08 1.73 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.738 2.415 . . . . 0.0 108.088 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.82 116.67 5.53 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.733 1.613 . . . . 0.0 107.831 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 150.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.51 172.36 47.7 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 124.339 1.025 . . . . 0.0 111.248 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' H ' ' HD2' ' A' ' 71' ' ' PRO . . . -83.98 -33.55 0.55 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.702 1.201 . . . . 0.0 111.459 158.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' ' H ' ' A' ' 70' ' ' ALA . 85.9 Cg_endo -71.15 -165.75 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.636 1.62 . . . . 0.0 110.001 160.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.8 p -64.23 -172.47 0.07 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.525 0.73 . . . . 0.0 109.858 162.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -71.59 47.34 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.393 2.277 . . . . 0.0 114.529 -158.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -58.31 -45.36 88.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.577 1.951 . . . . 0.0 110.923 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.86 61.4 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 112.867 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.94 -20.63 21.98 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.995 0.918 . . . . 0.0 110.476 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.92 -38.42 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.561 -1.337 . . . . 0.0 108.353 167.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.2 -0.64 10.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.444 0.698 . . . . 0.0 112.761 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.57 -51.11 3.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.592 1.557 . . . . 0.0 111.21 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pt -53.48 -40.51 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 119.967 1.258 . . . . 0.0 107.948 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -72.9 -29.09 62.87 Favored 'General case' 0 C--N 1.345 0.377 0 O-C-N 120.209 -1.557 . . . . 0.0 114.78 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.49 1.95 . . . . 0.0 109.291 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -71.64 11.01 0.55 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.994 1.318 . . . . 0.0 113.92 172.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.252 1.225 0 CA-C-N 120.151 1.341 . . . . 0.0 107.677 158.729 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 117.02 -1.467 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 m -66.15 143.69 57.12 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 122.227 2.285 . . . . 0.0 110.011 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -73.64 126.0 29.3 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.9 110.26 3.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -91.13 144.75 25.31 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.77 138.57 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -124.72 133.0 53.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.14 92.09 3.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.049 1.34 . . . . 0.0 109.118 -172.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -112.61 104.09 12.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.027 0.931 . . . . 0.0 109.857 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 t -178.57 170.92 1.59 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 108.65 170.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t -165.95 47.71 0.16 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.603 1.161 . . . . 0.0 109.889 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.18 -64.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.816 2.344 . . . . 0.0 110.303 -161.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ttt -156.44 -115.72 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 159.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 m 50.74 -172.0 0.01 OUTLIER Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 119.135 0.88 . . . . 0.0 109.573 -159.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -67.71 2.63 2.34 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.298 1.142 . . . . 0.0 113.679 166.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 69.28 -32.01 0.22 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 128.095 2.558 . . . . 0.0 113.428 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.2 m -56.88 -49.48 93.62 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.063 1.745 . . . . 0.0 114.24 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.82 88.63 1.05 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 N-CA-C 107.967 -1.59 . . . . 0.0 107.967 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 -100.21 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.44 51.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.58 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -51.4 -67.73 0.23 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.99 1.316 . . . . 0.0 111.466 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -65.17 -39.4 92.88 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.328 -0.858 . . . . 0.0 110.965 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.5 t -65.05 -43.13 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 120.202 1.364 . . . . 0.0 110.227 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.83 -45.39 86.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 110.568 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -58.66 -60.44 3.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.925 1.29 . . . . 0.0 110.246 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 p -73.75 -33.27 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.203 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.49 70.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 121.032 1.742 . . . . 0.0 111.373 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -61.2 -13.07 15.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.25 -20.08 1.67 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.2 mtp -138.72 78.25 31.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 127.791 2.437 . . . . 0.0 107.304 168.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -70.9 25.28 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 125.29 3.994 . . . . 0.0 115.053 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -178.02 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.11 -1.618 . . . . 0.0 110.488 -159.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.05 3.85 7.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.142 0.883 . . . . 0.0 111.639 169.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.1 136.92 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 109.329 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -128.54 125.41 38.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 159.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.47 102.42 9.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.393 -2.076 . . . . 0.0 105.393 173.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -92.05 130.66 37.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.79 104.64 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.94 1.696 . . . . 0.0 106.49 -168.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.69 67.22 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -58.8 144.14 45.02 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.581 0.705 . . . . 0.0 109.647 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.37 141.87 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.3 ttm -178.66 -70.01 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 128.394 2.677 . . . . 0.0 104.621 -173.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.27 0.941 . . . . 0.0 111.046 170.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t30 43.57 54.48 11.01 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.7 2.4 . . . . 0.0 112.513 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.5 151.49 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.087 1.858 . . . . 0.0 112.464 -169.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -63.95 -12.54 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -37.49 32.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 119.591 1.087 . . . . 0.0 113.755 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -37.78 12.61 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 165.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.7 mtp -65.78 -11.89 49.63 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.62 -22.83 64.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.623 1.169 . . . . 0.0 113.125 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -66.99 151.12 48.24 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.255 0.934 . . . . 0.0 112.498 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.07 -45.83 42.35 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 126.215 1.864 . . . . 0.0 112.487 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.265 4.2 tt -133.37 83.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.516 1.15 . . . . 0.0 108.263 158.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -33.93 58.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.165 169.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 28.66 -116.67 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.829 2.452 . . . . 0.0 112.215 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -179.07 160.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 130.661 3.585 . . . . 0.0 105.673 164.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.21 119.28 5.37 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 CA-C-N 120.581 1.243 . . . . 0.0 110.124 -14.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m -80.39 98.94 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.208 1.803 . . . . 0.0 108.077 -164.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mm -109.48 151.79 11.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -121.3 141.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.446 ' CD1' ' HE3' ' A' ' 73' ' ' LYS . 36.6 pt -135.98 145.81 30.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.808 0.843 . . . . 0.0 109.857 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.17 -62.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.066 2.146 . . . . 0.0 110.89 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.42 -5.38 0.04 OUTLIER Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.932 2.206 . . . . 0.0 112.556 158.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.69 154.55 18.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.328 2.064 . . . . 0.0 116.177 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.2 m -105.12 131.78 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.3 1.44 . . . . 0.0 109.005 -161.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 21.5 tt0 -178.36 167.06 1.89 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.04 -1.038 . . . . 0.0 109.13 -165.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -162.02 125.72 3.14 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -170.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.61 109.07 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.69 -177.28 17.82 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.843 1.211 . . . . 0.0 110.337 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' H ' ' HD2' ' A' ' 71' ' ' PRO . . . -89.55 -32.79 0.38 Allowed Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.297 161.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 70' ' ' ALA . 86.8 Cg_endo -73.46 -170.98 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.847 1.695 . . . . 0.0 109.255 160.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.1 p -60.67 -176.22 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.755 1.622 . . . . 0.0 111.499 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HZ3' ' HB3' ' A' ' 66' ' ' GLU . 6.4 ttpt -71.96 36.9 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.783 2.033 . . . . 0.0 113.142 -163.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -50.32 -44.81 54.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.492 1.917 . . . . 0.0 110.857 -164.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.67 65.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.779 1.631 . . . . 0.0 113.319 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.51 -26.94 19.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.0 0.52 . . . . 0.0 110.741 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . 0.266 22.4 t -61.81 -40.02 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 125.025 1.33 . . . . 0.0 108.294 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.0 -13.99 14.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.653 1.581 . . . . 0.0 112.542 170.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.39 -44.61 7.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 116.903 -1.522 . . . . 0.0 111.324 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pt -56.0 -29.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.882 1.674 . . . . 0.0 112.599 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -51.93 -64.27 0.87 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.131 165.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -59.74 3.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.058 -174.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -161.11 101.3 1.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.398 1.879 . . . . 0.0 109.844 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.264 0 C-N-CA 129.778 3.231 . . . . 0.0 116.8 170.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 37.5 mtt . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t -148.12 -43.93 0.16 Allowed 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.636 -0.665 . . . . 0.0 110.616 174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt 57.65 91.76 0.04 OUTLIER 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.518 1.527 . . . . 0.0 111.859 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.2 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -158.95 87.24 2.22 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.7 35.67 0.52 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.53 2.82 . . . . 0.0 112.287 -172.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.2 ttt 56.63 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.304 3.442 . . . . 0.0 114.893 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -78.15 -84.92 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.662 -1.637 . . . . 0.0 109.579 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.06 78.98 2.45 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.883 2.388 . . . . 0.0 111.188 -175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -129.2 28.53 5.25 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.544 1.138 . . . . 0.0 110.566 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.6 m -132.63 -57.55 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.799 1.24 . . . . 0.0 108.269 172.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.2 85.33 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.805 1.67 . . . . 0.0 109.027 164.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.01 116.59 16.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.98 86.96 4.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 21.2 m-85 -73.09 156.56 38.58 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.86 0.838 . . . . 0.0 111.618 -169.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.434 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.09 38.62 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.49 5.68 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.373 171.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.78 -40.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 120.41 1.459 . . . . 0.0 109.495 172.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -57.0 -23.17 44.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.928 0.785 . . . . 0.0 112.056 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -4.35 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 C--O 1.252 1.206 0 CA-C-N 120.062 1.301 . . . . 0.0 109.529 -176.681 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 62.6 mtt . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.0 p 153.06 -169.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.984 2.114 . . . . 0.0 107.273 -142.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt 14.46 80.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 128.997 2.919 . . . . 0.0 113.177 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.26 150.65 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.325 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -98.76 134.27 41.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.343 1.057 . . . . 0.0 109.032 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.9 149.61 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.14 146.26 42.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.47 96.64 4.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.111 0.965 . . . . 0.0 108.399 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.465 ' C ' ' HG1' ' A' ' 9' ' ' THR . 34.4 t80 -121.99 86.62 2.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.251 1.024 . . . . 0.0 110.385 -169.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 10' ' ' SER . 1.2 m -156.91 -157.51 0.7 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.451 1.9 . . . . 0.0 107.826 174.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.544 ' H ' HG22 ' A' ' 9' ' ' THR . 73.2 m 120.08 93.33 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.206 1 C-N-CA 133.345 4.658 . . . . 0.0 107.17 -175.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.97 -70.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 N-CA-C 107.269 -1.858 . . . . 0.0 107.269 159.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.3 ttt -162.68 -37.99 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 124.41 1.084 . . . . 0.0 109.008 163.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 m -51.73 -58.89 9.4 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 116.621 -1.657 . . . . 0.0 114.217 -171.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.12 -80.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 CA-C-N 122.042 1.765 . . . . 0.0 109.778 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 49.26 37.0 10.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.459 1.504 . . . . 0.0 113.585 165.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -172.03 -59.59 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.153 2.581 . . . . 0.0 108.886 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.16 -99.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.741 2.294 . . . . 0.0 110.764 -175.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.37 -92.71 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.186 1.794 . . . . 0.0 112.978 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.57 -29.36 36.92 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 124.933 1.293 . . . . 0.0 111.791 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.19 -43.44 87.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 119.67 1.123 . . . . 0.0 111.094 172.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -71.22 -42.51 68.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.332 0.969 . . . . 0.0 109.277 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 t -64.16 -44.05 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.549 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.64 -34.76 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 119.536 -1.977 . . . . 0.0 110.761 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.94 -51.19 70.34 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.88 0.872 . . . . 0.0 110.327 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.47 -61.72 2.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.527 1.931 . . . . 0.0 110.063 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -59.53 -44.96 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.3 67.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.548 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -58.46 -35.31 71.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.287 -1.34 . . . . 0.0 112.507 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -106.44 -38.13 6.29 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.469 1.94 . . . . 0.0 112.063 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.2 mtm -121.25 77.97 34.24 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 127.651 2.38 . . . . 0.0 107.037 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.92 11.62 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.941 3.761 . . . . 0.0 113.876 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.62 -59.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.611 1.565 . . . . 0.0 108.22 -159.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.93 50.6 0.47 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.16 2.584 . . . . 0.0 113.082 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.95 92.36 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.485 1.114 . . . . 0.0 109.78 -166.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -102.03 72.85 1.35 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.907 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -77.41 111.53 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.39 117.76 23.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -85.16 123.35 30.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 160.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 96.16 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 155.26 15.87 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.89 150.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.243 1.417 . . . . 0.0 112.922 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.482 ' C ' ' H ' ' A' ' 44' ' ' ASN 0.255 15.1 ptt? 54.35 -172.97 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.372 2.269 . . . . 0.0 111.496 -174.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 63.77 -17.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.899 2.08 . . . . 0.0 114.016 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 42' ' ' MET . 3.8 p-10 -68.65 149.75 97.86 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 127.804 2.442 . . . . 0.0 111.066 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.2 174.45 12.81 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.605 2.203 . . . . 0.0 108.859 160.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.69 0.45 4.21 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.089 -1.007 . . . . 0.0 113.449 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -29.82 3.84 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -175.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.5 -53.13 4.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.352 0.524 . . . . 0.0 112.298 171.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.8 mtp -66.73 -7.56 21.85 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -171.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.99 -22.96 58.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.364 1.466 . . . . 0.0 113.372 166.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 21.9 m-85 -64.91 154.66 36.73 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.777 0.831 . . . . 0.0 109.176 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -18.09 75.7 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.626 -0.672 . . . . 0.0 112.517 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.24 73.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 122.566 1.174 . . . . 0.0 108.802 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 93.9 mtp -73.76 24.9 0.07 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.932 0.893 . . . . 0.0 112.227 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.11 -45.74 71.93 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.102 1.361 . . . . 0.0 113.237 -164.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t 67.41 133.52 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.317 1.847 . . . . 0.0 109.137 -164.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -66.1 121.29 3.36 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.95 1.375 . . . . 0.0 111.243 -9.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.2 m -83.48 106.06 14.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.08 159.55 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.64 128.66 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 170.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -123.69 156.12 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 116.663 -1.637 . . . . 0.0 108.85 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 45.27 -67.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.767 2.427 . . . . 0.0 114.761 -167.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.69 -9.57 0.1 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.132 1.825 . . . . 0.0 113.112 160.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.62 125.31 35.6 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.367 2.083 . . . . 0.0 111.94 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 t -72.03 140.25 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.43 1.492 . . . . 0.0 107.617 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.402 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 4.0 tp10 -178.69 166.53 1.72 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.902 2.081 . . . . 0.0 107.905 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -126.17 152.84 45.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.177 1.791 . . . . 0.0 106.996 165.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.0 mm -129.86 79.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.24 -164.49 36.75 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.799 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.3 1.5 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.99 -162.72 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 CA-C-N 123.517 2.292 . . . . 0.0 109.822 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.4 p -78.2 -150.6 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.751 -1.843 . . . . 0.0 107.65 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 3.5 tppt? -79.06 34.37 0.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.076 -2.265 . . . . 0.0 110.848 -174.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.303 29.7 mt-10 -62.08 -25.55 67.77 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -158.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.21 88.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.775 1.17 . . . . 0.0 111.408 170.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -33.98 53.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.862 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.3 t -48.17 -50.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.846 1.659 . . . . 0.0 107.558 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.56 -10.9 13.56 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.24 -47.24 3.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.219 1.407 . . . . 0.0 112.097 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.2 pt -64.12 -33.09 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.414 1.461 . . . . 0.0 111.241 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -57.51 -24.78 57.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.028 1.286 . . . . 0.0 111.621 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.28 0.0 OUTLIER -91.4 -56.31 3.18 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 117.466 -1.254 . . . . 0.0 107.678 -171.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -110.44 -92.34 0.45 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.182 1.355 . . . . 0.0 110.401 167.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.358 0 C-N-CA 130.799 3.639 . . . . 0.0 104.254 -159.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.6 m -62.83 0.68 0.5 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -68.38 135.66 52.13 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 121.045 1.748 . . . . 0.0 107.352 168.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 t -80.89 154.54 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.34 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -106.51 96.91 5.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -103.1 139.85 38.09 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.23 101.34 5.34 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 123.36 0.664 . . . . 0.0 109.857 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.63 82.51 1.63 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.347 2.259 . . . . 0.0 106.741 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -161.13 -179.37 7.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.926 1.29 . . . . 0.0 107.722 166.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p -136.8 92.95 14.15 Favored Pre-proline 0 C--O 1.235 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 167.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.98 -176.5 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.971 1.781 . . . . 0.0 108.878 170.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.85 85.0 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.492 1.917 . . . . 0.0 111.859 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.3 m 50.25 177.72 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.943 3.297 . . . . 0.0 113.09 -172.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.04 1.22 1.63 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.78 1.653 . . . . 0.0 112.554 159.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -47.97 81.8 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 120.914 -1.116 . . . . 0.0 108.738 166.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.9 m -63.39 131.73 94.91 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 165.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -68.97 -46.13 1.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 120.846 1.03 . . . . 0.0 113.154 -171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.87 -104.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.116 1.766 . . . . 0.0 111.499 -169.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.01 68.31 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.879 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -38.14 -60.07 0.8 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.951 1.25 . . . . 0.0 111.271 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.78 -39.6 61.65 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.566 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -53.44 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.796 1.18 . . . . 0.0 108.089 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.4 t -51.66 -52.53 20.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 128.167 2.587 . . . . 0.0 109.889 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.5 -44.38 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.612 1.097 . . . . 0.0 111.059 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.68 -43.08 99.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.7 1.2 . . . . 0.0 111.062 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.1 m -78.58 -29.42 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.495 -0.753 . . . . 0.0 112.561 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.95 -25.21 60.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.329 1.052 . . . . 0.0 111.766 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.0 -24.43 58.16 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.79 -0.569 . . . . 0.0 110.526 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -89.5 -57.95 2.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.807 1.243 . . . . 0.0 110.088 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.6 mtm -129.63 89.04 47.95 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.495 1.118 . . . . 0.0 110.511 -171.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.76 34.21 0.52 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.375 3.383 . . . . 0.0 113.084 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -178.3 -51.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.984 1.314 . . . . 0.0 110.615 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.24 -24.63 66.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.406 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.12 98.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 164.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -83.69 135.71 34.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.551 1.941 . . . . 0.0 106.837 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 m -135.06 147.12 29.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 118.941 0.791 . . . . 0.0 112.571 -164.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -140.01 117.9 11.75 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.952 1.301 . . . . 0.0 108.043 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -99.84 84.43 2.9 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.68 75.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -60.51 92.05 0.02 OUTLIER 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.932 1.293 . . . . 0.0 109.457 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.255 9.6 p 39.25 -67.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 131.66 3.984 . . . . 0.0 116.346 -167.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.7 ttp -54.99 151.44 8.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.864 1.211 . . . . 0.0 112.931 -158.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 64.93 34.51 8.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.534 1.534 . . . . 0.0 109.52 -158.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.24 103.6 0.51 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.493 1.917 . . . . 0.0 110.771 -165.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -94.19 139.95 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.731 1.62 . . . . 0.0 111.474 -169.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -64.6 -7.01 8.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.608 -1.308 . . . . 0.0 112.392 170.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.93 -41.48 11.58 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.186 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.47 -27.89 17.16 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 172.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.0 mtt -63.25 -4.99 2.87 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.825 -1.172 . . . . 0.0 111.447 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.68 -25.68 67.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.237 1.415 . . . . 0.0 113.11 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.407 ' CE2' HG13 ' A' ' 65' ' ' VAL . 33.2 m-85 -80.74 -154.98 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.076 1.35 . . . . 0.0 110.821 -168.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.29 -170.12 0.71 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 158.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.262 18.6 tt -31.05 -67.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.895 1.678 . . . . 0.0 113.275 -159.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 14.1 mmt 36.99 35.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.263 2.625 . . . . 0.0 114.485 167.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.79 -68.49 0.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 171.13 6.78 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.745 1.618 . . . . 0.0 107.629 158.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.21 128.94 17.4 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 109.685 -0.929 . . . . 0.0 109.685 -20.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 m -106.45 114.3 28.33 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -164.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.3 mm -132.3 124.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -159.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.08 128.06 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 168.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.06 161.49 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.3 m120 45.69 -92.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.708 1.203 . . . . 0.0 111.306 -170.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.21 1.31 3.37 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.25 160.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.08 115.08 27.74 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.599 1.56 . . . . 0.0 111.503 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 HG13 ' CE2' ' A' ' 51' ' ' TYR . 8.0 p -57.36 141.09 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.001 1.32 . . . . 0.0 109.843 159.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -178.7 -178.68 0.59 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 106.395 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -139.13 -36.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.77 1.228 . . . . 0.0 112.217 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.274 31.9 mm 49.71 -74.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 127.398 2.279 . . . . 0.0 112.133 -160.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.92 -176.6 25.68 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.732 1.151 . . . . 0.0 114.142 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' H ' ' HD2' ' A' ' 71' ' ' PRO . . . -77.25 -47.44 2.59 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.909 1.284 . . . . 0.0 108.7 158.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD2' ' H ' ' A' ' 70' ' ' ALA . 72.6 Cg_endo -65.76 174.97 4.89 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 CA-C-N 120.756 1.306 . . . . 0.0 108.826 158.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.22 178.5 0.51 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.551 -0.718 . . . . 0.0 112.068 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -68.05 64.84 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.393 1.877 . . . . 0.0 113.776 -159.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.282 -0.886 . . . . 0.0 111.816 -160.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.7 79.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.946 0.794 . . . . 0.0 110.726 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -29.57 62.47 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.88 175.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.13 -46.56 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.818 1.645 . . . . 0.0 109.106 166.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -3.8 3.85 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.967 1.707 . . . . 0.0 112.538 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.46 -45.52 2.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.698 1.599 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 pt -61.65 -23.66 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.998 1.272 . . . . 0.0 110.881 171.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -43.03 74.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.269 0.941 . . . . 0.0 111.857 169.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.272 0.4 OUTLIER -81.97 -53.74 5.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.334 0.515 . . . . 0.0 110.736 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -155.09 -77.22 0.1 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.243 0.733 1 C-N-CA 132.379 4.272 . . . . 0.0 104.902 167.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 37.5 mtt . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t -148.12 -43.93 0.16 Allowed 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.636 -0.665 . . . . 0.0 110.616 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt 57.65 91.76 0.04 OUTLIER 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.518 1.527 . . . . 0.0 111.859 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -158.95 87.24 2.22 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.7 35.67 0.52 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.53 2.82 . . . . 0.0 112.287 -172.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.2 ttt 56.63 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.304 3.442 . . . . 0.0 114.893 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -78.15 -84.92 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.662 -1.637 . . . . 0.0 109.579 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.06 78.98 2.45 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.883 2.388 . . . . 0.0 111.188 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -129.2 28.51 5.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.54 1.136 . . . . 0.0 110.586 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.6 m -132.63 -57.55 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.799 1.24 . . . . 0.0 108.269 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.2 85.33 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.805 1.67 . . . . 0.0 109.027 164.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.03 116.53 16.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.94 86.96 4.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 21.3 m-85 -73.04 156.55 38.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.861 0.839 . . . . 0.0 111.631 -169.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.434 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.07 38.6 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.75 -31.47 5.62 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.36 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.75 -40.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.41 1.459 . . . . 0.0 109.518 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -56.99 -23.17 44.12 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.89 0.768 . . . . 0.0 112.056 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -4.35 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 C--O 1.252 1.206 0 CA-C-N 120.062 1.301 . . . . 0.0 109.529 -176.681 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.3 m -154.26 155.35 35.03 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.511 1.525 . . . . 0.0 107.066 155.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -139.96 157.89 44.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.471 1.032 . . . . 0.0 111.494 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.38 160.33 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.859 1.264 . . . . 0.0 109.56 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 154.84 46.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 167.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.12 149.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 108.636 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -135.12 150.65 50.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.662 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.08 91.56 3.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.889 2.476 . . . . 0.0 106.678 167.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -94.67 82.25 3.93 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.4 p -140.43 169.87 16.86 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.093 -1.004 . . . . 0.0 109.792 -175.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 t -164.36 -59.45 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.355 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -59.64 133.68 53.02 Favored 'Trans proline' 0 C--N 1.353 0.778 0 N-CA-C 108.211 -1.496 . . . . 0.0 108.211 166.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.8 mtp -139.11 -171.29 3.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.027 2.131 . . . . 0.0 108.773 -170.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.272 85.5 m 119.33 -75.96 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.575 1 C-N-CA 132.134 4.174 . . . . 0.0 107.611 -175.502 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.35 -4.44 9.37 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.433 2.089 . . . . 0.0 113.744 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -141.13 56.12 1.55 Allowed 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 124.877 1.271 . . . . 0.0 109.381 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.9 m -56.52 -53.82 60.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.097 168.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.59 61.55 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.136 1.891 . . . . 0.0 110.643 177.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 -81.45 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.792 . . . . 0.0 111.617 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -19.43 45.37 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.372 -0.83 . . . . 0.0 112.003 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -65.03 -59.95 3.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.889 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -54.73 -45.39 74.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.18 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.24 -37.27 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 118.271 -1.372 . . . . 0.0 110.061 -174.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.251 3.3 p -67.36 -33.6 63.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 O-C-N 119.565 -1.96 . . . . 0.0 110.843 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.05 -53.84 53.09 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 120.928 1.694 . . . . 0.0 110.185 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.98 -60.69 2.12 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.98 2.512 . . . . 0.0 109.566 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.2 -40.58 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -25.91 64.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.8 -0.619 . . . . 0.0 110.241 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -38.39 -54.85 1.43 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.368 0.667 . . . . 0.0 111.009 165.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.28 -24.68 16.09 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.414 1.085 . . . . 0.0 112.797 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 46.7 mtt -144.74 78.61 12.77 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.271 1.028 . . . . 0.0 109.416 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.13 34.77 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.981 3.12 . . . . 0.0 113.054 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.97 -48.83 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.132 0.973 . . . . 0.0 109.294 -175.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.49 14.7 0.12 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.9 -1.048 . . . . 0.0 113.046 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.3 t -111.84 103.14 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 120.725 1.602 . . . . 0.0 107.488 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -76.76 96.59 4.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.76 153.29 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.547 0.612 . . . . 0.0 110.285 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.15 146.94 39.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.242 0.474 . . . . 0.0 110.409 158.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -107.74 69.92 0.76 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.744 2.418 . . . . 0.0 107.521 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.89 84.86 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 128.03 34.29 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 110.664 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -74.3 120.3 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.7 mmt -177.98 -74.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 -166.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -132.96 92.91 3.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -144.58 133.01 10.88 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.031 -0.985 . . . . 0.0 108.963 -159.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.03 152.01 74.32 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.125 1.883 . . . . 0.0 111.424 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.91 5.8 0.2 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -11.27 8.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 121.169 1.804 . . . . 0.0 115.363 -171.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.534 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -92.85 -33.57 14.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.969 2.622 . . . . 0.0 115.778 159.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtt -69.0 -6.84 30.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -64.09 -25.49 68.12 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.165 0.986 . . . . 0.0 111.664 163.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 16.1 m-85 -84.13 153.44 23.71 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.664 0.786 . . . . 0.0 110.587 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.74 42.49 1.54 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.949 1.261 . . . . 0.0 113.111 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tp -138.87 -52.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.8 1.64 . . . . 0.0 108.243 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 32.2 mtt 58.51 -2.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.421 2.288 . . . . 0.0 115.782 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.29 -161.06 0.2 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.65 1.98 . . . . 0.0 111.796 -175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -155.58 159.36 31.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.388 2.275 . . . . 0.0 106.27 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.94 109.66 1.23 Allowed 'Cis proline' 0 C--N 1.35 0.617 0 CA-C-N 121.069 1.418 . . . . 0.0 110.829 -9.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -93.19 132.86 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.508 ' HB ' ' HE2' ' A' ' 73' ' ' LYS . 20.4 mm -134.91 146.32 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -168.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.63 121.09 66.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.572 HG13 ' HZ3' ' A' ' 73' ' ' LYS . 2.7 pp -109.36 145.24 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 125.155 1.535 . . . . 0.0 108.082 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 57.97 -45.96 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.036 2.135 . . . . 0.0 115.749 -169.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.69 -11.67 0.3 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 130.326 3.822 . . . . 0.0 109.982 -168.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -91.51 124.15 35.46 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.316 2.247 . . . . 0.0 113.173 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.4 HG23 ' CD2' ' A' ' 51' ' ' TYR . 12.3 p -75.18 149.92 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.573 0.749 . . . . 0.0 110.354 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.502 ' CB ' ' HZ1' ' A' ' 73' ' ' LYS . 3.6 tp10 -178.44 171.64 1.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.764 2.026 . . . . 0.0 108.471 173.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.33 139.03 40.58 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.365 1.066 . . . . 0.0 109.473 167.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 mm -121.54 71.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 122.495 1.14 . . . . 0.0 108.315 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.04 -164.26 26.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 122.456 1.031 . . . . 0.0 113.431 160.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.62 6.02 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 116.273 -1.822 . . . . 0.0 115.801 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.13 -111.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 CA-C-N 123.122 2.151 . . . . 0.0 108.769 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.6 p -126.0 -116.99 0.27 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 121.561 1.982 . . . . 0.0 107.794 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.572 ' HZ3' HG13 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -92.11 14.84 14.85 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.075 1.75 . . . . 0.0 113.49 172.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -30.36 -50.49 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.021 2.601 . . . . 0.0 118.021 -163.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.93 -43.62 78.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.464 1.029 . . . . 0.0 111.766 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 -34.11 68.65 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.333 0.653 . . . . 0.0 109.969 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -48.65 -53.87 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.908 1.683 . . . . 0.0 108.37 171.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -67.62 -16.19 64.04 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.745 -0.597 . . . . 0.0 112.293 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.58 -49.19 9.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.311 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -60.44 -35.23 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 120.221 1.373 . . . . 0.0 109.885 174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.15 -19.69 47.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.542 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.255 0.0 OUTLIER -91.15 -67.5 0.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 109.145 159.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 -142.17 -71.77 0.33 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.384 1.074 . . . . 0.0 108.876 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.735 0 C-N-CA 131.441 3.896 . . . . 0.0 103.884 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 42.3 mtt . . . . . 0 C--O 1.239 0.505 0 CA-C-O 121.661 0.743 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.6 m -167.75 151.0 6.0 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 129.939 3.296 . . . . 0.0 105.657 168.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -129.12 162.12 28.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.381 0.991 . . . . 0.0 111.476 170.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.34 133.23 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -124.47 117.31 24.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.088 0.858 . . . . 0.0 109.559 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.42 150.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 125.963 1.705 . . . . 0.0 107.681 -172.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -140.02 139.05 35.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.21 78.18 1.13 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -80.26 88.38 5.51 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.673 1.225 . . . . 0.0 107.761 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.8 p -141.75 -149.22 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -166.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.6 t 160.11 -65.81 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 128.857 2.863 . . . . 0.0 108.087 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -61.99 150.35 86.71 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 CA-C-N 120.721 1.293 . . . . 0.0 110.866 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.1 mtm -140.61 159.24 42.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.281 2.232 . . . . 0.0 107.523 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.6 m 141.84 -72.31 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.304 1 C-N-CA 131.906 4.082 . . . . 0.0 107.201 -168.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -67.53 -19.61 48.42 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.378 2.052 . . . . 0.0 112.044 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -133.03 162.4 31.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 160.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -115.65 -82.1 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 115.911 -1.995 . . . . 0.0 105.945 158.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.94 -22.33 37.85 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.497 3.464 . . . . 0.0 117.791 -161.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 44.18 -100.1 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.813 2.045 . . . . 0.0 112.344 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.85 72.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.538 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -61.01 -37.07 81.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.437 1.471 . . . . 0.0 111.413 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -66.53 -51.74 53.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.685 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.35 -32.06 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 118.487 -1.285 . . . . 0.0 110.187 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -63.86 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 117.703 -1.142 . . . . 0.0 108.768 165.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -58.93 -38.5 79.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.81 1.186 . . . . 0.0 111.048 -170.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.75 -53.96 50.97 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 110.155 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.33 -39.35 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.63 68.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.56 1.544 . . . . 0.0 111.814 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.561 ' ND2' ' HZ3' ' A' ' 81' ' ' LYS . 25.4 t-20 -52.77 -39.88 62.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.918 0.887 . . . . 0.0 110.012 169.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -93.49 -46.93 7.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.899 1.28 . . . . 0.0 111.495 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.33 87.35 47.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 126.009 1.724 . . . . 0.0 108.099 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.59 13.0 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.889 2.393 . . . . 0.0 112.877 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -142.57 -55.02 0.42 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -162.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.23 48.46 1.49 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.611 -0.68 . . . . 0.0 110.991 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.36 83.43 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.563 1.145 . . . . 0.0 108.921 -164.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.38 128.88 35.52 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -146.59 97.15 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 125.551 1.54 . . . . 0.0 107.067 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -80.08 144.09 33.43 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 109.837 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.39 115.57 29.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.258 0.2 OUTLIER -129.26 86.45 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -54.86 127.14 27.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 159.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 p -50.85 143.23 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.674 1.59 . . . . 0.0 112.075 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 ttt -142.19 -82.23 0.2 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 173.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.13 -2.82 26.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.478 1.111 . . . . 0.0 112.595 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.1 t30 35.83 57.76 2.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 127.432 2.293 . . . . 0.0 112.398 -168.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.74 137.22 37.99 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.182 1.255 . . . . 0.0 109.841 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -59.87 -20.71 58.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 116.32 -1.8 . . . . 0.0 112.182 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.34 -47.76 0.86 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.045 1.293 . . . . 0.0 112.332 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.1 -33.47 15.45 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 117.233 2.309 . . . . 0.0 117.233 169.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.65 3.21 26.21 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.318 -0.864 . . . . 0.0 112.89 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.27 -143.67 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.929 2.091 . . . . 0.0 109.51 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CE2' HG21 ' A' ' 65' ' ' VAL . 10.0 m-85 68.86 -167.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 0.0 111.192 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 5.74 81.92 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.067 0.842 . . . . 0.0 113.458 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.96 -59.58 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.958 1.303 . . . . 0.0 107.912 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtm 49.7 13.27 0.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.703 1.601 . . . . 0.0 114.818 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.58 106.09 5.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.391 1.476 . . . . 0.0 109.638 -168.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 m -56.69 158.03 9.21 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.022 . . . . 0.0 111.596 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.33 112.71 1.76 Allowed 'Cis proline' 0 C--N 1.354 0.828 0 CA-C-N 121.024 1.401 . . . . 0.0 111.066 -0.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.6 m -86.94 110.67 20.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.232 1.413 . . . . 0.0 107.266 -169.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 mm -115.45 152.05 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.75 132.88 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 164.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.417 HG13 ' HE3' ' A' ' 73' ' ' LYS . 2.5 pp -122.48 153.69 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 161.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 47.35 -69.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.9 2.88 . . . . 0.0 113.259 -171.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.77 4.05 0.24 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.6 2.048 . . . . 0.0 113.78 162.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.95 120.25 31.81 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 126.753 2.021 . . . . 0.0 110.106 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.433 HG21 ' CE2' ' A' ' 51' ' ' TYR . 7.2 p -72.82 133.7 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.799 0.727 . . . . 0.0 109.298 166.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 4.0 tp10 -161.56 163.05 30.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.244 1.817 . . . . 0.0 108.403 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -126.25 153.63 44.48 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 159.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm -141.99 149.0 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.71 -167.13 30.13 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 122.291 0.939 . . . . 0.0 113.312 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.61 -34.18 0.98 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 116.761 -1.59 . . . . 0.0 115.14 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.93 -109.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.282 1.851 . . . . 0.0 110.757 -164.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.3 p -114.72 -146.72 0.41 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 159.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HZ2' ' HB3' ' A' ' 66' ' ' GLU . 4.8 ttpt -79.08 20.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.051 -1.656 . . . . 0.0 111.42 -169.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -61.62 -28.94 69.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -158.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -48.98 -48.52 43.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.41 1.084 . . . . 0.0 112.422 165.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.72 -33.83 40.59 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 117.014 -1.47 . . . . 0.0 109.913 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . 0.291 2.6 m -68.29 -37.92 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 122.724 2.511 . . . . 0.0 110.961 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.56 -19.54 3.95 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.245 2.218 . . . . 0.0 111.257 165.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.97 -46.0 7.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.788 166.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.0 pt -53.73 -28.99 17.13 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-N 122.266 2.303 . . . . 0.0 112.092 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.561 ' HZ3' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -62.0 -79.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.355 164.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -16.23 25.07 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -170.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.41 -10.35 50.44 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.378 173.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.245 0.855 0 CA-C-N 120.867 1.667 . . . . 0.0 108.707 170.51 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.25 103.28 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.47 123.7 31.21 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.839 0.856 . . . . 0.0 110.221 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.89 141.2 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -134.83 146.96 49.77 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -128.93 88.38 2.71 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.579 1.551 . . . . 0.0 106.968 -173.369 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CG ' ' HB3' ' A' ' 48' ' ' ALA . 16.5 t80 -105.92 93.9 4.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.821 1.249 . . . . 0.0 107.869 -175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.586 HG21 ' HB3' ' A' ' 57' ' ' PRO . 2.4 m -177.72 156.84 1.16 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.588 2.355 . . . . 0.0 105.587 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 160.568 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.459 -0.511 0 CA-C-O 119.273 -0.386 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 46.88 -118.46 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.386 1.475 . . . . 0.0 110.159 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.54 65.09 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.648 -1.168 . . . . 0.0 111.981 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -62.29 -44.08 97.34 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.934 1.243 . . . . 0.0 110.431 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -66.07 -52.26 50.51 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.471 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.55 -41.53 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 117.827 -1.082 . . . . 0.0 109.452 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 p -62.5 -51.02 77.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.431 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -41.8 94.67 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.664 1.575 . . . . 0.0 110.08 -175.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.11 -50.6 71.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.776 1.23 . . . . 0.0 110.037 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.1 m -77.17 -29.66 17.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.85 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.13 64.36 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 120.292 1.405 . . . . 0.0 110.622 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.83 -44.29 90.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.855 0.752 . . . . 0.0 110.506 168.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.95 -55.01 9.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.734 2.014 . . . . 0.0 110.343 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.7 mmt -134.22 85.29 39.4 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 127.414 2.285 . . . . 0.0 109.265 -167.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.01 39.02 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.644 3.562 . . . . 0.0 111.747 -172.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -178.19 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.023 0.929 . . . . 0.0 110.709 -171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.7 48.02 0.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.746 0.703 . . . . 0.0 110.963 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.35 134.41 64.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -128.44 131.73 48.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.52 110.73 20.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.728 0.811 . . . . 0.0 109.225 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.33 102.38 15.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.56 96.56 10.13 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -112.35 85.12 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.05 116.44 2.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.13 99.86 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.824 0.821 . . . . 0.0 110.868 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.5 156.6 0.94 Allowed 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 134.129 4.972 . . . . 0.0 103.782 -178.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 36.69 54.56 1.13 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.914 2.086 . . . . 0.0 114.186 163.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.35 154.73 0.92 Allowed Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 127.469 2.308 . . . . 0.0 109.384 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.04 160.4 33.45 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 -170.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -78.96 25.72 0.27 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.01 1.324 . . . . 0.0 111.339 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -25.09 63.01 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB3' ' CG ' ' A' ' 8' ' ' PHE . . . -91.71 -36.56 13.52 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 167.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmm -73.2 -6.45 45.92 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.218 1.007 . . . . 0.0 113.151 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.29 -119.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.565 0.746 . . . . 0.0 109.023 158.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.8 m-30 60.59 -171.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.728 1.611 . . . . 0.0 110.309 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.71 -14.3 80.01 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.173 171.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.49 -49.97 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 109.16 -170.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.9 mtm 41.29 46.93 2.88 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.678 2.391 . . . . 0.0 111.365 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 106.89 1.64 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.515 1.126 . . . . 0.0 109.075 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -59.7 158.26 23.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.548 0.739 . . . . 0.0 111.804 168.007 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.586 ' HB3' HG21 ' A' ' 9' ' ' THR . 60.8 Cg_endo -74.33 118.49 5.15 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.245 0.766 . . . . 0.0 110.59 -6.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -86.63 116.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 107.4 -170.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 72' ' ' THR . 24.8 mm -134.11 140.85 45.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 121.031 -1.043 . . . . 0.0 108.592 -168.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.51 129.79 69.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.61 146.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 45.77 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 129.857 3.263 . . . . 0.0 116.877 -159.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 169.76 -10.29 0.05 OUTLIER Glycine 0 CA--C 1.542 1.72 1 C-N-CA 131.252 4.263 . . . . 0.0 110.906 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -91.07 132.68 35.88 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 120.218 2.009 . . . . 0.0 111.247 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.03 127.11 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.613 1.965 . . . . 0.0 108.727 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -161.22 -179.69 7.65 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 -171.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.75 129.32 6.05 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -140.17 92.82 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 118.541 0.61 . . . . 0.0 109.643 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.21 -177.4 17.26 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.541 1.067 . . . . 0.0 112.171 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.98 -50.06 33.73 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.976 -1.011 . . . . 0.0 111.104 161.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -68.38 178.52 3.66 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.171 1.454 . . . . 0.0 110.673 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.572 HG22 HD11 ' A' ' 59' ' ' ILE . 5.2 p -58.14 -173.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.878 2.471 . . . . 0.0 111.322 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -70.41 39.65 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.281 1.832 . . . . 0.0 113.957 -163.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.81 -38.49 78.74 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.925 1.69 . . . . 0.0 111.697 -168.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.26 68.67 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.292 1.037 . . . . 0.0 113.085 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -26.6 26.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.532 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.1 -36.26 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 120.582 -1.324 . . . . 0.0 109.781 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -60.75 -6.57 1.8 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.235 2.614 . . . . 0.0 113.624 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.4 -36.13 2.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.537 1.535 . . . . 0.0 112.469 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pt -61.43 -30.99 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.568 1.531 . . . . 0.0 109.13 165.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -64.88 -22.15 66.94 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.699 1.136 . . . . 0.0 113.897 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -46.96 7.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.928 0.891 . . . . 0.0 110.244 -168.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.303 0 C-N-CA 127.184 2.194 . . . . 0.0 105.786 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.84 105.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 108.637 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -89.96 113.94 25.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.427 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.9 mt -126.27 140.47 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.08 138.71 40.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.43 90.68 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.066 1.346 . . . . 0.0 107.75 -174.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -105.81 76.41 1.18 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.54 1.638 . . . . 0.0 107.004 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.2 m -147.39 164.79 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 CA--C 1.538 0.696 0 CA-C-O 120.836 0.265 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.35 -74.84 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.909 1.684 . . . . 0.0 112.715 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -23.1 67.29 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.513 -0.742 . . . . 0.0 112.389 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -54.18 11.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -65.88 -34.97 79.36 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.612 -1.185 . . . . 0.0 111.054 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 26' ' ' VAL . 76.9 t -58.49 -50.27 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.938 1.245 . . . . 0.0 109.512 174.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.34 -33.29 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 120.869 1.668 . . . . 0.0 112.341 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.54 -47.05 80.22 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.217 1.007 . . . . 0.0 109.385 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -57.99 -49.66 76.08 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.875 1.67 . . . . 0.0 110.192 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 5' ' ' ILE . 11.0 m -79.88 -25.24 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.23 -25.41 67.67 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 120.631 1.559 . . . . 0.0 110.129 174.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.28 -13.83 9.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.51 -57.53 1.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.331 1.852 . . . . 0.0 110.055 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.1 mtt -118.87 90.34 40.49 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 108.089 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.9 13.28 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.532 2.821 . . . . 0.0 115.32 -166.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -177.78 -26.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.89 1.677 . . . . 0.0 112.742 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.75 -9.1 17.74 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.28 1.855 . . . . 0.0 111.809 161.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.86 137.71 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.829 1.252 . . . . 0.0 110.942 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -136.68 98.63 3.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.41 99.43 8.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -78.64 117.89 20.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 118.77 30.1 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 84.62 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -60.41 119.52 8.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.221 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.62 110.52 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.5 mtm -140.84 -56.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.03 -16.04 60.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.309 1.444 . . . . 0.0 111.082 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.0 t30 35.98 58.71 3.1 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 127.888 2.475 . . . . 0.0 113.06 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.31 145.49 59.92 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.641 2.894 . . . . 0.0 112.737 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.45 -18.41 18.21 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.717 0.807 . . . . 0.0 112.771 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -39.4 63.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 112.857 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.58 -40.62 11.23 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.201 0.909 . . . . 0.0 112.423 163.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.5 mmm -64.38 -5.87 6.06 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -64.51 -24.04 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.5 1.52 . . . . 0.0 112.133 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -62.34 161.0 12.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.756 1.222 . . . . 0.0 111.563 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.68 -39.81 93.81 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.255 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.407 HD11 ' HB3' ' A' ' 55' ' ' ALA . 4.7 tp -52.34 -58.14 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.088 0.944 . . . . 0.0 111.195 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.0 mtt 55.15 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.198 2.599 . . . . 0.0 116.496 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 53' ' ' ILE . . . -73.13 -171.05 0.84 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.73 2.012 . . . . 0.0 111.966 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.74 136.98 19.11 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.9 159.33 72.61 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 C-N-CA 125.117 -0.785 . . . . 0.0 111.099 -8.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -122.08 128.9 51.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.14 162.83 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.84 136.85 55.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 165.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.426 HD13 HG22 ' A' ' 80' ' ' ILE . 1.8 pp -127.17 146.82 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.822 1.192 . . . . 0.0 108.387 169.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.3 t30 51.61 -36.9 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 130.103 3.361 . . . . 0.0 117.267 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.34 -8.58 0.04 OUTLIER Glycine 0 CA--C 1.541 1.71 1 C-N-CA 131.158 4.218 . . . . 0.0 110.928 167.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -91.76 120.36 32.42 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 126.358 1.863 . . . . 0.0 112.465 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.03 143.36 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.945 1.298 . . . . 0.0 107.885 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -178.29 166.59 1.9 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.486 1.514 . . . . 0.0 109.743 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.91 148.92 44.22 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.682 1.193 . . . . 0.0 109.074 165.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.02 137.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -177.93 51.82 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.371 0.532 . . . . 0.0 113.743 168.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.01 -45.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.143 1.377 . . . . 0.0 112.616 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.09 -172.48 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.327 1.51 . . . . 0.0 109.59 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 p -65.33 -163.17 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.515 -0.741 . . . . 0.0 110.926 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.79 27.82 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -158.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -29.3 -53.3 0.12 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.157 3.783 . . . . 0.0 113.654 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.75 -54.6 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.302 1.041 . . . . 0.0 111.503 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -27.33 62.4 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.609 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -42.84 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 120.138 1.336 . . . . 0.0 109.327 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.91 -12.9 41.19 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.691 -0.63 . . . . 0.0 111.971 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.43 -39.0 8.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.201 1.401 . . . . 0.0 111.689 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.426 HG22 HD13 ' A' ' 61' ' ' ILE . 2.9 pt -56.45 -41.28 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 121.395 1.907 . . . . 0.0 110.015 174.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -19.96 61.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -30.17 30.79 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.753 1.615 . . . . 0.0 109.406 173.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 125.388 1.475 . . . . 0.0 111.807 175.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.5 tptt . . . . . 0 C--O 1.235 0.337 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 62' ' ' ASN . 93.2 t -87.21 149.69 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -128.8 115.74 18.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.472 HD13 HG11 ' A' ' 26' ' ' VAL . 1.4 mp -101.95 144.02 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 163.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -142.08 157.25 45.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.33 88.29 2.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.403 1.481 . . . . 0.0 109.016 -167.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -109.51 105.72 15.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -178.93 169.02 1.61 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 109.84 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 127.253 2.221 . . . . 0.0 107.375 170.866 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 CA--C 1.54 0.81 0 CA-C-O 119.176 -0.427 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.37 -125.41 0.55 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.936 2.095 . . . . 0.0 110.87 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.17 -32.13 6.61 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.306 -1.33 . . . . 0.0 113.449 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -56.38 -47.33 79.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.087 2.221 . . . . 0.0 111.332 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.9 -36.09 37.01 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 116.178 -1.868 . . . . 0.0 112.426 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.427 HG12 HG21 ' A' ' 5' ' ' ILE . 2.1 t -66.35 -31.74 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 CA-C-N 120.088 1.313 . . . . 0.0 108.455 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HA ' HG11 ' A' ' 36' ' ' VAL . 53.2 t -59.78 -55.9 20.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 119.668 -1.895 . . . . 0.0 110.538 166.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -54.9 -42.36 72.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.297 1.408 . . . . 0.0 110.966 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.09 -71.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.696 2.399 . . . . 0.0 109.679 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HB ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -76.12 -21.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 118.386 -1.325 . . . . 0.0 113.338 -175.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.27 68.67 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -58.36 -28.41 65.1 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.445 1.02 . . . . 0.0 112.54 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -83.12 -64.45 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 108.967 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.1 mmt -131.05 85.73 53.82 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 124.743 1.217 . . . . 0.0 110.396 -166.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 69.44 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.3 2.666 . . . . 0.0 107.837 163.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -179.14 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.033 2.533 . . . . 0.0 106.941 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.16 4.27 46.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -160.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG21 ' HB ' ' A' ' 26' ' ' VAL . 2.5 t -103.91 114.98 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.585 -168.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -77.43 152.45 34.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -152.52 57.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.485 1.914 . . . . 0.0 108.024 -169.175 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -64.92 136.6 57.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -172.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -115.66 102.77 10.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 77.85 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.458 1.123 . . . . 0.0 108.928 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -62.18 147.24 48.35 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.486 -0.759 . . . . 0.0 112.479 -173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.15 93.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 ttp -153.01 -62.98 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.18 1.792 . . . . 0.0 107.331 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -145.19 11.18 1.33 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.664 0.786 . . . . 0.0 111.371 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -76.42 148.79 80.83 Favored Pre-proline 0 C--O 1.238 0.49 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.89 139.84 63.97 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.137 2.558 . . . . 0.0 110.337 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -69.25 19.26 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.977 1.711 . . . . 0.0 113.45 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -34.2 45.29 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.147 1.379 . . . . 0.0 114.594 -169.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.07 18.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -26.07 65.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.504 1.522 . . . . 0.0 112.578 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.32 -17.52 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.624 1.102 . . . . 0.0 113.565 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -66.87 145.36 55.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.739 1.616 . . . . 0.0 109.535 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.35 -29.77 31.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tp -54.11 -44.59 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.17 1.485 . . . . 0.0 111.221 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 45.6 mtm 41.61 32.74 0.26 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.677 2.391 . . . . 0.0 114.206 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.07 -178.26 3.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.736 1.615 . . . . 0.0 110.352 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.29 160.08 61.21 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.384 1.474 . . . . 0.0 109.96 -161.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.59 126.2 9.19 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 CA-C-N 119.406 0.823 . . . . 0.0 110.325 -12.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 m -78.01 80.99 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.634 1.974 . . . . 0.0 106.706 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.12 154.92 3.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.8 128.4 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.449 ' CG2' ' HE3' ' A' ' 73' ' ' LYS . 44.0 pt -128.13 143.01 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.225 1.01 . . . . 0.0 110.745 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.605 ' HA ' HG13 ' A' ' 3' ' ' VAL 0.259 34.5 t30 47.23 -50.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.035 2.934 . . . . 0.0 115.982 -163.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.69 -14.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.562 1.553 . . . . 0.0 112.233 159.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.82 152.75 19.97 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 120.514 2.157 . . . . 0.0 112.483 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.43 161.35 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.053 0.541 . . . . 0.0 109.678 173.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -178.62 165.51 1.69 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.382 2.273 . . . . 0.0 108.135 160.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.96 154.48 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 166.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.553 HG21 ' HB3' ' A' ' 75' ' ' ALA . 12.0 mm -130.16 78.82 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.79 -163.71 35.23 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.73 7.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 116.642 -1.647 . . . . 0.0 115.208 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.14 177.67 7.93 Favored 'Trans proline' 0 C--N 1.355 0.87 0 CA-C-N 122.776 2.027 . . . . 0.0 109.946 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -60.93 -173.2 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.41 1.084 . . . . 0.0 109.654 160.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' C ' HG23 ' A' ' 77' ' ' VAL . 4.0 tppt? -74.81 19.85 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 119.657 -1.902 . . . . 0.0 113.996 -159.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -29.35 -49.57 0.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 130.55 3.54 . . . . 0.0 116.534 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.553 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -60.37 -50.79 72.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.653 1.115 . . . . 0.0 110.907 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.04 -28.25 61.32 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.254 -1.355 . . . . 0.0 111.273 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.46 HG23 ' C ' ' A' ' 73' ' ' LYS . 56.1 t -54.87 -53.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.899 1.227 . . . . 0.0 108.297 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -63.33 -28.57 70.1 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.889 -0.507 . . . . 0.0 111.745 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.17 -67.07 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.792 -0.568 . . . . 0.0 110.045 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -60.32 -25.99 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.585 1.084 . . . . 0.0 112.772 -167.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.6 -31.5 71.58 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.038 1.29 . . . . 0.0 113.949 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.68 47.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.343 1.429 . . . . 0.0 109.408 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 129.717 3.207 . . . . 0.0 103.402 -175.387 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.47 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 57' ' ' PRO . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 N-CA-C 116.502 1.693 . . . . 0.0 116.502 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG21 ' A' ' 65' ' ' VAL . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' HG22 ' A' ' 9' ' ' THR . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 8' ' ' PHE . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' CG2' ' A' ' 80' ' ' ILE . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' CE2' ' A' ' 51' ' ' TYR . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.61 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.415 ' CG2' HD12 ' A' ' 61' ' ' ILE . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.47 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 57' ' ' PRO . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 N-CA-C 116.502 1.693 . . . . 0.0 116.502 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG21 ' A' ' 65' ' ' VAL . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' HG22 ' A' ' 9' ' ' THR . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 8' ' ' PHE . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' CG2' ' A' ' 80' ' ' ILE . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' CE2' ' A' ' 51' ' ' TYR . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.61 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.415 ' CG2' HD12 ' A' ' 61' ' ' ILE . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 tttp . . . . . 0 C--O 1.234 0.274 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.51 112.79 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 130.59 36.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 159.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.731 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.0 mt -123.68 145.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 158.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -136.69 152.18 50.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mp -126.95 79.84 1.91 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -76.82 85.08 3.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' ASN . 37.4 p -136.5 166.2 24.07 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.537 -1.352 . . . . 0.0 109.745 -164.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.534 0.355 0 O-C-N 120.064 -1.648 . . . . 0.0 110.339 -178.493 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 N--CA 1.457 -0.664 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.83 -143.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 130.381 3.472 . . . . 0.0 103.223 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.22 -42.86 4.47 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.977 1.311 . . . . 0.0 112.895 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -55.86 -49.83 72.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.949 0.795 . . . . 0.0 112.283 176.09 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -58.81 -60.6 3.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.647 ' O ' HG22 ' A' ' 26' ' ' VAL . 3.6 t -57.32 -41.01 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 O-C-N 125.259 1.599 . . . . 0.0 108.936 -167.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.451 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -44.34 92.03 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 121.253 1.842 . . . . 0.0 110.146 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.91 -35.64 78.97 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.294 3.038 . . . . 0.0 111.849 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.877 HG23 HG11 ' A' ' 34' ' ' VAL . 19.2 m -105.72 -20.57 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -23.74 67.49 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 120.543 1.519 . . . . 0.0 110.173 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -47.95 -44.5 30.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.986 0.515 . . . . 0.0 112.03 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.06 -41.38 14.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.216 1.006 . . . . 0.0 111.304 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.5 mtm -139.19 75.39 34.29 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 110.457 -164.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.67 43.86 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.416 3.41 . . . . 0.0 113.441 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -178.27 -53.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.241 2.217 . . . . 0.0 108.897 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.05 67.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.072 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.877 HG11 HG23 ' A' ' 26' ' ' VAL . 2.3 t -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.35 154.79 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 158.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.16 110.89 15.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.53 104.75 17.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -80.87 106.88 13.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.88 88.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -66.28 123.27 19.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.704 -178.23 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.18 113.34 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 125.7 1.6 . . . . 0.0 107.811 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 ttt -160.41 -113.14 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -68.75 -21.79 64.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.73 1.605 . . . . 0.0 111.129 166.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -52.48 111.46 2.58 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 125.379 1.472 . . . . 0.0 109.998 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 158.82 55.2 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 112.201 -163.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -64.62 19.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.216 2.206 . . . . 0.0 114.842 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -20.27 33.77 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.044 -1.66 . . . . 0.0 113.941 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.75 -35.4 14.16 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 121.122 -0.986 . . . . 0.0 112.155 166.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -8.67 55.18 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.846 -1.159 . . . . 0.0 112.441 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -61.4 -26.87 68.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.98 0.912 . . . . 0.0 111.219 167.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -70.46 132.18 45.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.363 0.665 . . . . 0.0 109.958 -176.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.83 0.29 1.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 117.004 1.562 . . . . 0.0 117.004 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 tp -64.54 -50.22 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.026 1.913 . . . . 0.0 109.258 161.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.8 mtt 51.25 -8.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 130.938 3.695 . . . . 0.0 117.164 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.84 -172.15 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 110.447 163.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.403 ' HA ' ' N ' ' A' ' 58' ' ' THR . 7.2 p -178.05 144.66 0.51 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.863 1.665 . . . . 0.0 106.942 -158.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.17 108.24 0.26 Allowed 'Cis proline' 0 C--N 1.355 0.902 0 CA-C-N 122.157 1.806 . . . . 0.0 114.844 6.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.403 ' N ' ' HA ' ' A' ' 56' ' ' VAL . 11.7 m -79.67 113.43 17.82 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.734 1.614 . . . . 0.0 107.395 -168.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mm -117.77 114.46 45.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.7 t -83.53 134.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 164.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.442 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 1.9 pp -132.0 158.25 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.052 161.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.0 -77.52 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.441 1.497 . . . . 0.0 112.335 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 64' ' ' ASP . . . -172.28 20.67 0.07 OUTLIER Glycine 0 CA--C 1.542 1.774 1 C-N-CA 131.245 4.26 . . . . 0.0 109.512 170.331 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.419 ' H ' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -90.91 151.92 20.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 131.691 3.997 . . . . 0.0 107.386 169.329 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.03 110.55 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 108.606 -164.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.93 -177.7 6.06 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.883 . . . . 0.0 111.925 -159.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.32 115.44 2.57 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.963 0.905 . . . . 0.0 108.604 158.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.556 HG21 ' HB3' ' A' ' 75' ' ' ALA . 17.9 mm -84.98 74.36 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.24 -160.27 42.07 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.904 1.28 . . . . 0.0 113.756 159.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.33 1.38 Allowed Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 115.594 -2.146 . . . . 0.0 116.581 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.63 -127.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 124.115 2.505 . . . . 0.0 109.707 170.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -115.84 -114.54 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 121.133 1.788 . . . . 0.0 107.64 167.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.442 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -91.07 5.23 49.72 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.802 1.637 . . . . 0.0 111.404 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.502 22.2 mt-10 -37.8 -49.07 1.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -158.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -63.41 -34.98 78.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 123.337 2.789 . . . . 0.0 113.018 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.55 -22.88 26.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.454 1.102 . . . . 0.0 109.316 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -34.08 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.286 -1.509 . . . . 0.0 110.266 172.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -57.11 -22.75 42.11 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.653 -0.654 . . . . 0.0 111.551 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.1 -48.34 8.15 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.93 1.292 . . . . 0.0 110.47 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -56.91 -35.34 46.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 119.869 1.213 . . . . 0.0 111.523 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -67.07 -32.83 74.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.312 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -50.07 10.86 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 118.969 0.804 . . . . 0.0 108.85 170.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 . . . . . 0 CA--C 1.529 0.158 0 C-N-CA 124.015 0.926 . . . . 0.0 110.734 173.781 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.8 tttt . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.64 113.31 33.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.73 138.41 37.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' HB ' HG12 ' A' ' 36' ' ' VAL . 4.7 mp -134.87 137.4 50.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -137.01 147.13 46.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tp -137.64 80.45 1.81 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -173.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -91.43 96.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.471 1.108 . . . . 0.0 108.081 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 t -178.62 174.35 1.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.995 2.118 . . . . 0.0 106.908 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.538 0.492 0 C-N-CA 124.968 1.307 . . . . 0.0 107.614 169.92 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 N--CA 1.455 -0.749 0 CA-C-O 121.312 0.463 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.02 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.243 2.217 . . . . 0.0 112.645 -167.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.4 73.27 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-O 116.293 -1.813 . . . . 0.0 110.807 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -52.57 -50.67 62.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.272 1.851 . . . . 0.0 109.93 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -59.12 -57.67 12.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 117.304 -1.331 . . . . 0.0 111.503 171.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.54 -36.28 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 119.556 1.071 . . . . 0.0 110.852 -169.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.545 HG12 HG11 ' A' ' 36' ' ' VAL . 4.5 m -78.18 -30.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 O-C-N 120.3 -1.5 . . . . 0.0 111.966 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.49 -44.62 95.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.989 1.268 . . . . 0.0 108.712 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.77 -56.08 26.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.288 2.235 . . . . 0.0 109.839 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 m -72.44 -28.85 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 117.684 -1.151 . . . . 0.0 112.969 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.56 -24.58 67.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.99 1.723 . . . . 0.0 111.209 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 -16.77 29.05 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -31.69 1.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.385 1.074 . . . . 0.0 111.987 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 mmt -128.86 67.91 78.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 127.171 2.189 . . . . 0.0 108.365 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.52 32.69 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 126.085 4.523 . . . . 0.0 114.248 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -178.15 -57.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.03 -1.669 . . . . 0.0 109.184 -159.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.93 14.12 0.32 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.158 1.383 . . . . 0.0 113.925 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 p -90.64 91.37 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.696 1.998 . . . . 0.0 110.019 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 81.99 3.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.16 0.984 . . . . 0.0 108.711 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.545 HG11 HG12 ' A' ' 23' ' ' VAL . 4.0 m -95.52 139.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 127.063 2.145 . . . . 0.0 110.828 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -129.12 106.45 8.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -80.64 120.86 25.11 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.16 91.9 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 122.794 1.283 . . . . 0.0 109.908 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -50.46 113.23 0.83 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.783 2.033 . . . . 0.0 110.751 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.69 110.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 163.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.5 mtp -178.97 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 129.075 2.95 . . . . 0.0 104.052 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -155.26 98.74 2.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 102.322 -3.214 . . . . 0.0 102.322 -163.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.99 155.98 31.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 121.416 -0.802 . . . . 0.0 111.59 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.67 164.15 16.68 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.845 2.364 . . . . 0.0 112.966 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -73.33 -7.29 50.98 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.977 1.311 . . . . 0.0 112.789 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.56 -37.05 3.31 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -172.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' H ' ' HD3' ' A' ' 47' ' ' LYS . . . -91.55 -28.62 17.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.136 0.88 . . . . 0.0 113.073 177.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.93 -9.61 46.52 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.502 -0.749 . . . . 0.0 111.406 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.0 -25.9 67.29 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.633 1.106 . . . . 0.0 111.04 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CD2' HG21 ' A' ' 65' ' ' VAL . 23.0 m-85 -72.3 159.25 34.36 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.098 0.951 . . . . 0.0 111.913 -163.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 131.05 47.06 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.263 0.8 OUTLIER 60.33 -23.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.07 3.348 . . . . 0.0 115.885 -177.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.8 -62.1 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.439 2.696 . . . . 0.0 111.785 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.76 -68.84 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 131.079 3.752 . . . . 0.0 112.865 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.9 t 77.85 125.03 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 128.326 2.651 . . . . 0.0 108.281 -165.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.54 165.12 76.84 Favored 'Cis proline' 0 N--CA 1.454 -0.814 0 CA-C-N 119.702 0.929 . . . . 0.0 111.878 0.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.3 m -145.38 102.16 3.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 -164.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.8 133.37 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -166.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.9 t -100.0 132.11 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pp -120.96 142.65 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 161.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 52.63 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.702 3.201 . . . . 0.0 116.617 -169.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.52 -11.51 0.74 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 129.65 3.5 . . . . 0.0 111.001 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -92.14 111.9 23.63 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.006 2.122 . . . . 0.0 111.785 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.5 p -68.37 130.96 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.316 1.046 . . . . 0.0 109.187 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.27 -176.09 5.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.352 1.861 . . . . 0.0 106.574 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -168.31 130.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.526 1.966 . . . . 0.0 109.396 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.278 1.4 mt -121.45 75.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-O 122.023 0.916 . . . . 0.0 109.824 -173.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.72 -165.96 16.67 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.327 168.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.59 11.22 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 116.968 -1.491 . . . . 0.0 114.03 167.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.25 176.54 9.04 Favored 'Trans proline' 0 C--N 1.354 0.84 0 CA-C-N 122.385 1.888 . . . . 0.0 109.932 170.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -177.47 0.42 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.873 0.869 . . . . 0.0 110.789 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.49 30.44 0.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.478 -1.389 . . . . 0.0 112.62 -161.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.314 4.0 mt-10 -64.63 -20.55 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.152 -1.593 . . . . 0.0 114.505 -161.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.2 -48.75 74.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.816 -1.178 . . . . 0.0 112.277 167.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -24.51 56.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.235 -0.916 . . . . 0.0 110.808 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -38.2 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.722 -1.236 . . . . 0.0 108.924 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -54.23 -25.84 25.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.775 1.171 . . . . 0.0 111.312 170.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.28 -57.12 4.24 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.173 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . 0.257 2.6 pt -55.7 -35.35 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.733 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -85.24 -17.22 37.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.509 -1.71 . . . . 0.0 115.453 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -32.41 73.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 122.814 2.552 . . . . 0.0 109.582 165.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 127.481 2.312 . . . . 0.0 108.175 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -75.48 111.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.38 61.8 6.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.494 1.118 . . . . 0.0 110.877 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.05 136.23 27.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.18 141.33 42.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.32 85.01 2.24 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -159.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.91 84.22 1.89 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 0.0 109.059 -165.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -138.79 -179.43 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 -167.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 120.974 1.715 . . . . 0.0 110.003 169.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo . . . . . 0 N--CA 1.452 -0.917 0 N-CA-C 106.529 -2.143 . . . . 0.0 106.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 -86.27 0.2 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.98 -40.96 59.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.91 170.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -52.23 -44.98 65.12 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -68.38 -43.54 77.13 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 120.074 1.306 . . . . 0.0 110.059 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 t -67.89 -32.38 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.43 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.5 t -53.13 -62.43 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.742 1.617 . . . . 0.0 107.815 164.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -64.25 -35.62 81.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.263 0.483 . . . . 0.0 111.358 -169.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' HG2' HG13 ' A' ' 77' ' ' VAL . 3.5 tp10 -62.49 -53.0 61.28 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.334 1.053 . . . . 0.0 110.118 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -67.14 -36.16 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -25.28 68.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.816 1.189 . . . . 0.0 112.272 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -52.16 -37.85 55.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 168.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -105.15 -55.09 2.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.556 1.542 . . . . 0.0 109.348 -165.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.6 79.48 12.54 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 127.703 2.401 . . . . 0.0 108.588 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.63 26.68 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.422 3.415 . . . . 0.0 112.777 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.14 -57.11 0.2 Allowed 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.622 -1.299 . . . . 0.0 110.751 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.03 -1.98 4.83 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -80.97 87.76 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.439 2.295 . . . . 0.0 111.495 -165.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -92.85 125.68 37.58 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 t -136.18 105.35 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.439 1.018 . . . . 0.0 110.876 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -88.64 119.28 28.96 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -88.09 122.35 31.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 98.86 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 171.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -69.14 149.25 48.85 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 116.943 -1.903 . . . . 0.0 109.021 166.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.35 123.38 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.46 -94.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.535 1.534 . . . . 0.0 107.722 -163.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.4 -36.34 83.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.823 1.647 . . . . 0.0 110.526 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 53.91 78.88 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.44 1.896 . . . . 0.0 111.504 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.48 157.26 56.73 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.018 2.479 . . . . 0.0 111.276 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -65.43 -20.32 66.32 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.75 -0.594 . . . . 0.0 111.727 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -32.1 53.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.86 -1.067 . . . . 0.0 113.817 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.54 -40.79 11.17 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.077 1.308 . . . . 0.0 113.504 163.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.4 mtp -66.09 -12.3 54.6 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.48 -20.74 66.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.863 1.665 . . . . 0.0 112.242 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.463 ' CZ ' HG11 ' A' ' 65' ' ' VAL . 4.6 m-85 -77.38 172.1 13.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.473 1.033 . . . . 0.0 109.709 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.46 -67.78 1.55 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.05 74.72 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 123.286 1.517 . . . . 0.0 108.26 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.25 36.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.604 -1.635 . . . . 0.0 114.762 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.75 -81.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.461 1.105 . . . . 0.0 113.663 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -178.45 152.7 0.8 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.26 1.424 . . . . 0.0 109.176 -168.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.95 94.32 0.13 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.577 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -20.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.0 m -72.6 108.27 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.914 1.285 . . . . 0.0 107.638 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 mm -112.94 155.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.92 142.77 42.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 168.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.289 7.8 pt -107.76 -119.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 116.583 -1.675 . . . . 0.0 111.085 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -53.57 -33.13 53.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.854 2.57 . . . . 0.0 112.439 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.53 -28.21 0.02 OUTLIER Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.336 0.97 . . . . 0.0 111.428 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.19 157.68 37.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.921 0.86 . . . . 0.0 111.317 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG11 ' CZ ' ' A' ' 51' ' ' TYR . 2.2 m -118.09 120.54 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.646 1.578 . . . . 0.0 108.18 -158.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.3 159.53 28.64 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -159.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -155.49 132.47 10.72 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.539 HG21 ' HB3' ' A' ' 75' ' ' ALA . 26.6 mm -135.26 118.73 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -168.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.06 -164.7 54.94 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 -34.79 0.75 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 116.621 -1.657 . . . . 0.0 114.434 169.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.28 -158.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 CA-C-N 122.34 1.872 . . . . 0.0 109.831 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -66.2 -171.71 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.466 -1.396 . . . . 0.0 109.818 160.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -77.17 49.06 0.66 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -158.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.69 -41.21 63.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -158.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.539 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -70.33 -41.57 73.08 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.835 -1.166 . . . . 0.0 112.136 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -77.25 -25.81 51.88 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.938 0.79 . . . . 0.0 110.923 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 25' ' ' GLU . 12.7 t -55.53 -48.03 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.863 1.665 . . . . 0.0 107.807 167.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.9 -8.25 10.62 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -100.98 -51.48 3.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.763 -1.211 . . . . 0.0 110.156 176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.7 pt -59.57 -23.06 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 O-C-N 121.262 -0.899 . . . . 0.0 111.615 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -62.46 -32.37 73.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.665 1.121 . . . . 0.0 113.219 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -42.26 10.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.578 1.081 . . . . 0.0 112.259 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 131.234 3.814 . . . . 0.0 121.022 -171.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.406 0.622 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 t -58.73 140.71 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 160.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 147.06 36.08 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 36' ' ' VAL . 31.7 mt -141.59 129.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 71.5 mt-10 -128.59 128.03 43.43 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.14 69.56 1.16 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.669 1.988 . . . . 0.0 106.029 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -81.63 83.35 7.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.451 HG22 ' CB ' ' A' ' 57' ' ' PRO . 23.6 p -128.77 179.09 5.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.94 -1.1 . . . . 0.0 108.508 -166.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 117.054 -1.45 . . . . 0.0 112.343 171.259 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 CA--C 1.544 0.976 0 N-CA-C 108.706 -1.306 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.25 -80.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.804 1.642 . . . . 0.0 114.128 -158.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.05 -26.37 68.22 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.959 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -62.18 -47.74 83.15 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.231 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -49.09 69.51 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 120.412 1.46 . . . . 0.0 108.974 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 18.2 t -63.32 -34.07 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 117.662 -1.615 . . . . 0.0 110.342 -169.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.44 -45.37 75.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.532 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -53.17 -48.22 68.19 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.98 1.718 . . . . 0.0 109.487 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.78 -54.24 47.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 129.191 2.996 . . . . 0.0 110.23 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.72 -38.89 45.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.758 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.36 -28.24 66.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 120.615 1.552 . . . . 0.0 110.655 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -57.19 -25.72 59.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.549 1.14 . . . . 0.0 112.587 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.01 -23.11 6.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.275 1.03 . . . . 0.0 111.895 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.8 mtp -133.93 75.61 66.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 127.277 2.231 . . . . 0.0 110.629 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.55 29.63 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.518 3.478 . . . . 0.0 114.178 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -178.31 -48.39 0.01 OUTLIER 'General case' 0 C--O 1.236 0.348 0 O-C-N 120.325 -1.485 . . . . 0.0 109.693 -164.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.43 54.51 1.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.349 0.66 . . . . 0.0 110.518 169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.02 136.31 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.36 138.05 51.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -142.98 127.0 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 124.172 0.989 . . . . 0.0 109.691 -168.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -127.61 110.97 13.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 167.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.74 106.5 9.6 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 166.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.3 90.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.94 108.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 161.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.7 t -44.35 110.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.324 1.85 . . . . 0.0 109.126 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 tpp -140.03 -67.68 0.43 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.9 86.54 2.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -139.42 148.53 56.89 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.59 137.92 67.0 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 N-CA-C 106.266 -2.244 . . . . 0.0 106.266 161.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -73.17 39.33 0.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -31.23 70.2 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 120.792 -1.193 . . . . 0.0 112.609 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.36 -31.77 15.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 111.551 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.9 mtt -65.75 -7.56 16.42 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.932 -1.105 . . . . 0.0 112.132 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.56 -30.46 64.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.411 1.084 . . . . 0.0 111.008 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.77 169.05 8.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.767 0.827 . . . . 0.0 110.306 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.45 -30.32 77.53 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.656 -1.636 . . . . 0.0 112.536 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -51.14 -66.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.803 1.802 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 31.5 mtt 59.08 -39.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.961 2.504 . . . . 0.0 114.719 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.21 99.97 0.21 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.92 1.688 . . . . 0.0 110.984 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.1 m -60.59 150.18 75.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 121.528 -0.732 . . . . 0.0 109.407 159.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.451 ' CB ' HG22 ' A' ' 9' ' ' THR . 98.5 Cg_endo -72.22 113.14 2.08 Favored 'Cis proline' 0 C--N 1.349 0.603 0 CA-C-N 120.666 1.273 . . . . 0.0 111.93 1.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -96.78 117.88 32.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.219 2.208 . . . . 0.0 106.294 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.01 119.04 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -167.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -102.05 131.25 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.017 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.466 HD13 ' HE3' ' A' ' 73' ' ' LYS . 16.7 pt -128.26 163.37 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 125.032 1.458 . . . . 0.0 108.717 168.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 t30 48.16 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 111.63 -159.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.93 -3.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.443 0 C-N-CA 128.155 2.788 . . . . 0.0 111.892 167.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -91.54 129.83 37.46 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.232 2.016 . . . . 0.0 111.7 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.27 140.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.612 0.765 . . . . 0.0 109.733 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.18 -178.17 6.55 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -164.61 115.58 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.79 81.02 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 119.532 1.06 . . . . 0.0 110.468 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 171.9 23.17 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.376 -1.284 . . . . 0.0 112.007 166.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.71 3.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 115.958 -1.973 . . . . 0.0 115.836 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.08 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.367 2.238 . . . . 0.0 111.047 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 p -134.95 -127.99 0.16 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.934 2.094 . . . . 0.0 108.435 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HE3' HD13 ' A' ' 61' ' ' ILE . 2.8 ttpt -91.91 20.62 5.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.208 -1.558 . . . . 0.0 114.923 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -41.98 -45.11 3.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.618 2.008 . . . . 0.0 113.299 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.23 -49.65 60.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.569 1.148 . . . . 0.0 113.302 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -85.37 -21.86 28.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.03 -40.53 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.37 -29.05 65.7 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.471 -0.768 . . . . 0.0 112.455 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.599 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -77.53 -50.08 13.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 111.226 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 pt -60.44 -37.51 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.164 -0.96 . . . . 0.0 111.585 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -36.61 84.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.636 1.107 . . . . 0.0 113.237 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -21.47 45.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.44 1.473 . . . . 0.0 113.006 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 126.126 1.771 . . . . 0.0 109.281 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.315 0.579 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.77 101.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.74 160.37 32.73 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.811 0.815 . . . . 0.0 110.129 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 26' ' ' VAL . 3.0 mp -147.99 138.98 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 129.181 2.992 . . . . 0.0 105.135 167.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -135.7 146.87 48.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.56 82.98 2.06 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.785 1.234 . . . . 0.0 109.379 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.6 89.82 2.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.094 1.358 . . . . 0.0 108.5 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -135.69 179.69 6.18 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.856 -1.153 . . . . 0.0 113.279 -161.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 127.385 2.274 . . . . 0.0 108.278 -173.835 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.455 -0.792 0 N-CA-C 109.314 -1.072 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.52 -94.42 0.32 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB2' ' HD1' ' A' ' 38' ' ' TYR . . . -57.19 -25.29 58.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.264 174.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -56.61 -54.66 43.39 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.814 0.846 . . . . 0.0 111.755 171.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.6 mtt-85 -60.71 -45.21 95.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 118.659 0.663 . . . . 0.0 109.594 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.9 t -68.69 -34.58 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.563 -170.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.44 -32.57 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 121.133 1.788 . . . . 0.0 110.885 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -60.54 -53.68 54.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.815 1.189 . . . . 0.0 109.043 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.38 -36.97 77.33 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 122.915 0.486 . . . . 0.0 111.595 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 5' ' ' ILE . 59.2 t -74.7 -35.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.975 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.7 70.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.642 1.564 . . . . 0.0 111.169 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -57.72 -22.23 45.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.56 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -112.55 -31.52 6.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.974 1.261 . . . . 0.0 112.069 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -145.14 85.84 7.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.549 1.939 . . . . 0.0 110.338 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.88 45.47 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.176 3.251 . . . . 0.0 110.913 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -178.0 -66.77 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.711 1.604 . . . . 0.0 109.035 -166.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.87 1.11 4.74 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.27 141.33 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.267 1.427 . . . . 0.0 108.988 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.31 130.06 30.22 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 164.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.63 92.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.815 1.246 . . . . 0.0 110.52 -159.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 104.33 16.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.415 ' HD1' ' HB2' ' A' ' 19' ' ' ALA . 31.0 t80 -75.61 121.75 22.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 159.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.09 92.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.7 161.72 14.53 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.745 -1.222 . . . . 0.0 109.948 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.5 mtp -178.59 -87.05 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.586 2.354 . . . . 0.0 105.665 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -68.17 -19.06 64.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.721 1.208 . . . . 0.0 111.983 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.08 56.13 17.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.394 1.878 . . . . 0.0 111.606 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.35 140.78 65.43 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.934 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.76 -15.62 42.7 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.814 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -40.25 -45.37 2.06 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.378 1.471 . . . . 0.0 112.333 162.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.07 -46.01 8.0 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 168.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mtp -68.57 -5.47 20.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.42 -26.27 63.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.378 1.071 . . . . 0.0 111.317 164.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -76.33 118.48 19.08 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.269 1.028 . . . . 0.0 110.243 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.59 -5.5 23.87 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.437 -1.201 . . . . 0.0 114.878 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 pt -68.44 -46.55 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.875 1.838 . . . . 0.0 109.603 170.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.3 mtt 47.08 -11.42 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.632 3.173 . . . . 0.0 117.447 -169.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.7 68.9 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.397 1.879 . . . . 0.0 115.735 -159.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.311 28.8 m 50.98 166.72 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 128.251 2.62 . . . . 0.0 113.625 -161.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -65.52 105.78 0.34 Allowed 'Cis proline' 0 C--N 1.356 0.948 0 CA-C-N 121.55 1.589 . . . . 0.0 109.99 -14.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 m -79.89 124.49 28.71 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.803 1.641 . . . . 0.0 107.066 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.82 166.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 t -142.94 134.16 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.417 HG12 ' HZ1' ' A' ' 73' ' ' LYS . 37.1 pt -101.42 -157.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.745 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -23.23 -51.34 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.495 2.318 . . . . 0.0 114.91 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.22 -27.2 0.22 Allowed Glycine 0 CA--C 1.533 1.215 0 O-C-N 124.163 0.914 . . . . 0.0 112.106 158.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.55 140.59 29.6 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.684 1.742 . . . . 0.0 112.585 -163.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.71 147.64 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.173 2.189 . . . . 0.0 108.478 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -178.57 160.13 1.2 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.555 1.542 . . . . 0.0 109.401 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 146.89 52.51 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 159.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 mm -124.78 88.44 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.38 -165.16 51.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 121.664 0.591 . . . . 0.0 112.418 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -72.76 -22.84 0.54 Allowed Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 174.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 41.9 Cg_endo -65.65 177.17 2.96 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 123.67 2.346 . . . . 0.0 110.632 164.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.1 p -70.55 -159.77 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 159.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.417 ' HZ1' HG12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -77.29 23.26 0.2 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 119.199 -2.188 . . . . 0.0 112.746 -170.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -44.93 -37.92 4.31 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.84 2.456 . . . . 0.0 112.508 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.87 -66.47 0.38 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.481 1.112 . . . . 0.0 111.567 169.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -23.31 64.25 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.647 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -39.8 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.568 1.531 . . . . 0.0 108.559 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -62.34 -7.46 4.39 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.05 -37.83 7.19 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.204 1.366 . . . . 0.0 112.376 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -42.78 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.569 1.077 . . . . 0.0 108.598 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -15.25 60.92 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.394 -1.441 . . . . 0.0 113.927 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -52.73 9.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.59 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? . . . . . 0 N--CA 1.472 0.649 0 CA-C-N 119.827 1.194 . . . . 0.0 112.307 174.901 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt . . . . . 0 C--O 1.237 0.408 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.461 HG13 ' HA ' ' A' ' 62' ' ' ASN . 59.5 t -66.08 130.97 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.673 1.124 . . . . 0.0 108.507 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -106.2 147.04 29.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.261 -0.899 . . . . 0.0 109.224 170.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.567 HD13 ' HA ' ' A' ' 61' ' ' ILE . 4.4 mm -133.29 134.61 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -130.06 143.86 51.03 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.478 HD13 HD12 ' A' ' 59' ' ' ILE . 3.4 mm? -121.44 78.67 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 16.0 t80 -88.97 80.14 7.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 m -152.33 159.39 43.47 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.352 -1.468 . . . . 0.0 110.468 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 162.657 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 CA-C-O 117.925 -0.948 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 43.08 -117.0 0.44 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.201 1.4 . . . . 0.0 110.389 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.59 -32.75 29.83 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 116.15 -1.881 . . . . 0.0 114.246 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -59.1 -59.07 6.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 121.457 1.935 . . . . 0.0 109.639 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -61.63 -50.26 73.27 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.495 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.4 -40.59 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 117.017 -1.468 . . . . 0.0 108.577 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.87 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 120.479 1.49 . . . . 0.0 109.657 171.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -58.69 -43.14 89.92 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.905 1.23 . . . . 0.0 110.653 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.28 -54.62 34.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.646 1.178 . . . . 0.0 110.653 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 HG11 ' A' ' 34' ' ' VAL . 34.5 m -71.6 -29.2 33.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.793 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.93 64.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.691 1.132 . . . . 0.0 110.125 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.77 -40.05 78.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.189 0.45 . . . . 0.0 110.078 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -76.56 -51.69 11.16 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.329 1.051 . . . . 0.0 111.909 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.4 mtt -141.38 82.94 13.93 Favored Pre-proline 0 C--N 1.333 -0.152 0 C-N-CA 127.517 2.327 . . . . 0.0 108.755 -167.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -68.85 8.81 0.52 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.205 1.937 . . . . 0.0 114.147 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.7 -40.69 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.551 1.141 . . . . 0.0 112.376 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -6.4 19.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.519 1.054 . . . . 0.0 111.812 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.53 HG11 HG23 ' A' ' 26' ' ' VAL . 1.5 t -80.66 144.72 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 119.496 1.044 . . . . 0.0 109.319 170.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 141.62 51.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.171 2.188 . . . . 0.0 105.182 165.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.35 129.04 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 124.019 0.928 . . . . 0.0 109.725 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -121.15 97.54 5.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -85.91 93.06 8.84 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.276 0.2 OUTLIER -116.27 92.42 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 123.056 1.408 . . . . 0.0 107.815 -170.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.06 124.15 20.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.967 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.79 117.45 5.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.59 -63.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -143.67 51.35 1.34 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -160.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -139.5 151.18 66.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.857 0.863 . . . . 0.0 111.101 -165.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.98 134.76 32.95 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.295 2.663 . . . . 0.0 111.852 -172.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -70.68 7.03 1.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.344 -0.848 . . . . 0.0 112.779 173.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.7 -31.63 17.03 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.079 1.752 . . . . 0.0 113.311 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -92.35 -41.48 10.33 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.616 0.644 . . . . 0.0 111.103 164.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.14 -0.75 3.56 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.83 -143.44 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.196 1.398 . . . . 0.0 109.662 159.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 67.6 -168.03 0.2 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.563 1.545 . . . . 0.0 111.725 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.87 162.76 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 158.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.293 1.5 tp 41.79 63.99 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 123.225 1.488 . . . . 0.0 112.563 -165.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtt -67.87 -22.33 65.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.687 163.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.02 0.84 4.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.906 1.282 . . . . 0.0 113.926 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 70.31 164.07 0.14 Allowed Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.406 1.482 . . . . 0.0 110.49 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.15 125.94 10.61 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.674 1.276 . . . . 0.0 111.474 -9.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.1 m -95.4 98.09 10.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.478 HD12 HD13 ' A' ' 7' ' ' LEU . 31.5 mm -119.48 120.4 63.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -167.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.63 127.95 47.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.567 ' HA ' HD13 ' A' ' 5' ' ' ILE . 8.9 pt -123.91 142.17 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.83 0.741 . . . . 0.0 109.885 169.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.461 ' HA ' HG13 ' A' ' 3' ' ' VAL . 18.5 t30 48.08 -42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.288 3.035 . . . . 0.0 116.886 -159.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.96 -15.6 0.06 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 128.414 2.911 . . . . 0.0 111.255 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -91.06 160.61 15.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.413 1.606 . . . . 0.0 110.17 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.64 127.55 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.82 0.848 . . . . 0.0 109.209 -158.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.93 173.39 15.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.026 0.83 . . . . 0.0 111.015 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.92 155.51 48.94 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.782 1.633 . . . . 0.0 106.874 159.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.6 mm -141.06 136.17 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.01 -171.34 45.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.82 -30.97 0.64 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.374 -1.774 . . . . 0.0 114.209 164.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -85.41 -166.54 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 CA-C-N 123.005 2.109 . . . . 0.0 110.53 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -63.33 175.63 0.95 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.054 0.941 . . . . 0.0 111.661 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HZ1' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -77.26 21.5 0.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.518 1.527 . . . . 0.0 113.771 -160.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -35.45 -40.8 0.16 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.312 2.245 . . . . 0.0 114.654 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.48 -64.76 0.72 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.714 1.606 . . . . 0.0 111.703 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -68.36 -28.15 66.87 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.042 0.537 . . . . 0.0 110.698 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.13 -34.65 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.25 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.45 -16.55 55.86 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.529 -1.357 . . . . 0.0 113.745 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.48 -47.81 7.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.351 1.432 . . . . 0.0 110.466 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.87 -24.84 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.024 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -64.01 -46.5 84.23 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.129 0.877 . . . . 0.0 111.282 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.85 -49.49 8.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -165.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 . . . . . 0 N--CA 1.463 0.18 0 C-N-CA 129.128 2.971 . . . . 0.0 114.629 -165.744 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? . . . . . 0 C--O 1.234 0.278 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -105.39 103.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 158.17 35.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.446 HD13 HG22 ' A' ' 36' ' ' VAL . 4.8 mp -143.39 138.94 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 161.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -129.08 144.16 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 mt -138.37 89.62 2.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.404 1.082 . . . . 0.0 108.465 -170.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t80 -113.63 97.25 6.31 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.211 1.805 . . . . 0.0 108.917 -164.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t -178.91 -177.25 0.48 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.989 1.716 . . . . 0.0 106.626 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 CA--C 1.539 0.558 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.285 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo . . . . . 0 CA--C 1.537 0.665 0 CA-C-O 118.21 -0.829 . . . . 0.0 114.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.73 -81.21 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.875 1.67 . . . . 0.0 113.496 -166.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.18 -25.35 68.04 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.491 -1.242 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -61.39 -59.29 5.5 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.203 0.91 . . . . 0.0 109.791 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -61.6 -43.15 99.39 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.762 -0.586 . . . . 0.0 111.005 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -66.36 -33.71 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.942 -173.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.24 -27.41 13.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 CA-C-N 120.368 1.44 . . . . 0.0 111.88 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -61.23 -57.58 11.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 108.252 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -49.27 -66.18 0.44 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.328 1.851 . . . . 0.0 107.688 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.47 -27.95 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.686 1.13 . . . . 0.0 112.872 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 -26.35 68.01 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.829 1.649 . . . . 0.0 111.249 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -53.72 -48.98 69.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.221 0.919 . . . . 0.0 111.466 167.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.51 -51.77 47.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.587 0.63 . . . . 0.0 109.978 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.59 88.48 8.69 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.668 1.587 . . . . 0.0 109.367 -169.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.41 27.27 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.021 3.147 . . . . 0.0 110.95 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -151.67 -68.33 0.17 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.152 1.381 . . . . 0.0 108.62 -158.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.21 -5.03 28.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.16 139.44 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 119.175 0.898 . . . . 0.0 110.294 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.28 123.31 24.02 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 5' ' ' ILE . 33.6 t -117.02 140.02 41.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -116.97 100.6 7.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.57 115.68 17.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 160.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.266 0.2 OUTLIER -129.23 101.32 6.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.766 1.27 . . . . 0.0 107.876 177.406 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.1 129.03 38.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.244 1.418 . . . . 0.0 108.324 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.55 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -178.94 -72.26 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 128.458 2.703 . . . . 0.0 106.328 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.6 -41.8 59.81 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -58.86 142.79 84.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.061 0.944 . . . . 0.0 112.159 -167.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.01 136.45 32.37 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.911 1.741 . . . . 0.0 108.254 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.08 -12.88 2.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.542 1.537 . . . . 0.0 113.386 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -4.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.833 2.853 . . . . 0.0 118.468 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -91.42 -63.89 1.2 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 121.5 1.954 . . . . 0.0 107.546 158.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.435 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -40.83 -21.22 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 129.738 3.215 . . . . 0.0 115.254 174.086 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.91 -20.38 3.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.802 2.041 . . . . 0.0 114.84 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -52.58 175.39 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.019 2.928 . . . . 0.0 115.555 -164.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -43.42 127.41 5.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.822 1.201 . . . . 0.0 110.837 164.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.289 0.2 OUTLIER 60.12 -24.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 129.435 3.094 . . . . 0.0 115.895 -170.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtm 62.24 -73.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 128.628 2.771 . . . . 0.0 110.754 -172.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 36.27 -130.95 0.1 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.187 2.595 . . . . 0.0 110.965 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -179.32 154.28 0.74 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 128.937 2.895 . . . . 0.0 105.138 175.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.93 -179.87 8.81 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 119.483 0.851 . . . . 0.0 112.0 -14.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -128.69 127.19 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 168.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -129.56 163.71 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 65' ' ' VAL . 19.4 t -138.75 130.93 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 102.907 -2.998 . . . . 0.0 102.907 169.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.411 HG23 ' NZ ' ' A' ' 73' ' ' LYS . 41.0 pt -99.21 -161.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 117.005 -1.474 . . . . 0.0 108.9 168.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -20.17 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.823 2.449 . . . . 0.0 114.308 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.68 -13.61 1.42 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.869 -0.962 . . . . 0.0 112.668 158.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -91.32 113.86 26.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.331 1.566 . . . . 0.0 113.186 -159.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 60' ' ' VAL . 57.5 t -58.42 135.35 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.421 1.489 . . . . 0.0 107.855 164.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 6.6 tt0 -178.57 169.33 1.74 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.862 2.065 . . . . 0.0 107.842 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -158.93 139.63 12.61 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 119.907 -1.745 . . . . 0.0 106.662 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.89 133.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -174.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 175.37 49.82 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.127 0.892 . . . . 0.0 111.966 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.21 -42.62 2.11 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.735 1.214 . . . . 0.0 112.825 164.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.12 -176.66 1.95 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 CA-C-N 121.798 1.678 . . . . 0.0 109.354 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -62.85 -175.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.518 -0.739 . . . . 0.0 111.119 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HZ3' ' HB3' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -70.45 32.99 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.886 2.074 . . . . 0.0 114.64 -158.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.34 -34.63 64.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.236 -1.54 . . . . 0.0 112.017 -172.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.81 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.49 1.116 . . . . 0.0 111.7 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -82.51 -28.8 30.88 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.928 174.639 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.24 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 120.697 1.589 . . . . 0.0 109.97 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -12.5 23.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.18 -37.28 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.718 2.007 . . . . 0.0 111.418 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.29 -34.4 40.03 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 121.677 2.035 . . . . 0.0 110.251 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -53.81 -35.28 61.23 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -31.42 16.33 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 170.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.313 0 C-N-CA 124.834 1.253 . . . . 0.0 111.696 -169.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 62' ' ' ASN . 11.0 t -65.12 130.06 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 168.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.14 141.5 33.94 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 165.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 26' ' ' VAL . 4.9 mp -138.43 85.38 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -172.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -93.71 128.67 40.04 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.653 HD13 HD12 ' A' ' 59' ' ' ILE . 4.2 mm? -100.21 87.12 3.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 164.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 48' ' ' ALA . 15.2 t80 -91.05 95.64 10.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.971 0.891 . . . . 0.0 108.65 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -178.47 172.1 1.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.192 1.797 . . . . 0.0 108.136 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 164.915 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 CA--C 1.542 0.903 0 N-CA-C 109.586 -0.967 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.41 ' HB1' HG21 ' A' ' 72' ' ' THR . . . -52.92 -77.5 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.68 1.992 . . . . 0.0 111.994 -166.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.92 78.48 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 118.224 -0.893 . . . . 0.0 108.796 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -48.64 -46.08 39.41 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.278 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -68.04 -53.0 28.97 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 121.02 1.737 . . . . 0.0 111.085 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.72 -40.2 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.017 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HA ' HG22 ' A' ' 26' ' ' VAL . 6.7 m -73.98 -32.68 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 126.113 1.765 . . . . 0.0 112.637 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.64 -49.31 62.52 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.632 1.106 . . . . 0.0 108.139 164.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -76.98 -44.43 31.12 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.074 0.949 . . . . 0.0 110.531 -164.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG21 HG12 ' A' ' 5' ' ' ILE . 20.5 m -72.57 -26.44 24.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.95 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.49 63.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.936 1.698 . . . . 0.0 110.328 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.24 -41.18 99.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.303 1.041 . . . . 0.0 109.878 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.7 -56.82 7.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.146 0.579 . . . . 0.0 110.63 171.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.0 mtt -146.86 86.83 6.48 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 125.355 1.462 . . . . 0.0 109.214 -159.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.25 41.4 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.437 2.758 . . . . 0.0 111.66 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -151.56 -66.36 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 127.198 2.199 . . . . 0.0 108.061 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 45.45 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.977 1.711 . . . . 0.0 111.775 -173.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.14 83.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.065 1.346 . . . . 0.0 109.928 -161.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -89.24 110.8 21.52 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.46 142.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.034 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -156.52 152.16 27.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.354 1.073 . . . . 0.0 112.068 158.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.58 90.57 4.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.386 2.274 . . . . 0.0 106.334 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.45 85.33 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 121.56 12.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 93.67 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 mmt -143.6 -52.99 0.35 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.94 1.696 . . . . 0.0 109.089 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 13.3 6.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.143 2.177 . . . . 0.0 110.845 -169.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.14 154.42 30.57 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.554 2.342 . . . . 0.0 115.594 -160.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.23 145.06 77.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.788 2.325 . . . . 0.0 110.592 170.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -66.33 -9.8 36.68 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.381 -0.824 . . . . 0.0 111.041 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -61.0 -18.02 55.3 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -175.157 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.24 -39.54 11.47 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 119.974 -1.704 . . . . 0.0 112.068 161.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.2 mtm -63.35 -12.98 34.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.121 -0.987 . . . . 0.0 112.543 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.14 -26.66 68.45 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.564 1.146 . . . . 0.0 110.902 168.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CD2' HG21 ' A' ' 65' ' ' VAL . 29.5 m-85 -66.6 114.65 5.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 108.953 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.69 8.14 3.48 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.576 1.39 . . . . 0.0 116.576 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -69.83 -52.59 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.937 1.869 . . . . 0.0 108.587 159.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . 0.279 0.1 OUTLIER 40.9 7.74 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.926 3.29 . . . . 0.0 117.815 -169.079 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -178.44 0.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 123.392 1.568 . . . . 0.0 109.354 159.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.04 158.56 48.33 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.194 -0.941 . . . . 0.0 108.922 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB2' HD11 ' A' ' 59' ' ' ILE . 66.3 Cg_endo -70.21 128.76 13.6 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 -10.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -77.78 106.13 9.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.653 HD12 HD13 ' A' ' 7' ' ' LEU . 14.7 mm -118.93 121.54 67.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -111.81 111.28 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pp -101.07 167.75 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 169.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' A' ' 3' ' ' VAL . 14.9 m120 30.33 -81.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.07 1.748 . . . . 0.0 114.501 -161.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.53 10.19 1.46 Allowed Glycine 0 CA--C 1.534 1.243 0 CA-C-N 120.241 1.382 . . . . 0.0 114.139 165.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -86.52 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.33 1.565 . . . . 0.0 113.358 -166.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' A' ' 51' ' ' TYR . 4.1 p 114.78 134.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 1 C-N-CA 133.766 4.826 . . . . 0.0 106.753 -163.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -178.72 167.08 1.73 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.738 2.415 . . . . 0.0 108.088 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.82 116.67 5.53 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.733 1.613 . . . . 0.0 107.831 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 150.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.51 172.36 47.7 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 124.339 1.025 . . . . 0.0 111.248 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -83.98 -33.55 0.55 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.702 1.201 . . . . 0.0 111.459 158.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 85.9 Cg_endo -71.15 -165.75 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.636 1.62 . . . . 0.0 110.001 160.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.41 HG21 ' HB1' ' A' ' 18' ' ' ALA . 30.8 p -64.23 -172.47 0.07 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.525 0.73 . . . . 0.0 109.858 162.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -71.59 47.34 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.393 2.277 . . . . 0.0 114.529 -158.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -58.31 -45.36 88.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.577 1.951 . . . . 0.0 110.923 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.86 61.4 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 112.867 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.94 -20.63 21.98 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.995 0.918 . . . . 0.0 110.476 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.92 -38.42 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.561 -1.337 . . . . 0.0 108.353 167.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.2 -0.64 10.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.444 0.698 . . . . 0.0 112.761 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.57 -51.11 3.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.592 1.557 . . . . 0.0 111.21 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pt -53.48 -40.51 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 119.967 1.258 . . . . 0.0 107.948 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -72.9 -29.09 62.87 Favored 'General case' 0 C--N 1.345 0.377 0 O-C-N 120.209 -1.557 . . . . 0.0 114.78 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.49 1.95 . . . . 0.0 109.291 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.994 1.318 . . . . 0.0 113.92 172.957 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.2 tttt . . . . . 0 C--O 1.232 0.161 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.9 110.26 3.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -91.13 144.75 25.31 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.77 138.57 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -124.72 133.0 53.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.14 92.09 3.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.049 1.34 . . . . 0.0 109.118 -172.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -112.61 104.09 12.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.027 0.931 . . . . 0.0 109.857 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 t -178.57 170.92 1.59 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 108.65 170.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.547 0.855 0 C-N-CA 124.603 1.161 . . . . 0.0 109.889 169.87 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 N--CA 1.456 -0.708 0 N-CA-C 107.967 -1.59 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 -100.21 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.44 51.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.58 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -51.4 -67.73 0.23 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.99 1.316 . . . . 0.0 111.466 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -65.17 -39.4 92.88 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.328 -0.858 . . . . 0.0 110.965 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 26' ' ' VAL . 51.5 t -65.05 -43.13 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 120.202 1.364 . . . . 0.0 110.227 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.83 -45.39 86.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 110.568 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -58.66 -60.44 3.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.925 1.29 . . . . 0.0 110.246 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 22' ' ' VAL . 1.2 p -73.75 -33.27 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.203 -176.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.49 70.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 121.032 1.742 . . . . 0.0 111.373 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -61.2 -13.07 15.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.25 -20.08 1.67 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.2 mtp -138.72 78.25 31.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 127.791 2.437 . . . . 0.0 107.304 168.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -70.9 25.28 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 125.29 3.994 . . . . 0.0 115.053 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -178.02 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.11 -1.618 . . . . 0.0 110.488 -159.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.05 3.85 7.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.142 0.883 . . . . 0.0 111.639 169.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.1 136.92 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 109.329 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -128.54 125.41 38.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 159.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.47 102.42 9.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.393 -2.076 . . . . 0.0 105.393 173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -92.05 130.66 37.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.79 104.64 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.94 1.696 . . . . 0.0 106.49 -168.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.69 67.22 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -58.8 144.14 45.02 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.581 0.705 . . . . 0.0 109.647 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.37 141.87 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.3 ttm -178.66 -70.01 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 128.394 2.677 . . . . 0.0 104.621 -173.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.27 0.941 . . . . 0.0 111.046 170.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t30 43.57 54.48 11.01 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.7 2.4 . . . . 0.0 112.513 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.5 151.49 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.087 1.858 . . . . 0.0 112.464 -169.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -63.95 -12.54 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -37.49 32.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 119.591 1.087 . . . . 0.0 113.755 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -37.78 12.61 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 165.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.7 mtp -65.78 -11.89 49.63 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.62 -22.83 64.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.623 1.169 . . . . 0.0 113.125 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -66.99 151.12 48.24 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.255 0.934 . . . . 0.0 112.498 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.07 -45.83 42.35 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 126.215 1.864 . . . . 0.0 112.487 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.265 4.2 tt -133.37 83.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.516 1.15 . . . . 0.0 108.263 158.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -33.93 58.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.165 169.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 28.66 -116.67 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.829 2.452 . . . . 0.0 112.215 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -179.07 160.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 130.661 3.585 . . . . 0.0 105.673 164.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.21 119.28 5.37 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 CA-C-N 120.581 1.243 . . . . 0.0 110.124 -14.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m -80.39 98.94 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.208 1.803 . . . . 0.0 108.077 -164.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mm -109.48 151.79 11.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -121.3 141.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.505 HD13 ' HE3' ' A' ' 73' ' ' LYS . 36.6 pt -135.98 145.81 30.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.808 0.843 . . . . 0.0 109.857 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.17 -62.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.066 2.146 . . . . 0.0 110.89 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.42 -5.38 0.04 OUTLIER Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.932 2.206 . . . . 0.0 112.556 158.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.69 154.55 18.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.328 2.064 . . . . 0.0 116.177 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.2 m -105.12 131.78 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.3 1.44 . . . . 0.0 109.005 -161.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 21.5 tt0 -178.36 167.06 1.89 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.04 -1.038 . . . . 0.0 109.13 -165.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -162.02 125.72 3.14 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -170.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.61 109.07 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.69 -177.28 17.82 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.843 1.211 . . . . 0.0 110.337 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -89.55 -32.79 0.38 Allowed Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.297 161.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 86.8 Cg_endo -73.46 -170.98 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.847 1.695 . . . . 0.0 109.255 160.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.1 p -60.67 -176.22 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.755 1.622 . . . . 0.0 111.499 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HE3' HD13 ' A' ' 61' ' ' ILE . 6.4 ttpt -71.96 36.9 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.783 2.033 . . . . 0.0 113.142 -163.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -50.32 -44.81 54.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.492 1.917 . . . . 0.0 110.857 -164.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.67 65.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.779 1.631 . . . . 0.0 113.319 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.51 -26.94 19.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.0 0.52 . . . . 0.0 110.741 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . 0.266 22.4 t -61.81 -40.02 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 125.025 1.33 . . . . 0.0 108.294 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.0 -13.99 14.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.653 1.581 . . . . 0.0 112.542 170.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.39 -44.61 7.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 116.903 -1.522 . . . . 0.0 111.324 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.43 ' CG2' HD12 ' A' ' 61' ' ' ILE . 2.2 pt -56.0 -29.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.882 1.674 . . . . 0.0 112.599 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -51.93 -64.27 0.87 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.131 165.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -67.61 -59.74 3.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.058 -174.57 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 82' ' ' LYS . 2.6 mpt_? . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 126.398 1.879 . . . . 0.0 109.844 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.767 0.794 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 62' ' ' ASN . 91.2 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.01 116.59 16.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.98 86.96 4.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 39' ' ' ILE 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.447 ' CD2' HG21 ' A' ' 65' ' ' VAL . 21.2 m-85 -73.09 156.56 38.58 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.86 0.838 . . . . 0.0 111.618 -169.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 55' ' ' ALA . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' H ' HG13 ' A' ' 53' ' ' ILE . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.444 HG12 ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.814 ' HA ' HG13 ' A' ' 3' ' ' VAL . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.09 38.62 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.49 5.68 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.373 171.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.404 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.78 -40.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 120.41 1.459 . . . . 0.0 109.495 172.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -57.0 -23.17 44.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.928 0.785 . . . . 0.0 112.056 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.26 150.65 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.325 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -98.76 134.27 41.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.343 1.057 . . . . 0.0 109.032 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.9 149.61 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.14 146.26 42.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.47 96.64 4.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.111 0.965 . . . . 0.0 108.399 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -121.99 86.62 2.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.251 1.024 . . . . 0.0 110.385 -169.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 10' ' ' SER . 1.2 m -156.91 -157.51 0.7 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.451 1.9 . . . . 0.0 107.826 174.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.655 ' H ' HG22 ' A' ' 9' ' ' THR . 73.2 m . . . . . 0 CA--C 1.53 0.206 1 C-N-CA 133.345 4.658 . . . . 0.0 107.17 -175.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.459 -0.519 0 CA-C-O 118.92 -0.533 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.37 -92.71 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.186 1.794 . . . . 0.0 112.978 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.57 -29.36 36.92 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 124.933 1.293 . . . . 0.0 111.791 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.19 -43.44 87.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 119.67 1.123 . . . . 0.0 111.094 172.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -71.22 -42.51 68.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.332 0.969 . . . . 0.0 109.277 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 t -64.16 -44.05 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.549 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.64 -34.76 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 119.536 -1.977 . . . . 0.0 110.761 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.94 -51.19 70.34 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.88 0.872 . . . . 0.0 110.327 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.47 -61.72 2.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.527 1.931 . . . . 0.0 110.063 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -59.53 -44.96 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.3 67.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.548 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -58.46 -35.31 71.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.287 -1.34 . . . . 0.0 112.507 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -106.44 -38.13 6.29 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.469 1.94 . . . . 0.0 112.063 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.2 mtm -121.25 77.97 34.24 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 127.651 2.38 . . . . 0.0 107.037 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.92 11.62 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.941 3.761 . . . . 0.0 113.876 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.62 -59.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.611 1.565 . . . . 0.0 108.22 -159.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.93 50.6 0.47 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.16 2.584 . . . . 0.0 113.082 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.95 92.36 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.485 1.114 . . . . 0.0 109.78 -166.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -102.03 72.85 1.35 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.907 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -77.41 111.53 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.39 117.76 23.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -85.16 123.35 30.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 160.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 96.16 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 155.26 15.87 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.89 150.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.243 1.417 . . . . 0.0 112.922 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.415 ' C ' ' H ' ' A' ' 44' ' ' ASN 0.255 15.1 ptt? 54.35 -172.97 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.372 2.269 . . . . 0.0 111.496 -174.497 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 63.77 -17.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.899 2.08 . . . . 0.0 114.016 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 42' ' ' MET . 3.8 p-10 -68.65 149.75 97.86 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 127.804 2.442 . . . . 0.0 111.066 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.2 174.45 12.81 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.605 2.203 . . . . 0.0 108.859 160.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.69 0.45 4.21 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.089 -1.007 . . . . 0.0 113.449 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -48.03 -29.82 3.84 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -175.053 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.5 -53.13 4.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.352 0.524 . . . . 0.0 112.298 171.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.8 mtp -66.73 -7.56 21.85 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -171.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.99 -22.96 58.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.364 1.466 . . . . 0.0 113.372 166.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CD2' HG11 ' A' ' 65' ' ' VAL . 21.9 m-85 -64.91 154.66 36.73 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.777 0.831 . . . . 0.0 109.176 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -18.09 75.7 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.626 -0.672 . . . . 0.0 112.517 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.24 73.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 122.566 1.174 . . . . 0.0 108.802 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 93.9 mtp -73.76 24.9 0.07 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.932 0.893 . . . . 0.0 112.227 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.11 -45.74 71.93 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.102 1.361 . . . . 0.0 113.237 -164.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t 67.41 133.52 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.317 1.847 . . . . 0.0 109.137 -164.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.568 ' HB3' HG21 ' A' ' 9' ' ' THR . 24.5 Cg_endo -66.1 121.29 3.36 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.95 1.375 . . . . 0.0 111.243 -9.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.2 m -83.48 106.06 14.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.08 159.55 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.64 128.66 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 170.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.53 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -123.69 156.12 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 116.663 -1.637 . . . . 0.0 108.85 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 45.27 -67.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.767 2.427 . . . . 0.0 114.761 -167.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.69 -9.57 0.1 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.132 1.825 . . . . 0.0 113.112 160.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.62 125.31 35.6 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.367 2.083 . . . . 0.0 111.94 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 51' ' ' TYR . 16.0 t -72.03 140.25 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.43 1.492 . . . . 0.0 107.617 174.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -178.69 166.53 1.72 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.902 2.081 . . . . 0.0 107.905 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -126.17 152.84 45.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.177 1.791 . . . . 0.0 106.996 165.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 75' ' ' ALA . 7.0 mm -129.86 79.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.24 -164.49 36.75 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.799 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.3 1.5 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.99 -162.72 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 CA-C-N 123.517 2.292 . . . . 0.0 109.822 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.4 p -78.2 -150.6 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.751 -1.843 . . . . 0.0 107.65 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.53 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 3.5 tppt? -79.06 34.37 0.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.076 -2.265 . . . . 0.0 110.848 -174.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.303 29.7 mt-10 -62.08 -25.55 67.77 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -158.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -66.34 -42.21 88.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.775 1.17 . . . . 0.0 111.408 170.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -33.98 53.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.862 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.3 t -48.17 -50.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.846 1.659 . . . . 0.0 107.558 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.56 -10.9 13.56 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.24 -47.24 3.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.219 1.407 . . . . 0.0 112.097 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.2 pt -64.12 -33.09 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.414 1.461 . . . . 0.0 111.241 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -57.51 -24.78 57.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.028 1.286 . . . . 0.0 111.621 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.28 0.0 OUTLIER -91.4 -56.31 3.18 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 117.466 -1.254 . . . . 0.0 107.678 -171.384 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.469 0.483 0 CA-C-N 120.182 1.355 . . . . 0.0 110.401 167.129 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt . . . . . 0 C--O 1.235 0.327 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 62' ' ' ASN . 4.0 t -80.89 154.54 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.34 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -106.51 96.91 5.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -103.1 139.85 38.09 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -132.23 101.34 5.34 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 123.36 0.664 . . . . 0.0 109.857 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.63 82.51 1.63 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.347 2.259 . . . . 0.0 106.741 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -161.13 -179.37 7.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.926 1.29 . . . . 0.0 107.722 166.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p . . . . . 0 C--O 1.235 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 167.725 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 N--CA 1.448 -1.172 0 CA-C-O 118.948 -0.522 . . . . 0.0 113.154 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.87 -104.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.116 1.766 . . . . 0.0 111.499 -169.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.01 68.31 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.879 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -38.14 -60.07 0.8 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.951 1.25 . . . . 0.0 111.271 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.78 -39.6 61.65 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.566 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -53.44 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.796 1.18 . . . . 0.0 108.089 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.4 t -51.66 -52.53 20.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 128.167 2.587 . . . . 0.0 109.889 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.5 -44.38 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.612 1.097 . . . . 0.0 111.059 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.68 -43.08 99.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.7 1.2 . . . . 0.0 111.062 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.681 ' CG2' HG11 ' A' ' 34' ' ' VAL . 31.1 m -78.58 -29.42 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.495 -0.753 . . . . 0.0 112.561 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.95 -25.21 60.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.329 1.052 . . . . 0.0 111.766 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.0 -24.43 58.16 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.79 -0.569 . . . . 0.0 110.526 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -89.5 -57.95 2.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.807 1.243 . . . . 0.0 110.088 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.505 ' HB2' HG23 ' A' ' 34' ' ' VAL . 41.6 mtm -129.63 89.04 47.95 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.495 1.118 . . . . 0.0 110.511 -171.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.76 34.21 0.52 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.375 3.383 . . . . 0.0 113.084 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -178.3 -51.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.984 1.314 . . . . 0.0 110.615 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.24 -24.63 66.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.406 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.681 HG11 ' CG2' ' A' ' 26' ' ' VAL . 51.5 t -72.12 98.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 164.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -83.69 135.71 34.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.551 1.941 . . . . 0.0 106.837 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.4 ' CG1' HG12 ' A' ' 34' ' ' VAL . 21.6 m -135.06 147.12 29.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 118.941 0.791 . . . . 0.0 112.571 -164.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -140.01 117.9 11.75 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.952 1.301 . . . . 0.0 108.043 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -99.84 84.43 2.9 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -90.68 75.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -60.51 92.05 0.02 OUTLIER 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.932 1.293 . . . . 0.0 109.457 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.255 9.6 p 39.25 -67.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 131.66 3.984 . . . . 0.0 116.346 -167.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.7 ttp -54.99 151.44 8.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.864 1.211 . . . . 0.0 112.931 -158.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 64.93 34.51 8.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.534 1.534 . . . . 0.0 109.52 -158.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -67.24 103.6 0.51 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.493 1.917 . . . . 0.0 110.771 -165.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 44' ' ' ASN . 6.8 Cg_endo -94.19 139.95 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.731 1.62 . . . . 0.0 111.474 -169.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -64.6 -7.01 8.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.608 -1.308 . . . . 0.0 112.392 170.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.93 -41.48 11.58 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.186 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.47 -27.89 17.16 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 172.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.0 mtt -63.25 -4.99 2.87 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.825 -1.172 . . . . 0.0 111.447 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.68 -25.68 67.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.237 1.415 . . . . 0.0 113.11 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.606 ' CE2' HG11 ' A' ' 65' ' ' VAL . 33.2 m-85 -80.74 -154.98 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.076 1.35 . . . . 0.0 110.821 -168.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.29 -170.12 0.71 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 158.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 54' ' ' MET 0.262 18.6 tt -31.05 -67.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.895 1.678 . . . . 0.0 113.275 -159.194 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.473 ' H ' HG23 ' A' ' 53' ' ' ILE . 14.1 mmt 36.99 35.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.263 2.625 . . . . 0.0 114.485 167.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.79 -68.49 0.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 171.13 6.78 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.745 1.618 . . . . 0.0 107.629 158.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.21 128.94 17.4 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 109.685 -0.929 . . . . 0.0 109.685 -20.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 m -106.45 114.3 28.33 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -164.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.511 HD11 HG22 ' A' ' 72' ' ' THR . 27.3 mm -132.3 124.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -159.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.08 128.06 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 168.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.8 pp -120.06 161.49 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.475 ' HA ' HG13 ' A' ' 3' ' ' VAL . 3.3 m120 45.69 -92.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.708 1.203 . . . . 0.0 111.306 -170.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.21 1.31 3.37 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.25 160.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.08 115.08 27.74 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.599 1.56 . . . . 0.0 111.503 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 51' ' ' TYR . 8.0 p -57.36 141.09 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.001 1.32 . . . . 0.0 109.843 159.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -178.7 -178.68 0.59 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 106.395 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -139.13 -36.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.77 1.228 . . . . 0.0 112.217 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.274 31.9 mm 49.71 -74.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 127.398 2.279 . . . . 0.0 112.133 -160.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.92 -176.6 25.68 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.732 1.151 . . . . 0.0 114.142 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.25 -47.44 2.59 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.909 1.284 . . . . 0.0 108.7 158.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.76 174.97 4.89 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 CA-C-N 120.756 1.306 . . . . 0.0 108.826 158.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.511 HG22 HD11 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -63.22 178.5 0.51 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.551 -0.718 . . . . 0.0 112.068 178.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -68.05 64.84 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.393 1.877 . . . . 0.0 113.776 -159.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.282 -0.886 . . . . 0.0 111.816 -160.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.7 79.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.946 0.794 . . . . 0.0 110.726 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -29.57 62.47 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.88 175.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.13 -46.56 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.818 1.645 . . . . 0.0 109.106 166.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -3.8 3.85 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.967 1.707 . . . . 0.0 112.538 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.46 -45.52 2.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.698 1.599 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 61' ' ' ILE . 3.7 pt -61.65 -23.66 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.998 1.272 . . . . 0.0 110.881 171.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -43.03 74.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.269 0.941 . . . . 0.0 111.857 169.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.272 0.4 OUTLIER -81.97 -53.74 5.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.334 0.515 . . . . 0.0 110.736 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.218 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.767 0.794 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 62' ' ' ASN . 91.9 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.03 116.53 16.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.94 86.96 4.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 39' ' ' ILE 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.447 ' CD2' HG21 ' A' ' 65' ' ' VAL . 21.3 m-85 -73.04 156.55 38.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.861 0.839 . . . . 0.0 111.631 -169.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 55' ' ' ALA . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' H ' HG13 ' A' ' 53' ' ' ILE . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.444 HG12 ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.814 ' HA ' HG13 ' A' ' 3' ' ' VAL . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.07 38.6 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.75 -31.47 5.62 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.36 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.404 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.75 -40.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.41 1.459 . . . . 0.0 109.518 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -56.99 -23.17 44.12 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.89 0.768 . . . . 0.0 112.056 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 pttt . . . . . 0 C--O 1.234 0.238 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 62' ' ' ASN . 2.4 t -97.38 160.33 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.859 1.264 . . . . 0.0 109.56 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 154.84 46.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 167.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.12 149.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 108.636 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -135.12 150.65 50.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.662 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.405 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 1.3 mm? -123.08 91.56 3.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.889 2.476 . . . . 0.0 106.678 167.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -94.67 82.25 3.93 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.4 p -140.43 169.87 16.86 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.093 -1.004 . . . . 0.0 109.792 -175.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.355 176.625 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 CA--C 1.542 0.883 0 N-CA-C 110.643 -0.56 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB1' ' CD1' ' A' ' 7' ' ' LEU . . . -68.83 -81.45 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.792 . . . . 0.0 111.617 -168.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -19.43 45.37 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.372 -0.83 . . . . 0.0 112.003 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -65.03 -59.95 3.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.889 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -54.73 -45.39 74.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.18 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.24 -37.27 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 118.271 -1.372 . . . . 0.0 110.061 -174.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.251 3.3 p -67.36 -33.6 63.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 O-C-N 119.565 -1.96 . . . . 0.0 110.843 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.05 -53.84 53.09 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 120.928 1.694 . . . . 0.0 110.185 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.41 ' OE2' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -45.98 -60.69 2.12 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.98 2.512 . . . . 0.0 109.566 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.015 HG11 HG11 ' A' ' 34' ' ' VAL . 8.6 p -77.2 -40.58 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -25.91 64.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.8 -0.619 . . . . 0.0 110.241 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -38.39 -54.85 1.43 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.368 0.667 . . . . 0.0 111.009 165.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.28 -24.68 16.09 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.414 1.085 . . . . 0.0 112.797 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.531 ' CB ' HG23 ' A' ' 34' ' ' VAL . 46.7 mtt -144.74 78.61 12.77 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.271 1.028 . . . . 0.0 109.416 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.13 34.77 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.981 3.12 . . . . 0.0 113.054 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.97 -48.83 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.132 0.973 . . . . 0.0 109.294 -175.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.49 14.7 0.12 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.9 -1.048 . . . . 0.0 113.046 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.015 HG11 HG11 ' A' ' 26' ' ' VAL . 54.3 t -111.84 103.14 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 120.725 1.602 . . . . 0.0 107.488 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -76.76 96.59 4.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.76 153.29 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.547 0.612 . . . . 0.0 110.285 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.15 146.94 39.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.242 0.474 . . . . 0.0 110.409 158.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -107.74 69.92 0.76 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.744 2.418 . . . . 0.0 107.521 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.487 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -79.89 84.86 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.14 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 128.03 34.29 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 110.664 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -74.3 120.3 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.7 mmt -177.98 -74.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 -166.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -132.96 92.91 3.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -144.58 133.01 10.88 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.031 -0.985 . . . . 0.0 108.963 -159.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.03 152.01 74.32 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.125 1.883 . . . . 0.0 111.424 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.91 5.8 0.2 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -11.27 8.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 121.169 1.804 . . . . 0.0 115.363 -171.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -92.85 -33.57 14.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.969 2.622 . . . . 0.0 115.778 159.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtt -69.0 -6.84 30.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -64.09 -25.49 68.12 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.165 0.986 . . . . 0.0 111.664 163.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 16.1 m-85 -84.13 153.44 23.71 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.664 0.786 . . . . 0.0 110.587 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.74 42.49 1.54 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.949 1.261 . . . . 0.0 113.111 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.454 HG13 ' H ' ' A' ' 55' ' ' ALA . 2.9 tp -138.87 -52.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.8 1.64 . . . . 0.0 108.243 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 32.2 mtt 58.51 -2.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.421 2.288 . . . . 0.0 115.782 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.454 ' H ' HG13 ' A' ' 53' ' ' ILE . . . -77.29 -161.06 0.2 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.65 1.98 . . . . 0.0 111.796 -175.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -155.58 159.36 31.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.388 2.275 . . . . 0.0 106.27 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.94 109.66 1.23 Allowed 'Cis proline' 0 C--N 1.35 0.617 0 CA-C-N 121.069 1.418 . . . . 0.0 110.829 -9.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -93.19 132.86 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.599 ' HB ' ' HE2' ' A' ' 73' ' ' LYS . 20.4 mm -134.91 146.32 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -168.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.63 121.09 66.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.454 HG23 ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -109.36 145.24 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 125.155 1.535 . . . . 0.0 108.082 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.436 ' HA ' HG13 ' A' ' 3' ' ' VAL . 23.7 t-20 57.97 -45.96 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.036 2.135 . . . . 0.0 115.749 -169.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.69 -11.67 0.3 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 130.326 3.822 . . . . 0.0 109.982 -168.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -91.51 124.15 35.46 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.316 2.247 . . . . 0.0 113.173 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 51' ' ' TYR . 12.3 p -75.18 149.92 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.573 0.749 . . . . 0.0 110.354 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -178.44 171.64 1.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.764 2.026 . . . . 0.0 108.471 173.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.33 139.03 40.58 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.365 1.066 . . . . 0.0 109.473 167.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 75' ' ' ALA . 7.9 mm -121.54 71.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 122.495 1.14 . . . . 0.0 108.315 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.04 -164.26 26.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 122.456 1.031 . . . . 0.0 113.431 160.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.62 6.02 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 116.273 -1.822 . . . . 0.0 115.801 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.13 -111.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 CA-C-N 123.122 2.151 . . . . 0.0 108.769 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.6 p -126.0 -116.99 0.27 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 121.561 1.982 . . . . 0.0 107.794 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.599 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -92.11 14.84 14.85 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.075 1.75 . . . . 0.0 113.49 172.583 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -30.36 -50.49 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.021 2.601 . . . . 0.0 118.021 -163.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -67.93 -43.62 78.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.464 1.029 . . . . 0.0 111.766 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 -34.11 68.65 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.333 0.653 . . . . 0.0 109.969 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' OE2' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -48.65 -53.87 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.908 1.683 . . . . 0.0 108.37 171.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -67.62 -16.19 64.04 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.745 -0.597 . . . . 0.0 112.293 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.405 ' HA ' ' HE3' ' A' ' 82' ' ' LYS . . . -83.58 -49.19 9.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.311 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -60.44 -35.23 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 120.221 1.373 . . . . 0.0 109.885 174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.15 -19.69 47.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.542 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 79' ' ' ALA 0.255 0.0 OUTLIER -91.15 -67.5 0.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 109.145 159.159 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 . . . . . 0 N--CA 1.463 0.192 0 C-N-CA 124.384 1.074 . . . . 0.0 108.876 -179.879 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.34 133.23 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -124.47 117.31 24.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.088 0.858 . . . . 0.0 109.559 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.42 150.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 125.963 1.705 . . . . 0.0 107.681 -172.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -140.02 139.05 35.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 59' ' ' ILE . 3.6 mm? -114.21 78.18 1.13 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -80.26 88.38 5.51 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.673 1.225 . . . . 0.0 107.761 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.8 p -141.75 -149.22 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -166.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 41' ' ' VAL . 29.6 t . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 128.857 2.863 . . . . 0.0 108.087 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo . . . . . 0 CA--C 1.536 0.588 0 N-CA-C 117.791 2.189 . . . . 0.0 117.791 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 44.18 -100.1 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.813 2.045 . . . . 0.0 112.344 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.85 72.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.538 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -61.01 -37.07 81.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.437 1.471 . . . . 0.0 111.413 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -66.53 -51.74 53.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.685 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.35 -32.06 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 118.487 -1.285 . . . . 0.0 110.187 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -63.86 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 117.703 -1.142 . . . . 0.0 108.768 165.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -58.93 -38.5 79.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.81 1.186 . . . . 0.0 111.048 -170.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.445 ' OE2' HG23 ' A' ' 77' ' ' VAL . 1.7 tp10 -60.75 -53.96 50.97 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 110.155 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.33 -39.35 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.63 68.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.56 1.544 . . . . 0.0 111.814 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.77 -39.88 62.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.918 0.887 . . . . 0.0 110.012 169.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -93.49 -46.93 7.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.899 1.28 . . . . 0.0 111.495 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.33 87.35 47.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 126.009 1.724 . . . . 0.0 108.099 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.59 13.0 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.889 2.393 . . . . 0.0 112.877 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -142.57 -55.02 0.42 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -162.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.23 48.46 1.49 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.611 -0.68 . . . . 0.0 110.991 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.36 83.43 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.563 1.145 . . . . 0.0 108.921 -164.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.38 128.88 35.52 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -146.59 97.15 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 125.551 1.54 . . . . 0.0 107.067 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -80.08 144.09 33.43 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 109.837 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.39 115.57 29.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.258 0.2 OUTLIER -129.26 86.45 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -54.86 127.14 27.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 159.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.44 ' H ' ' HB2' ' A' ' 10' ' ' SER . 1.5 p -50.85 143.23 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.674 1.59 . . . . 0.0 112.075 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 ttt -142.19 -82.23 0.2 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 173.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.13 -2.82 26.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.478 1.111 . . . . 0.0 112.595 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.1 t30 35.83 57.76 2.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 127.432 2.293 . . . . 0.0 112.398 -168.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.74 137.22 37.99 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.182 1.255 . . . . 0.0 109.841 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -59.87 -20.71 58.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 116.32 -1.8 . . . . 0.0 112.182 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -37.34 -47.76 0.86 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.045 1.293 . . . . 0.0 112.332 171.086 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' A' ' 58' ' ' THR . . . -91.1 -33.47 15.45 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 117.233 2.309 . . . . 0.0 117.233 169.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.65 3.21 26.21 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.318 -0.864 . . . . 0.0 112.89 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.27 -143.67 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.929 2.091 . . . . 0.0 109.51 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 65' ' ' VAL . 10.0 m-85 68.86 -167.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 0.0 111.192 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 5.74 81.92 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.067 0.842 . . . . 0.0 113.458 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 55' ' ' ALA . 0.4 OUTLIER -94.96 -59.58 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.958 1.303 . . . . 0.0 107.912 178.189 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtm 49.7 13.27 0.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.703 1.601 . . . . 0.0 114.818 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 53' ' ' ILE . . . -140.58 106.09 5.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.391 1.476 . . . . 0.0 109.638 -168.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 m -56.69 158.03 9.21 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.022 . . . . 0.0 111.596 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.33 112.71 1.76 Allowed 'Cis proline' 0 C--N 1.354 0.828 0 CA-C-N 121.024 1.401 . . . . 0.0 111.066 -0.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.459 HG21 ' HB1' ' A' ' 48' ' ' ALA . 21.6 m -86.94 110.67 20.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.232 1.413 . . . . 0.0 107.266 -169.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.543 HD12 HD13 ' A' ' 7' ' ' LEU . 13.2 mm -115.45 152.05 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -174.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.75 132.88 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 164.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.432 HG13 ' HE3' ' A' ' 73' ' ' LYS . 2.5 pp -122.48 153.69 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 161.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 47.35 -69.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.9 2.88 . . . . 0.0 113.259 -171.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.77 4.05 0.24 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.6 2.048 . . . . 0.0 113.78 162.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.95 120.25 31.81 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 126.753 2.021 . . . . 0.0 110.106 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 51' ' ' TYR . 7.2 p -72.82 133.7 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.799 0.727 . . . . 0.0 109.298 166.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 4.0 tp10 -161.56 163.05 30.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.244 1.817 . . . . 0.0 108.403 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -126.25 153.63 44.48 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 159.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 75' ' ' ALA . 1.6 mm -141.99 149.0 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.71 -167.13 30.13 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 122.291 0.939 . . . . 0.0 113.312 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.61 -34.18 0.98 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 116.761 -1.59 . . . . 0.0 115.14 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.93 -109.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.282 1.851 . . . . 0.0 110.757 -164.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.3 p -114.72 -146.72 0.41 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 159.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HE3' HG13 ' A' ' 61' ' ' ILE . 4.8 ttpt -79.08 20.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.051 -1.656 . . . . 0.0 111.42 -169.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.838 ' HA ' HG22 ' A' ' 77' ' ' VAL . 9.1 mt-10 -61.62 -28.94 69.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -158.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -48.98 -48.52 43.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.41 1.084 . . . . 0.0 112.422 165.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.72 -33.83 40.59 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 117.014 -1.47 . . . . 0.0 109.913 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.838 HG22 ' HA ' ' A' ' 74' ' ' GLU 0.291 2.6 m -68.29 -37.92 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 122.724 2.511 . . . . 0.0 110.961 -175.259 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.56 -19.54 3.95 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.245 2.218 . . . . 0.0 111.257 165.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.97 -46.0 7.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.788 166.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.0 pt -53.73 -28.99 17.13 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-N 122.266 2.303 . . . . 0.0 112.092 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -79.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.355 164.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -16.23 25.07 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -170.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.43 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.359 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.378 173.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.407 ' HB3' ' HE3' ' A' ' 4' ' ' LYS . 13.3 m -147.63 2.4 0.72 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.349 1.86 . . . . 0.0 111.15 -173.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.06 162.62 0.16 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.837 2.455 . . . . 0.0 111.907 -165.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.25 103.28 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 1' ' ' SER . 0.6 OUTLIER -85.47 123.7 31.21 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.839 0.856 . . . . 0.0 110.221 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.89 141.2 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -134.83 146.96 49.77 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -128.93 88.38 2.71 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.579 1.551 . . . . 0.0 106.968 -173.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CG ' ' HB3' ' A' ' 48' ' ' ALA . 16.5 t80 -105.92 93.9 4.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.821 1.249 . . . . 0.0 107.869 -175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.586 HG21 ' HB3' ' A' ' 57' ' ' PRO . 2.4 m -177.72 156.84 1.16 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.588 2.355 . . . . 0.0 105.587 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t -128.28 85.79 59.58 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 160.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.54 137.87 40.44 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.073 1.849 . . . . 0.0 107.493 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -134.62 -31.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.506 -163.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.0 m -77.25 -79.36 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 116.933 -1.508 . . . . 0.0 108.524 167.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.42 111.23 3.26 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 123.315 2.22 . . . . 0.0 109.283 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -72.82 72.43 1.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.478 -0.764 . . . . 0.0 109.529 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.4 m -62.97 153.06 81.99 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 124.651 1.181 . . . . 0.0 109.151 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.54 -21.54 72.96 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.039 2.493 . . . . 0.0 112.258 169.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 46.88 -118.46 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.386 1.475 . . . . 0.0 110.159 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.54 65.09 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.648 -1.168 . . . . 0.0 111.981 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -62.29 -44.08 97.34 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.934 1.243 . . . . 0.0 110.431 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -66.07 -52.26 50.51 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.471 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.55 -41.53 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 117.827 -1.082 . . . . 0.0 109.452 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 p -62.5 -51.02 77.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.431 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -41.8 94.67 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.664 1.575 . . . . 0.0 110.08 -175.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.11 -50.6 71.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.776 1.23 . . . . 0.0 110.037 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.1 m -77.17 -29.66 17.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.85 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.13 64.36 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 120.292 1.405 . . . . 0.0 110.622 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.83 -44.29 90.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.855 0.752 . . . . 0.0 110.506 168.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.95 -55.01 9.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.734 2.014 . . . . 0.0 110.343 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.7 mmt -134.22 85.29 39.4 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 127.414 2.285 . . . . 0.0 109.265 -167.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.01 39.02 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.644 3.562 . . . . 0.0 111.747 -172.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -178.19 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.023 0.929 . . . . 0.0 110.709 -171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.7 48.02 0.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.746 0.703 . . . . 0.0 110.963 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.35 134.41 64.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -128.44 131.73 48.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.52 110.73 20.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.728 0.811 . . . . 0.0 109.225 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.33 102.38 15.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.56 96.56 10.13 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -112.35 85.12 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.05 116.44 2.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.13 99.86 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.824 0.821 . . . . 0.0 110.868 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.5 156.6 0.94 Allowed 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 134.129 4.972 . . . . 0.0 103.782 -178.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 36.69 54.56 1.13 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.914 2.086 . . . . 0.0 114.186 163.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.35 154.73 0.92 Allowed Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 127.469 2.308 . . . . 0.0 109.384 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.04 160.4 33.45 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 -170.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -78.96 25.72 0.27 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.01 1.324 . . . . 0.0 111.339 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -25.09 63.01 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB3' ' CG ' ' A' ' 8' ' ' PHE . . . -91.71 -36.56 13.52 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 167.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmm -73.2 -6.45 45.92 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.218 1.007 . . . . 0.0 113.151 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.29 -119.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.565 0.746 . . . . 0.0 109.023 158.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.8 m-30 60.59 -171.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.728 1.611 . . . . 0.0 110.309 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.71 -14.3 80.01 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.173 171.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.49 -49.97 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 109.16 -170.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.9 mtm 41.29 46.93 2.88 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.678 2.391 . . . . 0.0 111.365 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 106.89 1.64 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.515 1.126 . . . . 0.0 109.075 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -59.7 158.26 23.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.548 0.739 . . . . 0.0 111.804 168.007 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.586 ' HB3' HG21 ' A' ' 9' ' ' THR . 60.8 Cg_endo -74.33 118.49 5.15 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.245 0.766 . . . . 0.0 110.59 -6.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -86.63 116.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 107.4 -170.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 72' ' ' THR . 24.8 mm -134.11 140.85 45.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 121.031 -1.043 . . . . 0.0 108.592 -168.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.51 129.79 69.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.61 146.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 45.77 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 129.857 3.263 . . . . 0.0 116.877 -159.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 169.76 -10.29 0.05 OUTLIER Glycine 0 CA--C 1.542 1.72 1 C-N-CA 131.252 4.263 . . . . 0.0 110.906 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -91.07 132.68 35.88 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 120.218 2.009 . . . . 0.0 111.247 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.03 127.11 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.613 1.965 . . . . 0.0 108.727 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -161.22 -179.69 7.65 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 -171.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.75 129.32 6.05 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -140.17 92.82 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 118.541 0.61 . . . . 0.0 109.643 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.21 -177.4 17.26 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.541 1.067 . . . . 0.0 112.171 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.98 -50.06 33.73 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.976 -1.011 . . . . 0.0 111.104 161.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -68.38 178.52 3.66 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.171 1.454 . . . . 0.0 110.673 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.572 HG22 HD11 ' A' ' 59' ' ' ILE . 5.2 p -58.14 -173.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.878 2.471 . . . . 0.0 111.322 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -70.41 39.65 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.281 1.832 . . . . 0.0 113.957 -163.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.81 -38.49 78.74 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.925 1.69 . . . . 0.0 111.697 -168.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.26 68.67 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.292 1.037 . . . . 0.0 113.085 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -26.6 26.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.532 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.1 -36.26 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 120.582 -1.324 . . . . 0.0 109.781 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -60.75 -6.57 1.8 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.235 2.614 . . . . 0.0 113.624 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.4 -36.13 2.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.537 1.535 . . . . 0.0 112.469 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pt -61.43 -30.99 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.568 1.531 . . . . 0.0 109.13 165.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -64.88 -22.15 66.94 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.699 1.136 . . . . 0.0 113.897 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -46.96 7.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.928 0.891 . . . . 0.0 110.244 -168.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.53 81.43 0.02 OUTLIER 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.184 2.194 . . . . 0.0 105.786 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.25 1.127 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.5 178.541 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 42.9 mtt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.5 m -70.2 81.39 0.52 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.797 1.239 . . . . 0.0 112.333 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 164.43 36.4 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.937 1.695 . . . . 0.0 106.427 158.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.84 105.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 108.637 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -89.96 113.94 25.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.427 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.9 mt -126.27 140.47 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.08 138.71 40.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.43 90.68 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.066 1.346 . . . . 0.0 107.75 -174.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -105.81 76.41 1.18 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.54 1.638 . . . . 0.0 107.004 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.2 m -147.39 164.79 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.39 85.09 60.1 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.11 113.96 2.62 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.317 2.011 . . . . 0.0 108.156 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -122.57 -57.73 1.72 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.0 t -56.14 -57.9 19.67 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 116.971 -1.49 . . . . 0.0 110.798 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.68 -13.49 11.87 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.978 1.785 . . . . 0.0 112.625 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 46.98 15.51 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 129.254 3.022 . . . . 0.0 116.873 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.8 m -65.18 156.77 80.03 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -167.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.86 62.48 4.81 Favored 'Trans proline' 0 CA--C 1.538 0.696 1 C-N-CA 125.888 4.392 . . . . 0.0 111.84 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.35 -74.84 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.909 1.684 . . . . 0.0 112.715 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -23.1 67.29 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.513 -0.742 . . . . 0.0 112.389 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -54.18 11.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -65.88 -34.97 79.36 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.612 -1.185 . . . . 0.0 111.054 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 26' ' ' VAL . 76.9 t -58.49 -50.27 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.938 1.245 . . . . 0.0 109.512 174.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.34 -33.29 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 120.869 1.668 . . . . 0.0 112.341 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.54 -47.05 80.22 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.217 1.007 . . . . 0.0 109.385 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -57.99 -49.66 76.08 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.875 1.67 . . . . 0.0 110.192 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 5' ' ' ILE . 11.0 m -79.88 -25.24 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.23 -25.41 67.67 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 120.631 1.559 . . . . 0.0 110.129 174.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.28 -13.83 9.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.51 -57.53 1.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.331 1.852 . . . . 0.0 110.055 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.1 mtt -118.87 90.34 40.49 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 108.089 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.9 13.28 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.532 2.821 . . . . 0.0 115.32 -166.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -177.78 -26.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.89 1.677 . . . . 0.0 112.742 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.75 -9.1 17.74 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.28 1.855 . . . . 0.0 111.809 161.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.86 137.71 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.829 1.252 . . . . 0.0 110.942 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -136.68 98.63 3.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.41 99.43 8.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -78.64 117.89 20.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 118.77 30.1 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 84.62 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -60.41 119.52 8.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.221 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.62 110.52 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.5 mtm -140.84 -56.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.03 -16.04 60.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.309 1.444 . . . . 0.0 111.082 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.0 t30 35.98 58.71 3.1 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 127.888 2.475 . . . . 0.0 113.06 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.31 145.49 59.92 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.641 2.894 . . . . 0.0 112.737 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.45 -18.41 18.21 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.717 0.807 . . . . 0.0 112.771 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -39.4 63.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 112.857 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.58 -40.62 11.23 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.201 0.909 . . . . 0.0 112.423 163.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.5 mmm -64.38 -5.87 6.06 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -64.51 -24.04 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.5 1.52 . . . . 0.0 112.133 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -62.34 161.0 12.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.756 1.222 . . . . 0.0 111.563 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.68 -39.81 93.81 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.255 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.407 HD11 ' HB3' ' A' ' 55' ' ' ALA . 4.7 tp -52.34 -58.14 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.088 0.944 . . . . 0.0 111.195 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.0 mtt 55.15 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.198 2.599 . . . . 0.0 116.496 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 53' ' ' ILE . . . -73.13 -171.05 0.84 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.73 2.012 . . . . 0.0 111.966 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.74 136.98 19.11 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.9 159.33 72.61 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 C-N-CA 125.117 -0.785 . . . . 0.0 111.099 -8.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -122.08 128.9 51.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.14 162.83 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.84 136.85 55.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 165.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.426 HD13 HG22 ' A' ' 80' ' ' ILE . 1.8 pp -127.17 146.82 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.822 1.192 . . . . 0.0 108.387 169.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.3 t30 51.61 -36.9 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 130.103 3.361 . . . . 0.0 117.267 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.34 -8.58 0.04 OUTLIER Glycine 0 CA--C 1.541 1.71 1 C-N-CA 131.158 4.218 . . . . 0.0 110.928 167.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -91.76 120.36 32.42 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 126.358 1.863 . . . . 0.0 112.465 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.03 143.36 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.945 1.298 . . . . 0.0 107.885 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -178.29 166.59 1.9 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.486 1.514 . . . . 0.0 109.743 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.91 148.92 44.22 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.682 1.193 . . . . 0.0 109.074 165.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.02 137.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -177.93 51.82 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.371 0.532 . . . . 0.0 113.743 168.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.01 -45.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.143 1.377 . . . . 0.0 112.616 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.09 -172.48 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.327 1.51 . . . . 0.0 109.59 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 p -65.33 -163.17 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.515 -0.741 . . . . 0.0 110.926 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.79 27.82 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -158.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -29.3 -53.3 0.12 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.157 3.783 . . . . 0.0 113.654 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.75 -54.6 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.302 1.041 . . . . 0.0 111.503 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -27.33 62.4 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.609 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -42.84 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 120.138 1.336 . . . . 0.0 109.327 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.91 -12.9 41.19 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.691 -0.63 . . . . 0.0 111.971 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.43 -39.0 8.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.201 1.401 . . . . 0.0 111.689 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.426 HG22 HD13 ' A' ' 61' ' ' ILE . 2.9 pt -56.45 -41.28 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 121.395 1.907 . . . . 0.0 110.015 174.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -19.96 61.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -30.17 30.79 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.753 1.615 . . . . 0.0 109.406 173.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 -55.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.388 1.475 . . . . 0.0 111.807 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.25 -1.357 . . . . 0.0 110.16 -163.821 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.138 0.494 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 m -156.91 62.48 0.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 126.126 1.771 . . . . 0.0 106.656 162.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -71.2 99.63 1.93 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.784 0.834 . . . . 0.0 109.004 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 62' ' ' ASN . 93.2 t -87.21 149.69 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -128.8 115.74 18.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.472 HD13 HG11 ' A' ' 26' ' ' VAL . 1.4 mp -101.95 144.02 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 163.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -142.08 157.25 45.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.33 88.29 2.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.403 1.481 . . . . 0.0 109.016 -167.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -109.51 105.72 15.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -178.93 169.02 1.61 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 109.84 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p -129.69 77.24 77.35 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 127.253 2.221 . . . . 0.0 107.375 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.04 69.63 6.96 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.881 2.387 . . . . 0.0 111.661 -170.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.2 ttt -55.48 -42.08 73.86 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.794 1.237 . . . . 0.0 112.092 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.8 m -80.22 -71.7 0.14 Allowed Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 117.289 -1.338 . . . . 0.0 111.041 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.89 -26.67 15.29 Favored 'Trans proline' 0 C--N 1.351 0.7 0 CA-C-N 122.241 1.836 . . . . 0.0 113.364 -170.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 57.82 -61.37 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.214 2.205 . . . . 0.0 113.312 -163.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.2 m 58.73 168.69 0.07 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.176 1.79 . . . . 0.0 110.341 -159.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.12 -14.29 42.79 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.267 1.978 . . . . 0.0 112.345 161.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.37 -125.41 0.55 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.936 2.095 . . . . 0.0 110.87 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.17 -32.13 6.61 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.306 -1.33 . . . . 0.0 113.449 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -56.38 -47.33 79.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.087 2.221 . . . . 0.0 111.332 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.9 -36.09 37.01 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 116.178 -1.868 . . . . 0.0 112.426 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.427 HG12 HG21 ' A' ' 5' ' ' ILE . 2.1 t -66.35 -31.74 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 CA-C-N 120.088 1.313 . . . . 0.0 108.455 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HA ' HG11 ' A' ' 36' ' ' VAL . 53.2 t -59.78 -55.9 20.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 119.668 -1.895 . . . . 0.0 110.538 166.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -54.9 -42.36 72.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.297 1.408 . . . . 0.0 110.966 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.09 -71.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.696 2.399 . . . . 0.0 109.679 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HB ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -76.12 -21.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 118.386 -1.325 . . . . 0.0 113.338 -175.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.27 68.67 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -58.36 -28.41 65.1 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.445 1.02 . . . . 0.0 112.54 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -83.12 -64.45 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 108.967 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.1 mmt -131.05 85.73 53.82 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 124.743 1.217 . . . . 0.0 110.396 -166.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 69.44 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.3 2.666 . . . . 0.0 107.837 163.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -179.14 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.033 2.533 . . . . 0.0 106.941 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.16 4.27 46.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -160.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG21 ' HB ' ' A' ' 26' ' ' VAL . 2.5 t -103.91 114.98 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.585 -168.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -77.43 152.45 34.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -152.52 57.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.485 1.914 . . . . 0.0 108.024 -169.175 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -64.92 136.6 57.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -172.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -115.66 102.77 10.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 77.85 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.458 1.123 . . . . 0.0 108.928 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -62.18 147.24 48.35 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.486 -0.759 . . . . 0.0 112.479 -173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.15 93.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 ttp -153.01 -62.98 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.18 1.792 . . . . 0.0 107.331 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -145.19 11.18 1.33 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.664 0.786 . . . . 0.0 111.371 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -76.42 148.79 80.83 Favored Pre-proline 0 C--O 1.238 0.49 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.89 139.84 63.97 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.137 2.558 . . . . 0.0 110.337 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -69.25 19.26 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.977 1.711 . . . . 0.0 113.45 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -34.2 45.29 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.147 1.379 . . . . 0.0 114.594 -169.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.07 18.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -26.07 65.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.504 1.522 . . . . 0.0 112.578 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.32 -17.52 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.624 1.102 . . . . 0.0 113.565 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -66.87 145.36 55.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.739 1.616 . . . . 0.0 109.535 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.35 -29.77 31.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tp -54.11 -44.59 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.17 1.485 . . . . 0.0 111.221 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 45.6 mtm 41.61 32.74 0.26 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.677 2.391 . . . . 0.0 114.206 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.07 -178.26 3.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.736 1.615 . . . . 0.0 110.352 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.29 160.08 61.21 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.384 1.474 . . . . 0.0 109.96 -161.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.59 126.2 9.19 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 CA-C-N 119.406 0.823 . . . . 0.0 110.325 -12.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 m -78.01 80.99 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.634 1.974 . . . . 0.0 106.706 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.12 154.92 3.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.8 128.4 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.449 ' CG2' ' HE3' ' A' ' 73' ' ' LYS . 44.0 pt -128.13 143.01 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.225 1.01 . . . . 0.0 110.745 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.605 ' HA ' HG13 ' A' ' 3' ' ' VAL 0.259 34.5 t30 47.23 -50.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.035 2.934 . . . . 0.0 115.982 -163.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.69 -14.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.562 1.553 . . . . 0.0 112.233 159.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.82 152.75 19.97 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 120.514 2.157 . . . . 0.0 112.483 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.43 161.35 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.053 0.541 . . . . 0.0 109.678 173.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -178.62 165.51 1.69 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.382 2.273 . . . . 0.0 108.135 160.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.96 154.48 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 166.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.553 HG21 ' HB3' ' A' ' 75' ' ' ALA . 12.0 mm -130.16 78.82 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.79 -163.71 35.23 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.73 7.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 116.642 -1.647 . . . . 0.0 115.208 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.14 177.67 7.93 Favored 'Trans proline' 0 C--N 1.355 0.87 0 CA-C-N 122.776 2.027 . . . . 0.0 109.946 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -60.93 -173.2 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.41 1.084 . . . . 0.0 109.654 160.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' C ' HG23 ' A' ' 77' ' ' VAL . 4.0 tppt? -74.81 19.85 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 119.657 -1.902 . . . . 0.0 113.996 -159.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -29.35 -49.57 0.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 130.55 3.54 . . . . 0.0 116.534 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -60.37 -50.79 72.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.653 1.115 . . . . 0.0 110.907 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.04 -28.25 61.32 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.254 -1.355 . . . . 0.0 111.273 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.46 HG23 ' C ' ' A' ' 73' ' ' LYS . 56.1 t -54.87 -53.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.899 1.227 . . . . 0.0 108.297 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -63.33 -28.57 70.1 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.889 -0.507 . . . . 0.0 111.745 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.17 -67.07 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.792 -0.568 . . . . 0.0 110.045 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -60.32 -25.99 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.585 1.084 . . . . 0.0 112.772 -167.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.6 -31.5 71.58 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.038 1.29 . . . . 0.0 113.949 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.68 47.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.343 1.429 . . . . 0.0 109.408 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 171.25 133.41 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 129.717 3.207 . . . . 0.0 103.402 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.246 0.889 0 C-N-CA 127.214 2.206 . . . . 0.0 111.36 163.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.0 mtt . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 117.201 -1.38 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.1 m -143.28 -29.7 0.52 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -161.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp 36.54 50.28 0.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.197 1.799 . . . . 0.0 112.769 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.47 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 57' ' ' PRO . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p -132.33 153.84 81.38 Favored Pre-proline 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.92 94.11 1.01 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.647 2.232 . . . . 0.0 107.251 172.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 mtt -61.04 -31.37 71.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.87 -0.585 . . . . 0.0 111.225 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.6 m 132.89 -60.03 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 1 C-N-CA 132.323 4.249 . . . . 0.0 109.112 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.77 -73.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.818 1.679 . . . . 0.0 109.969 171.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -67.34 129.53 40.21 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 90.4 m -146.61 -49.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.488 1.515 . . . . 0.0 113.607 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 16' ' ' CYS . 10.4 Cg_endo -61.72 -18.84 62.66 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 122.027 1.76 . . . . 0.0 116.502 -166.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG21 ' A' ' 65' ' ' VAL . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' HG22 ' A' ' 9' ' ' THR . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 8' ' ' PHE . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' CG2' ' A' ' 80' ' ' ILE . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' CE2' ' A' ' 51' ' ' TYR . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.61 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.415 ' CG2' HD12 ' A' ' 61' ' ' ILE . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 -39.51 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.574 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.0 mtt . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 117.201 -1.38 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.1 m -143.28 -29.7 0.52 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -161.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp 36.54 50.28 0.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.197 1.799 . . . . 0.0 112.769 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.47 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 57' ' ' PRO . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p -132.33 153.84 81.38 Favored Pre-proline 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.92 94.11 1.01 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.647 2.232 . . . . 0.0 107.251 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 mtt -61.04 -31.37 71.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.87 -0.585 . . . . 0.0 111.225 -174.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.6 m 132.89 -60.03 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 1 C-N-CA 132.323 4.249 . . . . 0.0 109.112 -173.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.77 -73.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.818 1.679 . . . . 0.0 109.969 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -67.34 129.53 40.21 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 90.4 m -146.61 -49.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.488 1.515 . . . . 0.0 113.607 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 16' ' ' CYS . 10.4 Cg_endo -61.72 -18.84 62.66 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 122.027 1.76 . . . . 0.0 116.502 -166.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG21 ' A' ' 65' ' ' VAL . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' HG22 ' A' ' 9' ' ' THR . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 8' ' ' PHE . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' CG2' ' A' ' 80' ' ' ILE . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' CE2' ' A' ' 51' ' ' TYR . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.61 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.415 ' CG2' HD12 ' A' ' 61' ' ' ILE . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 -39.51 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.574 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' A' ' 1' ' ' SER . 8.2 tpt . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.419 ' H ' ' HG3' ' A' ' 0' ' ' MET . 26.6 m 74.47 93.07 0.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.171 1.788 . . . . 0.0 107.72 -169.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -118.64 110.87 17.83 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.51 112.79 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 130.59 36.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 159.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.731 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.0 mt -123.68 145.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 158.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -136.69 152.18 50.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mp -126.95 79.84 1.91 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -76.82 85.08 3.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' ASN . 37.4 p -136.5 166.2 24.07 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.537 -1.352 . . . . 0.0 109.745 -164.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 3.2 t -165.09 -42.46 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 O-C-N 120.064 -1.648 . . . . 0.0 110.339 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HD2' ' H ' ' A' ' 10' ' ' SER . 38.3 Cg_endo -63.79 90.83 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 121.285 1.495 . . . . 0.0 109.814 163.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.54 176.73 8.18 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.609 2.764 . . . . 0.0 107.945 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.261 90.7 m 110.4 -63.56 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 131.162 3.785 . . . . 0.0 109.267 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.19 40.14 0.5 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.855 2.37 . . . . 0.0 111.474 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -139.68 82.14 1.86 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.365 2.666 . . . . 0.0 104.731 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.6 m -66.79 -52.41 33.41 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 118.339 -0.839 . . . . 0.0 109.451 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.92 157.63 61.1 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 120.757 1.306 . . . . 0.0 109.003 160.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.83 -143.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 130.381 3.472 . . . . 0.0 103.223 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.22 -42.86 4.47 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.977 1.311 . . . . 0.0 112.895 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -55.86 -49.83 72.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.949 0.795 . . . . 0.0 112.283 176.09 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -58.81 -60.6 3.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.647 ' O ' HG22 ' A' ' 26' ' ' VAL . 3.6 t -57.32 -41.01 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 O-C-N 125.259 1.599 . . . . 0.0 108.936 -167.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.451 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -44.34 92.03 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 121.253 1.842 . . . . 0.0 110.146 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.91 -35.64 78.97 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.294 3.038 . . . . 0.0 111.849 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.877 HG23 HG11 ' A' ' 34' ' ' VAL . 19.2 m -105.72 -20.57 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -23.74 67.49 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 120.543 1.519 . . . . 0.0 110.173 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -47.95 -44.5 30.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.986 0.515 . . . . 0.0 112.03 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.06 -41.38 14.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.216 1.006 . . . . 0.0 111.304 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.5 mtm -139.19 75.39 34.29 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 110.457 -164.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.67 43.86 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.416 3.41 . . . . 0.0 113.441 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -178.27 -53.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.241 2.217 . . . . 0.0 108.897 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.05 67.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.072 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.877 HG11 HG23 ' A' ' 26' ' ' VAL . 2.3 t -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.35 154.79 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 158.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.16 110.89 15.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.53 104.75 17.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -80.87 106.88 13.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.88 88.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -66.28 123.27 19.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.704 -178.23 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.18 113.34 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 125.7 1.6 . . . . 0.0 107.811 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 ttt -160.41 -113.14 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -68.75 -21.79 64.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.73 1.605 . . . . 0.0 111.129 166.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -52.48 111.46 2.58 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 125.379 1.472 . . . . 0.0 109.998 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 158.82 55.2 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 112.201 -163.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -64.62 19.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.216 2.206 . . . . 0.0 114.842 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -20.27 33.77 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.044 -1.66 . . . . 0.0 113.941 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.75 -35.4 14.16 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 121.122 -0.986 . . . . 0.0 112.155 166.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -8.67 55.18 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.846 -1.159 . . . . 0.0 112.441 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -61.4 -26.87 68.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.98 0.912 . . . . 0.0 111.219 167.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -70.46 132.18 45.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.363 0.665 . . . . 0.0 109.958 -176.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.83 0.29 1.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 117.004 1.562 . . . . 0.0 117.004 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 tp -64.54 -50.22 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.026 1.913 . . . . 0.0 109.258 161.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.8 mtt 51.25 -8.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 130.938 3.695 . . . . 0.0 117.164 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.84 -172.15 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 110.447 163.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.403 ' HA ' ' N ' ' A' ' 58' ' ' THR . 7.2 p -178.05 144.66 0.51 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.863 1.665 . . . . 0.0 106.942 -158.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.17 108.24 0.26 Allowed 'Cis proline' 0 C--N 1.355 0.902 0 CA-C-N 122.157 1.806 . . . . 0.0 114.844 6.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.403 ' N ' ' HA ' ' A' ' 56' ' ' VAL . 11.7 m -79.67 113.43 17.82 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.734 1.614 . . . . 0.0 107.395 -168.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mm -117.77 114.46 45.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.7 t -83.53 134.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 164.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.442 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 1.9 pp -132.0 158.25 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.052 161.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.0 -77.52 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.441 1.497 . . . . 0.0 112.335 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 64' ' ' ASP . . . -172.28 20.67 0.07 OUTLIER Glycine 0 CA--C 1.542 1.774 1 C-N-CA 131.245 4.26 . . . . 0.0 109.512 170.331 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' H ' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -90.91 151.92 20.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 131.691 3.997 . . . . 0.0 107.386 169.329 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.03 110.55 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 108.606 -164.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.93 -177.7 6.06 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.883 . . . . 0.0 111.925 -159.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.32 115.44 2.57 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.963 0.905 . . . . 0.0 108.604 158.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.556 HG21 ' HB3' ' A' ' 75' ' ' ALA . 17.9 mm -84.98 74.36 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.24 -160.27 42.07 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.904 1.28 . . . . 0.0 113.756 159.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.33 1.38 Allowed Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 115.594 -2.146 . . . . 0.0 116.581 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.63 -127.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 124.115 2.505 . . . . 0.0 109.707 170.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -115.84 -114.54 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 121.133 1.788 . . . . 0.0 107.64 167.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.442 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -91.07 5.23 49.72 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.802 1.637 . . . . 0.0 111.404 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.502 22.2 mt-10 -37.8 -49.07 1.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -158.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -63.41 -34.98 78.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 123.337 2.789 . . . . 0.0 113.018 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.55 -22.88 26.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.454 1.102 . . . . 0.0 109.316 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -34.08 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.286 -1.509 . . . . 0.0 110.266 172.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -57.11 -22.75 42.11 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.653 -0.654 . . . . 0.0 111.551 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.1 -48.34 8.15 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.93 1.292 . . . . 0.0 110.47 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -56.91 -35.34 46.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 119.869 1.213 . . . . 0.0 111.523 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -67.07 -32.83 74.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.312 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -50.07 10.86 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 118.969 0.804 . . . . 0.0 108.85 170.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -160.98 -71.4 0.06 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.015 0.926 . . . . 0.0 110.734 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 C--O 1.249 1.039 0 C-N-CA 126.727 2.011 . . . . 0.0 106.668 -158.002 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 50.8 mtp . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.6 t -167.11 87.31 0.29 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 165.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -144.34 122.33 12.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.64 113.31 33.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.73 138.41 37.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' HB ' HG12 ' A' ' 36' ' ' VAL . 4.7 mp -134.87 137.4 50.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -137.01 147.13 46.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tp -137.64 80.45 1.81 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -173.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -91.43 96.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.471 1.108 . . . . 0.0 108.081 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 t -178.62 174.35 1.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.995 2.118 . . . . 0.0 106.908 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m -138.89 62.95 29.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.968 1.307 . . . . 0.0 107.614 169.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.11 85.56 1.81 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.044 2.496 . . . . 0.0 108.642 -169.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.5 mpp? 55.72 41.28 30.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.551 0.74 . . . . 0.0 110.305 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 25.0 m -44.24 -53.55 13.71 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.74 38.98 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 122.917 2.412 . . . . 0.0 112.579 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.23 -48.81 0.13 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.498 2.719 . . . . 0.0 106.492 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.9 m -119.95 105.35 42.89 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.085 1.754 . . . . 0.0 107.813 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -77.86 75.7 4.67 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.848 2.365 . . . . 0.0 111.022 -176.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.02 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.243 2.217 . . . . 0.0 112.645 -167.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.4 73.27 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-O 116.293 -1.813 . . . . 0.0 110.807 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -52.57 -50.67 62.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.272 1.851 . . . . 0.0 109.93 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -59.12 -57.67 12.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 117.304 -1.331 . . . . 0.0 111.503 171.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.54 -36.28 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 119.556 1.071 . . . . 0.0 110.852 -169.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.545 HG12 HG11 ' A' ' 36' ' ' VAL . 4.5 m -78.18 -30.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 O-C-N 120.3 -1.5 . . . . 0.0 111.966 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.49 -44.62 95.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.989 1.268 . . . . 0.0 108.712 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.77 -56.08 26.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.288 2.235 . . . . 0.0 109.839 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 m -72.44 -28.85 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 117.684 -1.151 . . . . 0.0 112.969 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.56 -24.58 67.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.99 1.723 . . . . 0.0 111.209 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 -16.77 29.05 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -31.69 1.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.385 1.074 . . . . 0.0 111.987 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 mmt -128.86 67.91 78.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 127.171 2.189 . . . . 0.0 108.365 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.52 32.69 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 126.085 4.523 . . . . 0.0 114.248 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -178.15 -57.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.03 -1.669 . . . . 0.0 109.184 -159.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.93 14.12 0.32 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.158 1.383 . . . . 0.0 113.925 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 p -90.64 91.37 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.696 1.998 . . . . 0.0 110.019 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 81.99 3.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.16 0.984 . . . . 0.0 108.711 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.545 HG11 HG12 ' A' ' 23' ' ' VAL . 4.0 m -95.52 139.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 127.063 2.145 . . . . 0.0 110.828 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -129.12 106.45 8.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -80.64 120.86 25.11 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.16 91.9 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 122.794 1.283 . . . . 0.0 109.908 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -50.46 113.23 0.83 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.783 2.033 . . . . 0.0 110.751 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.69 110.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 163.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.5 mtp -178.97 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 129.075 2.95 . . . . 0.0 104.052 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -155.26 98.74 2.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 102.322 -3.214 . . . . 0.0 102.322 -163.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.99 155.98 31.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 121.416 -0.802 . . . . 0.0 111.59 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.67 164.15 16.68 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.845 2.364 . . . . 0.0 112.966 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -73.33 -7.29 50.98 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.977 1.311 . . . . 0.0 112.789 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.56 -37.05 3.31 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -172.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' H ' ' HD3' ' A' ' 47' ' ' LYS . . . -91.55 -28.62 17.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.136 0.88 . . . . 0.0 113.073 177.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.93 -9.61 46.52 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.502 -0.749 . . . . 0.0 111.406 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.0 -25.9 67.29 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.633 1.106 . . . . 0.0 111.04 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CD2' HG21 ' A' ' 65' ' ' VAL . 23.0 m-85 -72.3 159.25 34.36 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.098 0.951 . . . . 0.0 111.913 -163.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 131.05 47.06 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.263 0.8 OUTLIER 60.33 -23.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.07 3.348 . . . . 0.0 115.885 -177.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.8 -62.1 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.439 2.696 . . . . 0.0 111.785 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.76 -68.84 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 131.079 3.752 . . . . 0.0 112.865 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.9 t 77.85 125.03 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 128.326 2.651 . . . . 0.0 108.281 -165.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.54 165.12 76.84 Favored 'Cis proline' 0 N--CA 1.454 -0.814 0 CA-C-N 119.702 0.929 . . . . 0.0 111.878 0.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.3 m -145.38 102.16 3.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 -164.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.8 133.37 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -166.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.9 t -100.0 132.11 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pp -120.96 142.65 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 161.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 52.63 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.702 3.201 . . . . 0.0 116.617 -169.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.52 -11.51 0.74 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 129.65 3.5 . . . . 0.0 111.001 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -92.14 111.9 23.63 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.006 2.122 . . . . 0.0 111.785 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.5 p -68.37 130.96 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.316 1.046 . . . . 0.0 109.187 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.27 -176.09 5.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.352 1.861 . . . . 0.0 106.574 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -168.31 130.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.526 1.966 . . . . 0.0 109.396 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.278 1.4 mt -121.45 75.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-O 122.023 0.916 . . . . 0.0 109.824 -173.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.72 -165.96 16.67 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.327 168.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.59 11.22 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 116.968 -1.491 . . . . 0.0 114.03 167.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.25 176.54 9.04 Favored 'Trans proline' 0 C--N 1.354 0.84 0 CA-C-N 122.385 1.888 . . . . 0.0 109.932 170.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -177.47 0.42 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.873 0.869 . . . . 0.0 110.789 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.49 30.44 0.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.478 -1.389 . . . . 0.0 112.62 -161.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.314 4.0 mt-10 -64.63 -20.55 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.152 -1.593 . . . . 0.0 114.505 -161.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.2 -48.75 74.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.816 -1.178 . . . . 0.0 112.277 167.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -24.51 56.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.235 -0.916 . . . . 0.0 110.808 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -38.2 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.722 -1.236 . . . . 0.0 108.924 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -54.23 -25.84 25.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.775 1.171 . . . . 0.0 111.312 170.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.28 -57.12 4.24 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.173 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . 0.257 2.6 pt -55.7 -35.35 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.733 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -85.24 -17.22 37.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.509 -1.71 . . . . 0.0 115.453 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -32.41 73.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 122.814 2.552 . . . . 0.0 109.582 165.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 147.96 107.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.481 2.312 . . . . 0.0 108.175 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.252 1.216 0 C-N-CA 128.898 2.879 . . . . 0.0 113.654 173.396 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.5 mtp . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m -150.27 121.53 7.83 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 121.259 1.845 . . . . 0.0 110.279 169.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.88 108.54 1.75 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.523 1.529 . . . . 0.0 107.097 159.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -75.48 111.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.38 61.8 6.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.494 1.118 . . . . 0.0 110.877 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.05 136.23 27.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.18 141.33 42.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.32 85.01 2.24 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -159.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.91 84.22 1.89 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 0.0 109.059 -165.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -138.79 -179.43 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 -167.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -149.86 71.59 9.57 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 120.974 1.715 . . . . 0.0 110.003 169.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.05 135.95 28.51 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.904 1.736 . . . . 0.0 109.047 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 31.4 ttm -127.99 -23.63 3.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.77 0.828 . . . . 0.0 112.465 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.0 m -112.12 -45.53 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 117.431 -1.271 . . . . 0.0 112.53 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -86.16 69.8 4.61 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.446 2.097 . . . . 0.0 109.45 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -65.46 86.73 0.07 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.262 1.025 . . . . 0.0 108.432 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.1 m -111.44 162.21 21.98 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 125.989 1.716 . . . . 0.0 109.428 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -61.63 105.86 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 106.529 -2.143 . . . . 0.0 106.529 158.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 -86.27 0.2 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.98 -40.96 59.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.91 170.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -52.23 -44.98 65.12 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -68.38 -43.54 77.13 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 120.074 1.306 . . . . 0.0 110.059 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 t -67.89 -32.38 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.43 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.5 t -53.13 -62.43 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.742 1.617 . . . . 0.0 107.815 164.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -64.25 -35.62 81.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.263 0.483 . . . . 0.0 111.358 -169.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' HG2' HG13 ' A' ' 77' ' ' VAL . 3.5 tp10 -62.49 -53.0 61.28 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.334 1.053 . . . . 0.0 110.118 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -67.14 -36.16 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -25.28 68.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.816 1.189 . . . . 0.0 112.272 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -52.16 -37.85 55.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 168.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -105.15 -55.09 2.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.556 1.542 . . . . 0.0 109.348 -165.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.6 79.48 12.54 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 127.703 2.401 . . . . 0.0 108.588 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.63 26.68 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.422 3.415 . . . . 0.0 112.777 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.14 -57.11 0.2 Allowed 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.622 -1.299 . . . . 0.0 110.751 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.03 -1.98 4.83 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -80.97 87.76 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.439 2.295 . . . . 0.0 111.495 -165.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -92.85 125.68 37.58 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 t -136.18 105.35 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.439 1.018 . . . . 0.0 110.876 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -88.64 119.28 28.96 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -88.09 122.35 31.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 98.86 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 171.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -69.14 149.25 48.85 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 116.943 -1.903 . . . . 0.0 109.021 166.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.35 123.38 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.46 -94.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.535 1.534 . . . . 0.0 107.722 -163.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.4 -36.34 83.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.823 1.647 . . . . 0.0 110.526 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 53.91 78.88 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.44 1.896 . . . . 0.0 111.504 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.48 157.26 56.73 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.018 2.479 . . . . 0.0 111.276 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -65.43 -20.32 66.32 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.75 -0.594 . . . . 0.0 111.727 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -32.1 53.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.86 -1.067 . . . . 0.0 113.817 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.54 -40.79 11.17 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.077 1.308 . . . . 0.0 113.504 163.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.4 mtp -66.09 -12.3 54.6 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.48 -20.74 66.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.863 1.665 . . . . 0.0 112.242 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.463 ' CZ ' HG11 ' A' ' 65' ' ' VAL . 4.6 m-85 -77.38 172.1 13.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.473 1.033 . . . . 0.0 109.709 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.46 -67.78 1.55 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.05 74.72 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 123.286 1.517 . . . . 0.0 108.26 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.25 36.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.604 -1.635 . . . . 0.0 114.762 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.75 -81.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.461 1.105 . . . . 0.0 113.663 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -178.45 152.7 0.8 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.26 1.424 . . . . 0.0 109.176 -168.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.95 94.32 0.13 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.577 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -20.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.0 m -72.6 108.27 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.914 1.285 . . . . 0.0 107.638 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 mm -112.94 155.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.92 142.77 42.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 168.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.289 7.8 pt -107.76 -119.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 116.583 -1.675 . . . . 0.0 111.085 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -53.57 -33.13 53.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.854 2.57 . . . . 0.0 112.439 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.53 -28.21 0.02 OUTLIER Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.336 0.97 . . . . 0.0 111.428 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.19 157.68 37.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.921 0.86 . . . . 0.0 111.317 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG11 ' CZ ' ' A' ' 51' ' ' TYR . 2.2 m -118.09 120.54 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.646 1.578 . . . . 0.0 108.18 -158.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.3 159.53 28.64 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -159.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -155.49 132.47 10.72 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.539 HG21 ' HB3' ' A' ' 75' ' ' ALA . 26.6 mm -135.26 118.73 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -168.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.06 -164.7 54.94 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 -34.79 0.75 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 116.621 -1.657 . . . . 0.0 114.434 169.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.28 -158.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 CA-C-N 122.34 1.872 . . . . 0.0 109.831 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -66.2 -171.71 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.466 -1.396 . . . . 0.0 109.818 160.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -77.17 49.06 0.66 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -158.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.69 -41.21 63.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -158.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.539 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -70.33 -41.57 73.08 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.835 -1.166 . . . . 0.0 112.136 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -77.25 -25.81 51.88 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.938 0.79 . . . . 0.0 110.923 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 25' ' ' GLU . 12.7 t -55.53 -48.03 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.863 1.665 . . . . 0.0 107.807 167.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.9 -8.25 10.62 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -100.98 -51.48 3.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.763 -1.211 . . . . 0.0 110.156 176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.7 pt -59.57 -23.06 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 O-C-N 121.262 -0.899 . . . . 0.0 111.615 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -62.46 -32.37 73.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.665 1.121 . . . . 0.0 113.219 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -42.26 10.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.578 1.081 . . . . 0.0 112.259 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 34.31 13.45 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 131.234 3.814 . . . . 0.0 121.022 -171.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.239 0 CA-C-N 121.494 1.952 . . . . 0.0 108.963 159.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.6 m -42.0 122.43 2.09 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.006 1.322 . . . . 0.0 110.786 165.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.598 ' H ' ' HB1' ' A' ' 33' ' ' ALA . 32.4 ttpt 68.41 92.29 0.08 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 127.86 2.464 . . . . 0.0 111.478 -166.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 t -58.73 140.71 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 160.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 147.06 36.08 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 36' ' ' VAL . 31.7 mt -141.59 129.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 71.5 mt-10 -128.59 128.03 43.43 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.14 69.56 1.16 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.669 1.988 . . . . 0.0 106.029 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -81.63 83.35 7.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.451 HG22 ' CB ' ' A' ' 57' ' ' PRO . 23.6 p -128.77 179.09 5.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.94 -1.1 . . . . 0.0 108.508 -166.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p 175.42 -63.81 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 CA-C-O 117.054 -1.45 . . . . 0.0 112.343 171.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.75 86.62 1.47 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.515 2.144 . . . . 0.0 111.882 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -166.19 149.97 7.62 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.683 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.3 m -69.76 168.58 16.64 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 158.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.26 46.16 0.7 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.232 2.621 . . . . 0.0 111.625 167.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -22.4 61.18 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.768 2.027 . . . . 0.0 113.769 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.4 m -133.32 149.83 73.54 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 167.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.85 72.8 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.922 2.415 . . . . 0.0 108.706 159.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.25 -80.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.804 1.642 . . . . 0.0 114.128 -158.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.05 -26.37 68.22 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.959 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -62.18 -47.74 83.15 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.231 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -49.09 69.51 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 120.412 1.46 . . . . 0.0 108.974 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 18.2 t -63.32 -34.07 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 117.662 -1.615 . . . . 0.0 110.342 -169.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.44 -45.37 75.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.532 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -53.17 -48.22 68.19 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.98 1.718 . . . . 0.0 109.487 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.78 -54.24 47.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 129.191 2.996 . . . . 0.0 110.23 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.72 -38.89 45.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.758 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.36 -28.24 66.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 120.615 1.552 . . . . 0.0 110.655 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -57.19 -25.72 59.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.549 1.14 . . . . 0.0 112.587 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.01 -23.11 6.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.275 1.03 . . . . 0.0 111.895 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.8 mtp -133.93 75.61 66.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 127.277 2.231 . . . . 0.0 110.629 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.55 29.63 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.518 3.478 . . . . 0.0 114.178 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -178.31 -48.39 0.01 OUTLIER 'General case' 0 C--O 1.236 0.348 0 O-C-N 120.325 -1.485 . . . . 0.0 109.693 -164.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.598 ' HB1' ' H ' ' A' ' 2' ' ' LYS . . . -77.43 54.51 1.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.349 0.66 . . . . 0.0 110.518 169.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.02 136.31 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.36 138.05 51.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -142.98 127.0 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 124.172 0.989 . . . . 0.0 109.691 -168.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -127.61 110.97 13.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 167.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.74 106.5 9.6 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 166.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.3 90.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.94 108.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 161.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.7 t -44.35 110.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.324 1.85 . . . . 0.0 109.126 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 tpp -140.03 -67.68 0.43 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.9 86.54 2.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -139.42 148.53 56.89 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.59 137.92 67.0 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 N-CA-C 106.266 -2.244 . . . . 0.0 106.266 161.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -73.17 39.33 0.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -31.23 70.2 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 120.792 -1.193 . . . . 0.0 112.609 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.36 -31.77 15.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 111.551 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.9 mtt -65.75 -7.56 16.42 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.932 -1.105 . . . . 0.0 112.132 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.56 -30.46 64.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.411 1.084 . . . . 0.0 111.008 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.77 169.05 8.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.767 0.827 . . . . 0.0 110.306 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.45 -30.32 77.53 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.656 -1.636 . . . . 0.0 112.536 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -51.14 -66.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.803 1.802 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 31.5 mtt 59.08 -39.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.961 2.504 . . . . 0.0 114.719 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.21 99.97 0.21 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.92 1.688 . . . . 0.0 110.984 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.1 m -60.59 150.18 75.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 121.528 -0.732 . . . . 0.0 109.407 159.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.451 ' CB ' HG22 ' A' ' 9' ' ' THR . 98.5 Cg_endo -72.22 113.14 2.08 Favored 'Cis proline' 0 C--N 1.349 0.603 0 CA-C-N 120.666 1.273 . . . . 0.0 111.93 1.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -96.78 117.88 32.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.219 2.208 . . . . 0.0 106.294 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.01 119.04 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -167.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -102.05 131.25 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.017 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.466 HD13 ' HE3' ' A' ' 73' ' ' LYS . 16.7 pt -128.26 163.37 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 125.032 1.458 . . . . 0.0 108.717 168.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 t30 48.16 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 111.63 -159.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.93 -3.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.443 0 C-N-CA 128.155 2.788 . . . . 0.0 111.892 167.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -91.54 129.83 37.46 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.232 2.016 . . . . 0.0 111.7 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.27 140.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.612 0.765 . . . . 0.0 109.733 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.18 -178.17 6.55 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -164.61 115.58 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.79 81.02 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 119.532 1.06 . . . . 0.0 110.468 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 171.9 23.17 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.376 -1.284 . . . . 0.0 112.007 166.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.71 3.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 115.958 -1.973 . . . . 0.0 115.836 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.08 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.367 2.238 . . . . 0.0 111.047 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 p -134.95 -127.99 0.16 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.934 2.094 . . . . 0.0 108.435 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HE3' HD13 ' A' ' 61' ' ' ILE . 2.8 ttpt -91.91 20.62 5.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.208 -1.558 . . . . 0.0 114.923 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -41.98 -45.11 3.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.618 2.008 . . . . 0.0 113.299 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.23 -49.65 60.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.569 1.148 . . . . 0.0 113.302 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -85.37 -21.86 28.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.03 -40.53 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.37 -29.05 65.7 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.471 -0.768 . . . . 0.0 112.455 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.599 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -77.53 -50.08 13.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 111.226 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 pt -60.44 -37.51 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.164 -0.96 . . . . 0.0 111.585 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -36.61 84.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.636 1.107 . . . . 0.0 113.237 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -21.47 45.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.44 1.473 . . . . 0.0 113.006 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.18 -73.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.126 1.771 . . . . 0.0 109.281 169.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.154 1.782 . . . . 0.0 107.268 -169.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.3 m 38.34 -123.84 0.28 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.256 2.222 . . . . 0.0 112.713 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? 27.72 73.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.976 2.51 . . . . 0.0 111.747 -165.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.77 101.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.74 160.37 32.73 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.811 0.815 . . . . 0.0 110.129 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 26' ' ' VAL . 3.0 mp -147.99 138.98 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 129.181 2.992 . . . . 0.0 105.135 167.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -135.7 146.87 48.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.56 82.98 2.06 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.785 1.234 . . . . 0.0 109.379 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.6 89.82 2.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.094 1.358 . . . . 0.0 108.5 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -135.69 179.69 6.18 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.856 -1.153 . . . . 0.0 113.279 -161.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t 178.75 -56.92 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.385 2.274 . . . . 0.0 108.278 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.38 93.4 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.407 2.071 . . . . 0.0 111.29 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 ttp -151.62 93.1 1.83 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.182 1.793 . . . . 0.0 107.094 -168.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.8 m -131.48 -72.59 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 117.186 -1.388 . . . . 0.0 110.355 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.79 -46.2 5.36 Favored 'Trans proline' 0 C--N 1.353 0.77 0 CA-C-N 122.251 1.84 . . . . 0.0 110.95 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -78.31 63.78 3.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 t -56.63 -56.14 35.59 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.481 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.14 118.99 6.0 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-N 121.38 1.529 . . . . 0.0 109.314 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.52 -94.42 0.32 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB2' ' HD1' ' A' ' 38' ' ' TYR . . . -57.19 -25.29 58.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.264 174.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -56.61 -54.66 43.39 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.814 0.846 . . . . 0.0 111.755 171.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.6 mtt-85 -60.71 -45.21 95.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 118.659 0.663 . . . . 0.0 109.594 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.9 t -68.69 -34.58 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.563 -170.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.44 -32.57 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 121.133 1.788 . . . . 0.0 110.885 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -60.54 -53.68 54.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.815 1.189 . . . . 0.0 109.043 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.38 -36.97 77.33 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 122.915 0.486 . . . . 0.0 111.595 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 5' ' ' ILE . 59.2 t -74.7 -35.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.975 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.7 70.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.642 1.564 . . . . 0.0 111.169 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -57.72 -22.23 45.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.56 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -112.55 -31.52 6.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.974 1.261 . . . . 0.0 112.069 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -145.14 85.84 7.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.549 1.939 . . . . 0.0 110.338 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.88 45.47 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.176 3.251 . . . . 0.0 110.913 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -178.0 -66.77 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.711 1.604 . . . . 0.0 109.035 -166.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.87 1.11 4.74 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.27 141.33 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.267 1.427 . . . . 0.0 108.988 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.31 130.06 30.22 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 164.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.63 92.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.815 1.246 . . . . 0.0 110.52 -159.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 104.33 16.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' HD1' ' HB2' ' A' ' 19' ' ' ALA . 31.0 t80 -75.61 121.75 22.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 159.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.09 92.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.7 161.72 14.53 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.745 -1.222 . . . . 0.0 109.948 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.5 mtp -178.59 -87.05 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.586 2.354 . . . . 0.0 105.665 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -68.17 -19.06 64.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.721 1.208 . . . . 0.0 111.983 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.08 56.13 17.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.394 1.878 . . . . 0.0 111.606 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.35 140.78 65.43 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.934 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.76 -15.62 42.7 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.814 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -40.25 -45.37 2.06 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.378 1.471 . . . . 0.0 112.333 162.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.07 -46.01 8.0 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 168.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mtp -68.57 -5.47 20.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.42 -26.27 63.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.378 1.071 . . . . 0.0 111.317 164.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -76.33 118.48 19.08 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.269 1.028 . . . . 0.0 110.243 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.59 -5.5 23.87 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.437 -1.201 . . . . 0.0 114.878 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 pt -68.44 -46.55 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.875 1.838 . . . . 0.0 109.603 170.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.3 mtt 47.08 -11.42 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.632 3.173 . . . . 0.0 117.447 -169.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.7 68.9 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.397 1.879 . . . . 0.0 115.735 -159.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.311 28.8 m 50.98 166.72 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 128.251 2.62 . . . . 0.0 113.625 -161.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -65.52 105.78 0.34 Allowed 'Cis proline' 0 C--N 1.356 0.948 0 CA-C-N 121.55 1.589 . . . . 0.0 109.99 -14.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 m -79.89 124.49 28.71 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.803 1.641 . . . . 0.0 107.066 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.82 166.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 t -142.94 134.16 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.417 HG12 ' HZ1' ' A' ' 73' ' ' LYS . 37.1 pt -101.42 -157.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.745 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -23.23 -51.34 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.495 2.318 . . . . 0.0 114.91 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.22 -27.2 0.22 Allowed Glycine 0 CA--C 1.533 1.215 0 O-C-N 124.163 0.914 . . . . 0.0 112.106 158.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.55 140.59 29.6 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.684 1.742 . . . . 0.0 112.585 -163.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.71 147.64 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.173 2.189 . . . . 0.0 108.478 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -178.57 160.13 1.2 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.555 1.542 . . . . 0.0 109.401 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 146.89 52.51 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 159.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 mm -124.78 88.44 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.38 -165.16 51.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 121.664 0.591 . . . . 0.0 112.418 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -72.76 -22.84 0.54 Allowed Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 174.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 41.9 Cg_endo -65.65 177.17 2.96 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 123.67 2.346 . . . . 0.0 110.632 164.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.1 p -70.55 -159.77 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 159.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.417 ' HZ1' HG12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -77.29 23.26 0.2 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 119.199 -2.188 . . . . 0.0 112.746 -170.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -44.93 -37.92 4.31 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.84 2.456 . . . . 0.0 112.508 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.87 -66.47 0.38 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.481 1.112 . . . . 0.0 111.567 169.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -23.31 64.25 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.647 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -39.8 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.568 1.531 . . . . 0.0 108.559 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -62.34 -7.46 4.39 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.05 -37.83 7.19 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.204 1.366 . . . . 0.0 112.376 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -42.78 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.569 1.077 . . . . 0.0 108.598 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -15.25 60.92 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.394 -1.441 . . . . 0.0 113.927 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -52.73 9.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.59 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -159.54 49.24 0.31 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.827 1.194 . . . . 0.0 112.307 174.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.426 0.0 OUTLIER . . . . . 0 C--O 1.245 0.845 0 C-N-CA 126.738 2.015 . . . . 0.0 113.667 -162.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 42.1 tpp . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.5 m 48.3 46.53 20.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.484 1.114 . . . . 0.0 112.083 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -142.04 156.65 45.43 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.764 0.826 . . . . 0.0 110.086 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.461 HG13 ' HA ' ' A' ' 62' ' ' ASN . 59.5 t -66.08 130.97 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.673 1.124 . . . . 0.0 108.507 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -106.2 147.04 29.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.261 -0.899 . . . . 0.0 109.224 170.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.567 HD13 ' HA ' ' A' ' 61' ' ' ILE . 4.4 mm -133.29 134.61 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -130.06 143.86 51.03 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.478 HD13 HD12 ' A' ' 59' ' ' ILE . 3.4 mm? -121.44 78.67 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 16.0 t80 -88.97 80.14 7.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 m -152.33 159.39 43.47 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.352 -1.468 . . . . 0.0 110.468 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.9 t -145.61 105.04 4.27 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 162.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.53 122.5 6.03 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.966 1.777 . . . . 0.0 110.715 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 46.8 ttm -91.84 91.48 7.93 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.4 m 113.18 -58.42 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.302 0 C-N-CA 131.055 3.742 . . . . 0.0 111.045 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.59 58.58 7.07 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.803 2.335 . . . . 0.0 110.999 -173.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -61.7 111.03 1.68 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.8 m -121.43 162.71 34.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 125.701 1.6 . . . . 0.0 108.119 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.34 -21.25 71.27 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.764 1.643 . . . . 0.0 113.856 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 43.08 -117.0 0.44 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.201 1.4 . . . . 0.0 110.389 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.59 -32.75 29.83 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 116.15 -1.881 . . . . 0.0 114.246 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -59.1 -59.07 6.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 121.457 1.935 . . . . 0.0 109.639 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -61.63 -50.26 73.27 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.495 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.4 -40.59 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 117.017 -1.468 . . . . 0.0 108.577 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.87 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 120.479 1.49 . . . . 0.0 109.657 171.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -58.69 -43.14 89.92 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.905 1.23 . . . . 0.0 110.653 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.28 -54.62 34.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.646 1.178 . . . . 0.0 110.653 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 HG11 ' A' ' 34' ' ' VAL . 34.5 m -71.6 -29.2 33.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.793 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.93 64.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.691 1.132 . . . . 0.0 110.125 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.77 -40.05 78.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.189 0.45 . . . . 0.0 110.078 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -76.56 -51.69 11.16 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.329 1.051 . . . . 0.0 111.909 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.4 mtt -141.38 82.94 13.93 Favored Pre-proline 0 C--N 1.333 -0.152 0 C-N-CA 127.517 2.327 . . . . 0.0 108.755 -167.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -68.85 8.81 0.52 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.205 1.937 . . . . 0.0 114.147 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.7 -40.69 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.551 1.141 . . . . 0.0 112.376 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -6.4 19.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.519 1.054 . . . . 0.0 111.812 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.53 HG11 HG23 ' A' ' 26' ' ' VAL . 1.5 t -80.66 144.72 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 119.496 1.044 . . . . 0.0 109.319 170.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 141.62 51.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.171 2.188 . . . . 0.0 105.182 165.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.35 129.04 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 124.019 0.928 . . . . 0.0 109.725 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -121.15 97.54 5.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -85.91 93.06 8.84 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.276 0.2 OUTLIER -116.27 92.42 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 123.056 1.408 . . . . 0.0 107.815 -170.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.06 124.15 20.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.967 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.79 117.45 5.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.59 -63.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -143.67 51.35 1.34 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -160.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -139.5 151.18 66.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.857 0.863 . . . . 0.0 111.101 -165.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.98 134.76 32.95 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.295 2.663 . . . . 0.0 111.852 -172.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -70.68 7.03 1.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.344 -0.848 . . . . 0.0 112.779 173.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.7 -31.63 17.03 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.079 1.752 . . . . 0.0 113.311 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -92.35 -41.48 10.33 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.616 0.644 . . . . 0.0 111.103 164.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.14 -0.75 3.56 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.83 -143.44 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.196 1.398 . . . . 0.0 109.662 159.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 67.6 -168.03 0.2 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.563 1.545 . . . . 0.0 111.725 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.87 162.76 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 158.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.293 1.5 tp 41.79 63.99 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 123.225 1.488 . . . . 0.0 112.563 -165.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtt -67.87 -22.33 65.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.687 163.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.02 0.84 4.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.906 1.282 . . . . 0.0 113.926 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 70.31 164.07 0.14 Allowed Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.406 1.482 . . . . 0.0 110.49 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.15 125.94 10.61 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.674 1.276 . . . . 0.0 111.474 -9.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.1 m -95.4 98.09 10.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.478 HD12 HD13 ' A' ' 7' ' ' LEU . 31.5 mm -119.48 120.4 63.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -167.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.63 127.95 47.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.567 ' HA ' HD13 ' A' ' 5' ' ' ILE . 8.9 pt -123.91 142.17 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.83 0.741 . . . . 0.0 109.885 169.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.461 ' HA ' HG13 ' A' ' 3' ' ' VAL . 18.5 t30 48.08 -42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.288 3.035 . . . . 0.0 116.886 -159.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.96 -15.6 0.06 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 128.414 2.911 . . . . 0.0 111.255 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -91.06 160.61 15.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.413 1.606 . . . . 0.0 110.17 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.64 127.55 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.82 0.848 . . . . 0.0 109.209 -158.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.93 173.39 15.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.026 0.83 . . . . 0.0 111.015 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.92 155.51 48.94 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.782 1.633 . . . . 0.0 106.874 159.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.6 mm -141.06 136.17 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.01 -171.34 45.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.82 -30.97 0.64 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.374 -1.774 . . . . 0.0 114.209 164.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -85.41 -166.54 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 CA-C-N 123.005 2.109 . . . . 0.0 110.53 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -63.33 175.63 0.95 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.054 0.941 . . . . 0.0 111.661 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HZ1' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -77.26 21.5 0.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.518 1.527 . . . . 0.0 113.771 -160.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -35.45 -40.8 0.16 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.312 2.245 . . . . 0.0 114.654 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.48 -64.76 0.72 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.714 1.606 . . . . 0.0 111.703 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -68.36 -28.15 66.87 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.042 0.537 . . . . 0.0 110.698 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.13 -34.65 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.25 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.45 -16.55 55.86 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.529 -1.357 . . . . 0.0 113.745 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.48 -47.81 7.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.351 1.432 . . . . 0.0 110.466 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.87 -24.84 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.024 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -64.01 -46.5 84.23 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.129 0.877 . . . . 0.0 111.282 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.85 -49.49 8.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -165.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 53.29 -58.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 129.128 2.971 . . . . 0.0 114.629 -165.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.479 1.912 . . . . 0.0 110.507 -169.574 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m -67.45 113.76 5.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.706 0.402 . . . . 0.0 110.285 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -144.05 126.21 15.57 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 168.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -105.39 103.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 158.17 35.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.446 HD13 HG22 ' A' ' 36' ' ' VAL . 4.8 mp -143.39 138.94 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 161.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -129.08 144.16 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 mt -138.37 89.62 2.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.404 1.082 . . . . 0.0 108.465 -170.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t80 -113.63 97.25 6.31 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.211 1.805 . . . . 0.0 108.917 -164.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t -178.91 -177.25 0.48 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.989 1.716 . . . . 0.0 106.626 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 t -158.23 69.71 3.86 Favored Pre-proline 0 CA--C 1.539 0.558 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.6 127.76 18.68 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.107 1.872 . . . . 0.0 109.26 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.6 ttt -55.88 105.89 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.765 1.226 . . . . 0.0 109.096 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.296 96.3 m 108.23 -76.11 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 131.352 3.861 . . . . 0.0 109.369 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.44 3.78 2.0 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 CA-C-N 123.346 2.231 . . . . 0.0 115.683 -172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.16 47.75 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.642 1.564 . . . . 0.0 113.396 163.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -138.46 -64.48 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 125.043 1.337 . . . . 0.0 109.629 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.85 -8.15 21.67 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.882 1.722 . . . . 0.0 114.235 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.73 -81.21 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.875 1.67 . . . . 0.0 113.496 -166.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.18 -25.35 68.04 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.491 -1.242 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -61.39 -59.29 5.5 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.203 0.91 . . . . 0.0 109.791 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -61.6 -43.15 99.39 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.762 -0.586 . . . . 0.0 111.005 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -66.36 -33.71 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.942 -173.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.24 -27.41 13.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 CA-C-N 120.368 1.44 . . . . 0.0 111.88 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -61.23 -57.58 11.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 108.252 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -49.27 -66.18 0.44 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.328 1.851 . . . . 0.0 107.688 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.47 -27.95 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.686 1.13 . . . . 0.0 112.872 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 -26.35 68.01 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.829 1.649 . . . . 0.0 111.249 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -53.72 -48.98 69.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.221 0.919 . . . . 0.0 111.466 167.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.51 -51.77 47.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.587 0.63 . . . . 0.0 109.978 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.59 88.48 8.69 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.668 1.587 . . . . 0.0 109.367 -169.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.41 27.27 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.021 3.147 . . . . 0.0 110.95 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -151.67 -68.33 0.17 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.152 1.381 . . . . 0.0 108.62 -158.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.21 -5.03 28.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.16 139.44 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 119.175 0.898 . . . . 0.0 110.294 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.28 123.31 24.02 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 5' ' ' ILE . 33.6 t -117.02 140.02 41.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -116.97 100.6 7.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.57 115.68 17.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 160.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.266 0.2 OUTLIER -129.23 101.32 6.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.766 1.27 . . . . 0.0 107.876 177.406 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.1 129.03 38.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.244 1.418 . . . . 0.0 108.324 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.55 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -178.94 -72.26 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 128.458 2.703 . . . . 0.0 106.328 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.6 -41.8 59.81 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -58.86 142.79 84.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.061 0.944 . . . . 0.0 112.159 -167.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.01 136.45 32.37 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.911 1.741 . . . . 0.0 108.254 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.08 -12.88 2.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.542 1.537 . . . . 0.0 113.386 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -4.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.833 2.853 . . . . 0.0 118.468 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -91.42 -63.89 1.2 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 121.5 1.954 . . . . 0.0 107.546 158.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.435 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -40.83 -21.22 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 129.738 3.215 . . . . 0.0 115.254 174.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.91 -20.38 3.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.802 2.041 . . . . 0.0 114.84 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -52.58 175.39 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.019 2.928 . . . . 0.0 115.555 -164.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -43.42 127.41 5.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.822 1.201 . . . . 0.0 110.837 164.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.289 0.2 OUTLIER 60.12 -24.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 129.435 3.094 . . . . 0.0 115.895 -170.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtm 62.24 -73.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 128.628 2.771 . . . . 0.0 110.754 -172.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 36.27 -130.95 0.1 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.187 2.595 . . . . 0.0 110.965 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -179.32 154.28 0.74 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 128.937 2.895 . . . . 0.0 105.138 175.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.93 -179.87 8.81 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 119.483 0.851 . . . . 0.0 112.0 -14.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -128.69 127.19 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 168.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -129.56 163.71 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 65' ' ' VAL . 19.4 t -138.75 130.93 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 102.907 -2.998 . . . . 0.0 102.907 169.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.411 HG23 ' NZ ' ' A' ' 73' ' ' LYS . 41.0 pt -99.21 -161.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 117.005 -1.474 . . . . 0.0 108.9 168.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -20.17 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.823 2.449 . . . . 0.0 114.308 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.68 -13.61 1.42 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.869 -0.962 . . . . 0.0 112.668 158.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -91.32 113.86 26.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.331 1.566 . . . . 0.0 113.186 -159.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 60' ' ' VAL . 57.5 t -58.42 135.35 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.421 1.489 . . . . 0.0 107.855 164.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 6.6 tt0 -178.57 169.33 1.74 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.862 2.065 . . . . 0.0 107.842 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -158.93 139.63 12.61 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 119.907 -1.745 . . . . 0.0 106.662 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.89 133.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -174.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 175.37 49.82 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.127 0.892 . . . . 0.0 111.966 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.21 -42.62 2.11 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.735 1.214 . . . . 0.0 112.825 164.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.12 -176.66 1.95 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 CA-C-N 121.798 1.678 . . . . 0.0 109.354 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -62.85 -175.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.518 -0.739 . . . . 0.0 111.119 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HZ3' ' HB3' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -70.45 32.99 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.886 2.074 . . . . 0.0 114.64 -158.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.34 -34.63 64.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.236 -1.54 . . . . 0.0 112.017 -172.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.81 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.49 1.116 . . . . 0.0 111.7 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -82.51 -28.8 30.88 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.928 174.639 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.24 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 120.697 1.589 . . . . 0.0 109.97 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -12.5 23.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.18 -37.28 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.718 2.007 . . . . 0.0 111.418 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.29 -34.4 40.03 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 121.677 2.035 . . . . 0.0 110.251 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -53.81 -35.28 61.23 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -31.42 16.33 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 170.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.84 -66.32 0.4 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.834 1.253 . . . . 0.0 111.696 -169.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 C--O 1.255 1.343 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -178.294 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 58.0 mtp . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 p -151.73 169.95 20.95 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.104 0.562 . . . . 0.0 111.274 -164.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 108.86 104.61 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 131.046 3.738 . . . . 0.0 107.617 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 62' ' ' ASN . 11.0 t -65.12 130.06 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 168.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.14 141.5 33.94 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 165.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 26' ' ' VAL . 4.9 mp -138.43 85.38 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -172.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -93.71 128.67 40.04 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.653 HD13 HD12 ' A' ' 59' ' ' ILE . 4.2 mm? -100.21 87.12 3.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 164.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 48' ' ' ALA . 15.2 t80 -91.05 95.64 10.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.971 0.891 . . . . 0.0 108.65 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -178.47 172.1 1.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.192 1.797 . . . . 0.0 108.136 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 t -138.06 101.73 8.46 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 164.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.85 58.59 6.1 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.583 2.855 . . . . 0.0 110.914 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 39.9 ttm -62.42 -23.44 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.376 1.47 . . . . 0.0 111.835 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 72.2 m -79.11 -73.05 0.12 Allowed Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 116.736 -1.602 . . . . 0.0 110.659 170.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 13' ' ' CYS . 43.3 Cg_endo -85.48 -9.85 7.89 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 CA-C-N 122.982 2.101 . . . . 0.0 115.699 -168.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 53.62 25.25 4.77 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 m -55.17 154.2 11.2 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.726 0.693 . . . . 0.0 112.336 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.37 57.22 3.44 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.429 3.42 . . . . 0.0 109.586 166.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.41 ' HB1' HG21 ' A' ' 72' ' ' THR . . . -52.92 -77.5 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.68 1.992 . . . . 0.0 111.994 -166.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.92 78.48 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 118.224 -0.893 . . . . 0.0 108.796 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -48.64 -46.08 39.41 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.278 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -68.04 -53.0 28.97 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 121.02 1.737 . . . . 0.0 111.085 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.72 -40.2 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.017 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HA ' HG22 ' A' ' 26' ' ' VAL . 6.7 m -73.98 -32.68 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 126.113 1.765 . . . . 0.0 112.637 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.64 -49.31 62.52 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.632 1.106 . . . . 0.0 108.139 164.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -76.98 -44.43 31.12 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.074 0.949 . . . . 0.0 110.531 -164.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG21 HG12 ' A' ' 5' ' ' ILE . 20.5 m -72.57 -26.44 24.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.95 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.49 63.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.936 1.698 . . . . 0.0 110.328 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.24 -41.18 99.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.303 1.041 . . . . 0.0 109.878 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.7 -56.82 7.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.146 0.579 . . . . 0.0 110.63 171.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.0 mtt -146.86 86.83 6.48 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 125.355 1.462 . . . . 0.0 109.214 -159.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.25 41.4 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.437 2.758 . . . . 0.0 111.66 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -151.56 -66.36 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 127.198 2.199 . . . . 0.0 108.061 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 45.45 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.977 1.711 . . . . 0.0 111.775 -173.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.14 83.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.065 1.346 . . . . 0.0 109.928 -161.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -89.24 110.8 21.52 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.46 142.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.034 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -156.52 152.16 27.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.354 1.073 . . . . 0.0 112.068 158.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.58 90.57 4.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.386 2.274 . . . . 0.0 106.334 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.45 85.33 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 121.56 12.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 93.67 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 mmt -143.6 -52.99 0.35 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.94 1.696 . . . . 0.0 109.089 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 13.3 6.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.143 2.177 . . . . 0.0 110.845 -169.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.14 154.42 30.57 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.554 2.342 . . . . 0.0 115.594 -160.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.23 145.06 77.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.788 2.325 . . . . 0.0 110.592 170.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -66.33 -9.8 36.68 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.381 -0.824 . . . . 0.0 111.041 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -61.0 -18.02 55.3 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -175.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.24 -39.54 11.47 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 119.974 -1.704 . . . . 0.0 112.068 161.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.2 mtm -63.35 -12.98 34.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.121 -0.987 . . . . 0.0 112.543 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.14 -26.66 68.45 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.564 1.146 . . . . 0.0 110.902 168.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CD2' HG21 ' A' ' 65' ' ' VAL . 29.5 m-85 -66.6 114.65 5.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 108.953 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.69 8.14 3.48 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.576 1.39 . . . . 0.0 116.576 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -69.83 -52.59 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.937 1.869 . . . . 0.0 108.587 159.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . 0.279 0.1 OUTLIER 40.9 7.74 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.926 3.29 . . . . 0.0 117.815 -169.079 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -178.44 0.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 123.392 1.568 . . . . 0.0 109.354 159.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.04 158.56 48.33 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.194 -0.941 . . . . 0.0 108.922 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB2' HD11 ' A' ' 59' ' ' ILE . 66.3 Cg_endo -70.21 128.76 13.6 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 -10.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -77.78 106.13 9.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.653 HD12 HD13 ' A' ' 7' ' ' LEU . 14.7 mm -118.93 121.54 67.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -111.81 111.28 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pp -101.07 167.75 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 169.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' A' ' 3' ' ' VAL . 14.9 m120 30.33 -81.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.07 1.748 . . . . 0.0 114.501 -161.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.53 10.19 1.46 Allowed Glycine 0 CA--C 1.534 1.243 0 CA-C-N 120.241 1.382 . . . . 0.0 114.139 165.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -86.52 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.33 1.565 . . . . 0.0 113.358 -166.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' A' ' 51' ' ' TYR . 4.1 p 114.78 134.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 1 C-N-CA 133.766 4.826 . . . . 0.0 106.753 -163.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -178.72 167.08 1.73 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.738 2.415 . . . . 0.0 108.088 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.82 116.67 5.53 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.733 1.613 . . . . 0.0 107.831 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 150.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.51 172.36 47.7 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 124.339 1.025 . . . . 0.0 111.248 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -83.98 -33.55 0.55 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.702 1.201 . . . . 0.0 111.459 158.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 85.9 Cg_endo -71.15 -165.75 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.636 1.62 . . . . 0.0 110.001 160.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.41 HG21 ' HB1' ' A' ' 18' ' ' ALA . 30.8 p -64.23 -172.47 0.07 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.525 0.73 . . . . 0.0 109.858 162.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -71.59 47.34 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.393 2.277 . . . . 0.0 114.529 -158.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -58.31 -45.36 88.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.577 1.951 . . . . 0.0 110.923 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.86 61.4 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 112.867 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.94 -20.63 21.98 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.995 0.918 . . . . 0.0 110.476 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.92 -38.42 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.561 -1.337 . . . . 0.0 108.353 167.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.2 -0.64 10.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.444 0.698 . . . . 0.0 112.761 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.57 -51.11 3.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.592 1.557 . . . . 0.0 111.21 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pt -53.48 -40.51 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 119.967 1.258 . . . . 0.0 107.948 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -72.9 -29.09 62.87 Favored 'General case' 0 C--N 1.345 0.377 0 O-C-N 120.209 -1.557 . . . . 0.0 114.78 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.49 1.95 . . . . 0.0 109.291 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -71.64 11.01 0.55 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.994 1.318 . . . . 0.0 113.92 172.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.252 1.225 0 CA-C-N 120.151 1.341 . . . . 0.0 107.677 158.729 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 117.02 -1.467 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 m -66.15 143.69 57.12 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 122.227 2.285 . . . . 0.0 110.011 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -73.64 126.0 29.3 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.9 110.26 3.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -91.13 144.75 25.31 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.77 138.57 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -124.72 133.0 53.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.14 92.09 3.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.049 1.34 . . . . 0.0 109.118 -172.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -112.61 104.09 12.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.027 0.931 . . . . 0.0 109.857 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 t -178.57 170.92 1.59 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 108.65 170.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t -165.95 47.71 0.16 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.603 1.161 . . . . 0.0 109.889 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.18 -64.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.816 2.344 . . . . 0.0 110.303 -161.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ttt -156.44 -115.72 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 159.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 3.4 m 50.74 -172.0 0.01 OUTLIER Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 119.135 0.88 . . . . 0.0 109.573 -159.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 13.8 Cg_endo -67.71 2.63 2.34 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.298 1.142 . . . . 0.0 113.679 166.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 69.28 -32.01 0.22 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 128.095 2.558 . . . . 0.0 113.428 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.2 m -56.88 -49.48 93.62 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.063 1.745 . . . . 0.0 114.24 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.82 88.63 1.05 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 N-CA-C 107.967 -1.59 . . . . 0.0 107.967 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 -100.21 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.44 51.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.58 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -51.4 -67.73 0.23 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.99 1.316 . . . . 0.0 111.466 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -65.17 -39.4 92.88 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.328 -0.858 . . . . 0.0 110.965 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 26' ' ' VAL . 51.5 t -65.05 -43.13 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 120.202 1.364 . . . . 0.0 110.227 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.83 -45.39 86.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 110.568 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -58.66 -60.44 3.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.925 1.29 . . . . 0.0 110.246 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 22' ' ' VAL . 1.2 p -73.75 -33.27 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.203 -176.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.49 70.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 121.032 1.742 . . . . 0.0 111.373 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -61.2 -13.07 15.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.25 -20.08 1.67 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.2 mtp -138.72 78.25 31.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 127.791 2.437 . . . . 0.0 107.304 168.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -70.9 25.28 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 125.29 3.994 . . . . 0.0 115.053 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -178.02 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.11 -1.618 . . . . 0.0 110.488 -159.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.05 3.85 7.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.142 0.883 . . . . 0.0 111.639 169.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.1 136.92 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 109.329 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -128.54 125.41 38.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 159.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.47 102.42 9.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.393 -2.076 . . . . 0.0 105.393 173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -92.05 130.66 37.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.79 104.64 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.94 1.696 . . . . 0.0 106.49 -168.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.69 67.22 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -58.8 144.14 45.02 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.581 0.705 . . . . 0.0 109.647 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.37 141.87 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.3 ttm -178.66 -70.01 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 128.394 2.677 . . . . 0.0 104.621 -173.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.27 0.941 . . . . 0.0 111.046 170.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t30 43.57 54.48 11.01 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.7 2.4 . . . . 0.0 112.513 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.5 151.49 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.087 1.858 . . . . 0.0 112.464 -169.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -63.95 -12.54 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -37.49 32.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 119.591 1.087 . . . . 0.0 113.755 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -37.78 12.61 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 165.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.7 mtp -65.78 -11.89 49.63 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.62 -22.83 64.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.623 1.169 . . . . 0.0 113.125 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -66.99 151.12 48.24 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.255 0.934 . . . . 0.0 112.498 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.07 -45.83 42.35 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 126.215 1.864 . . . . 0.0 112.487 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.265 4.2 tt -133.37 83.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.516 1.15 . . . . 0.0 108.263 158.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -33.93 58.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.165 169.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 28.66 -116.67 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.829 2.452 . . . . 0.0 112.215 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -179.07 160.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 130.661 3.585 . . . . 0.0 105.673 164.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.21 119.28 5.37 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 CA-C-N 120.581 1.243 . . . . 0.0 110.124 -14.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m -80.39 98.94 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.208 1.803 . . . . 0.0 108.077 -164.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mm -109.48 151.79 11.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -121.3 141.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.505 HD13 ' HE3' ' A' ' 73' ' ' LYS . 36.6 pt -135.98 145.81 30.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.808 0.843 . . . . 0.0 109.857 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.17 -62.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.066 2.146 . . . . 0.0 110.89 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.42 -5.38 0.04 OUTLIER Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.932 2.206 . . . . 0.0 112.556 158.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.69 154.55 18.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.328 2.064 . . . . 0.0 116.177 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.2 m -105.12 131.78 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.3 1.44 . . . . 0.0 109.005 -161.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 21.5 tt0 -178.36 167.06 1.89 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.04 -1.038 . . . . 0.0 109.13 -165.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -162.02 125.72 3.14 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -170.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.61 109.07 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.69 -177.28 17.82 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.843 1.211 . . . . 0.0 110.337 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -89.55 -32.79 0.38 Allowed Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.297 161.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 86.8 Cg_endo -73.46 -170.98 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.847 1.695 . . . . 0.0 109.255 160.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.1 p -60.67 -176.22 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.755 1.622 . . . . 0.0 111.499 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HE3' HD13 ' A' ' 61' ' ' ILE . 6.4 ttpt -71.96 36.9 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.783 2.033 . . . . 0.0 113.142 -163.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -50.32 -44.81 54.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.492 1.917 . . . . 0.0 110.857 -164.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.67 65.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.779 1.631 . . . . 0.0 113.319 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.51 -26.94 19.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.0 0.52 . . . . 0.0 110.741 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . 0.266 22.4 t -61.81 -40.02 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 125.025 1.33 . . . . 0.0 108.294 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.0 -13.99 14.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.653 1.581 . . . . 0.0 112.542 170.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.39 -44.61 7.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 116.903 -1.522 . . . . 0.0 111.324 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.43 ' CG2' HD12 ' A' ' 61' ' ' ILE . 2.2 pt -56.0 -29.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.882 1.674 . . . . 0.0 112.599 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -51.93 -64.27 0.87 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.131 165.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -67.61 -59.74 3.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.058 -174.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 82' ' ' LYS . 2.6 mpt_? -161.11 101.3 1.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.398 1.879 . . . . 0.0 109.844 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.264 0 C-N-CA 129.778 3.231 . . . . 0.0 116.8 170.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 37.5 mtt . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t -148.12 -43.93 0.16 Allowed 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.636 -0.665 . . . . 0.0 110.616 174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt 57.65 91.76 0.04 OUTLIER 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.518 1.527 . . . . 0.0 111.859 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 62' ' ' ASN . 91.2 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -158.95 87.24 2.22 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.7 35.67 0.52 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.53 2.82 . . . . 0.0 112.287 -172.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.2 ttt 56.63 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.304 3.442 . . . . 0.0 114.893 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -78.15 -84.92 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.662 -1.637 . . . . 0.0 109.579 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.06 78.98 2.45 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.883 2.388 . . . . 0.0 111.188 -175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -129.2 28.53 5.25 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.544 1.138 . . . . 0.0 110.566 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 16.6 m -132.63 -57.55 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.799 1.24 . . . . 0.0 108.269 172.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 16' ' ' CYS . 87.7 Cg_endo -70.2 85.33 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.805 1.67 . . . . 0.0 109.027 164.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.01 116.59 16.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.98 86.96 4.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 39' ' ' ILE 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.447 ' CD2' HG21 ' A' ' 65' ' ' VAL . 21.2 m-85 -73.09 156.56 38.58 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.86 0.838 . . . . 0.0 111.618 -169.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 55' ' ' ALA . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' H ' HG13 ' A' ' 53' ' ' ILE . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.444 HG12 ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.814 ' HA ' HG13 ' A' ' 3' ' ' VAL . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.09 38.62 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.49 5.68 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.373 171.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.404 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.78 -40.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 120.41 1.459 . . . . 0.0 109.495 172.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -57.0 -23.17 44.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.928 0.785 . . . . 0.0 112.056 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -4.35 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 C--O 1.252 1.206 0 CA-C-N 120.062 1.301 . . . . 0.0 109.529 -176.681 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 62.6 mtt . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.0 p 153.06 -169.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.984 2.114 . . . . 0.0 107.273 -142.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt 14.46 80.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 128.997 2.919 . . . . 0.0 113.177 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.26 150.65 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.325 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -98.76 134.27 41.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.343 1.057 . . . . 0.0 109.032 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.9 149.61 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.14 146.26 42.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.47 96.64 4.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.111 0.965 . . . . 0.0 108.399 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -121.99 86.62 2.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.251 1.024 . . . . 0.0 110.385 -169.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 10' ' ' SER . 1.2 m -156.91 -157.51 0.7 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.451 1.9 . . . . 0.0 107.826 174.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.655 ' H ' HG22 ' A' ' 9' ' ' THR . 73.2 m 120.08 93.33 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.206 1 C-N-CA 133.345 4.658 . . . . 0.0 107.17 -175.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.97 -70.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 N-CA-C 107.269 -1.858 . . . . 0.0 107.269 159.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.3 ttt -162.68 -37.99 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 124.41 1.084 . . . . 0.0 109.008 163.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 m -51.73 -58.89 9.4 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 116.621 -1.657 . . . . 0.0 114.217 -171.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.12 -80.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 CA-C-N 122.042 1.765 . . . . 0.0 109.778 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 49.26 37.0 10.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.459 1.504 . . . . 0.0 113.585 165.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -172.03 -59.59 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.153 2.581 . . . . 0.0 108.886 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.16 -99.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.741 2.294 . . . . 0.0 110.764 -175.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.37 -92.71 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.186 1.794 . . . . 0.0 112.978 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.57 -29.36 36.92 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 124.933 1.293 . . . . 0.0 111.791 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.19 -43.44 87.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 119.67 1.123 . . . . 0.0 111.094 172.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -71.22 -42.51 68.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.332 0.969 . . . . 0.0 109.277 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 t -64.16 -44.05 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.549 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.64 -34.76 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 119.536 -1.977 . . . . 0.0 110.761 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.94 -51.19 70.34 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.88 0.872 . . . . 0.0 110.327 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.47 -61.72 2.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.527 1.931 . . . . 0.0 110.063 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -59.53 -44.96 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.3 67.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.548 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -58.46 -35.31 71.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.287 -1.34 . . . . 0.0 112.507 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -106.44 -38.13 6.29 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.469 1.94 . . . . 0.0 112.063 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.2 mtm -121.25 77.97 34.24 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 127.651 2.38 . . . . 0.0 107.037 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.92 11.62 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.941 3.761 . . . . 0.0 113.876 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.62 -59.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.611 1.565 . . . . 0.0 108.22 -159.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.93 50.6 0.47 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.16 2.584 . . . . 0.0 113.082 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.95 92.36 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.485 1.114 . . . . 0.0 109.78 -166.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -102.03 72.85 1.35 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.907 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -77.41 111.53 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.39 117.76 23.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -85.16 123.35 30.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 160.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 96.16 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 155.26 15.87 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.89 150.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.243 1.417 . . . . 0.0 112.922 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.415 ' C ' ' H ' ' A' ' 44' ' ' ASN 0.255 15.1 ptt? 54.35 -172.97 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.372 2.269 . . . . 0.0 111.496 -174.497 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 63.77 -17.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.899 2.08 . . . . 0.0 114.016 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 42' ' ' MET . 3.8 p-10 -68.65 149.75 97.86 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 127.804 2.442 . . . . 0.0 111.066 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.2 174.45 12.81 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.605 2.203 . . . . 0.0 108.859 160.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.69 0.45 4.21 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.089 -1.007 . . . . 0.0 113.449 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -48.03 -29.82 3.84 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -175.053 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.5 -53.13 4.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.352 0.524 . . . . 0.0 112.298 171.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.8 mtp -66.73 -7.56 21.85 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -171.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.99 -22.96 58.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.364 1.466 . . . . 0.0 113.372 166.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CD2' HG11 ' A' ' 65' ' ' VAL . 21.9 m-85 -64.91 154.66 36.73 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.777 0.831 . . . . 0.0 109.176 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -18.09 75.7 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.626 -0.672 . . . . 0.0 112.517 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.24 73.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 122.566 1.174 . . . . 0.0 108.802 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 93.9 mtp -73.76 24.9 0.07 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.932 0.893 . . . . 0.0 112.227 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.11 -45.74 71.93 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.102 1.361 . . . . 0.0 113.237 -164.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t 67.41 133.52 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.317 1.847 . . . . 0.0 109.137 -164.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.568 ' HB3' HG21 ' A' ' 9' ' ' THR . 24.5 Cg_endo -66.1 121.29 3.36 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.95 1.375 . . . . 0.0 111.243 -9.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.2 m -83.48 106.06 14.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.08 159.55 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.64 128.66 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 170.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.53 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -123.69 156.12 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 116.663 -1.637 . . . . 0.0 108.85 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 45.27 -67.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.767 2.427 . . . . 0.0 114.761 -167.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.69 -9.57 0.1 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.132 1.825 . . . . 0.0 113.112 160.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.62 125.31 35.6 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.367 2.083 . . . . 0.0 111.94 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 51' ' ' TYR . 16.0 t -72.03 140.25 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.43 1.492 . . . . 0.0 107.617 174.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -178.69 166.53 1.72 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.902 2.081 . . . . 0.0 107.905 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -126.17 152.84 45.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.177 1.791 . . . . 0.0 106.996 165.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 75' ' ' ALA . 7.0 mm -129.86 79.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.24 -164.49 36.75 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.799 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.3 1.5 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.99 -162.72 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 CA-C-N 123.517 2.292 . . . . 0.0 109.822 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.4 p -78.2 -150.6 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.751 -1.843 . . . . 0.0 107.65 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.53 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 3.5 tppt? -79.06 34.37 0.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.076 -2.265 . . . . 0.0 110.848 -174.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.303 29.7 mt-10 -62.08 -25.55 67.77 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -158.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -66.34 -42.21 88.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.775 1.17 . . . . 0.0 111.408 170.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -33.98 53.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.862 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.3 t -48.17 -50.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.846 1.659 . . . . 0.0 107.558 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.56 -10.9 13.56 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.24 -47.24 3.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.219 1.407 . . . . 0.0 112.097 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.2 pt -64.12 -33.09 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.414 1.461 . . . . 0.0 111.241 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -57.51 -24.78 57.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.028 1.286 . . . . 0.0 111.621 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.28 0.0 OUTLIER -91.4 -56.31 3.18 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 117.466 -1.254 . . . . 0.0 107.678 -171.384 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -110.44 -92.34 0.45 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.182 1.355 . . . . 0.0 110.401 167.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.358 0 C-N-CA 130.799 3.639 . . . . 0.0 104.254 -159.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.6 m -62.83 0.68 0.5 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -68.38 135.66 52.13 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 121.045 1.748 . . . . 0.0 107.352 168.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 62' ' ' ASN . 4.0 t -80.89 154.54 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.34 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -106.51 96.91 5.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -103.1 139.85 38.09 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -132.23 101.34 5.34 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 123.36 0.664 . . . . 0.0 109.857 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.63 82.51 1.63 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.347 2.259 . . . . 0.0 106.741 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -161.13 -179.37 7.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.926 1.29 . . . . 0.0 107.722 166.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p -136.8 92.95 14.15 Favored Pre-proline 0 C--O 1.235 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 167.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.98 -176.5 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.971 1.781 . . . . 0.0 108.878 170.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.85 85.0 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.492 1.917 . . . . 0.0 111.859 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 32.3 m 50.25 177.72 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.943 3.297 . . . . 0.0 113.09 -172.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 40.1 Cg_endo -64.04 1.22 1.63 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.78 1.653 . . . . 0.0 112.554 159.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -47.97 81.8 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 120.914 -1.116 . . . . 0.0 108.738 166.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.9 m -63.39 131.73 94.91 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 165.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -68.97 -46.13 1.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 120.846 1.03 . . . . 0.0 113.154 -171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.87 -104.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.116 1.766 . . . . 0.0 111.499 -169.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.01 68.31 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.879 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -38.14 -60.07 0.8 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.951 1.25 . . . . 0.0 111.271 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.78 -39.6 61.65 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.566 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -53.44 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.796 1.18 . . . . 0.0 108.089 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.4 t -51.66 -52.53 20.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 128.167 2.587 . . . . 0.0 109.889 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.5 -44.38 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.612 1.097 . . . . 0.0 111.059 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.68 -43.08 99.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.7 1.2 . . . . 0.0 111.062 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.681 ' CG2' HG11 ' A' ' 34' ' ' VAL . 31.1 m -78.58 -29.42 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.495 -0.753 . . . . 0.0 112.561 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.95 -25.21 60.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.329 1.052 . . . . 0.0 111.766 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.0 -24.43 58.16 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.79 -0.569 . . . . 0.0 110.526 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -89.5 -57.95 2.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.807 1.243 . . . . 0.0 110.088 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.505 ' HB2' HG23 ' A' ' 34' ' ' VAL . 41.6 mtm -129.63 89.04 47.95 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.495 1.118 . . . . 0.0 110.511 -171.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.76 34.21 0.52 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.375 3.383 . . . . 0.0 113.084 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -178.3 -51.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.984 1.314 . . . . 0.0 110.615 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.24 -24.63 66.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.406 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.681 HG11 ' CG2' ' A' ' 26' ' ' VAL . 51.5 t -72.12 98.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 164.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -83.69 135.71 34.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.551 1.941 . . . . 0.0 106.837 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.4 ' CG1' HG12 ' A' ' 34' ' ' VAL . 21.6 m -135.06 147.12 29.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 118.941 0.791 . . . . 0.0 112.571 -164.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -140.01 117.9 11.75 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.952 1.301 . . . . 0.0 108.043 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -99.84 84.43 2.9 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -90.68 75.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -60.51 92.05 0.02 OUTLIER 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.932 1.293 . . . . 0.0 109.457 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.255 9.6 p 39.25 -67.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 131.66 3.984 . . . . 0.0 116.346 -167.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.7 ttp -54.99 151.44 8.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.864 1.211 . . . . 0.0 112.931 -158.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 64.93 34.51 8.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.534 1.534 . . . . 0.0 109.52 -158.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -67.24 103.6 0.51 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.493 1.917 . . . . 0.0 110.771 -165.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 44' ' ' ASN . 6.8 Cg_endo -94.19 139.95 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.731 1.62 . . . . 0.0 111.474 -169.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -64.6 -7.01 8.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.608 -1.308 . . . . 0.0 112.392 170.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.93 -41.48 11.58 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.186 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.47 -27.89 17.16 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 172.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.0 mtt -63.25 -4.99 2.87 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.825 -1.172 . . . . 0.0 111.447 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.68 -25.68 67.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.237 1.415 . . . . 0.0 113.11 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.606 ' CE2' HG11 ' A' ' 65' ' ' VAL . 33.2 m-85 -80.74 -154.98 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.076 1.35 . . . . 0.0 110.821 -168.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.29 -170.12 0.71 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 158.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 54' ' ' MET 0.262 18.6 tt -31.05 -67.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.895 1.678 . . . . 0.0 113.275 -159.194 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.473 ' H ' HG23 ' A' ' 53' ' ' ILE . 14.1 mmt 36.99 35.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.263 2.625 . . . . 0.0 114.485 167.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.79 -68.49 0.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 171.13 6.78 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.745 1.618 . . . . 0.0 107.629 158.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.21 128.94 17.4 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 109.685 -0.929 . . . . 0.0 109.685 -20.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 m -106.45 114.3 28.33 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -164.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.511 HD11 HG22 ' A' ' 72' ' ' THR . 27.3 mm -132.3 124.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -159.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.08 128.06 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 168.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.8 pp -120.06 161.49 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.475 ' HA ' HG13 ' A' ' 3' ' ' VAL . 3.3 m120 45.69 -92.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.708 1.203 . . . . 0.0 111.306 -170.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.21 1.31 3.37 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.25 160.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.08 115.08 27.74 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.599 1.56 . . . . 0.0 111.503 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 51' ' ' TYR . 8.0 p -57.36 141.09 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.001 1.32 . . . . 0.0 109.843 159.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -178.7 -178.68 0.59 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 106.395 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -139.13 -36.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.77 1.228 . . . . 0.0 112.217 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.274 31.9 mm 49.71 -74.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 127.398 2.279 . . . . 0.0 112.133 -160.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.92 -176.6 25.68 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.732 1.151 . . . . 0.0 114.142 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.25 -47.44 2.59 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.909 1.284 . . . . 0.0 108.7 158.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.76 174.97 4.89 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 CA-C-N 120.756 1.306 . . . . 0.0 108.826 158.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.511 HG22 HD11 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -63.22 178.5 0.51 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.551 -0.718 . . . . 0.0 112.068 178.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -68.05 64.84 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.393 1.877 . . . . 0.0 113.776 -159.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.282 -0.886 . . . . 0.0 111.816 -160.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.7 79.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.946 0.794 . . . . 0.0 110.726 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -29.57 62.47 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.88 175.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.13 -46.56 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.818 1.645 . . . . 0.0 109.106 166.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -3.8 3.85 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.967 1.707 . . . . 0.0 112.538 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.46 -45.52 2.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.698 1.599 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 61' ' ' ILE . 3.7 pt -61.65 -23.66 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.998 1.272 . . . . 0.0 110.881 171.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -43.03 74.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.269 0.941 . . . . 0.0 111.857 169.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.272 0.4 OUTLIER -81.97 -53.74 5.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.334 0.515 . . . . 0.0 110.736 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -155.09 -77.22 0.1 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.243 0.733 1 C-N-CA 132.379 4.272 . . . . 0.0 104.902 167.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 37.5 mtt . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t -148.12 -43.93 0.16 Allowed 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.636 -0.665 . . . . 0.0 110.616 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt 57.65 91.76 0.04 OUTLIER 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.518 1.527 . . . . 0.0 111.859 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 62' ' ' ASN . 91.9 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -158.95 87.24 2.22 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.7 35.67 0.52 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.53 2.82 . . . . 0.0 112.287 -172.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.2 ttt 56.63 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.304 3.442 . . . . 0.0 114.893 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -78.15 -84.92 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.662 -1.637 . . . . 0.0 109.579 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.06 78.98 2.45 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.883 2.388 . . . . 0.0 111.188 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -129.2 28.51 5.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.54 1.136 . . . . 0.0 110.586 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 16.6 m -132.63 -57.55 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.799 1.24 . . . . 0.0 108.269 172.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 16' ' ' CYS . 87.7 Cg_endo -70.2 85.33 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.805 1.67 . . . . 0.0 109.027 164.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.03 116.53 16.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.94 86.96 4.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 39' ' ' ILE 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.447 ' CD2' HG21 ' A' ' 65' ' ' VAL . 21.3 m-85 -73.04 156.55 38.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.861 0.839 . . . . 0.0 111.631 -169.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 55' ' ' ALA . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' H ' HG13 ' A' ' 53' ' ' ILE . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.444 HG12 ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.814 ' HA ' HG13 ' A' ' 3' ' ' VAL . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.07 38.6 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.75 -31.47 5.62 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.36 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.404 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.75 -40.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.41 1.459 . . . . 0.0 109.518 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -56.99 -23.17 44.12 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.89 0.768 . . . . 0.0 112.056 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -4.35 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 C--O 1.252 1.206 0 CA-C-N 120.062 1.301 . . . . 0.0 109.529 -176.681 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.3 m -154.26 155.35 35.03 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.511 1.525 . . . . 0.0 107.066 155.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -139.96 157.89 44.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.471 1.032 . . . . 0.0 111.494 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 62' ' ' ASN . 2.4 t -97.38 160.33 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.859 1.264 . . . . 0.0 109.56 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 154.84 46.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 167.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.12 149.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 108.636 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -135.12 150.65 50.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.662 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.405 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 1.3 mm? -123.08 91.56 3.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.889 2.476 . . . . 0.0 106.678 167.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -94.67 82.25 3.93 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.4 p -140.43 169.87 16.86 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.093 -1.004 . . . . 0.0 109.792 -175.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 t -164.36 -59.45 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.355 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -59.64 133.68 53.02 Favored 'Trans proline' 0 C--N 1.353 0.778 0 N-CA-C 108.211 -1.496 . . . . 0.0 108.211 166.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.8 mtp -139.11 -171.29 3.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.027 2.131 . . . . 0.0 108.773 -170.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.272 85.5 m 119.33 -75.96 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.575 1 C-N-CA 132.134 4.174 . . . . 0.0 107.611 -175.502 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.35 -4.44 9.37 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.433 2.089 . . . . 0.0 113.744 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -141.13 56.12 1.55 Allowed 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 124.877 1.271 . . . . 0.0 109.381 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.9 m -56.52 -53.82 60.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.097 168.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.59 61.55 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.136 1.891 . . . . 0.0 110.643 177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB1' ' CD1' ' A' ' 7' ' ' LEU . . . -68.83 -81.45 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.792 . . . . 0.0 111.617 -168.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -19.43 45.37 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.372 -0.83 . . . . 0.0 112.003 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -65.03 -59.95 3.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.889 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -54.73 -45.39 74.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.18 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.24 -37.27 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 118.271 -1.372 . . . . 0.0 110.061 -174.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.251 3.3 p -67.36 -33.6 63.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 O-C-N 119.565 -1.96 . . . . 0.0 110.843 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.05 -53.84 53.09 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 120.928 1.694 . . . . 0.0 110.185 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.41 ' OE2' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -45.98 -60.69 2.12 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.98 2.512 . . . . 0.0 109.566 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.015 HG11 HG11 ' A' ' 34' ' ' VAL . 8.6 p -77.2 -40.58 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -25.91 64.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.8 -0.619 . . . . 0.0 110.241 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -38.39 -54.85 1.43 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.368 0.667 . . . . 0.0 111.009 165.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.28 -24.68 16.09 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.414 1.085 . . . . 0.0 112.797 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.531 ' CB ' HG23 ' A' ' 34' ' ' VAL . 46.7 mtt -144.74 78.61 12.77 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.271 1.028 . . . . 0.0 109.416 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.13 34.77 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.981 3.12 . . . . 0.0 113.054 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.97 -48.83 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.132 0.973 . . . . 0.0 109.294 -175.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.49 14.7 0.12 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.9 -1.048 . . . . 0.0 113.046 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.015 HG11 HG11 ' A' ' 26' ' ' VAL . 54.3 t -111.84 103.14 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 120.725 1.602 . . . . 0.0 107.488 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -76.76 96.59 4.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.76 153.29 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.547 0.612 . . . . 0.0 110.285 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.15 146.94 39.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.242 0.474 . . . . 0.0 110.409 158.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -107.74 69.92 0.76 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.744 2.418 . . . . 0.0 107.521 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.487 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -79.89 84.86 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.14 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 128.03 34.29 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 110.664 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -74.3 120.3 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.7 mmt -177.98 -74.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 -166.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -132.96 92.91 3.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -144.58 133.01 10.88 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.031 -0.985 . . . . 0.0 108.963 -159.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.03 152.01 74.32 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.125 1.883 . . . . 0.0 111.424 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.91 5.8 0.2 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -11.27 8.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 121.169 1.804 . . . . 0.0 115.363 -171.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -92.85 -33.57 14.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.969 2.622 . . . . 0.0 115.778 159.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtt -69.0 -6.84 30.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -64.09 -25.49 68.12 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.165 0.986 . . . . 0.0 111.664 163.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 16.1 m-85 -84.13 153.44 23.71 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.664 0.786 . . . . 0.0 110.587 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.74 42.49 1.54 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.949 1.261 . . . . 0.0 113.111 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.454 HG13 ' H ' ' A' ' 55' ' ' ALA . 2.9 tp -138.87 -52.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.8 1.64 . . . . 0.0 108.243 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 32.2 mtt 58.51 -2.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.421 2.288 . . . . 0.0 115.782 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.454 ' H ' HG13 ' A' ' 53' ' ' ILE . . . -77.29 -161.06 0.2 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.65 1.98 . . . . 0.0 111.796 -175.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -155.58 159.36 31.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.388 2.275 . . . . 0.0 106.27 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.94 109.66 1.23 Allowed 'Cis proline' 0 C--N 1.35 0.617 0 CA-C-N 121.069 1.418 . . . . 0.0 110.829 -9.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -93.19 132.86 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.599 ' HB ' ' HE2' ' A' ' 73' ' ' LYS . 20.4 mm -134.91 146.32 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -168.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.63 121.09 66.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG23 ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -109.36 145.24 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 125.155 1.535 . . . . 0.0 108.082 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.436 ' HA ' HG13 ' A' ' 3' ' ' VAL . 23.7 t-20 57.97 -45.96 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.036 2.135 . . . . 0.0 115.749 -169.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.69 -11.67 0.3 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 130.326 3.822 . . . . 0.0 109.982 -168.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -91.51 124.15 35.46 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.316 2.247 . . . . 0.0 113.173 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 51' ' ' TYR . 12.3 p -75.18 149.92 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.573 0.749 . . . . 0.0 110.354 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -178.44 171.64 1.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.764 2.026 . . . . 0.0 108.471 173.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.33 139.03 40.58 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.365 1.066 . . . . 0.0 109.473 167.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 75' ' ' ALA . 7.9 mm -121.54 71.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 122.495 1.14 . . . . 0.0 108.315 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.04 -164.26 26.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 122.456 1.031 . . . . 0.0 113.431 160.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.62 6.02 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 116.273 -1.822 . . . . 0.0 115.801 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.13 -111.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 CA-C-N 123.122 2.151 . . . . 0.0 108.769 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.6 p -126.0 -116.99 0.27 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 121.561 1.982 . . . . 0.0 107.794 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.599 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -92.11 14.84 14.85 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.075 1.75 . . . . 0.0 113.49 172.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -30.36 -50.49 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.021 2.601 . . . . 0.0 118.021 -163.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -67.93 -43.62 78.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.464 1.029 . . . . 0.0 111.766 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 -34.11 68.65 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.333 0.653 . . . . 0.0 109.969 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' OE2' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -48.65 -53.87 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.908 1.683 . . . . 0.0 108.37 171.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -67.62 -16.19 64.04 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.745 -0.597 . . . . 0.0 112.293 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.405 ' HA ' ' HE3' ' A' ' 82' ' ' LYS . . . -83.58 -49.19 9.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.311 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -60.44 -35.23 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 120.221 1.373 . . . . 0.0 109.885 174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.15 -19.69 47.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.542 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 79' ' ' ALA 0.255 0.0 OUTLIER -91.15 -67.5 0.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 109.145 159.159 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 -142.17 -71.77 0.33 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.384 1.074 . . . . 0.0 108.876 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.735 0 C-N-CA 131.441 3.896 . . . . 0.0 103.884 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 42.3 mtt . . . . . 0 C--O 1.239 0.505 0 CA-C-O 121.661 0.743 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.6 m -167.75 151.0 6.0 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 129.939 3.296 . . . . 0.0 105.657 168.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -129.12 162.12 28.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.381 0.991 . . . . 0.0 111.476 170.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.34 133.23 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -124.47 117.31 24.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.088 0.858 . . . . 0.0 109.559 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.42 150.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 125.963 1.705 . . . . 0.0 107.681 -172.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -140.02 139.05 35.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 59' ' ' ILE . 3.6 mm? -114.21 78.18 1.13 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -80.26 88.38 5.51 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.673 1.225 . . . . 0.0 107.761 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.8 p -141.75 -149.22 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -166.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 41' ' ' VAL . 29.6 t 160.11 -65.81 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 128.857 2.863 . . . . 0.0 108.087 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -61.99 150.35 86.71 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 CA-C-N 120.721 1.293 . . . . 0.0 110.866 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.1 mtm -140.61 159.24 42.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.281 2.232 . . . . 0.0 107.523 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.6 m 141.84 -72.31 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.304 1 C-N-CA 131.906 4.082 . . . . 0.0 107.201 -168.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -67.53 -19.61 48.42 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.378 2.052 . . . . 0.0 112.044 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -133.03 162.4 31.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 160.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -115.65 -82.1 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 115.911 -1.995 . . . . 0.0 105.945 158.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.94 -22.33 37.85 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.497 3.464 . . . . 0.0 117.791 -161.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 44.18 -100.1 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.813 2.045 . . . . 0.0 112.344 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.85 72.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.538 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -61.01 -37.07 81.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.437 1.471 . . . . 0.0 111.413 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -66.53 -51.74 53.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.685 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.35 -32.06 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 118.487 -1.285 . . . . 0.0 110.187 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -63.86 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 117.703 -1.142 . . . . 0.0 108.768 165.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -58.93 -38.5 79.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.81 1.186 . . . . 0.0 111.048 -170.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.445 ' OE2' HG23 ' A' ' 77' ' ' VAL . 1.7 tp10 -60.75 -53.96 50.97 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 110.155 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.33 -39.35 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.63 68.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.56 1.544 . . . . 0.0 111.814 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.77 -39.88 62.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.918 0.887 . . . . 0.0 110.012 169.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -93.49 -46.93 7.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.899 1.28 . . . . 0.0 111.495 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.33 87.35 47.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 126.009 1.724 . . . . 0.0 108.099 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.59 13.0 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.889 2.393 . . . . 0.0 112.877 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -142.57 -55.02 0.42 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -162.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.23 48.46 1.49 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.611 -0.68 . . . . 0.0 110.991 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.36 83.43 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.563 1.145 . . . . 0.0 108.921 -164.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.38 128.88 35.52 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -146.59 97.15 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 125.551 1.54 . . . . 0.0 107.067 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -80.08 144.09 33.43 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 109.837 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.39 115.57 29.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.258 0.2 OUTLIER -129.26 86.45 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -54.86 127.14 27.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 159.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' H ' ' HB2' ' A' ' 10' ' ' SER . 1.5 p -50.85 143.23 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.674 1.59 . . . . 0.0 112.075 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 ttt -142.19 -82.23 0.2 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 173.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.13 -2.82 26.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.478 1.111 . . . . 0.0 112.595 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.1 t30 35.83 57.76 2.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 127.432 2.293 . . . . 0.0 112.398 -168.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.74 137.22 37.99 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.182 1.255 . . . . 0.0 109.841 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -59.87 -20.71 58.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 116.32 -1.8 . . . . 0.0 112.182 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -37.34 -47.76 0.86 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.045 1.293 . . . . 0.0 112.332 171.086 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' A' ' 58' ' ' THR . . . -91.1 -33.47 15.45 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 117.233 2.309 . . . . 0.0 117.233 169.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.65 3.21 26.21 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.318 -0.864 . . . . 0.0 112.89 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.27 -143.67 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.929 2.091 . . . . 0.0 109.51 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 65' ' ' VAL . 10.0 m-85 68.86 -167.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 0.0 111.192 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 5.74 81.92 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.067 0.842 . . . . 0.0 113.458 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 55' ' ' ALA . 0.4 OUTLIER -94.96 -59.58 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.958 1.303 . . . . 0.0 107.912 178.189 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtm 49.7 13.27 0.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.703 1.601 . . . . 0.0 114.818 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 53' ' ' ILE . . . -140.58 106.09 5.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.391 1.476 . . . . 0.0 109.638 -168.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 m -56.69 158.03 9.21 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.022 . . . . 0.0 111.596 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.33 112.71 1.76 Allowed 'Cis proline' 0 C--N 1.354 0.828 0 CA-C-N 121.024 1.401 . . . . 0.0 111.066 -0.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.459 HG21 ' HB1' ' A' ' 48' ' ' ALA . 21.6 m -86.94 110.67 20.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.232 1.413 . . . . 0.0 107.266 -169.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.543 HD12 HD13 ' A' ' 7' ' ' LEU . 13.2 mm -115.45 152.05 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -174.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.75 132.88 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 164.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.432 HG13 ' HE3' ' A' ' 73' ' ' LYS . 2.5 pp -122.48 153.69 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 161.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 47.35 -69.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.9 2.88 . . . . 0.0 113.259 -171.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.77 4.05 0.24 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.6 2.048 . . . . 0.0 113.78 162.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.95 120.25 31.81 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 126.753 2.021 . . . . 0.0 110.106 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 51' ' ' TYR . 7.2 p -72.82 133.7 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.799 0.727 . . . . 0.0 109.298 166.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 4.0 tp10 -161.56 163.05 30.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.244 1.817 . . . . 0.0 108.403 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -126.25 153.63 44.48 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 159.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 75' ' ' ALA . 1.6 mm -141.99 149.0 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.71 -167.13 30.13 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 122.291 0.939 . . . . 0.0 113.312 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.61 -34.18 0.98 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 116.761 -1.59 . . . . 0.0 115.14 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.93 -109.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.282 1.851 . . . . 0.0 110.757 -164.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.3 p -114.72 -146.72 0.41 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 159.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HE3' HG13 ' A' ' 61' ' ' ILE . 4.8 ttpt -79.08 20.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.051 -1.656 . . . . 0.0 111.42 -169.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.838 ' HA ' HG22 ' A' ' 77' ' ' VAL . 9.1 mt-10 -61.62 -28.94 69.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -158.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -48.98 -48.52 43.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.41 1.084 . . . . 0.0 112.422 165.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.72 -33.83 40.59 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 117.014 -1.47 . . . . 0.0 109.913 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.838 HG22 ' HA ' ' A' ' 74' ' ' GLU 0.291 2.6 m -68.29 -37.92 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 122.724 2.511 . . . . 0.0 110.961 -175.259 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.56 -19.54 3.95 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.245 2.218 . . . . 0.0 111.257 165.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.97 -46.0 7.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.788 166.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.0 pt -53.73 -28.99 17.13 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-N 122.266 2.303 . . . . 0.0 112.092 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -79.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.355 164.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -16.23 25.07 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -170.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.43 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -67.41 -10.35 50.44 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.378 173.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.245 0.855 0 CA-C-N 120.867 1.667 . . . . 0.0 108.707 170.51 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.25 103.28 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.47 123.7 31.21 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.839 0.856 . . . . 0.0 110.221 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.89 141.2 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -134.83 146.96 49.77 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -128.93 88.38 2.71 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.579 1.551 . . . . 0.0 106.968 -173.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CG ' ' HB3' ' A' ' 48' ' ' ALA . 16.5 t80 -105.92 93.9 4.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.821 1.249 . . . . 0.0 107.869 -175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.586 HG21 ' HB3' ' A' ' 57' ' ' PRO . 2.4 m -177.72 156.84 1.16 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.588 2.355 . . . . 0.0 105.587 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 160.568 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.459 -0.511 0 CA-C-O 119.273 -0.386 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 46.88 -118.46 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.386 1.475 . . . . 0.0 110.159 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.54 65.09 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.648 -1.168 . . . . 0.0 111.981 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -62.29 -44.08 97.34 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.934 1.243 . . . . 0.0 110.431 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -66.07 -52.26 50.51 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.471 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.55 -41.53 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 117.827 -1.082 . . . . 0.0 109.452 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 p -62.5 -51.02 77.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.431 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -41.8 94.67 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.664 1.575 . . . . 0.0 110.08 -175.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.11 -50.6 71.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.776 1.23 . . . . 0.0 110.037 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.1 m -77.17 -29.66 17.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.85 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.13 64.36 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 120.292 1.405 . . . . 0.0 110.622 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.83 -44.29 90.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.855 0.752 . . . . 0.0 110.506 168.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.95 -55.01 9.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.734 2.014 . . . . 0.0 110.343 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.7 mmt -134.22 85.29 39.4 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 127.414 2.285 . . . . 0.0 109.265 -167.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.01 39.02 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.644 3.562 . . . . 0.0 111.747 -172.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -178.19 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.023 0.929 . . . . 0.0 110.709 -171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.7 48.02 0.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.746 0.703 . . . . 0.0 110.963 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.35 134.41 64.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -128.44 131.73 48.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.52 110.73 20.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.728 0.811 . . . . 0.0 109.225 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.33 102.38 15.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.56 96.56 10.13 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -112.35 85.12 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.05 116.44 2.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.13 99.86 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.824 0.821 . . . . 0.0 110.868 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.5 156.6 0.94 Allowed 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 134.129 4.972 . . . . 0.0 103.782 -178.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 36.69 54.56 1.13 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.914 2.086 . . . . 0.0 114.186 163.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.35 154.73 0.92 Allowed Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 127.469 2.308 . . . . 0.0 109.384 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.04 160.4 33.45 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 -170.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -78.96 25.72 0.27 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.01 1.324 . . . . 0.0 111.339 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -25.09 63.01 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB3' ' CG ' ' A' ' 8' ' ' PHE . . . -91.71 -36.56 13.52 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 167.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmm -73.2 -6.45 45.92 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.218 1.007 . . . . 0.0 113.151 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.29 -119.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.565 0.746 . . . . 0.0 109.023 158.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.8 m-30 60.59 -171.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.728 1.611 . . . . 0.0 110.309 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.71 -14.3 80.01 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.173 171.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.49 -49.97 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 109.16 -170.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.9 mtm 41.29 46.93 2.88 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.678 2.391 . . . . 0.0 111.365 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 106.89 1.64 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.515 1.126 . . . . 0.0 109.075 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -59.7 158.26 23.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.548 0.739 . . . . 0.0 111.804 168.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.586 ' HB3' HG21 ' A' ' 9' ' ' THR . 60.8 Cg_endo -74.33 118.49 5.15 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.245 0.766 . . . . 0.0 110.59 -6.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -86.63 116.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 107.4 -170.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 72' ' ' THR . 24.8 mm -134.11 140.85 45.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 121.031 -1.043 . . . . 0.0 108.592 -168.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.51 129.79 69.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.61 146.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 45.77 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 129.857 3.263 . . . . 0.0 116.877 -159.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 169.76 -10.29 0.05 OUTLIER Glycine 0 CA--C 1.542 1.72 1 C-N-CA 131.252 4.263 . . . . 0.0 110.906 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -91.07 132.68 35.88 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 120.218 2.009 . . . . 0.0 111.247 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.03 127.11 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.613 1.965 . . . . 0.0 108.727 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -161.22 -179.69 7.65 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 -171.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.75 129.32 6.05 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -140.17 92.82 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 118.541 0.61 . . . . 0.0 109.643 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.21 -177.4 17.26 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.541 1.067 . . . . 0.0 112.171 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.98 -50.06 33.73 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.976 -1.011 . . . . 0.0 111.104 161.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -68.38 178.52 3.66 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.171 1.454 . . . . 0.0 110.673 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.572 HG22 HD11 ' A' ' 59' ' ' ILE . 5.2 p -58.14 -173.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.878 2.471 . . . . 0.0 111.322 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -70.41 39.65 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.281 1.832 . . . . 0.0 113.957 -163.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.81 -38.49 78.74 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.925 1.69 . . . . 0.0 111.697 -168.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.26 68.67 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.292 1.037 . . . . 0.0 113.085 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -26.6 26.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.532 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.1 -36.26 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 120.582 -1.324 . . . . 0.0 109.781 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -60.75 -6.57 1.8 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.235 2.614 . . . . 0.0 113.624 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.4 -36.13 2.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.537 1.535 . . . . 0.0 112.469 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pt -61.43 -30.99 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.568 1.531 . . . . 0.0 109.13 165.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -64.88 -22.15 66.94 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.699 1.136 . . . . 0.0 113.897 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -46.96 7.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.928 0.891 . . . . 0.0 110.244 -168.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.303 0 C-N-CA 127.184 2.194 . . . . 0.0 105.786 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.84 105.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 108.637 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -89.96 113.94 25.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.427 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.9 mt -126.27 140.47 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.08 138.71 40.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.43 90.68 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.066 1.346 . . . . 0.0 107.75 -174.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -105.81 76.41 1.18 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.54 1.638 . . . . 0.0 107.004 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.2 m -147.39 164.79 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 CA--C 1.538 0.696 0 CA-C-O 120.836 0.265 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.35 -74.84 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.909 1.684 . . . . 0.0 112.715 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -23.1 67.29 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.513 -0.742 . . . . 0.0 112.389 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -54.18 11.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -65.88 -34.97 79.36 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.612 -1.185 . . . . 0.0 111.054 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 26' ' ' VAL . 76.9 t -58.49 -50.27 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.938 1.245 . . . . 0.0 109.512 174.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.34 -33.29 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 120.869 1.668 . . . . 0.0 112.341 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.54 -47.05 80.22 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.217 1.007 . . . . 0.0 109.385 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -57.99 -49.66 76.08 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.875 1.67 . . . . 0.0 110.192 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 5' ' ' ILE . 11.0 m -79.88 -25.24 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.23 -25.41 67.67 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 120.631 1.559 . . . . 0.0 110.129 174.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.28 -13.83 9.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.51 -57.53 1.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.331 1.852 . . . . 0.0 110.055 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.1 mtt -118.87 90.34 40.49 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 108.089 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.9 13.28 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.532 2.821 . . . . 0.0 115.32 -166.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -177.78 -26.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.89 1.677 . . . . 0.0 112.742 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.75 -9.1 17.74 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.28 1.855 . . . . 0.0 111.809 161.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.86 137.71 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.829 1.252 . . . . 0.0 110.942 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -136.68 98.63 3.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.41 99.43 8.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -78.64 117.89 20.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 118.77 30.1 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 84.62 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -60.41 119.52 8.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.221 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.62 110.52 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.5 mtm -140.84 -56.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.03 -16.04 60.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.309 1.444 . . . . 0.0 111.082 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.0 t30 35.98 58.71 3.1 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 127.888 2.475 . . . . 0.0 113.06 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.31 145.49 59.92 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.641 2.894 . . . . 0.0 112.737 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.45 -18.41 18.21 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.717 0.807 . . . . 0.0 112.771 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -39.4 63.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 112.857 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.58 -40.62 11.23 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.201 0.909 . . . . 0.0 112.423 163.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.5 mmm -64.38 -5.87 6.06 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -64.51 -24.04 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.5 1.52 . . . . 0.0 112.133 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -62.34 161.0 12.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.756 1.222 . . . . 0.0 111.563 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.68 -39.81 93.81 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.255 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.407 HD11 ' HB3' ' A' ' 55' ' ' ALA . 4.7 tp -52.34 -58.14 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.088 0.944 . . . . 0.0 111.195 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.0 mtt 55.15 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.198 2.599 . . . . 0.0 116.496 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 53' ' ' ILE . . . -73.13 -171.05 0.84 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.73 2.012 . . . . 0.0 111.966 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.74 136.98 19.11 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.9 159.33 72.61 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 C-N-CA 125.117 -0.785 . . . . 0.0 111.099 -8.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -122.08 128.9 51.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.14 162.83 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.84 136.85 55.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 165.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.426 HD13 HG22 ' A' ' 80' ' ' ILE . 1.8 pp -127.17 146.82 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.822 1.192 . . . . 0.0 108.387 169.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.3 t30 51.61 -36.9 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 130.103 3.361 . . . . 0.0 117.267 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.34 -8.58 0.04 OUTLIER Glycine 0 CA--C 1.541 1.71 1 C-N-CA 131.158 4.218 . . . . 0.0 110.928 167.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -91.76 120.36 32.42 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 126.358 1.863 . . . . 0.0 112.465 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.03 143.36 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.945 1.298 . . . . 0.0 107.885 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -178.29 166.59 1.9 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.486 1.514 . . . . 0.0 109.743 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.91 148.92 44.22 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.682 1.193 . . . . 0.0 109.074 165.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.02 137.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -177.93 51.82 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.371 0.532 . . . . 0.0 113.743 168.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.01 -45.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.143 1.377 . . . . 0.0 112.616 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.09 -172.48 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.327 1.51 . . . . 0.0 109.59 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 p -65.33 -163.17 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.515 -0.741 . . . . 0.0 110.926 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.79 27.82 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -158.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -29.3 -53.3 0.12 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.157 3.783 . . . . 0.0 113.654 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.75 -54.6 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.302 1.041 . . . . 0.0 111.503 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -27.33 62.4 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.609 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -42.84 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 120.138 1.336 . . . . 0.0 109.327 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.91 -12.9 41.19 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.691 -0.63 . . . . 0.0 111.971 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.43 -39.0 8.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.201 1.401 . . . . 0.0 111.689 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.426 HG22 HD13 ' A' ' 61' ' ' ILE . 2.9 pt -56.45 -41.28 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 121.395 1.907 . . . . 0.0 110.015 174.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -19.96 61.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -30.17 30.79 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.753 1.615 . . . . 0.0 109.406 173.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 125.388 1.475 . . . . 0.0 111.807 175.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.5 tptt . . . . . 0 C--O 1.235 0.337 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 62' ' ' ASN . 93.2 t -87.21 149.69 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -128.8 115.74 18.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.472 HD13 HG11 ' A' ' 26' ' ' VAL . 1.4 mp -101.95 144.02 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 163.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -142.08 157.25 45.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.33 88.29 2.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.403 1.481 . . . . 0.0 109.016 -167.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -109.51 105.72 15.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -178.93 169.02 1.61 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 109.84 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 127.253 2.221 . . . . 0.0 107.375 170.866 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 CA--C 1.54 0.81 0 CA-C-O 119.176 -0.427 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.37 -125.41 0.55 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.936 2.095 . . . . 0.0 110.87 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.17 -32.13 6.61 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.306 -1.33 . . . . 0.0 113.449 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -56.38 -47.33 79.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.087 2.221 . . . . 0.0 111.332 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.9 -36.09 37.01 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 116.178 -1.868 . . . . 0.0 112.426 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.427 HG12 HG21 ' A' ' 5' ' ' ILE . 2.1 t -66.35 -31.74 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 CA-C-N 120.088 1.313 . . . . 0.0 108.455 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HA ' HG11 ' A' ' 36' ' ' VAL . 53.2 t -59.78 -55.9 20.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 119.668 -1.895 . . . . 0.0 110.538 166.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -54.9 -42.36 72.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.297 1.408 . . . . 0.0 110.966 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.09 -71.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.696 2.399 . . . . 0.0 109.679 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HB ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -76.12 -21.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 118.386 -1.325 . . . . 0.0 113.338 -175.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.27 68.67 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -58.36 -28.41 65.1 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.445 1.02 . . . . 0.0 112.54 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -83.12 -64.45 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 108.967 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.1 mmt -131.05 85.73 53.82 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 124.743 1.217 . . . . 0.0 110.396 -166.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 69.44 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.3 2.666 . . . . 0.0 107.837 163.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -179.14 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.033 2.533 . . . . 0.0 106.941 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.16 4.27 46.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -160.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG21 ' HB ' ' A' ' 26' ' ' VAL . 2.5 t -103.91 114.98 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.585 -168.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -77.43 152.45 34.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -152.52 57.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.485 1.914 . . . . 0.0 108.024 -169.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -64.92 136.6 57.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -172.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -115.66 102.77 10.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 77.85 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.458 1.123 . . . . 0.0 108.928 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.18 147.24 48.35 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.486 -0.759 . . . . 0.0 112.479 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.15 93.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 ttp -153.01 -62.98 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.18 1.792 . . . . 0.0 107.331 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -145.19 11.18 1.33 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.664 0.786 . . . . 0.0 111.371 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -76.42 148.79 80.83 Favored Pre-proline 0 C--O 1.238 0.49 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.89 139.84 63.97 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.137 2.558 . . . . 0.0 110.337 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -69.25 19.26 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.977 1.711 . . . . 0.0 113.45 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -34.2 45.29 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.147 1.379 . . . . 0.0 114.594 -169.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.07 18.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -26.07 65.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.504 1.522 . . . . 0.0 112.578 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.32 -17.52 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.624 1.102 . . . . 0.0 113.565 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -66.87 145.36 55.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.739 1.616 . . . . 0.0 109.535 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.35 -29.77 31.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tp -54.11 -44.59 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.17 1.485 . . . . 0.0 111.221 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 45.6 mtm 41.61 32.74 0.26 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.677 2.391 . . . . 0.0 114.206 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.07 -178.26 3.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.736 1.615 . . . . 0.0 110.352 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.29 160.08 61.21 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.384 1.474 . . . . 0.0 109.96 -161.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.59 126.2 9.19 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 CA-C-N 119.406 0.823 . . . . 0.0 110.325 -12.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 m -78.01 80.99 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.634 1.974 . . . . 0.0 106.706 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.12 154.92 3.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.8 128.4 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.449 ' CG2' ' HE3' ' A' ' 73' ' ' LYS . 44.0 pt -128.13 143.01 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.225 1.01 . . . . 0.0 110.745 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.605 ' HA ' HG13 ' A' ' 3' ' ' VAL 0.259 34.5 t30 47.23 -50.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.035 2.934 . . . . 0.0 115.982 -163.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.69 -14.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.562 1.553 . . . . 0.0 112.233 159.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.82 152.75 19.97 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 120.514 2.157 . . . . 0.0 112.483 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.43 161.35 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.053 0.541 . . . . 0.0 109.678 173.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -178.62 165.51 1.69 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.382 2.273 . . . . 0.0 108.135 160.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.96 154.48 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 166.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.553 HG21 ' HB3' ' A' ' 75' ' ' ALA . 12.0 mm -130.16 78.82 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.79 -163.71 35.23 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.73 7.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 116.642 -1.647 . . . . 0.0 115.208 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.14 177.67 7.93 Favored 'Trans proline' 0 C--N 1.355 0.87 0 CA-C-N 122.776 2.027 . . . . 0.0 109.946 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -60.93 -173.2 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.41 1.084 . . . . 0.0 109.654 160.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' C ' HG23 ' A' ' 77' ' ' VAL . 4.0 tppt? -74.81 19.85 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 119.657 -1.902 . . . . 0.0 113.996 -159.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -29.35 -49.57 0.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 130.55 3.54 . . . . 0.0 116.534 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.553 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -60.37 -50.79 72.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.653 1.115 . . . . 0.0 110.907 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.04 -28.25 61.32 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.254 -1.355 . . . . 0.0 111.273 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.46 HG23 ' C ' ' A' ' 73' ' ' LYS . 56.1 t -54.87 -53.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.899 1.227 . . . . 0.0 108.297 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -63.33 -28.57 70.1 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.889 -0.507 . . . . 0.0 111.745 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.17 -67.07 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.792 -0.568 . . . . 0.0 110.045 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -60.32 -25.99 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.585 1.084 . . . . 0.0 112.772 -167.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.6 -31.5 71.58 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.038 1.29 . . . . 0.0 113.949 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.68 47.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.343 1.429 . . . . 0.0 109.408 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 129.717 3.207 . . . . 0.0 103.402 -175.387 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.47 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 57' ' ' PRO . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 N-CA-C 116.502 1.693 . . . . 0.0 116.502 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG21 ' A' ' 65' ' ' VAL . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' HG22 ' A' ' 9' ' ' THR . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 8' ' ' PHE . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' CG2' ' A' ' 80' ' ' ILE . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' CE2' ' A' ' 51' ' ' TYR . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.61 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.415 ' CG2' HD12 ' A' ' 61' ' ' ILE . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.47 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 57' ' ' PRO . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 N-CA-C 116.502 1.693 . . . . 0.0 116.502 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG21 ' A' ' 65' ' ' VAL . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' HG22 ' A' ' 9' ' ' THR . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 8' ' ' PHE . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' CG2' ' A' ' 80' ' ' ILE . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' CE2' ' A' ' 51' ' ' TYR . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.61 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.415 ' CG2' HD12 ' A' ' 61' ' ' ILE . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 tttp . . . . . 0 C--O 1.234 0.274 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.51 112.79 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 130.59 36.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 159.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.731 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.0 mt -123.68 145.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 158.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -136.69 152.18 50.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mp -126.95 79.84 1.91 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -76.82 85.08 3.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' ASN . 37.4 p -136.5 166.2 24.07 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.537 -1.352 . . . . 0.0 109.745 -164.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.534 0.355 0 O-C-N 120.064 -1.648 . . . . 0.0 110.339 -178.493 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 N--CA 1.457 -0.664 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.83 -143.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 130.381 3.472 . . . . 0.0 103.223 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.22 -42.86 4.47 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.977 1.311 . . . . 0.0 112.895 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -55.86 -49.83 72.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.949 0.795 . . . . 0.0 112.283 176.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -58.81 -60.6 3.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.647 ' O ' HG22 ' A' ' 26' ' ' VAL . 3.6 t -57.32 -41.01 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 O-C-N 125.259 1.599 . . . . 0.0 108.936 -167.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.451 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -44.34 92.03 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 121.253 1.842 . . . . 0.0 110.146 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.91 -35.64 78.97 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.294 3.038 . . . . 0.0 111.849 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.877 HG23 HG11 ' A' ' 34' ' ' VAL . 19.2 m -105.72 -20.57 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -23.74 67.49 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 120.543 1.519 . . . . 0.0 110.173 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -47.95 -44.5 30.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.986 0.515 . . . . 0.0 112.03 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.06 -41.38 14.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.216 1.006 . . . . 0.0 111.304 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.5 mtm -139.19 75.39 34.29 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 110.457 -164.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.67 43.86 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.416 3.41 . . . . 0.0 113.441 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -178.27 -53.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.241 2.217 . . . . 0.0 108.897 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.05 67.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.072 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.877 HG11 HG23 ' A' ' 26' ' ' VAL . 2.3 t -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.35 154.79 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 158.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.16 110.89 15.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.53 104.75 17.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -80.87 106.88 13.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.88 88.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -66.28 123.27 19.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.704 -178.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.18 113.34 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 125.7 1.6 . . . . 0.0 107.811 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 ttt -160.41 -113.14 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -68.75 -21.79 64.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.73 1.605 . . . . 0.0 111.129 166.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -52.48 111.46 2.58 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 125.379 1.472 . . . . 0.0 109.998 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 158.82 55.2 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 112.201 -163.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -64.62 19.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.216 2.206 . . . . 0.0 114.842 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -20.27 33.77 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.044 -1.66 . . . . 0.0 113.941 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.75 -35.4 14.16 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 121.122 -0.986 . . . . 0.0 112.155 166.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -8.67 55.18 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.846 -1.159 . . . . 0.0 112.441 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -61.4 -26.87 68.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.98 0.912 . . . . 0.0 111.219 167.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -70.46 132.18 45.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.363 0.665 . . . . 0.0 109.958 -176.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.83 0.29 1.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 117.004 1.562 . . . . 0.0 117.004 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 tp -64.54 -50.22 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.026 1.913 . . . . 0.0 109.258 161.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.8 mtt 51.25 -8.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 130.938 3.695 . . . . 0.0 117.164 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.84 -172.15 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 110.447 163.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.403 ' HA ' ' N ' ' A' ' 58' ' ' THR . 7.2 p -178.05 144.66 0.51 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.863 1.665 . . . . 0.0 106.942 -158.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.17 108.24 0.26 Allowed 'Cis proline' 0 C--N 1.355 0.902 0 CA-C-N 122.157 1.806 . . . . 0.0 114.844 6.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.403 ' N ' ' HA ' ' A' ' 56' ' ' VAL . 11.7 m -79.67 113.43 17.82 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.734 1.614 . . . . 0.0 107.395 -168.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mm -117.77 114.46 45.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.7 t -83.53 134.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 164.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.442 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 1.9 pp -132.0 158.25 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.052 161.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.0 -77.52 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.441 1.497 . . . . 0.0 112.335 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 64' ' ' ASP . . . -172.28 20.67 0.07 OUTLIER Glycine 0 CA--C 1.542 1.774 1 C-N-CA 131.245 4.26 . . . . 0.0 109.512 170.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.419 ' H ' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -90.91 151.92 20.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 131.691 3.997 . . . . 0.0 107.386 169.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.03 110.55 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 108.606 -164.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.93 -177.7 6.06 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.883 . . . . 0.0 111.925 -159.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.32 115.44 2.57 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.963 0.905 . . . . 0.0 108.604 158.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.556 HG21 ' HB3' ' A' ' 75' ' ' ALA . 17.9 mm -84.98 74.36 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.24 -160.27 42.07 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.904 1.28 . . . . 0.0 113.756 159.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.33 1.38 Allowed Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 115.594 -2.146 . . . . 0.0 116.581 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.63 -127.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 124.115 2.505 . . . . 0.0 109.707 170.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -115.84 -114.54 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 121.133 1.788 . . . . 0.0 107.64 167.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.442 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -91.07 5.23 49.72 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.802 1.637 . . . . 0.0 111.404 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.502 22.2 mt-10 -37.8 -49.07 1.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -158.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -63.41 -34.98 78.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 123.337 2.789 . . . . 0.0 113.018 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.55 -22.88 26.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.454 1.102 . . . . 0.0 109.316 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -34.08 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.286 -1.509 . . . . 0.0 110.266 172.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -57.11 -22.75 42.11 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.653 -0.654 . . . . 0.0 111.551 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.1 -48.34 8.15 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.93 1.292 . . . . 0.0 110.47 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -56.91 -35.34 46.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 119.869 1.213 . . . . 0.0 111.523 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -67.07 -32.83 74.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.312 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -50.07 10.86 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 118.969 0.804 . . . . 0.0 108.85 170.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 . . . . . 0 CA--C 1.529 0.158 0 C-N-CA 124.015 0.926 . . . . 0.0 110.734 173.781 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.8 tttt . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.64 113.31 33.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.73 138.41 37.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' HB ' HG12 ' A' ' 36' ' ' VAL . 4.7 mp -134.87 137.4 50.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -137.01 147.13 46.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tp -137.64 80.45 1.81 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -173.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -91.43 96.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.471 1.108 . . . . 0.0 108.081 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 t -178.62 174.35 1.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.995 2.118 . . . . 0.0 106.908 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.538 0.492 0 C-N-CA 124.968 1.307 . . . . 0.0 107.614 169.92 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 N--CA 1.455 -0.749 0 CA-C-O 121.312 0.463 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.02 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.243 2.217 . . . . 0.0 112.645 -167.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.4 73.27 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-O 116.293 -1.813 . . . . 0.0 110.807 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -52.57 -50.67 62.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.272 1.851 . . . . 0.0 109.93 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -59.12 -57.67 12.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 117.304 -1.331 . . . . 0.0 111.503 171.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.54 -36.28 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 119.556 1.071 . . . . 0.0 110.852 -169.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.545 HG12 HG11 ' A' ' 36' ' ' VAL . 4.5 m -78.18 -30.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 O-C-N 120.3 -1.5 . . . . 0.0 111.966 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.49 -44.62 95.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.989 1.268 . . . . 0.0 108.712 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.77 -56.08 26.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.288 2.235 . . . . 0.0 109.839 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 m -72.44 -28.85 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 117.684 -1.151 . . . . 0.0 112.969 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.56 -24.58 67.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.99 1.723 . . . . 0.0 111.209 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 -16.77 29.05 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -31.69 1.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.385 1.074 . . . . 0.0 111.987 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 mmt -128.86 67.91 78.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 127.171 2.189 . . . . 0.0 108.365 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.52 32.69 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 126.085 4.523 . . . . 0.0 114.248 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -178.15 -57.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.03 -1.669 . . . . 0.0 109.184 -159.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.93 14.12 0.32 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.158 1.383 . . . . 0.0 113.925 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 p -90.64 91.37 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.696 1.998 . . . . 0.0 110.019 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 81.99 3.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.16 0.984 . . . . 0.0 108.711 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.545 HG11 HG12 ' A' ' 23' ' ' VAL . 4.0 m -95.52 139.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 127.063 2.145 . . . . 0.0 110.828 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -129.12 106.45 8.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -80.64 120.86 25.11 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.16 91.9 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 122.794 1.283 . . . . 0.0 109.908 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -50.46 113.23 0.83 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.783 2.033 . . . . 0.0 110.751 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.69 110.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 163.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.5 mtp -178.97 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 129.075 2.95 . . . . 0.0 104.052 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -155.26 98.74 2.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 102.322 -3.214 . . . . 0.0 102.322 -163.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.99 155.98 31.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 121.416 -0.802 . . . . 0.0 111.59 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.67 164.15 16.68 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.845 2.364 . . . . 0.0 112.966 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -73.33 -7.29 50.98 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.977 1.311 . . . . 0.0 112.789 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.56 -37.05 3.31 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -172.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' H ' ' HD3' ' A' ' 47' ' ' LYS . . . -91.55 -28.62 17.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.136 0.88 . . . . 0.0 113.073 177.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.93 -9.61 46.52 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.502 -0.749 . . . . 0.0 111.406 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.0 -25.9 67.29 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.633 1.106 . . . . 0.0 111.04 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CD2' HG21 ' A' ' 65' ' ' VAL . 23.0 m-85 -72.3 159.25 34.36 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.098 0.951 . . . . 0.0 111.913 -163.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 131.05 47.06 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.263 0.8 OUTLIER 60.33 -23.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.07 3.348 . . . . 0.0 115.885 -177.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.8 -62.1 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.439 2.696 . . . . 0.0 111.785 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.76 -68.84 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 131.079 3.752 . . . . 0.0 112.865 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.9 t 77.85 125.03 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 128.326 2.651 . . . . 0.0 108.281 -165.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.54 165.12 76.84 Favored 'Cis proline' 0 N--CA 1.454 -0.814 0 CA-C-N 119.702 0.929 . . . . 0.0 111.878 0.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.3 m -145.38 102.16 3.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 -164.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.8 133.37 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -166.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.9 t -100.0 132.11 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pp -120.96 142.65 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 161.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 52.63 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.702 3.201 . . . . 0.0 116.617 -169.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.52 -11.51 0.74 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 129.65 3.5 . . . . 0.0 111.001 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -92.14 111.9 23.63 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.006 2.122 . . . . 0.0 111.785 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.5 p -68.37 130.96 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.316 1.046 . . . . 0.0 109.187 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.27 -176.09 5.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.352 1.861 . . . . 0.0 106.574 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -168.31 130.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.526 1.966 . . . . 0.0 109.396 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.278 1.4 mt -121.45 75.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-O 122.023 0.916 . . . . 0.0 109.824 -173.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.72 -165.96 16.67 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.327 168.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.59 11.22 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 116.968 -1.491 . . . . 0.0 114.03 167.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.25 176.54 9.04 Favored 'Trans proline' 0 C--N 1.354 0.84 0 CA-C-N 122.385 1.888 . . . . 0.0 109.932 170.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -177.47 0.42 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.873 0.869 . . . . 0.0 110.789 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.49 30.44 0.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.478 -1.389 . . . . 0.0 112.62 -161.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.314 4.0 mt-10 -64.63 -20.55 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.152 -1.593 . . . . 0.0 114.505 -161.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.2 -48.75 74.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.816 -1.178 . . . . 0.0 112.277 167.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -24.51 56.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.235 -0.916 . . . . 0.0 110.808 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -38.2 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.722 -1.236 . . . . 0.0 108.924 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -54.23 -25.84 25.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.775 1.171 . . . . 0.0 111.312 170.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.28 -57.12 4.24 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.173 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . 0.257 2.6 pt -55.7 -35.35 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.733 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -85.24 -17.22 37.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.509 -1.71 . . . . 0.0 115.453 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -32.41 73.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 122.814 2.552 . . . . 0.0 109.582 165.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 127.481 2.312 . . . . 0.0 108.175 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -75.48 111.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.38 61.8 6.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.494 1.118 . . . . 0.0 110.877 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.05 136.23 27.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.18 141.33 42.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.32 85.01 2.24 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -159.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.91 84.22 1.89 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 0.0 109.059 -165.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -138.79 -179.43 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 -167.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 120.974 1.715 . . . . 0.0 110.003 169.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo . . . . . 0 N--CA 1.452 -0.917 0 N-CA-C 106.529 -2.143 . . . . 0.0 106.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 -86.27 0.2 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.98 -40.96 59.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.91 170.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -52.23 -44.98 65.12 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -68.38 -43.54 77.13 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 120.074 1.306 . . . . 0.0 110.059 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 t -67.89 -32.38 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.43 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.5 t -53.13 -62.43 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.742 1.617 . . . . 0.0 107.815 164.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -64.25 -35.62 81.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.263 0.483 . . . . 0.0 111.358 -169.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' HG2' HG13 ' A' ' 77' ' ' VAL . 3.5 tp10 -62.49 -53.0 61.28 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.334 1.053 . . . . 0.0 110.118 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -67.14 -36.16 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -25.28 68.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.816 1.189 . . . . 0.0 112.272 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -52.16 -37.85 55.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 168.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -105.15 -55.09 2.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.556 1.542 . . . . 0.0 109.348 -165.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.6 79.48 12.54 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 127.703 2.401 . . . . 0.0 108.588 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.63 26.68 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.422 3.415 . . . . 0.0 112.777 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.14 -57.11 0.2 Allowed 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.622 -1.299 . . . . 0.0 110.751 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.03 -1.98 4.83 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -80.97 87.76 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.439 2.295 . . . . 0.0 111.495 -165.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -92.85 125.68 37.58 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 t -136.18 105.35 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.439 1.018 . . . . 0.0 110.876 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -88.64 119.28 28.96 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -88.09 122.35 31.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 98.86 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 171.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -69.14 149.25 48.85 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 116.943 -1.903 . . . . 0.0 109.021 166.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.35 123.38 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.46 -94.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.535 1.534 . . . . 0.0 107.722 -163.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.4 -36.34 83.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.823 1.647 . . . . 0.0 110.526 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 53.91 78.88 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.44 1.896 . . . . 0.0 111.504 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.48 157.26 56.73 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.018 2.479 . . . . 0.0 111.276 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -65.43 -20.32 66.32 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.75 -0.594 . . . . 0.0 111.727 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -32.1 53.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.86 -1.067 . . . . 0.0 113.817 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.54 -40.79 11.17 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.077 1.308 . . . . 0.0 113.504 163.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.4 mtp -66.09 -12.3 54.6 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.48 -20.74 66.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.863 1.665 . . . . 0.0 112.242 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.463 ' CZ ' HG11 ' A' ' 65' ' ' VAL . 4.6 m-85 -77.38 172.1 13.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.473 1.033 . . . . 0.0 109.709 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.46 -67.78 1.55 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.05 74.72 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 123.286 1.517 . . . . 0.0 108.26 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.25 36.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.604 -1.635 . . . . 0.0 114.762 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.75 -81.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.461 1.105 . . . . 0.0 113.663 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -178.45 152.7 0.8 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.26 1.424 . . . . 0.0 109.176 -168.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.95 94.32 0.13 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.577 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -20.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.0 m -72.6 108.27 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.914 1.285 . . . . 0.0 107.638 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 mm -112.94 155.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.92 142.77 42.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 168.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.289 7.8 pt -107.76 -119.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 116.583 -1.675 . . . . 0.0 111.085 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -53.57 -33.13 53.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.854 2.57 . . . . 0.0 112.439 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.53 -28.21 0.02 OUTLIER Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.336 0.97 . . . . 0.0 111.428 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.19 157.68 37.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.921 0.86 . . . . 0.0 111.317 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG11 ' CZ ' ' A' ' 51' ' ' TYR . 2.2 m -118.09 120.54 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.646 1.578 . . . . 0.0 108.18 -158.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.3 159.53 28.64 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -159.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -155.49 132.47 10.72 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.539 HG21 ' HB3' ' A' ' 75' ' ' ALA . 26.6 mm -135.26 118.73 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -168.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.06 -164.7 54.94 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 -34.79 0.75 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 116.621 -1.657 . . . . 0.0 114.434 169.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.28 -158.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 CA-C-N 122.34 1.872 . . . . 0.0 109.831 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -66.2 -171.71 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.466 -1.396 . . . . 0.0 109.818 160.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -77.17 49.06 0.66 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -158.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.69 -41.21 63.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -158.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.539 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -70.33 -41.57 73.08 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.835 -1.166 . . . . 0.0 112.136 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -77.25 -25.81 51.88 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.938 0.79 . . . . 0.0 110.923 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 25' ' ' GLU . 12.7 t -55.53 -48.03 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.863 1.665 . . . . 0.0 107.807 167.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.9 -8.25 10.62 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -100.98 -51.48 3.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.763 -1.211 . . . . 0.0 110.156 176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.7 pt -59.57 -23.06 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 O-C-N 121.262 -0.899 . . . . 0.0 111.615 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -62.46 -32.37 73.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.665 1.121 . . . . 0.0 113.219 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -42.26 10.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.578 1.081 . . . . 0.0 112.259 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 131.234 3.814 . . . . 0.0 121.022 -171.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.406 0.622 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 t -58.73 140.71 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 160.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 147.06 36.08 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 36' ' ' VAL . 31.7 mt -141.59 129.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 71.5 mt-10 -128.59 128.03 43.43 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.14 69.56 1.16 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.669 1.988 . . . . 0.0 106.029 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -81.63 83.35 7.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.451 HG22 ' CB ' ' A' ' 57' ' ' PRO . 23.6 p -128.77 179.09 5.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.94 -1.1 . . . . 0.0 108.508 -166.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 117.054 -1.45 . . . . 0.0 112.343 171.259 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 CA--C 1.544 0.976 0 N-CA-C 108.706 -1.306 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.25 -80.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.804 1.642 . . . . 0.0 114.128 -158.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.05 -26.37 68.22 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.959 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -62.18 -47.74 83.15 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.231 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -49.09 69.51 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 120.412 1.46 . . . . 0.0 108.974 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 18.2 t -63.32 -34.07 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 117.662 -1.615 . . . . 0.0 110.342 -169.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.44 -45.37 75.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.532 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -53.17 -48.22 68.19 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.98 1.718 . . . . 0.0 109.487 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.78 -54.24 47.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 129.191 2.996 . . . . 0.0 110.23 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.72 -38.89 45.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.758 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.36 -28.24 66.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 120.615 1.552 . . . . 0.0 110.655 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -57.19 -25.72 59.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.549 1.14 . . . . 0.0 112.587 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.01 -23.11 6.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.275 1.03 . . . . 0.0 111.895 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.8 mtp -133.93 75.61 66.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 127.277 2.231 . . . . 0.0 110.629 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.55 29.63 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.518 3.478 . . . . 0.0 114.178 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -178.31 -48.39 0.01 OUTLIER 'General case' 0 C--O 1.236 0.348 0 O-C-N 120.325 -1.485 . . . . 0.0 109.693 -164.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.43 54.51 1.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.349 0.66 . . . . 0.0 110.518 169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.02 136.31 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.36 138.05 51.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -142.98 127.0 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 124.172 0.989 . . . . 0.0 109.691 -168.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -127.61 110.97 13.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 167.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.74 106.5 9.6 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 166.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.3 90.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.94 108.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 161.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.7 t -44.35 110.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.324 1.85 . . . . 0.0 109.126 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 tpp -140.03 -67.68 0.43 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.9 86.54 2.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -139.42 148.53 56.89 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.59 137.92 67.0 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 N-CA-C 106.266 -2.244 . . . . 0.0 106.266 161.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -73.17 39.33 0.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -31.23 70.2 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 120.792 -1.193 . . . . 0.0 112.609 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.36 -31.77 15.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 111.551 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.9 mtt -65.75 -7.56 16.42 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.932 -1.105 . . . . 0.0 112.132 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.56 -30.46 64.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.411 1.084 . . . . 0.0 111.008 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.77 169.05 8.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.767 0.827 . . . . 0.0 110.306 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.45 -30.32 77.53 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.656 -1.636 . . . . 0.0 112.536 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -51.14 -66.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.803 1.802 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 31.5 mtt 59.08 -39.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.961 2.504 . . . . 0.0 114.719 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.21 99.97 0.21 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.92 1.688 . . . . 0.0 110.984 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.1 m -60.59 150.18 75.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 121.528 -0.732 . . . . 0.0 109.407 159.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.451 ' CB ' HG22 ' A' ' 9' ' ' THR . 98.5 Cg_endo -72.22 113.14 2.08 Favored 'Cis proline' 0 C--N 1.349 0.603 0 CA-C-N 120.666 1.273 . . . . 0.0 111.93 1.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -96.78 117.88 32.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.219 2.208 . . . . 0.0 106.294 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.01 119.04 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -167.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -102.05 131.25 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.466 HD13 ' HE3' ' A' ' 73' ' ' LYS . 16.7 pt -128.26 163.37 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 125.032 1.458 . . . . 0.0 108.717 168.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 t30 48.16 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 111.63 -159.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.93 -3.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.443 0 C-N-CA 128.155 2.788 . . . . 0.0 111.892 167.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -91.54 129.83 37.46 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.232 2.016 . . . . 0.0 111.7 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.27 140.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.612 0.765 . . . . 0.0 109.733 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.18 -178.17 6.55 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -164.61 115.58 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.79 81.02 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 119.532 1.06 . . . . 0.0 110.468 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 171.9 23.17 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.376 -1.284 . . . . 0.0 112.007 166.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.71 3.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 115.958 -1.973 . . . . 0.0 115.836 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.08 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.367 2.238 . . . . 0.0 111.047 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 p -134.95 -127.99 0.16 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.934 2.094 . . . . 0.0 108.435 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HE3' HD13 ' A' ' 61' ' ' ILE . 2.8 ttpt -91.91 20.62 5.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.208 -1.558 . . . . 0.0 114.923 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -41.98 -45.11 3.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.618 2.008 . . . . 0.0 113.299 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.23 -49.65 60.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.569 1.148 . . . . 0.0 113.302 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -85.37 -21.86 28.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.03 -40.53 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.37 -29.05 65.7 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.471 -0.768 . . . . 0.0 112.455 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.599 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -77.53 -50.08 13.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 111.226 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 pt -60.44 -37.51 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.164 -0.96 . . . . 0.0 111.585 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -36.61 84.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.636 1.107 . . . . 0.0 113.237 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -21.47 45.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.44 1.473 . . . . 0.0 113.006 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 C-N-CA 126.126 1.771 . . . . 0.0 109.281 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.315 0.579 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.77 101.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.74 160.37 32.73 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.811 0.815 . . . . 0.0 110.129 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 26' ' ' VAL . 3.0 mp -147.99 138.98 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 129.181 2.992 . . . . 0.0 105.135 167.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -135.7 146.87 48.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.56 82.98 2.06 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.785 1.234 . . . . 0.0 109.379 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.6 89.82 2.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.094 1.358 . . . . 0.0 108.5 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -135.69 179.69 6.18 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.856 -1.153 . . . . 0.0 113.279 -161.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 127.385 2.274 . . . . 0.0 108.278 -173.835 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.455 -0.792 0 N-CA-C 109.314 -1.072 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.52 -94.42 0.32 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB2' ' HD1' ' A' ' 38' ' ' TYR . . . -57.19 -25.29 58.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.264 174.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -56.61 -54.66 43.39 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.814 0.846 . . . . 0.0 111.755 171.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.6 mtt-85 -60.71 -45.21 95.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 118.659 0.663 . . . . 0.0 109.594 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.9 t -68.69 -34.58 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.563 -170.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.44 -32.57 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 121.133 1.788 . . . . 0.0 110.885 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -60.54 -53.68 54.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.815 1.189 . . . . 0.0 109.043 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.38 -36.97 77.33 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 122.915 0.486 . . . . 0.0 111.595 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 5' ' ' ILE . 59.2 t -74.7 -35.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.975 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.7 70.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.642 1.564 . . . . 0.0 111.169 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -57.72 -22.23 45.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.56 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -112.55 -31.52 6.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.974 1.261 . . . . 0.0 112.069 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -145.14 85.84 7.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.549 1.939 . . . . 0.0 110.338 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.88 45.47 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.176 3.251 . . . . 0.0 110.913 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -178.0 -66.77 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.711 1.604 . . . . 0.0 109.035 -166.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.87 1.11 4.74 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.27 141.33 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.267 1.427 . . . . 0.0 108.988 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.31 130.06 30.22 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 164.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.63 92.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.815 1.246 . . . . 0.0 110.52 -159.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 104.33 16.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.415 ' HD1' ' HB2' ' A' ' 19' ' ' ALA . 31.0 t80 -75.61 121.75 22.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 159.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.09 92.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.7 161.72 14.53 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.745 -1.222 . . . . 0.0 109.948 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.5 mtp -178.59 -87.05 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.586 2.354 . . . . 0.0 105.665 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -68.17 -19.06 64.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.721 1.208 . . . . 0.0 111.983 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.08 56.13 17.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.394 1.878 . . . . 0.0 111.606 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.35 140.78 65.43 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.934 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.76 -15.62 42.7 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.814 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -40.25 -45.37 2.06 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.378 1.471 . . . . 0.0 112.333 162.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.07 -46.01 8.0 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 168.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mtp -68.57 -5.47 20.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.42 -26.27 63.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.378 1.071 . . . . 0.0 111.317 164.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -76.33 118.48 19.08 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.269 1.028 . . . . 0.0 110.243 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.59 -5.5 23.87 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.437 -1.201 . . . . 0.0 114.878 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 pt -68.44 -46.55 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.875 1.838 . . . . 0.0 109.603 170.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.3 mtt 47.08 -11.42 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.632 3.173 . . . . 0.0 117.447 -169.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.7 68.9 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.397 1.879 . . . . 0.0 115.735 -159.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.311 28.8 m 50.98 166.72 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 128.251 2.62 . . . . 0.0 113.625 -161.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -65.52 105.78 0.34 Allowed 'Cis proline' 0 C--N 1.356 0.948 0 CA-C-N 121.55 1.589 . . . . 0.0 109.99 -14.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 m -79.89 124.49 28.71 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.803 1.641 . . . . 0.0 107.066 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.82 166.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 t -142.94 134.16 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.417 HG12 ' HZ1' ' A' ' 73' ' ' LYS . 37.1 pt -101.42 -157.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.745 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -23.23 -51.34 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.495 2.318 . . . . 0.0 114.91 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.22 -27.2 0.22 Allowed Glycine 0 CA--C 1.533 1.215 0 O-C-N 124.163 0.914 . . . . 0.0 112.106 158.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.55 140.59 29.6 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.684 1.742 . . . . 0.0 112.585 -163.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.71 147.64 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.173 2.189 . . . . 0.0 108.478 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -178.57 160.13 1.2 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.555 1.542 . . . . 0.0 109.401 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 146.89 52.51 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 159.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 mm -124.78 88.44 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.38 -165.16 51.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 121.664 0.591 . . . . 0.0 112.418 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -72.76 -22.84 0.54 Allowed Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 174.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 41.9 Cg_endo -65.65 177.17 2.96 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 123.67 2.346 . . . . 0.0 110.632 164.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.1 p -70.55 -159.77 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 159.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.417 ' HZ1' HG12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -77.29 23.26 0.2 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 119.199 -2.188 . . . . 0.0 112.746 -170.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -44.93 -37.92 4.31 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.84 2.456 . . . . 0.0 112.508 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.87 -66.47 0.38 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.481 1.112 . . . . 0.0 111.567 169.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -23.31 64.25 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.647 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -39.8 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.568 1.531 . . . . 0.0 108.559 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -62.34 -7.46 4.39 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.05 -37.83 7.19 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.204 1.366 . . . . 0.0 112.376 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -42.78 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.569 1.077 . . . . 0.0 108.598 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -15.25 60.92 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.394 -1.441 . . . . 0.0 113.927 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -52.73 9.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.59 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? . . . . . 0 N--CA 1.472 0.649 0 CA-C-N 119.827 1.194 . . . . 0.0 112.307 174.901 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt . . . . . 0 C--O 1.237 0.408 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.461 HG13 ' HA ' ' A' ' 62' ' ' ASN . 59.5 t -66.08 130.97 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.673 1.124 . . . . 0.0 108.507 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -106.2 147.04 29.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.261 -0.899 . . . . 0.0 109.224 170.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.567 HD13 ' HA ' ' A' ' 61' ' ' ILE . 4.4 mm -133.29 134.61 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -130.06 143.86 51.03 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.478 HD13 HD12 ' A' ' 59' ' ' ILE . 3.4 mm? -121.44 78.67 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 16.0 t80 -88.97 80.14 7.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 m -152.33 159.39 43.47 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.352 -1.468 . . . . 0.0 110.468 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 162.657 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 CA-C-O 117.925 -0.948 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 43.08 -117.0 0.44 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.201 1.4 . . . . 0.0 110.389 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.59 -32.75 29.83 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 116.15 -1.881 . . . . 0.0 114.246 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -59.1 -59.07 6.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 121.457 1.935 . . . . 0.0 109.639 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -61.63 -50.26 73.27 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.495 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.4 -40.59 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 117.017 -1.468 . . . . 0.0 108.577 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.87 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 120.479 1.49 . . . . 0.0 109.657 171.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -58.69 -43.14 89.92 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.905 1.23 . . . . 0.0 110.653 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.28 -54.62 34.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.646 1.178 . . . . 0.0 110.653 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 HG11 ' A' ' 34' ' ' VAL . 34.5 m -71.6 -29.2 33.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.793 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.93 64.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.691 1.132 . . . . 0.0 110.125 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.77 -40.05 78.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.189 0.45 . . . . 0.0 110.078 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -76.56 -51.69 11.16 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.329 1.051 . . . . 0.0 111.909 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.4 mtt -141.38 82.94 13.93 Favored Pre-proline 0 C--N 1.333 -0.152 0 C-N-CA 127.517 2.327 . . . . 0.0 108.755 -167.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -68.85 8.81 0.52 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.205 1.937 . . . . 0.0 114.147 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.7 -40.69 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.551 1.141 . . . . 0.0 112.376 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -6.4 19.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.519 1.054 . . . . 0.0 111.812 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.53 HG11 HG23 ' A' ' 26' ' ' VAL . 1.5 t -80.66 144.72 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 119.496 1.044 . . . . 0.0 109.319 170.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 141.62 51.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.171 2.188 . . . . 0.0 105.182 165.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.35 129.04 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 124.019 0.928 . . . . 0.0 109.725 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -121.15 97.54 5.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -85.91 93.06 8.84 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.276 0.2 OUTLIER -116.27 92.42 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 123.056 1.408 . . . . 0.0 107.815 -170.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.06 124.15 20.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.967 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.79 117.45 5.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.59 -63.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -143.67 51.35 1.34 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -160.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -139.5 151.18 66.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.857 0.863 . . . . 0.0 111.101 -165.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.98 134.76 32.95 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.295 2.663 . . . . 0.0 111.852 -172.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -70.68 7.03 1.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.344 -0.848 . . . . 0.0 112.779 173.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.7 -31.63 17.03 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.079 1.752 . . . . 0.0 113.311 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -92.35 -41.48 10.33 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.616 0.644 . . . . 0.0 111.103 164.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.14 -0.75 3.56 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.83 -143.44 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.196 1.398 . . . . 0.0 109.662 159.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 67.6 -168.03 0.2 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.563 1.545 . . . . 0.0 111.725 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.87 162.76 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 158.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.293 1.5 tp 41.79 63.99 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 123.225 1.488 . . . . 0.0 112.563 -165.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtt -67.87 -22.33 65.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.687 163.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.02 0.84 4.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.906 1.282 . . . . 0.0 113.926 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 70.31 164.07 0.14 Allowed Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.406 1.482 . . . . 0.0 110.49 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.15 125.94 10.61 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.674 1.276 . . . . 0.0 111.474 -9.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.1 m -95.4 98.09 10.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.478 HD12 HD13 ' A' ' 7' ' ' LEU . 31.5 mm -119.48 120.4 63.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -167.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.63 127.95 47.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.567 ' HA ' HD13 ' A' ' 5' ' ' ILE . 8.9 pt -123.91 142.17 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.83 0.741 . . . . 0.0 109.885 169.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.461 ' HA ' HG13 ' A' ' 3' ' ' VAL . 18.5 t30 48.08 -42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.288 3.035 . . . . 0.0 116.886 -159.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.96 -15.6 0.06 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 128.414 2.911 . . . . 0.0 111.255 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -91.06 160.61 15.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.413 1.606 . . . . 0.0 110.17 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.64 127.55 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.82 0.848 . . . . 0.0 109.209 -158.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.93 173.39 15.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.026 0.83 . . . . 0.0 111.015 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.92 155.51 48.94 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.782 1.633 . . . . 0.0 106.874 159.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.6 mm -141.06 136.17 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.01 -171.34 45.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.82 -30.97 0.64 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.374 -1.774 . . . . 0.0 114.209 164.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -85.41 -166.54 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 CA-C-N 123.005 2.109 . . . . 0.0 110.53 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -63.33 175.63 0.95 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.054 0.941 . . . . 0.0 111.661 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HZ1' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -77.26 21.5 0.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.518 1.527 . . . . 0.0 113.771 -160.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -35.45 -40.8 0.16 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.312 2.245 . . . . 0.0 114.654 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.48 -64.76 0.72 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.714 1.606 . . . . 0.0 111.703 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -68.36 -28.15 66.87 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.042 0.537 . . . . 0.0 110.698 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.13 -34.65 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.25 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.45 -16.55 55.86 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.529 -1.357 . . . . 0.0 113.745 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.48 -47.81 7.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.351 1.432 . . . . 0.0 110.466 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.87 -24.84 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.024 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -64.01 -46.5 84.23 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.129 0.877 . . . . 0.0 111.282 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.85 -49.49 8.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -165.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 . . . . . 0 N--CA 1.463 0.18 0 C-N-CA 129.128 2.971 . . . . 0.0 114.629 -165.744 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? . . . . . 0 C--O 1.234 0.278 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -105.39 103.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 158.17 35.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.446 HD13 HG22 ' A' ' 36' ' ' VAL . 4.8 mp -143.39 138.94 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 161.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -129.08 144.16 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 mt -138.37 89.62 2.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.404 1.082 . . . . 0.0 108.465 -170.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t80 -113.63 97.25 6.31 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.211 1.805 . . . . 0.0 108.917 -164.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t -178.91 -177.25 0.48 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.989 1.716 . . . . 0.0 106.626 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 CA--C 1.539 0.558 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.285 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo . . . . . 0 CA--C 1.537 0.665 0 CA-C-O 118.21 -0.829 . . . . 0.0 114.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.73 -81.21 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.875 1.67 . . . . 0.0 113.496 -166.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.18 -25.35 68.04 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.491 -1.242 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -61.39 -59.29 5.5 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.203 0.91 . . . . 0.0 109.791 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -61.6 -43.15 99.39 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.762 -0.586 . . . . 0.0 111.005 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -66.36 -33.71 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.942 -173.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.24 -27.41 13.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 CA-C-N 120.368 1.44 . . . . 0.0 111.88 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -61.23 -57.58 11.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 108.252 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -49.27 -66.18 0.44 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.328 1.851 . . . . 0.0 107.688 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.47 -27.95 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.686 1.13 . . . . 0.0 112.872 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 -26.35 68.01 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.829 1.649 . . . . 0.0 111.249 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -53.72 -48.98 69.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.221 0.919 . . . . 0.0 111.466 167.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.51 -51.77 47.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.587 0.63 . . . . 0.0 109.978 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.59 88.48 8.69 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.668 1.587 . . . . 0.0 109.367 -169.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.41 27.27 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.021 3.147 . . . . 0.0 110.95 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -151.67 -68.33 0.17 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.152 1.381 . . . . 0.0 108.62 -158.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.21 -5.03 28.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.16 139.44 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 119.175 0.898 . . . . 0.0 110.294 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.28 123.31 24.02 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 5' ' ' ILE . 33.6 t -117.02 140.02 41.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -116.97 100.6 7.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.57 115.68 17.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 160.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.266 0.2 OUTLIER -129.23 101.32 6.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.766 1.27 . . . . 0.0 107.876 177.406 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.1 129.03 38.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.244 1.418 . . . . 0.0 108.324 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.55 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -178.94 -72.26 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 128.458 2.703 . . . . 0.0 106.328 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.6 -41.8 59.81 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -58.86 142.79 84.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.061 0.944 . . . . 0.0 112.159 -167.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.01 136.45 32.37 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.911 1.741 . . . . 0.0 108.254 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.08 -12.88 2.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.542 1.537 . . . . 0.0 113.386 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -4.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.833 2.853 . . . . 0.0 118.468 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -91.42 -63.89 1.2 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 121.5 1.954 . . . . 0.0 107.546 158.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.435 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -40.83 -21.22 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 129.738 3.215 . . . . 0.0 115.254 174.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.91 -20.38 3.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.802 2.041 . . . . 0.0 114.84 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -52.58 175.39 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.019 2.928 . . . . 0.0 115.555 -164.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -43.42 127.41 5.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.822 1.201 . . . . 0.0 110.837 164.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.289 0.2 OUTLIER 60.12 -24.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 129.435 3.094 . . . . 0.0 115.895 -170.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtm 62.24 -73.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 128.628 2.771 . . . . 0.0 110.754 -172.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 36.27 -130.95 0.1 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.187 2.595 . . . . 0.0 110.965 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -179.32 154.28 0.74 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 128.937 2.895 . . . . 0.0 105.138 175.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.93 -179.87 8.81 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 119.483 0.851 . . . . 0.0 112.0 -14.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -128.69 127.19 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 168.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -129.56 163.71 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 65' ' ' VAL . 19.4 t -138.75 130.93 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 102.907 -2.998 . . . . 0.0 102.907 169.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.411 HG23 ' NZ ' ' A' ' 73' ' ' LYS . 41.0 pt -99.21 -161.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 117.005 -1.474 . . . . 0.0 108.9 168.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -20.17 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.823 2.449 . . . . 0.0 114.308 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.68 -13.61 1.42 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.869 -0.962 . . . . 0.0 112.668 158.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -91.32 113.86 26.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.331 1.566 . . . . 0.0 113.186 -159.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 60' ' ' VAL . 57.5 t -58.42 135.35 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.421 1.489 . . . . 0.0 107.855 164.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 6.6 tt0 -178.57 169.33 1.74 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.862 2.065 . . . . 0.0 107.842 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -158.93 139.63 12.61 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 119.907 -1.745 . . . . 0.0 106.662 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.89 133.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -174.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 175.37 49.82 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.127 0.892 . . . . 0.0 111.966 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.21 -42.62 2.11 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.735 1.214 . . . . 0.0 112.825 164.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.12 -176.66 1.95 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 CA-C-N 121.798 1.678 . . . . 0.0 109.354 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -62.85 -175.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.518 -0.739 . . . . 0.0 111.119 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HZ3' ' HB3' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -70.45 32.99 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.886 2.074 . . . . 0.0 114.64 -158.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.34 -34.63 64.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.236 -1.54 . . . . 0.0 112.017 -172.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.81 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.49 1.116 . . . . 0.0 111.7 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -82.51 -28.8 30.88 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.928 174.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.24 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 120.697 1.589 . . . . 0.0 109.97 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -12.5 23.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.18 -37.28 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.718 2.007 . . . . 0.0 111.418 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.29 -34.4 40.03 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 121.677 2.035 . . . . 0.0 110.251 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -53.81 -35.28 61.23 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -31.42 16.33 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 170.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.313 0 C-N-CA 124.834 1.253 . . . . 0.0 111.696 -169.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 62' ' ' ASN . 11.0 t -65.12 130.06 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 168.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.14 141.5 33.94 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 165.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 26' ' ' VAL . 4.9 mp -138.43 85.38 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -172.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -93.71 128.67 40.04 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.653 HD13 HD12 ' A' ' 59' ' ' ILE . 4.2 mm? -100.21 87.12 3.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 164.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 48' ' ' ALA . 15.2 t80 -91.05 95.64 10.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.971 0.891 . . . . 0.0 108.65 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -178.47 172.1 1.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.192 1.797 . . . . 0.0 108.136 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 164.915 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 CA--C 1.542 0.903 0 N-CA-C 109.586 -0.967 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.41 ' HB1' HG21 ' A' ' 72' ' ' THR . . . -52.92 -77.5 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.68 1.992 . . . . 0.0 111.994 -166.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.92 78.48 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 118.224 -0.893 . . . . 0.0 108.796 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -48.64 -46.08 39.41 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.278 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -68.04 -53.0 28.97 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 121.02 1.737 . . . . 0.0 111.085 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.72 -40.2 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.017 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HA ' HG22 ' A' ' 26' ' ' VAL . 6.7 m -73.98 -32.68 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 126.113 1.765 . . . . 0.0 112.637 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.64 -49.31 62.52 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.632 1.106 . . . . 0.0 108.139 164.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -76.98 -44.43 31.12 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.074 0.949 . . . . 0.0 110.531 -164.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG21 HG12 ' A' ' 5' ' ' ILE . 20.5 m -72.57 -26.44 24.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.95 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.49 63.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.936 1.698 . . . . 0.0 110.328 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.24 -41.18 99.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.303 1.041 . . . . 0.0 109.878 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.7 -56.82 7.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.146 0.579 . . . . 0.0 110.63 171.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.0 mtt -146.86 86.83 6.48 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 125.355 1.462 . . . . 0.0 109.214 -159.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.25 41.4 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.437 2.758 . . . . 0.0 111.66 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -151.56 -66.36 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 127.198 2.199 . . . . 0.0 108.061 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 45.45 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.977 1.711 . . . . 0.0 111.775 -173.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.14 83.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.065 1.346 . . . . 0.0 109.928 -161.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -89.24 110.8 21.52 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.46 142.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.034 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -156.52 152.16 27.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.354 1.073 . . . . 0.0 112.068 158.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.58 90.57 4.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.386 2.274 . . . . 0.0 106.334 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.45 85.33 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 121.56 12.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 93.67 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 mmt -143.6 -52.99 0.35 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.94 1.696 . . . . 0.0 109.089 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 13.3 6.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.143 2.177 . . . . 0.0 110.845 -169.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.14 154.42 30.57 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.554 2.342 . . . . 0.0 115.594 -160.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.23 145.06 77.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.788 2.325 . . . . 0.0 110.592 170.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -66.33 -9.8 36.68 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.381 -0.824 . . . . 0.0 111.041 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -61.0 -18.02 55.3 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -175.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.24 -39.54 11.47 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 119.974 -1.704 . . . . 0.0 112.068 161.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.2 mtm -63.35 -12.98 34.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.121 -0.987 . . . . 0.0 112.543 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.14 -26.66 68.45 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.564 1.146 . . . . 0.0 110.902 168.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CD2' HG21 ' A' ' 65' ' ' VAL . 29.5 m-85 -66.6 114.65 5.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 108.953 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.69 8.14 3.48 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.576 1.39 . . . . 0.0 116.576 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -69.83 -52.59 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.937 1.869 . . . . 0.0 108.587 159.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . 0.279 0.1 OUTLIER 40.9 7.74 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.926 3.29 . . . . 0.0 117.815 -169.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -178.44 0.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 123.392 1.568 . . . . 0.0 109.354 159.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.04 158.56 48.33 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.194 -0.941 . . . . 0.0 108.922 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB2' HD11 ' A' ' 59' ' ' ILE . 66.3 Cg_endo -70.21 128.76 13.6 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 -10.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -77.78 106.13 9.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.653 HD12 HD13 ' A' ' 7' ' ' LEU . 14.7 mm -118.93 121.54 67.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -111.81 111.28 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pp -101.07 167.75 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 169.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' A' ' 3' ' ' VAL . 37.7 m-80 30.33 -81.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.07 1.748 . . . . 0.0 114.501 -161.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.53 10.19 1.46 Allowed Glycine 0 CA--C 1.534 1.243 0 CA-C-N 120.241 1.382 . . . . 0.0 114.139 165.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -86.52 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.33 1.565 . . . . 0.0 113.358 -166.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' A' ' 51' ' ' TYR . 4.1 p 114.78 134.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 1 C-N-CA 133.766 4.826 . . . . 0.0 106.753 -163.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -178.72 167.08 1.73 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.738 2.415 . . . . 0.0 108.088 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.82 116.67 5.53 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.733 1.613 . . . . 0.0 107.831 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 150.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.51 172.36 47.7 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 124.339 1.025 . . . . 0.0 111.248 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -83.98 -33.55 0.55 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.702 1.201 . . . . 0.0 111.459 158.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 85.9 Cg_endo -71.15 -165.75 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.636 1.62 . . . . 0.0 110.001 160.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.41 HG21 ' HB1' ' A' ' 18' ' ' ALA . 30.8 p -64.23 -172.47 0.07 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.525 0.73 . . . . 0.0 109.858 162.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -71.59 47.34 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.393 2.277 . . . . 0.0 114.529 -158.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -58.31 -45.36 88.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.577 1.951 . . . . 0.0 110.923 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.86 61.4 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 112.867 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.94 -20.63 21.98 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.995 0.918 . . . . 0.0 110.476 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.92 -38.42 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.561 -1.337 . . . . 0.0 108.353 167.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.2 -0.64 10.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.444 0.698 . . . . 0.0 112.761 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.57 -51.11 3.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.592 1.557 . . . . 0.0 111.21 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pt -53.48 -40.51 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 119.967 1.258 . . . . 0.0 107.948 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -72.9 -29.09 62.87 Favored 'General case' 0 C--N 1.345 0.377 0 O-C-N 120.209 -1.557 . . . . 0.0 114.78 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.49 1.95 . . . . 0.0 109.291 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.994 1.318 . . . . 0.0 113.92 172.957 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.2 tttt . . . . . 0 C--O 1.232 0.161 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.9 110.26 3.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -91.13 144.75 25.31 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.77 138.57 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -124.72 133.0 53.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.14 92.09 3.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.049 1.34 . . . . 0.0 109.118 -172.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -112.61 104.09 12.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.027 0.931 . . . . 0.0 109.857 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 t -178.57 170.92 1.59 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 108.65 170.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.547 0.855 0 C-N-CA 124.603 1.161 . . . . 0.0 109.889 169.87 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 N--CA 1.456 -0.708 0 N-CA-C 107.967 -1.59 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 -100.21 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.44 51.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.58 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -51.4 -67.73 0.23 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.99 1.316 . . . . 0.0 111.466 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -65.17 -39.4 92.88 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.328 -0.858 . . . . 0.0 110.965 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 26' ' ' VAL . 51.5 t -65.05 -43.13 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 120.202 1.364 . . . . 0.0 110.227 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.83 -45.39 86.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 110.568 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -58.66 -60.44 3.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.925 1.29 . . . . 0.0 110.246 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 22' ' ' VAL . 1.2 p -73.75 -33.27 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.203 -176.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.49 70.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 121.032 1.742 . . . . 0.0 111.373 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -61.2 -13.07 15.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.25 -20.08 1.67 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.2 mtp -138.72 78.25 31.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 127.791 2.437 . . . . 0.0 107.304 168.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -70.9 25.28 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 125.29 3.994 . . . . 0.0 115.053 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -178.02 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.11 -1.618 . . . . 0.0 110.488 -159.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.05 3.85 7.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.142 0.883 . . . . 0.0 111.639 169.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.1 136.92 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 109.329 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -128.54 125.41 38.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 159.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.47 102.42 9.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.393 -2.076 . . . . 0.0 105.393 173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -92.05 130.66 37.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.79 104.64 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.94 1.696 . . . . 0.0 106.49 -168.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.69 67.22 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -58.8 144.14 45.02 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.581 0.705 . . . . 0.0 109.647 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.37 141.87 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.3 ttm -178.66 -70.01 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 128.394 2.677 . . . . 0.0 104.621 -173.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.27 0.941 . . . . 0.0 111.046 170.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t30 43.57 54.48 11.01 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.7 2.4 . . . . 0.0 112.513 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.5 151.49 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.087 1.858 . . . . 0.0 112.464 -169.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -63.95 -12.54 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -37.49 32.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 119.591 1.087 . . . . 0.0 113.755 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -37.78 12.61 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 165.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.7 mtp -65.78 -11.89 49.63 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.62 -22.83 64.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.623 1.169 . . . . 0.0 113.125 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -66.99 151.12 48.24 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.255 0.934 . . . . 0.0 112.498 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.07 -45.83 42.35 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 126.215 1.864 . . . . 0.0 112.487 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.265 4.2 tt -133.37 83.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.516 1.15 . . . . 0.0 108.263 158.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -33.93 58.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.165 169.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 28.66 -116.67 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.829 2.452 . . . . 0.0 112.215 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -179.07 160.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 130.661 3.585 . . . . 0.0 105.673 164.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.21 119.28 5.37 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 CA-C-N 120.581 1.243 . . . . 0.0 110.124 -14.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m -80.39 98.94 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.208 1.803 . . . . 0.0 108.077 -164.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mm -109.48 151.79 11.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -121.3 141.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.505 HD13 ' HE3' ' A' ' 73' ' ' LYS . 36.6 pt -135.98 145.81 30.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.808 0.843 . . . . 0.0 109.857 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.17 -62.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.066 2.146 . . . . 0.0 110.89 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.42 -5.38 0.04 OUTLIER Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.932 2.206 . . . . 0.0 112.556 158.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.69 154.55 18.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.328 2.064 . . . . 0.0 116.177 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.2 m -105.12 131.78 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.3 1.44 . . . . 0.0 109.005 -161.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 21.5 tt0 -178.36 167.06 1.89 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.04 -1.038 . . . . 0.0 109.13 -165.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -162.02 125.72 3.14 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -170.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.61 109.07 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.69 -177.28 17.82 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.843 1.211 . . . . 0.0 110.337 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -89.55 -32.79 0.38 Allowed Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.297 161.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 86.8 Cg_endo -73.46 -170.98 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.847 1.695 . . . . 0.0 109.255 160.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.1 p -60.67 -176.22 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.755 1.622 . . . . 0.0 111.499 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HE3' HD13 ' A' ' 61' ' ' ILE . 6.4 ttpt -71.96 36.9 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.783 2.033 . . . . 0.0 113.142 -163.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -50.32 -44.81 54.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.492 1.917 . . . . 0.0 110.857 -164.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.67 65.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.779 1.631 . . . . 0.0 113.319 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.51 -26.94 19.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.0 0.52 . . . . 0.0 110.741 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . 0.266 22.4 t -61.81 -40.02 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 125.025 1.33 . . . . 0.0 108.294 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.0 -13.99 14.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.653 1.581 . . . . 0.0 112.542 170.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.39 -44.61 7.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 116.903 -1.522 . . . . 0.0 111.324 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.43 ' CG2' HD12 ' A' ' 61' ' ' ILE . 2.2 pt -56.0 -29.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.882 1.674 . . . . 0.0 112.599 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -51.93 -64.27 0.87 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.131 165.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -67.61 -59.74 3.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.058 -174.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 82' ' ' LYS . 2.6 mpt_? . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 126.398 1.879 . . . . 0.0 109.844 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.767 0.794 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 62' ' ' ASN . 91.2 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.01 116.59 16.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.98 86.96 4.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 39' ' ' ILE 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.447 ' CD2' HG21 ' A' ' 65' ' ' VAL . 21.2 m-85 -73.09 156.56 38.58 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.86 0.838 . . . . 0.0 111.618 -169.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 55' ' ' ALA . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' H ' HG13 ' A' ' 53' ' ' ILE . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.444 HG12 ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.814 ' HA ' HG13 ' A' ' 3' ' ' VAL . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.09 38.62 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.49 5.68 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.373 171.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.404 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.78 -40.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 120.41 1.459 . . . . 0.0 109.495 172.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -57.0 -23.17 44.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.928 0.785 . . . . 0.0 112.056 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.26 150.65 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.325 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -98.76 134.27 41.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.343 1.057 . . . . 0.0 109.032 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.9 149.61 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.14 146.26 42.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.47 96.64 4.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.111 0.965 . . . . 0.0 108.399 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -121.99 86.62 2.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.251 1.024 . . . . 0.0 110.385 -169.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 10' ' ' SER . 1.2 m -156.91 -157.51 0.7 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.451 1.9 . . . . 0.0 107.826 174.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.655 ' H ' HG22 ' A' ' 9' ' ' THR . 73.2 m . . . . . 0 CA--C 1.53 0.206 1 C-N-CA 133.345 4.658 . . . . 0.0 107.17 -175.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.459 -0.519 0 CA-C-O 118.92 -0.533 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.37 -92.71 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.186 1.794 . . . . 0.0 112.978 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.57 -29.36 36.92 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 124.933 1.293 . . . . 0.0 111.791 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.19 -43.44 87.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 119.67 1.123 . . . . 0.0 111.094 172.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -71.22 -42.51 68.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.332 0.969 . . . . 0.0 109.277 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 t -64.16 -44.05 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.549 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.64 -34.76 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 119.536 -1.977 . . . . 0.0 110.761 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.94 -51.19 70.34 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.88 0.872 . . . . 0.0 110.327 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.47 -61.72 2.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.527 1.931 . . . . 0.0 110.063 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -59.53 -44.96 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.3 67.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.548 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -58.46 -35.31 71.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.287 -1.34 . . . . 0.0 112.507 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -106.44 -38.13 6.29 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.469 1.94 . . . . 0.0 112.063 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.2 mtm -121.25 77.97 34.24 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 127.651 2.38 . . . . 0.0 107.037 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.92 11.62 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.941 3.761 . . . . 0.0 113.876 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.62 -59.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.611 1.565 . . . . 0.0 108.22 -159.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.93 50.6 0.47 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.16 2.584 . . . . 0.0 113.082 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.95 92.36 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.485 1.114 . . . . 0.0 109.78 -166.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -102.03 72.85 1.35 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.907 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -77.41 111.53 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.39 117.76 23.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -85.16 123.35 30.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 160.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 96.16 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 155.26 15.87 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.89 150.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.243 1.417 . . . . 0.0 112.922 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.415 ' C ' ' H ' ' A' ' 44' ' ' ASN 0.255 15.1 ptt? 54.35 -172.97 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.372 2.269 . . . . 0.0 111.496 -174.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 63.77 -17.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.899 2.08 . . . . 0.0 114.016 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 42' ' ' MET . 3.8 p-10 -68.65 149.75 97.86 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 127.804 2.442 . . . . 0.0 111.066 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.2 174.45 12.81 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.605 2.203 . . . . 0.0 108.859 160.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.69 0.45 4.21 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.089 -1.007 . . . . 0.0 113.449 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -48.03 -29.82 3.84 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -175.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.5 -53.13 4.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.352 0.524 . . . . 0.0 112.298 171.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.8 mtp -66.73 -7.56 21.85 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -171.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.99 -22.96 58.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.364 1.466 . . . . 0.0 113.372 166.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CD2' HG11 ' A' ' 65' ' ' VAL . 21.9 m-85 -64.91 154.66 36.73 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.777 0.831 . . . . 0.0 109.176 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -18.09 75.7 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.626 -0.672 . . . . 0.0 112.517 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.24 73.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 122.566 1.174 . . . . 0.0 108.802 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 93.9 mtp -73.76 24.9 0.07 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.932 0.893 . . . . 0.0 112.227 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.11 -45.74 71.93 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.102 1.361 . . . . 0.0 113.237 -164.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t 67.41 133.52 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.317 1.847 . . . . 0.0 109.137 -164.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.568 ' HB3' HG21 ' A' ' 9' ' ' THR . 24.5 Cg_endo -66.1 121.29 3.36 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.95 1.375 . . . . 0.0 111.243 -9.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.2 m -83.48 106.06 14.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.08 159.55 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.64 128.66 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 170.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.53 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -123.69 156.12 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 116.663 -1.637 . . . . 0.0 108.85 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 45.27 -67.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.767 2.427 . . . . 0.0 114.761 -167.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.69 -9.57 0.1 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.132 1.825 . . . . 0.0 113.112 160.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.62 125.31 35.6 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.367 2.083 . . . . 0.0 111.94 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 51' ' ' TYR . 16.0 t -72.03 140.25 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.43 1.492 . . . . 0.0 107.617 174.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -178.69 166.53 1.72 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.902 2.081 . . . . 0.0 107.905 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -126.17 152.84 45.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.177 1.791 . . . . 0.0 106.996 165.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 75' ' ' ALA . 7.0 mm -129.86 79.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.24 -164.49 36.75 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.799 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.3 1.5 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.99 -162.72 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 CA-C-N 123.517 2.292 . . . . 0.0 109.822 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.4 p -78.2 -150.6 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.751 -1.843 . . . . 0.0 107.65 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.53 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 3.5 tppt? -79.06 34.37 0.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.076 -2.265 . . . . 0.0 110.848 -174.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.303 29.7 mt-10 -62.08 -25.55 67.77 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -158.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -66.34 -42.21 88.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.775 1.17 . . . . 0.0 111.408 170.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -33.98 53.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.862 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.3 t -48.17 -50.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.846 1.659 . . . . 0.0 107.558 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.56 -10.9 13.56 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.24 -47.24 3.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.219 1.407 . . . . 0.0 112.097 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.2 pt -64.12 -33.09 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.414 1.461 . . . . 0.0 111.241 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -57.51 -24.78 57.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.028 1.286 . . . . 0.0 111.621 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.28 0.0 OUTLIER -91.4 -56.31 3.18 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 117.466 -1.254 . . . . 0.0 107.678 -171.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.469 0.483 0 CA-C-N 120.182 1.355 . . . . 0.0 110.401 167.129 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt . . . . . 0 C--O 1.235 0.327 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 62' ' ' ASN . 4.0 t -80.89 154.54 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.34 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -106.51 96.91 5.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -103.1 139.85 38.09 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -132.23 101.34 5.34 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 123.36 0.664 . . . . 0.0 109.857 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.63 82.51 1.63 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.347 2.259 . . . . 0.0 106.741 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -161.13 -179.37 7.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.926 1.29 . . . . 0.0 107.722 166.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p . . . . . 0 C--O 1.235 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 167.725 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 N--CA 1.448 -1.172 0 CA-C-O 118.948 -0.522 . . . . 0.0 113.154 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.87 -104.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.116 1.766 . . . . 0.0 111.499 -169.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.01 68.31 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.879 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -38.14 -60.07 0.8 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.951 1.25 . . . . 0.0 111.271 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.78 -39.6 61.65 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.566 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -53.44 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.796 1.18 . . . . 0.0 108.089 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.4 t -51.66 -52.53 20.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 128.167 2.587 . . . . 0.0 109.889 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.5 -44.38 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.612 1.097 . . . . 0.0 111.059 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.68 -43.08 99.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.7 1.2 . . . . 0.0 111.062 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.681 ' CG2' HG11 ' A' ' 34' ' ' VAL . 31.1 m -78.58 -29.42 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.495 -0.753 . . . . 0.0 112.561 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.95 -25.21 60.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.329 1.052 . . . . 0.0 111.766 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.0 -24.43 58.16 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.79 -0.569 . . . . 0.0 110.526 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -89.5 -57.95 2.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.807 1.243 . . . . 0.0 110.088 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.505 ' HB2' HG23 ' A' ' 34' ' ' VAL . 41.6 mtm -129.63 89.04 47.95 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.495 1.118 . . . . 0.0 110.511 -171.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.76 34.21 0.52 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.375 3.383 . . . . 0.0 113.084 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -178.3 -51.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.984 1.314 . . . . 0.0 110.615 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.24 -24.63 66.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.406 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.681 HG11 ' CG2' ' A' ' 26' ' ' VAL . 51.5 t -72.12 98.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 164.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -83.69 135.71 34.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.551 1.941 . . . . 0.0 106.837 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.4 ' CG1' HG12 ' A' ' 34' ' ' VAL . 21.6 m -135.06 147.12 29.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 118.941 0.791 . . . . 0.0 112.571 -164.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -140.01 117.9 11.75 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.952 1.301 . . . . 0.0 108.043 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -99.84 84.43 2.9 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -90.68 75.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -60.51 92.05 0.02 OUTLIER 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.932 1.293 . . . . 0.0 109.457 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.255 9.6 p 39.25 -67.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 131.66 3.984 . . . . 0.0 116.346 -167.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.7 ttp -54.99 151.44 8.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.864 1.211 . . . . 0.0 112.931 -158.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 64.93 34.51 8.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.534 1.534 . . . . 0.0 109.52 -158.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -67.24 103.6 0.51 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.493 1.917 . . . . 0.0 110.771 -165.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 44' ' ' ASN . 6.8 Cg_endo -94.19 139.95 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.731 1.62 . . . . 0.0 111.474 -169.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -64.6 -7.01 8.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.608 -1.308 . . . . 0.0 112.392 170.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.93 -41.48 11.58 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.186 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.47 -27.89 17.16 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 172.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.0 mtt -63.25 -4.99 2.87 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.825 -1.172 . . . . 0.0 111.447 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.68 -25.68 67.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.237 1.415 . . . . 0.0 113.11 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.606 ' CE2' HG11 ' A' ' 65' ' ' VAL . 33.2 m-85 -80.74 -154.98 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.076 1.35 . . . . 0.0 110.821 -168.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.29 -170.12 0.71 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 158.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 54' ' ' MET 0.262 18.6 tt -31.05 -67.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.895 1.678 . . . . 0.0 113.275 -159.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.473 ' H ' HG23 ' A' ' 53' ' ' ILE . 14.1 mmt 36.99 35.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.263 2.625 . . . . 0.0 114.485 167.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.79 -68.49 0.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 171.13 6.78 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.745 1.618 . . . . 0.0 107.629 158.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.21 128.94 17.4 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 109.685 -0.929 . . . . 0.0 109.685 -20.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 m -106.45 114.3 28.33 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -164.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.511 HD11 HG22 ' A' ' 72' ' ' THR . 27.3 mm -132.3 124.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -159.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.08 128.06 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 168.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.8 pp -120.06 161.49 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.475 ' HA ' HG13 ' A' ' 3' ' ' VAL . 3.3 m120 45.69 -92.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.708 1.203 . . . . 0.0 111.306 -170.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.21 1.31 3.37 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.25 160.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.08 115.08 27.74 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.599 1.56 . . . . 0.0 111.503 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 51' ' ' TYR . 8.0 p -57.36 141.09 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.001 1.32 . . . . 0.0 109.843 159.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -178.7 -178.68 0.59 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 106.395 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -139.13 -36.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.77 1.228 . . . . 0.0 112.217 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.274 31.9 mm 49.71 -74.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 127.398 2.279 . . . . 0.0 112.133 -160.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.92 -176.6 25.68 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.732 1.151 . . . . 0.0 114.142 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.25 -47.44 2.59 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.909 1.284 . . . . 0.0 108.7 158.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.76 174.97 4.89 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 CA-C-N 120.756 1.306 . . . . 0.0 108.826 158.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.511 HG22 HD11 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -63.22 178.5 0.51 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.551 -0.718 . . . . 0.0 112.068 178.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -68.05 64.84 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.393 1.877 . . . . 0.0 113.776 -159.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.282 -0.886 . . . . 0.0 111.816 -160.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.7 79.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.946 0.794 . . . . 0.0 110.726 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -29.57 62.47 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.88 175.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.13 -46.56 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.818 1.645 . . . . 0.0 109.106 166.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -3.8 3.85 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.967 1.707 . . . . 0.0 112.538 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.46 -45.52 2.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.698 1.599 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 61' ' ' ILE . 3.7 pt -61.65 -23.66 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.998 1.272 . . . . 0.0 110.881 171.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -43.03 74.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.269 0.941 . . . . 0.0 111.857 169.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.272 0.4 OUTLIER -81.97 -53.74 5.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.334 0.515 . . . . 0.0 110.736 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.218 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.767 0.794 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 62' ' ' ASN . 91.9 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 N-CA-C 109.027 -1.182 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.03 116.53 16.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.94 86.96 4.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 39' ' ' ILE 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.447 ' CD2' HG21 ' A' ' 65' ' ' VAL . 21.3 m-85 -73.04 156.55 38.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.861 0.839 . . . . 0.0 111.631 -169.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 55' ' ' ALA . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' H ' HG13 ' A' ' 53' ' ' ILE . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.444 HG12 ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.814 ' HA ' HG13 ' A' ' 3' ' ' VAL . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.07 38.6 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.75 -31.47 5.62 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.36 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.404 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.75 -40.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.41 1.459 . . . . 0.0 109.518 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -56.99 -23.17 44.12 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.89 0.768 . . . . 0.0 112.056 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 pttt . . . . . 0 C--O 1.234 0.238 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 62' ' ' ASN . 2.4 t -97.38 160.33 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.859 1.264 . . . . 0.0 109.56 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 154.84 46.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 167.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.12 149.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 108.636 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -135.12 150.65 50.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.662 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.405 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 1.3 mm? -123.08 91.56 3.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.889 2.476 . . . . 0.0 106.678 167.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -94.67 82.25 3.93 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.4 p -140.43 169.87 16.86 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.093 -1.004 . . . . 0.0 109.792 -175.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.355 176.625 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 CA--C 1.542 0.883 0 N-CA-C 110.643 -0.56 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB1' ' CD1' ' A' ' 7' ' ' LEU . . . -68.83 -81.45 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.792 . . . . 0.0 111.617 -168.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -19.43 45.37 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.372 -0.83 . . . . 0.0 112.003 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -65.03 -59.95 3.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.889 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -54.73 -45.39 74.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.18 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.24 -37.27 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 118.271 -1.372 . . . . 0.0 110.061 -174.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.251 3.3 p -67.36 -33.6 63.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 O-C-N 119.565 -1.96 . . . . 0.0 110.843 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.05 -53.84 53.09 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 120.928 1.694 . . . . 0.0 110.185 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.41 ' OE2' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -45.98 -60.69 2.12 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.98 2.512 . . . . 0.0 109.566 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.015 HG11 HG11 ' A' ' 34' ' ' VAL . 8.6 p -77.2 -40.58 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -25.91 64.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.8 -0.619 . . . . 0.0 110.241 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -38.39 -54.85 1.43 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.368 0.667 . . . . 0.0 111.009 165.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.28 -24.68 16.09 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.414 1.085 . . . . 0.0 112.797 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.531 ' CB ' HG23 ' A' ' 34' ' ' VAL . 46.7 mtt -144.74 78.61 12.77 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.271 1.028 . . . . 0.0 109.416 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.13 34.77 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.981 3.12 . . . . 0.0 113.054 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.97 -48.83 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.132 0.973 . . . . 0.0 109.294 -175.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.49 14.7 0.12 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.9 -1.048 . . . . 0.0 113.046 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.015 HG11 HG11 ' A' ' 26' ' ' VAL . 54.3 t -111.84 103.14 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 120.725 1.602 . . . . 0.0 107.488 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -76.76 96.59 4.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.76 153.29 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.547 0.612 . . . . 0.0 110.285 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.15 146.94 39.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.242 0.474 . . . . 0.0 110.409 158.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -107.74 69.92 0.76 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.744 2.418 . . . . 0.0 107.521 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.487 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -79.89 84.86 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 128.03 34.29 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 110.664 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -74.3 120.3 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.7 mmt -177.98 -74.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 -166.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -132.96 92.91 3.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -144.58 133.01 10.88 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.031 -0.985 . . . . 0.0 108.963 -159.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.03 152.01 74.32 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.125 1.883 . . . . 0.0 111.424 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.91 5.8 0.2 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -11.27 8.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 121.169 1.804 . . . . 0.0 115.363 -171.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -92.85 -33.57 14.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.969 2.622 . . . . 0.0 115.778 159.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtt -69.0 -6.84 30.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -64.09 -25.49 68.12 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.165 0.986 . . . . 0.0 111.664 163.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 16.1 m-85 -84.13 153.44 23.71 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.664 0.786 . . . . 0.0 110.587 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.74 42.49 1.54 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.949 1.261 . . . . 0.0 113.111 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.454 HG13 ' H ' ' A' ' 55' ' ' ALA . 2.9 tp -138.87 -52.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.8 1.64 . . . . 0.0 108.243 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 32.2 mtt 58.51 -2.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.421 2.288 . . . . 0.0 115.782 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.454 ' H ' HG13 ' A' ' 53' ' ' ILE . . . -77.29 -161.06 0.2 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.65 1.98 . . . . 0.0 111.796 -175.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -155.58 159.36 31.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.388 2.275 . . . . 0.0 106.27 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.94 109.66 1.23 Allowed 'Cis proline' 0 C--N 1.35 0.617 0 CA-C-N 121.069 1.418 . . . . 0.0 110.829 -9.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -93.19 132.86 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.599 ' HB ' ' HE2' ' A' ' 73' ' ' LYS . 20.4 mm -134.91 146.32 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -168.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.63 121.09 66.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.454 HG23 ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -109.36 145.24 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 125.155 1.535 . . . . 0.0 108.082 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.436 ' HA ' HG13 ' A' ' 3' ' ' VAL . 23.7 t-20 57.97 -45.96 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.036 2.135 . . . . 0.0 115.749 -169.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.69 -11.67 0.3 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 130.326 3.822 . . . . 0.0 109.982 -168.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -91.51 124.15 35.46 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.316 2.247 . . . . 0.0 113.173 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 51' ' ' TYR . 12.3 p -75.18 149.92 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.573 0.749 . . . . 0.0 110.354 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -178.44 171.64 1.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.764 2.026 . . . . 0.0 108.471 173.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.33 139.03 40.58 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.365 1.066 . . . . 0.0 109.473 167.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 75' ' ' ALA . 7.9 mm -121.54 71.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 122.495 1.14 . . . . 0.0 108.315 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.04 -164.26 26.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 122.456 1.031 . . . . 0.0 113.431 160.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.62 6.02 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 116.273 -1.822 . . . . 0.0 115.801 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.13 -111.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 CA-C-N 123.122 2.151 . . . . 0.0 108.769 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.6 p -126.0 -116.99 0.27 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 121.561 1.982 . . . . 0.0 107.794 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.599 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -92.11 14.84 14.85 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.075 1.75 . . . . 0.0 113.49 172.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -30.36 -50.49 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.021 2.601 . . . . 0.0 118.021 -163.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -67.93 -43.62 78.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.464 1.029 . . . . 0.0 111.766 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 -34.11 68.65 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.333 0.653 . . . . 0.0 109.969 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' OE2' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -48.65 -53.87 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.908 1.683 . . . . 0.0 108.37 171.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -67.62 -16.19 64.04 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.745 -0.597 . . . . 0.0 112.293 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.405 ' HA ' ' HE3' ' A' ' 82' ' ' LYS . . . -83.58 -49.19 9.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.311 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -60.44 -35.23 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 120.221 1.373 . . . . 0.0 109.885 174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.15 -19.69 47.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.542 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 79' ' ' ALA 0.255 0.0 OUTLIER -91.15 -67.5 0.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 109.145 159.159 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 . . . . . 0 N--CA 1.463 0.192 0 C-N-CA 124.384 1.074 . . . . 0.0 108.876 -179.879 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.34 133.23 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -124.47 117.31 24.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.088 0.858 . . . . 0.0 109.559 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.42 150.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 125.963 1.705 . . . . 0.0 107.681 -172.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -140.02 139.05 35.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 59' ' ' ILE . 3.6 mm? -114.21 78.18 1.13 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -80.26 88.38 5.51 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.673 1.225 . . . . 0.0 107.761 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.8 p -141.75 -149.22 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -166.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 41' ' ' VAL . 29.6 t . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 128.857 2.863 . . . . 0.0 108.087 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo . . . . . 0 CA--C 1.536 0.588 0 N-CA-C 117.791 2.189 . . . . 0.0 117.791 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 44.18 -100.1 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.813 2.045 . . . . 0.0 112.344 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.85 72.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.538 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -61.01 -37.07 81.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.437 1.471 . . . . 0.0 111.413 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -66.53 -51.74 53.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.685 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.35 -32.06 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 118.487 -1.285 . . . . 0.0 110.187 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -63.86 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 117.703 -1.142 . . . . 0.0 108.768 165.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -58.93 -38.5 79.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.81 1.186 . . . . 0.0 111.048 -170.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.445 ' OE2' HG23 ' A' ' 77' ' ' VAL . 1.7 tp10 -60.75 -53.96 50.97 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 110.155 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.33 -39.35 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.63 68.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.56 1.544 . . . . 0.0 111.814 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -52.77 -39.88 62.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.918 0.887 . . . . 0.0 110.012 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -93.49 -46.93 7.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.899 1.28 . . . . 0.0 111.495 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.33 87.35 47.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 126.009 1.724 . . . . 0.0 108.099 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.59 13.0 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.889 2.393 . . . . 0.0 112.877 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -142.57 -55.02 0.42 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -162.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.23 48.46 1.49 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.611 -0.68 . . . . 0.0 110.991 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.36 83.43 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.563 1.145 . . . . 0.0 108.921 -164.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.38 128.88 35.52 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -146.59 97.15 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 125.551 1.54 . . . . 0.0 107.067 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -80.08 144.09 33.43 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 109.837 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.39 115.57 29.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.258 0.2 OUTLIER -129.26 86.45 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -54.86 127.14 27.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 159.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.44 ' H ' ' HB2' ' A' ' 10' ' ' SER . 1.5 p -50.85 143.23 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.674 1.59 . . . . 0.0 112.075 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 ttt -142.19 -82.23 0.2 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 173.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.13 -2.82 26.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.478 1.111 . . . . 0.0 112.595 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.1 t30 35.83 57.76 2.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 127.432 2.293 . . . . 0.0 112.398 -168.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.74 137.22 37.99 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.182 1.255 . . . . 0.0 109.841 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -59.87 -20.71 58.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 116.32 -1.8 . . . . 0.0 112.182 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -37.34 -47.76 0.86 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.045 1.293 . . . . 0.0 112.332 171.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' A' ' 58' ' ' THR . . . -91.1 -33.47 15.45 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 117.233 2.309 . . . . 0.0 117.233 169.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.65 3.21 26.21 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.318 -0.864 . . . . 0.0 112.89 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.27 -143.67 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.929 2.091 . . . . 0.0 109.51 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 65' ' ' VAL . 10.0 m-85 68.86 -167.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 0.0 111.192 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 5.74 81.92 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.067 0.842 . . . . 0.0 113.458 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 55' ' ' ALA . 0.4 OUTLIER -94.96 -59.58 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.958 1.303 . . . . 0.0 107.912 178.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtm 49.7 13.27 0.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.703 1.601 . . . . 0.0 114.818 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 53' ' ' ILE . . . -140.58 106.09 5.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.391 1.476 . . . . 0.0 109.638 -168.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 m -56.69 158.03 9.21 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.022 . . . . 0.0 111.596 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.33 112.71 1.76 Allowed 'Cis proline' 0 C--N 1.354 0.828 0 CA-C-N 121.024 1.401 . . . . 0.0 111.066 -0.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.459 HG21 ' HB1' ' A' ' 48' ' ' ALA . 21.6 m -86.94 110.67 20.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.232 1.413 . . . . 0.0 107.266 -169.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.543 HD12 HD13 ' A' ' 7' ' ' LEU . 13.2 mm -115.45 152.05 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -174.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.75 132.88 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 164.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.432 HG13 ' HE3' ' A' ' 73' ' ' LYS . 2.5 pp -122.48 153.69 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 161.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 47.35 -69.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.9 2.88 . . . . 0.0 113.259 -171.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.77 4.05 0.24 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.6 2.048 . . . . 0.0 113.78 162.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.95 120.25 31.81 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 126.753 2.021 . . . . 0.0 110.106 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 51' ' ' TYR . 7.2 p -72.82 133.7 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.799 0.727 . . . . 0.0 109.298 166.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 4.0 tp10 -161.56 163.05 30.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.244 1.817 . . . . 0.0 108.403 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -126.25 153.63 44.48 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 159.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 75' ' ' ALA . 1.6 mm -141.99 149.0 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.71 -167.13 30.13 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 122.291 0.939 . . . . 0.0 113.312 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.61 -34.18 0.98 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 116.761 -1.59 . . . . 0.0 115.14 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.93 -109.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.282 1.851 . . . . 0.0 110.757 -164.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.3 p -114.72 -146.72 0.41 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 159.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HE3' HG13 ' A' ' 61' ' ' ILE . 4.8 ttpt -79.08 20.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.051 -1.656 . . . . 0.0 111.42 -169.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.838 ' HA ' HG22 ' A' ' 77' ' ' VAL . 9.1 mt-10 -61.62 -28.94 69.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -158.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -48.98 -48.52 43.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.41 1.084 . . . . 0.0 112.422 165.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.72 -33.83 40.59 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 117.014 -1.47 . . . . 0.0 109.913 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.838 HG22 ' HA ' ' A' ' 74' ' ' GLU 0.291 2.6 m -68.29 -37.92 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 122.724 2.511 . . . . 0.0 110.961 -175.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.56 -19.54 3.95 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.245 2.218 . . . . 0.0 111.257 165.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.97 -46.0 7.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.788 166.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.0 pt -53.73 -28.99 17.13 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-N 122.266 2.303 . . . . 0.0 112.092 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -79.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.355 164.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -16.23 25.07 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -170.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.43 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.359 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.378 173.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.407 ' HB3' ' HE3' ' A' ' 4' ' ' LYS . 13.3 m -147.63 2.4 0.72 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.349 1.86 . . . . 0.0 111.15 -173.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.06 162.62 0.16 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.837 2.455 . . . . 0.0 111.907 -165.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.25 103.28 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 1' ' ' SER . 0.6 OUTLIER -85.47 123.7 31.21 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.839 0.856 . . . . 0.0 110.221 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.89 141.2 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -134.83 146.96 49.77 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 169.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -128.93 88.38 2.71 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.579 1.551 . . . . 0.0 106.968 -173.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CG ' ' HB3' ' A' ' 48' ' ' ALA . 16.5 t80 -105.92 93.9 4.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.821 1.249 . . . . 0.0 107.869 -175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.586 HG21 ' HB3' ' A' ' 57' ' ' PRO . 2.4 m -177.72 156.84 1.16 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.588 2.355 . . . . 0.0 105.587 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t -128.28 85.79 59.58 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 160.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.54 137.87 40.44 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.073 1.849 . . . . 0.0 107.493 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -134.62 -31.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.506 -163.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.0 m -77.25 -79.36 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 116.933 -1.508 . . . . 0.0 108.524 167.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.42 111.23 3.26 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 123.315 2.22 . . . . 0.0 109.283 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -72.82 72.43 1.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.478 -0.764 . . . . 0.0 109.529 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.4 m -62.97 153.06 81.99 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 124.651 1.181 . . . . 0.0 109.151 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.54 -21.54 72.96 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.039 2.493 . . . . 0.0 112.258 169.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 46.88 -118.46 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.386 1.475 . . . . 0.0 110.159 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.54 65.09 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.648 -1.168 . . . . 0.0 111.981 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -62.29 -44.08 97.34 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.934 1.243 . . . . 0.0 110.431 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -66.07 -52.26 50.51 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.471 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.55 -41.53 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 117.827 -1.082 . . . . 0.0 109.452 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 p -62.5 -51.02 77.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.431 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -41.8 94.67 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.664 1.575 . . . . 0.0 110.08 -175.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.11 -50.6 71.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.776 1.23 . . . . 0.0 110.037 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.1 m -77.17 -29.66 17.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.85 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.13 64.36 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 120.292 1.405 . . . . 0.0 110.622 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.83 -44.29 90.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.855 0.752 . . . . 0.0 110.506 168.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.95 -55.01 9.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.734 2.014 . . . . 0.0 110.343 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.7 mmt -134.22 85.29 39.4 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 127.414 2.285 . . . . 0.0 109.265 -167.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.01 39.02 0.79 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.644 3.562 . . . . 0.0 111.747 -172.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -178.19 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.023 0.929 . . . . 0.0 110.709 -171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.7 48.02 0.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.746 0.703 . . . . 0.0 110.963 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.35 134.41 64.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -128.44 131.73 48.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.52 110.73 20.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 123.728 0.811 . . . . 0.0 109.225 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.33 102.38 15.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.56 96.56 10.13 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -112.35 85.12 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.05 116.44 2.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.13 99.86 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.824 0.821 . . . . 0.0 110.868 -171.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.5 156.6 0.94 Allowed 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 134.129 4.972 . . . . 0.0 103.782 -178.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 36.69 54.56 1.13 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.914 2.086 . . . . 0.0 114.186 163.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.35 154.73 0.92 Allowed Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 127.469 2.308 . . . . 0.0 109.384 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.04 160.4 33.45 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 -170.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -78.96 25.72 0.27 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.01 1.324 . . . . 0.0 111.339 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -25.09 63.01 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -168.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB3' ' CG ' ' A' ' 8' ' ' PHE . . . -91.71 -36.56 13.52 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 167.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmm -73.2 -6.45 45.92 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.218 1.007 . . . . 0.0 113.151 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.29 -119.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.565 0.746 . . . . 0.0 109.023 158.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.8 m-30 60.59 -171.68 0.14 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.728 1.611 . . . . 0.0 110.309 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.71 -14.3 80.01 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.173 171.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.49 -49.97 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 109.16 -170.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.9 mtm 41.29 46.93 2.88 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.678 2.391 . . . . 0.0 111.365 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.88 106.89 1.64 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.515 1.126 . . . . 0.0 109.075 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -59.7 158.26 23.98 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.548 0.739 . . . . 0.0 111.804 168.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.586 ' HB3' HG21 ' A' ' 9' ' ' THR . 60.8 Cg_endo -74.33 118.49 5.15 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.245 0.766 . . . . 0.0 110.59 -6.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -86.63 116.56 24.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 107.4 -170.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 72' ' ' THR . 24.8 mm -134.11 140.85 45.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 121.031 -1.043 . . . . 0.0 108.592 -168.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.51 129.79 69.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.61 146.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 45.77 -42.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 129.857 3.263 . . . . 0.0 116.877 -159.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 169.76 -10.29 0.05 OUTLIER Glycine 0 CA--C 1.542 1.72 1 C-N-CA 131.252 4.263 . . . . 0.0 110.906 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -91.07 132.68 35.88 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 120.218 2.009 . . . . 0.0 111.247 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.03 127.11 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.613 1.965 . . . . 0.0 108.727 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -161.22 -179.69 7.65 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.029 -1.044 . . . . 0.0 109.841 -171.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.75 129.32 6.05 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -140.17 92.82 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 118.541 0.61 . . . . 0.0 109.643 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.21 -177.4 17.26 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.541 1.067 . . . . 0.0 112.171 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.98 -50.06 33.73 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.976 -1.011 . . . . 0.0 111.104 161.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -68.38 178.52 3.66 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.171 1.454 . . . . 0.0 110.673 166.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.572 HG22 HD11 ' A' ' 59' ' ' ILE . 5.2 p -58.14 -173.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.878 2.471 . . . . 0.0 111.322 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -70.41 39.65 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.281 1.832 . . . . 0.0 113.957 -163.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.81 -38.49 78.74 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.925 1.69 . . . . 0.0 111.697 -168.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.26 68.67 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.292 1.037 . . . . 0.0 113.085 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -26.6 26.32 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.532 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.1 -36.26 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 120.582 -1.324 . . . . 0.0 109.781 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -60.75 -6.57 1.8 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.235 2.614 . . . . 0.0 113.624 169.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.4 -36.13 2.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.537 1.535 . . . . 0.0 112.469 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 pt -61.43 -30.99 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 120.568 1.531 . . . . 0.0 109.13 165.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -64.88 -22.15 66.94 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.699 1.136 . . . . 0.0 113.897 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -46.96 7.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.928 0.891 . . . . 0.0 110.244 -168.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.53 81.43 0.02 OUTLIER 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.184 2.194 . . . . 0.0 105.786 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.25 1.127 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.5 178.541 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 42.9 mtt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.5 m -70.2 81.39 0.52 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.797 1.239 . . . . 0.0 112.333 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 164.43 36.4 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.937 1.695 . . . . 0.0 106.427 158.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.84 105.02 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 108.637 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -89.96 113.94 25.68 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.427 ' CD1' HG21 ' A' ' 26' ' ' VAL . 14.9 mt -126.27 140.47 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.08 138.71 40.68 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.43 90.68 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.066 1.346 . . . . 0.0 107.75 -174.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -105.81 76.41 1.18 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.54 1.638 . . . . 0.0 107.004 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.2 m -147.39 164.79 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.39 85.09 60.1 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.11 113.96 2.62 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.317 2.011 . . . . 0.0 108.156 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -122.57 -57.73 1.72 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.0 t -56.14 -57.9 19.67 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 116.971 -1.49 . . . . 0.0 110.798 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.68 -13.49 11.87 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.978 1.785 . . . . 0.0 112.625 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 46.98 15.51 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 129.254 3.022 . . . . 0.0 116.873 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.8 m -65.18 156.77 80.03 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -167.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.86 62.48 4.81 Favored 'Trans proline' 0 CA--C 1.538 0.696 1 C-N-CA 125.888 4.392 . . . . 0.0 111.84 177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.35 -74.84 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.909 1.684 . . . . 0.0 112.715 -169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -23.1 67.29 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.513 -0.742 . . . . 0.0 112.389 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -54.18 11.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -65.88 -34.97 79.36 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 117.612 -1.185 . . . . 0.0 111.054 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 26' ' ' VAL . 76.9 t -58.49 -50.27 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 119.938 1.245 . . . . 0.0 109.512 174.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.34 -33.29 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 120.869 1.668 . . . . 0.0 112.341 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.54 -47.05 80.22 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.217 1.007 . . . . 0.0 109.385 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -57.99 -49.66 76.08 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.875 1.67 . . . . 0.0 110.192 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 5' ' ' ILE . 11.0 m -79.88 -25.24 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.23 -25.41 67.67 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 120.631 1.559 . . . . 0.0 110.129 174.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.28 -13.83 9.26 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.51 -57.53 1.82 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.331 1.852 . . . . 0.0 110.055 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.1 mtt -118.87 90.34 40.49 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 108.089 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.9 13.28 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.532 2.821 . . . . 0.0 115.32 -166.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -177.78 -26.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.89 1.677 . . . . 0.0 112.742 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.75 -9.1 17.74 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.28 1.855 . . . . 0.0 111.809 161.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.86 137.71 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.829 1.252 . . . . 0.0 110.942 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -136.68 98.63 3.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.41 99.43 8.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -78.64 117.89 20.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.35 118.77 30.1 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 84.62 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -60.41 119.52 8.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.221 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.62 110.52 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.5 mtm -140.84 -56.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.03 -16.04 60.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.309 1.444 . . . . 0.0 111.082 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.0 t30 35.98 58.71 3.1 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 127.888 2.475 . . . . 0.0 113.06 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.31 145.49 59.92 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.641 2.894 . . . . 0.0 112.737 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.45 -18.41 18.21 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.717 0.807 . . . . 0.0 112.771 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -39.4 63.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 112.857 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.58 -40.62 11.23 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.201 0.909 . . . . 0.0 112.423 163.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.5 mmm -64.38 -5.87 6.06 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -173.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -64.51 -24.04 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.5 1.52 . . . . 0.0 112.133 166.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -62.34 161.0 12.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.756 1.222 . . . . 0.0 111.563 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.68 -39.81 93.81 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.255 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.407 HD11 ' HB3' ' A' ' 55' ' ' ALA . 4.7 tp -52.34 -58.14 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.088 0.944 . . . . 0.0 111.195 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.0 mtt 55.15 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.198 2.599 . . . . 0.0 116.496 -169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 53' ' ' ILE . . . -73.13 -171.05 0.84 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.73 2.012 . . . . 0.0 111.966 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.74 136.98 19.11 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.9 159.33 72.61 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 C-N-CA 125.117 -0.785 . . . . 0.0 111.099 -8.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -122.08 128.9 51.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.14 162.83 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.84 136.85 55.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 165.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.426 HD13 HG22 ' A' ' 80' ' ' ILE . 1.8 pp -127.17 146.82 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.822 1.192 . . . . 0.0 108.387 169.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.3 t30 51.61 -36.9 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 130.103 3.361 . . . . 0.0 117.267 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.34 -8.58 0.04 OUTLIER Glycine 0 CA--C 1.541 1.71 1 C-N-CA 131.158 4.218 . . . . 0.0 110.928 167.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -91.76 120.36 32.42 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 126.358 1.863 . . . . 0.0 112.465 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.03 143.36 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.945 1.298 . . . . 0.0 107.885 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -178.29 166.59 1.9 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.486 1.514 . . . . 0.0 109.743 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.91 148.92 44.22 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.682 1.193 . . . . 0.0 109.074 165.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.02 137.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -177.93 51.82 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.371 0.532 . . . . 0.0 113.743 168.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.01 -45.34 3.84 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.143 1.377 . . . . 0.0 112.616 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.09 -172.48 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.327 1.51 . . . . 0.0 109.59 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.5 p -65.33 -163.17 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.515 -0.741 . . . . 0.0 110.926 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.79 27.82 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -158.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -29.3 -53.3 0.12 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.157 3.783 . . . . 0.0 113.654 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.75 -54.6 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.302 1.041 . . . . 0.0 111.503 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -27.33 62.4 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.609 175.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -42.84 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 120.138 1.336 . . . . 0.0 109.327 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.91 -12.9 41.19 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.691 -0.63 . . . . 0.0 111.971 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.43 -39.0 8.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.201 1.401 . . . . 0.0 111.689 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.426 HG22 HD13 ' A' ' 61' ' ' ILE . 2.9 pt -56.45 -41.28 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 121.395 1.907 . . . . 0.0 110.015 174.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -19.96 61.02 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -30.17 30.79 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.753 1.615 . . . . 0.0 109.406 173.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 -55.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.388 1.475 . . . . 0.0 111.807 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.25 -1.357 . . . . 0.0 110.16 -163.821 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.138 0.494 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 m -156.91 62.48 0.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 126.126 1.771 . . . . 0.0 106.656 162.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -71.2 99.63 1.93 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.784 0.834 . . . . 0.0 109.004 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 62' ' ' ASN . 93.2 t -87.21 149.69 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -128.8 115.74 18.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.472 HD13 HG11 ' A' ' 26' ' ' VAL . 1.4 mp -101.95 144.02 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 163.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -142.08 157.25 45.12 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.33 88.29 2.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.403 1.481 . . . . 0.0 109.016 -167.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -109.51 105.72 15.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -178.93 169.02 1.61 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 109.84 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p -129.69 77.24 77.35 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 127.253 2.221 . . . . 0.0 107.375 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.04 69.63 6.96 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.881 2.387 . . . . 0.0 111.661 -170.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.2 ttt -55.48 -42.08 73.86 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.794 1.237 . . . . 0.0 112.092 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.8 m -80.22 -71.7 0.14 Allowed Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 117.289 -1.338 . . . . 0.0 111.041 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.89 -26.67 15.29 Favored 'Trans proline' 0 C--N 1.351 0.7 0 CA-C-N 122.241 1.836 . . . . 0.0 113.364 -170.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 57.82 -61.37 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.214 2.205 . . . . 0.0 113.312 -163.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.2 m 58.73 168.69 0.07 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.176 1.79 . . . . 0.0 110.341 -159.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.12 -14.29 42.79 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.267 1.978 . . . . 0.0 112.345 161.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.37 -125.41 0.55 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.936 2.095 . . . . 0.0 110.87 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.17 -32.13 6.61 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.306 -1.33 . . . . 0.0 113.449 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -56.38 -47.33 79.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 122.087 2.221 . . . . 0.0 111.332 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.9 -36.09 37.01 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 116.178 -1.868 . . . . 0.0 112.426 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.427 HG12 HG21 ' A' ' 5' ' ' ILE . 2.1 t -66.35 -31.74 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 CA-C-N 120.088 1.313 . . . . 0.0 108.455 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HA ' HG11 ' A' ' 36' ' ' VAL . 53.2 t -59.78 -55.9 20.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 O-C-N 119.668 -1.895 . . . . 0.0 110.538 166.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -54.9 -42.36 72.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.297 1.408 . . . . 0.0 110.966 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.09 -71.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.696 2.399 . . . . 0.0 109.679 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HB ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -76.12 -21.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 118.386 -1.325 . . . . 0.0 113.338 -175.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.27 68.67 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -58.36 -28.41 65.1 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.445 1.02 . . . . 0.0 112.54 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -83.12 -64.45 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 108.967 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.1 mmt -131.05 85.73 53.82 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 124.743 1.217 . . . . 0.0 110.396 -166.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 69.44 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.3 2.666 . . . . 0.0 107.837 163.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -179.14 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.033 2.533 . . . . 0.0 106.941 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.16 4.27 46.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -160.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG21 ' HB ' ' A' ' 26' ' ' VAL . 2.5 t -103.91 114.98 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.585 -168.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -77.43 152.45 34.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 158.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -152.52 57.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.485 1.914 . . . . 0.0 108.024 -169.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -64.92 136.6 57.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -172.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -115.66 102.77 10.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 77.85 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.458 1.123 . . . . 0.0 108.928 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.18 147.24 48.35 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.486 -0.759 . . . . 0.0 112.479 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.15 93.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 ttp -153.01 -62.98 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.18 1.792 . . . . 0.0 107.331 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -145.19 11.18 1.33 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.664 0.786 . . . . 0.0 111.371 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -76.42 148.79 80.83 Favored Pre-proline 0 C--O 1.238 0.49 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.89 139.84 63.97 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.137 2.558 . . . . 0.0 110.337 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -69.25 19.26 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.977 1.711 . . . . 0.0 113.45 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -34.2 45.29 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.147 1.379 . . . . 0.0 114.594 -169.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.07 18.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -26.07 65.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.504 1.522 . . . . 0.0 112.578 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.32 -17.52 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.624 1.102 . . . . 0.0 113.565 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -66.87 145.36 55.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.739 1.616 . . . . 0.0 109.535 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.35 -29.77 31.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tp -54.11 -44.59 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.17 1.485 . . . . 0.0 111.221 173.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 45.6 mtm 41.61 32.74 0.26 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.677 2.391 . . . . 0.0 114.206 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.07 -178.26 3.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.736 1.615 . . . . 0.0 110.352 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.29 160.08 61.21 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.384 1.474 . . . . 0.0 109.96 -161.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.59 126.2 9.19 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 CA-C-N 119.406 0.823 . . . . 0.0 110.325 -12.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 m -78.01 80.99 4.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.634 1.974 . . . . 0.0 106.706 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.12 154.92 3.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.8 128.4 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.449 ' CG2' ' HE3' ' A' ' 73' ' ' LYS . 44.0 pt -128.13 143.01 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.225 1.01 . . . . 0.0 110.745 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.605 ' HA ' HG13 ' A' ' 3' ' ' VAL 0.259 34.5 t30 47.23 -50.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 129.035 2.934 . . . . 0.0 115.982 -163.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.69 -14.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.562 1.553 . . . . 0.0 112.233 159.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.82 152.75 19.97 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 120.514 2.157 . . . . 0.0 112.483 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.43 161.35 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.053 0.541 . . . . 0.0 109.678 173.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -178.62 165.51 1.69 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.382 2.273 . . . . 0.0 108.135 160.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.96 154.48 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 166.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.553 HG21 ' HB3' ' A' ' 75' ' ' ALA . 12.0 mm -130.16 78.82 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.79 -163.71 35.23 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.73 7.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 116.642 -1.647 . . . . 0.0 115.208 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.14 177.67 7.93 Favored 'Trans proline' 0 C--N 1.355 0.87 0 CA-C-N 122.776 2.027 . . . . 0.0 109.946 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -60.93 -173.2 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.41 1.084 . . . . 0.0 109.654 160.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' C ' HG23 ' A' ' 77' ' ' VAL . 4.0 tppt? -74.81 19.85 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 119.657 -1.902 . . . . 0.0 113.996 -159.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -29.35 -49.57 0.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 130.55 3.54 . . . . 0.0 116.534 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -60.37 -50.79 72.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.653 1.115 . . . . 0.0 110.907 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.04 -28.25 61.32 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.254 -1.355 . . . . 0.0 111.273 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.46 HG23 ' C ' ' A' ' 73' ' ' LYS . 56.1 t -54.87 -53.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.899 1.227 . . . . 0.0 108.297 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -63.33 -28.57 70.1 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.889 -0.507 . . . . 0.0 111.745 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.17 -67.07 0.54 Allowed 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.792 -0.568 . . . . 0.0 110.045 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -60.32 -25.99 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.585 1.084 . . . . 0.0 112.772 -167.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.6 -31.5 71.58 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.038 1.29 . . . . 0.0 113.949 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.68 47.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 120.343 1.429 . . . . 0.0 109.408 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 171.25 133.41 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 129.717 3.207 . . . . 0.0 103.402 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.246 0.889 0 C-N-CA 127.214 2.206 . . . . 0.0 111.36 163.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.0 mtt . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 117.201 -1.38 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.1 m -143.28 -29.7 0.52 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -161.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp 36.54 50.28 0.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.197 1.799 . . . . 0.0 112.769 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.47 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 57' ' ' PRO . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p -132.33 153.84 81.38 Favored Pre-proline 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.92 94.11 1.01 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.647 2.232 . . . . 0.0 107.251 172.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 mtt -61.04 -31.37 71.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.87 -0.585 . . . . 0.0 111.225 -174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.6 m 132.89 -60.03 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 1 C-N-CA 132.323 4.249 . . . . 0.0 109.112 -173.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.77 -73.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.818 1.679 . . . . 0.0 109.969 171.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -67.34 129.53 40.21 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 90.4 m -146.61 -49.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.488 1.515 . . . . 0.0 113.607 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 16' ' ' CYS . 10.4 Cg_endo -61.72 -18.84 62.66 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 122.027 1.76 . . . . 0.0 116.502 -166.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG21 ' A' ' 65' ' ' VAL . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' HG22 ' A' ' 9' ' ' THR . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 8' ' ' PHE . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' CG2' ' A' ' 80' ' ' ILE . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' CE2' ' A' ' 51' ' ' TYR . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.61 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.415 ' CG2' HD12 ' A' ' 61' ' ' ILE . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 -39.51 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.574 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.0 mtt . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 117.201 -1.38 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.1 m -143.28 -29.7 0.52 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -161.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 tptp 36.54 50.28 0.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.197 1.799 . . . . 0.0 112.769 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.69 147.6 8.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 118.139 -1.424 . . . . 0.0 108.787 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -115.29 161.46 18.45 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 165.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 tt -139.43 139.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.34 140.52 51.82 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.78 89.2 2.9 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.093 1.757 . . . . 0.0 107.411 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.47 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 39.2 t80 -100.64 81.46 2.32 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 57' ' ' PRO . 4.7 p -137.6 178.54 7.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.653 1.581 . . . . 0.0 108.915 -169.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.2 p -132.33 153.84 81.38 Favored Pre-proline 0 C--O 1.24 0.554 0 O-C-N 120.029 -1.669 . . . . 0.0 109.784 164.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.92 94.11 1.01 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.647 2.232 . . . . 0.0 107.251 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 mtt -61.04 -31.37 71.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.87 -0.585 . . . . 0.0 111.225 -174.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.6 m 132.89 -60.03 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.249 1 C-N-CA 132.323 4.249 . . . . 0.0 109.112 -173.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.77 -73.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.818 1.679 . . . . 0.0 109.969 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -67.34 129.53 40.21 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 90.4 m -146.61 -49.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.488 1.515 . . . . 0.0 113.607 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 16' ' ' CYS . 10.4 Cg_endo -61.72 -18.84 62.66 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 122.027 1.76 . . . . 0.0 116.502 -166.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 18.79 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 114.974 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -34.04 66.31 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 116.57 -1.681 . . . . 0.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.37 -50.85 66.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 121.965 2.166 . . . . 0.0 109.372 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -68.11 -48.35 65.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.269 0.486 . . . . 0.0 112.272 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.77 -35.38 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.498 -168.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.62 -38.61 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.985 1.314 . . . . 0.0 111.773 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.08 -42.76 60.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.315 0.961 . . . . 0.0 109.921 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.1 -34.48 37.89 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.245 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.41 -40.15 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 121.47 1.941 . . . . 0.0 112.03 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.05 61.02 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.42 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.84 -60.42 3.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.46 1.104 . . . . 0.0 108.172 169.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -70.25 -49.62 48.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.237 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.13 86.2 47.51 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.754 0.706 . . . . 0.0 110.059 -173.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.25 64.46 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.151 2.568 . . . . 0.0 109.183 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -178.83 -65.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.677 2.391 . . . . 0.0 107.854 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.69 1.4 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.968 1.307 . . . . 0.0 111.659 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 p -141.92 131.04 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 C-N-CA 126.499 1.919 . . . . 0.0 107.739 -171.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.63 150.94 43.58 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.594 1.957 . . . . 0.0 106.029 161.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.65 145.38 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.66 123.74 20.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -118.15 106.12 12.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.03 86.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -167.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -58.17 141.79 49.37 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 119.014 -0.517 . . . . 0.0 109.649 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.4 85.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.456 1.502 . . . . 0.0 110.2 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -178.89 164.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 130.4 3.48 . . . . 0.0 104.731 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 53.91 18.25 1.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 159.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -140.93 142.46 28.0 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 126.534 1.934 . . . . 0.0 107.356 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.72 168.39 8.6 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.515 2.143 . . . . 0.0 114.231 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.63 18.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.472 1.109 . . . . 0.0 112.376 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -54.98 -29.74 57.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.188 0.904 . . . . 0.0 112.354 174.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . . . -91.42 -37.61 13.09 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 112.164 167.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.9 mtp -66.84 -12.06 57.74 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.622 -1.299 . . . . 0.0 112.997 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.34 -19.72 63.63 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' HG21 ' A' ' 65' ' ' VAL . 18.3 m-85 -62.24 153.74 29.66 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.293 0.952 . . . . 0.0 110.975 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.14 147.21 49.11 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 pt 44.23 13.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 128.154 2.581 . . . . 0.0 114.034 -165.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.97 59.09 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.217 1.807 . . . . 0.0 109.782 -158.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.32 117.17 3.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.844 1.258 . . . . 0.0 109.411 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.22 148.6 42.85 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.464 ' HB2' HG22 ' A' ' 9' ' ' THR . 47.5 Cg_endo -72.17 132.55 25.83 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 CA-C-N 119.008 0.681 . . . . 0.0 110.611 -6.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 8' ' ' PHE . 52.3 m -71.73 119.81 16.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 171.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -123.7 137.47 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.59 134.37 59.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 167.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' CG2' ' A' ' 80' ' ' ILE . 43.7 pt -131.09 149.68 33.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.03 -75.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.164 1.386 . . . . 0.0 110.23 -164.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.13 5.46 0.12 Allowed Glycine 0 CA--C 1.539 1.592 0 C-N-CA 126.317 1.913 . . . . 0.0 113.991 159.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -91.97 139.95 30.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.322 2.061 . . . . 0.0 111.696 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' CE2' ' A' ' 51' ' ' TYR . 10.4 p -92.96 148.02 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.338 1.455 . . . . 0.0 112.102 -175.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.26 179.93 0.76 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.693 -1.255 . . . . 0.0 109.974 -161.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -173.01 130.63 0.49 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -175.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.99 97.63 2.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.08 -171.22 38.58 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 124.13 0.893 . . . . 0.0 111.655 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.48 -39.68 6.26 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.071 1.348 . . . . 0.0 113.58 165.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.36 173.65 10.31 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 122.539 1.942 . . . . 0.0 109.197 170.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 p -54.17 177.21 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.838 0.855 . . . . 0.0 110.893 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -71.41 43.62 0.09 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.998 1.719 . . . . 0.0 112.104 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -50.61 -39.54 50.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.549 1.522 . . . . 0.0 110.976 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.91 -69.49 0.11 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.845 1.258 . . . . 0.0 111.236 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -69.5 -22.91 63.57 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.181 0.901 . . . . 0.0 111.855 -176.213 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.13 -34.86 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.448 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.43 -17.44 44.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.664 -1.272 . . . . 0.0 112.231 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.61 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.95 -46.15 8.33 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.509 1.049 . . . . 0.0 110.713 172.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.415 ' CG2' HD12 ' A' ' 61' ' ' ILE . 1.3 pt -50.83 -39.4 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 120.674 1.579 . . . . 0.0 111.499 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -11.33 56.28 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 175.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -53.62 39.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 160.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.23 -39.51 0.01 OUTLIER 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.795 1.638 . . . . 0.0 110.958 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.574 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' A' ' 1' ' ' SER . 8.2 tpt . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.419 ' H ' ' HG3' ' A' ' 0' ' ' MET . 26.6 m 74.47 93.07 0.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.171 1.788 . . . . 0.0 107.72 -169.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -118.64 110.87 17.83 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.51 112.79 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 130.59 36.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 159.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.731 ' CD1' HG21 ' A' ' 26' ' ' VAL . 9.0 mt -123.68 145.31 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 158.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -136.69 152.18 50.1 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mp -126.95 79.84 1.91 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -76.82 85.08 3.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' ASN . 37.4 p -136.5 166.2 24.07 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.537 -1.352 . . . . 0.0 109.745 -164.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 3.2 t -165.09 -42.46 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.355 0 O-C-N 120.064 -1.648 . . . . 0.0 110.339 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HD2' ' H ' ' A' ' 10' ' ' SER . 38.3 Cg_endo -63.79 90.83 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 CA-C-N 121.285 1.495 . . . . 0.0 109.814 163.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.54 176.73 8.18 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.609 2.764 . . . . 0.0 107.945 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.261 90.7 m 110.4 -63.56 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 131.162 3.785 . . . . 0.0 109.267 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.19 40.14 0.5 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.855 2.37 . . . . 0.0 111.474 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -139.68 82.14 1.86 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.365 2.666 . . . . 0.0 104.731 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.6 m -66.79 -52.41 33.41 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 118.339 -0.839 . . . . 0.0 109.451 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.92 157.63 61.1 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 120.757 1.306 . . . . 0.0 109.003 160.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.83 -143.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 130.381 3.472 . . . . 0.0 103.223 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.22 -42.86 4.47 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.977 1.311 . . . . 0.0 112.895 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -55.86 -49.83 72.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.949 0.795 . . . . 0.0 112.283 176.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -58.81 -60.6 3.59 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.647 ' O ' HG22 ' A' ' 26' ' ' VAL . 3.6 t -57.32 -41.01 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 O-C-N 125.259 1.599 . . . . 0.0 108.936 -167.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -49.54 83.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.451 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -44.34 92.03 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 121.253 1.842 . . . . 0.0 110.146 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.91 -35.64 78.97 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.294 3.038 . . . . 0.0 111.849 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.877 HG23 HG11 ' A' ' 34' ' ' VAL . 19.2 m -105.72 -20.57 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -23.74 67.49 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 120.543 1.519 . . . . 0.0 110.173 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -47.95 -44.5 30.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.986 0.515 . . . . 0.0 112.03 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.06 -41.38 14.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.216 1.006 . . . . 0.0 111.304 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.5 mtm -139.19 75.39 34.29 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 110.457 -164.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.67 43.86 0.85 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.416 3.41 . . . . 0.0 113.441 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -178.27 -53.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.241 2.217 . . . . 0.0 108.897 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.05 67.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.072 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.877 HG11 HG23 ' A' ' 26' ' ' VAL . 2.3 t -76.66 132.21 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 169.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.35 154.79 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 158.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.16 110.89 15.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.53 104.75 17.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -80.87 106.88 13.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.88 88.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -66.28 123.27 19.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.704 -178.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.18 113.34 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 125.7 1.6 . . . . 0.0 107.811 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 ttt -160.41 -113.14 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -68.75 -21.79 64.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.73 1.605 . . . . 0.0 111.129 166.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -52.48 111.46 2.58 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 125.379 1.472 . . . . 0.0 109.998 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 158.82 55.2 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.651 2.234 . . . . 0.0 112.201 -163.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -64.62 19.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.216 2.206 . . . . 0.0 114.842 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -20.27 33.77 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.044 -1.66 . . . . 0.0 113.941 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.75 -35.4 14.16 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 121.122 -0.986 . . . . 0.0 112.155 166.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.22 -8.67 55.18 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.846 -1.159 . . . . 0.0 112.441 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -61.4 -26.87 68.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.98 0.912 . . . . 0.0 111.219 167.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -70.46 132.18 45.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.363 0.665 . . . . 0.0 109.958 -176.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.83 0.29 1.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 117.004 1.562 . . . . 0.0 117.004 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 tp -64.54 -50.22 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.026 1.913 . . . . 0.0 109.258 161.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.8 mtt 51.25 -8.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 130.938 3.695 . . . . 0.0 117.164 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.84 -172.15 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.444 1.498 . . . . 0.0 110.447 163.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.403 ' HA ' ' N ' ' A' ' 58' ' ' THR . 7.2 p -178.05 144.66 0.51 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.863 1.665 . . . . 0.0 106.942 -158.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.17 108.24 0.26 Allowed 'Cis proline' 0 C--N 1.355 0.902 0 CA-C-N 122.157 1.806 . . . . 0.0 114.844 6.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.403 ' N ' ' HA ' ' A' ' 56' ' ' VAL . 11.7 m -79.67 113.43 17.82 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.734 1.614 . . . . 0.0 107.395 -168.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mm -117.77 114.46 45.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.7 t -83.53 134.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 164.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.442 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 1.9 pp -132.0 158.25 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.052 161.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 51.0 -77.52 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.441 1.497 . . . . 0.0 112.335 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 64' ' ' ASP . . . -172.28 20.67 0.07 OUTLIER Glycine 0 CA--C 1.542 1.774 1 C-N-CA 131.245 4.26 . . . . 0.0 109.512 170.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' H ' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -90.91 151.92 20.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 131.691 3.997 . . . . 0.0 107.386 169.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.03 110.55 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.19 0.996 . . . . 0.0 108.606 -164.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.93 -177.7 6.06 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.883 . . . . 0.0 111.925 -159.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.32 115.44 2.57 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.963 0.905 . . . . 0.0 108.604 158.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.556 HG21 ' HB3' ' A' ' 75' ' ' ALA . 17.9 mm -84.98 74.36 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.24 -160.27 42.07 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.904 1.28 . . . . 0.0 113.756 159.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.33 1.38 Allowed Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 115.594 -2.146 . . . . 0.0 116.581 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.63 -127.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 124.115 2.505 . . . . 0.0 109.707 170.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.5 p -115.84 -114.54 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 121.133 1.788 . . . . 0.0 107.64 167.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.442 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -91.07 5.23 49.72 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.802 1.637 . . . . 0.0 111.404 176.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.502 22.2 mt-10 -37.8 -49.07 1.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -158.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -63.41 -34.98 78.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 123.337 2.789 . . . . 0.0 113.018 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.55 -22.88 26.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.454 1.102 . . . . 0.0 109.316 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -34.08 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.286 -1.509 . . . . 0.0 110.266 172.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -57.11 -22.75 42.11 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.653 -0.654 . . . . 0.0 111.551 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.1 -48.34 8.15 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.93 1.292 . . . . 0.0 110.47 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -56.91 -35.34 46.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-N 119.869 1.213 . . . . 0.0 111.523 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -67.07 -32.83 74.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.312 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -50.07 10.86 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 118.969 0.804 . . . . 0.0 108.85 170.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -160.98 -71.4 0.06 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.015 0.926 . . . . 0.0 110.734 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 C--O 1.249 1.039 0 C-N-CA 126.727 2.011 . . . . 0.0 106.668 -158.002 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 50.8 mtp . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.6 t -167.11 87.31 0.29 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 165.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -144.34 122.33 12.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.64 113.31 33.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.73 138.41 37.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' HB ' HG12 ' A' ' 36' ' ' VAL . 4.7 mp -134.87 137.4 50.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -137.01 147.13 46.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tp -137.64 80.45 1.81 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -173.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -91.43 96.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.471 1.108 . . . . 0.0 108.081 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 t -178.62 174.35 1.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.995 2.118 . . . . 0.0 106.908 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m -138.89 62.95 29.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 124.968 1.307 . . . . 0.0 107.614 169.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.11 85.56 1.81 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.044 2.496 . . . . 0.0 108.642 -169.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.5 mpp? 55.72 41.28 30.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.551 0.74 . . . . 0.0 110.305 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 25.0 m -44.24 -53.55 13.71 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.74 38.98 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 122.917 2.412 . . . . 0.0 112.579 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.23 -48.81 0.13 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.498 2.719 . . . . 0.0 106.492 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.9 m -119.95 105.35 42.89 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.085 1.754 . . . . 0.0 107.813 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -77.86 75.7 4.67 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.848 2.365 . . . . 0.0 111.022 -176.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.02 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.243 2.217 . . . . 0.0 112.645 -167.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.4 73.27 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-O 116.293 -1.813 . . . . 0.0 110.807 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -52.57 -50.67 62.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.272 1.851 . . . . 0.0 109.93 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -59.12 -57.67 12.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 117.304 -1.331 . . . . 0.0 111.503 171.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.54 -36.28 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 119.556 1.071 . . . . 0.0 110.852 -169.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.545 HG12 HG11 ' A' ' 36' ' ' VAL . 4.5 m -78.18 -30.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 O-C-N 120.3 -1.5 . . . . 0.0 111.966 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -60.49 -44.62 95.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.989 1.268 . . . . 0.0 108.712 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.77 -56.08 26.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.288 2.235 . . . . 0.0 109.839 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 m -72.44 -28.85 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 117.684 -1.151 . . . . 0.0 112.969 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.56 -24.58 67.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.99 1.723 . . . . 0.0 111.209 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 -16.77 29.05 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -31.69 1.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.385 1.074 . . . . 0.0 111.987 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 mmt -128.86 67.91 78.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 127.171 2.189 . . . . 0.0 108.365 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.52 32.69 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 126.085 4.523 . . . . 0.0 114.248 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -178.15 -57.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.03 -1.669 . . . . 0.0 109.184 -159.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.93 14.12 0.32 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.158 1.383 . . . . 0.0 113.925 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 p -90.64 91.37 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.696 1.998 . . . . 0.0 110.019 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 81.99 3.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.16 0.984 . . . . 0.0 108.711 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.545 HG11 HG12 ' A' ' 23' ' ' VAL . 4.0 m -95.52 139.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 127.063 2.145 . . . . 0.0 110.828 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -129.12 106.45 8.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -80.64 120.86 25.11 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.16 91.9 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 122.794 1.283 . . . . 0.0 109.908 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -50.46 113.23 0.83 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.783 2.033 . . . . 0.0 110.751 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.69 110.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 163.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.5 mtp -178.97 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 129.075 2.95 . . . . 0.0 104.052 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -155.26 98.74 2.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 102.322 -3.214 . . . . 0.0 102.322 -163.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.99 155.98 31.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 121.416 -0.802 . . . . 0.0 111.59 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.67 164.15 16.68 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.845 2.364 . . . . 0.0 112.966 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -73.33 -7.29 50.98 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.977 1.311 . . . . 0.0 112.789 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.56 -37.05 3.31 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -172.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' H ' ' HD3' ' A' ' 47' ' ' LYS . . . -91.55 -28.62 17.44 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.136 0.88 . . . . 0.0 113.073 177.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.93 -9.61 46.52 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.502 -0.749 . . . . 0.0 111.406 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.0 -25.9 67.29 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.633 1.106 . . . . 0.0 111.04 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CD2' HG21 ' A' ' 65' ' ' VAL . 23.0 m-85 -72.3 159.25 34.36 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.098 0.951 . . . . 0.0 111.913 -163.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 131.05 47.06 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.263 0.8 OUTLIER 60.33 -23.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 130.07 3.348 . . . . 0.0 115.885 -177.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.8 -62.1 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.439 2.696 . . . . 0.0 111.785 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.76 -68.84 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 131.079 3.752 . . . . 0.0 112.865 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.9 t 77.85 125.03 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 128.326 2.651 . . . . 0.0 108.281 -165.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.54 165.12 76.84 Favored 'Cis proline' 0 N--CA 1.454 -0.814 0 CA-C-N 119.702 0.929 . . . . 0.0 111.878 0.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.3 m -145.38 102.16 3.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 -164.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.8 133.37 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -166.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.9 t -100.0 132.11 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pp -120.96 142.65 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 161.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 52.63 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.702 3.201 . . . . 0.0 116.617 -169.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.52 -11.51 0.74 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 129.65 3.5 . . . . 0.0 111.001 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -92.14 111.9 23.63 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.006 2.122 . . . . 0.0 111.785 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.5 p -68.37 130.96 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.316 1.046 . . . . 0.0 109.187 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.27 -176.09 5.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.352 1.861 . . . . 0.0 106.574 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -168.31 130.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.526 1.966 . . . . 0.0 109.396 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.278 1.4 mt -121.45 75.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-O 122.023 0.916 . . . . 0.0 109.824 -173.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.72 -165.96 16.67 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.327 168.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.59 11.22 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 116.968 -1.491 . . . . 0.0 114.03 167.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.25 176.54 9.04 Favored 'Trans proline' 0 C--N 1.354 0.84 0 CA-C-N 122.385 1.888 . . . . 0.0 109.932 170.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -177.47 0.42 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.873 0.869 . . . . 0.0 110.789 170.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.49 30.44 0.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.478 -1.389 . . . . 0.0 112.62 -161.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.314 4.0 mt-10 -64.63 -20.55 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.152 -1.593 . . . . 0.0 114.505 -161.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.2 -48.75 74.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.816 -1.178 . . . . 0.0 112.277 167.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -24.51 56.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.235 -0.916 . . . . 0.0 110.808 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.36 -38.2 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 120.722 -1.236 . . . . 0.0 108.924 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -54.23 -25.84 25.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.775 1.171 . . . . 0.0 111.312 170.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.28 -57.12 4.24 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.173 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . 0.257 2.6 pt -55.7 -35.35 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.733 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -85.24 -17.22 37.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 116.509 -1.71 . . . . 0.0 115.453 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -32.41 73.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 122.814 2.552 . . . . 0.0 109.582 165.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 147.96 107.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.481 2.312 . . . . 0.0 108.175 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.252 1.216 0 C-N-CA 128.898 2.879 . . . . 0.0 113.654 173.396 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 41.5 mtp . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.1 m -150.27 121.53 7.83 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 121.259 1.845 . . . . 0.0 110.279 169.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.88 108.54 1.75 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.523 1.529 . . . . 0.0 107.097 159.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -75.48 111.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.38 61.8 6.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.494 1.118 . . . . 0.0 110.877 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.05 136.23 27.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.18 141.33 42.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.32 85.01 2.24 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -159.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -108.91 84.22 1.89 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 0.0 109.059 -165.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -138.79 -179.43 5.82 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 -167.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -149.86 71.59 9.57 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 120.974 1.715 . . . . 0.0 110.003 169.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.05 135.95 28.51 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.904 1.736 . . . . 0.0 109.047 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 31.4 ttm -127.99 -23.63 3.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.77 0.828 . . . . 0.0 112.465 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.0 m -112.12 -45.53 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 117.431 -1.271 . . . . 0.0 112.53 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -86.16 69.8 4.61 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.446 2.097 . . . . 0.0 109.45 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -65.46 86.73 0.07 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.262 1.025 . . . . 0.0 108.432 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.1 m -111.44 162.21 21.98 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 125.989 1.716 . . . . 0.0 109.428 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -61.63 105.86 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 106.529 -2.143 . . . . 0.0 106.529 158.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 -86.27 0.2 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.98 -40.96 59.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.91 170.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -52.23 -44.98 65.12 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 173.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -68.38 -43.54 77.13 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 120.074 1.306 . . . . 0.0 110.059 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 t -67.89 -32.38 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.43 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.5 t -53.13 -62.43 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.742 1.617 . . . . 0.0 107.815 164.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -64.25 -35.62 81.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.263 0.483 . . . . 0.0 111.358 -169.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' HG2' HG13 ' A' ' 77' ' ' VAL . 3.5 tp10 -62.49 -53.0 61.28 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.334 1.053 . . . . 0.0 110.118 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -67.14 -36.16 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -25.28 68.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 119.816 1.189 . . . . 0.0 112.272 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -52.16 -37.85 55.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.465 1.03 . . . . 0.0 111.075 168.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -105.15 -55.09 2.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.556 1.542 . . . . 0.0 109.348 -165.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.6 79.48 12.54 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 127.703 2.401 . . . . 0.0 108.588 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.63 26.68 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.422 3.415 . . . . 0.0 112.777 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.14 -57.11 0.2 Allowed 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.622 -1.299 . . . . 0.0 110.751 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.03 -1.98 4.83 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -80.97 87.76 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.439 2.295 . . . . 0.0 111.495 -165.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -92.85 125.68 37.58 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 t -136.18 105.35 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.439 1.018 . . . . 0.0 110.876 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -88.64 119.28 28.96 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -88.09 122.35 31.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 165.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 98.86 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 171.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -69.14 149.25 48.85 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 116.943 -1.903 . . . . 0.0 109.021 166.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.35 123.38 4.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.46 -94.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.535 1.534 . . . . 0.0 107.722 -163.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.4 -36.34 83.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.823 1.647 . . . . 0.0 110.526 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 m120 53.91 78.88 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.44 1.896 . . . . 0.0 111.504 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.48 157.26 56.73 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.018 2.479 . . . . 0.0 111.276 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -65.43 -20.32 66.32 Favored 'General case' 0 C--O 1.223 -0.332 0 O-C-N 121.75 -0.594 . . . . 0.0 111.727 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -32.1 53.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.86 -1.067 . . . . 0.0 113.817 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.54 -40.79 11.17 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.077 1.308 . . . . 0.0 113.504 163.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.4 mtp -66.09 -12.3 54.6 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.48 -20.74 66.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.863 1.665 . . . . 0.0 112.242 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.463 ' CZ ' HG11 ' A' ' 65' ' ' VAL . 4.6 m-85 -77.38 172.1 13.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.473 1.033 . . . . 0.0 109.709 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.46 -67.78 1.55 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.05 74.72 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 123.286 1.517 . . . . 0.0 108.26 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.25 36.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.604 -1.635 . . . . 0.0 114.762 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.75 -81.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.461 1.105 . . . . 0.0 113.663 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -178.45 152.7 0.8 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.26 1.424 . . . . 0.0 109.176 -168.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.95 94.32 0.13 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.577 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -20.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.0 m -72.6 108.27 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.914 1.285 . . . . 0.0 107.638 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 mm -112.94 155.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.92 142.77 42.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 168.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.289 7.8 pt -107.76 -119.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 116.583 -1.675 . . . . 0.0 111.085 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -53.57 -33.13 53.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 122.854 2.57 . . . . 0.0 112.439 173.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.53 -28.21 0.02 OUTLIER Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.336 0.97 . . . . 0.0 111.428 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.19 157.68 37.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.921 0.86 . . . . 0.0 111.317 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG11 ' CZ ' ' A' ' 51' ' ' TYR . 2.2 m -118.09 120.54 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.646 1.578 . . . . 0.0 108.18 -158.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.3 159.53 28.64 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -159.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -155.49 132.47 10.72 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.539 HG21 ' HB3' ' A' ' 75' ' ' ALA . 26.6 mm -135.26 118.73 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -168.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.06 -164.7 54.94 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 -34.79 0.75 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 116.621 -1.657 . . . . 0.0 114.434 169.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.28 -158.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 CA-C-N 122.34 1.872 . . . . 0.0 109.831 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 p -66.2 -171.71 0.12 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.466 -1.396 . . . . 0.0 109.818 160.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -77.17 49.06 0.66 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -158.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -52.69 -41.21 63.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -158.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.539 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -70.33 -41.57 73.08 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.835 -1.166 . . . . 0.0 112.136 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -77.25 -25.81 51.88 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.938 0.79 . . . . 0.0 110.923 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 25' ' ' GLU . 12.7 t -55.53 -48.03 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.863 1.665 . . . . 0.0 107.807 167.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.9 -8.25 10.62 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -100.98 -51.48 3.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.763 -1.211 . . . . 0.0 110.156 176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.7 pt -59.57 -23.06 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 O-C-N 121.262 -0.899 . . . . 0.0 111.615 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -62.46 -32.37 73.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.665 1.121 . . . . 0.0 113.219 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.4 -42.26 10.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.578 1.081 . . . . 0.0 112.259 177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 34.31 13.45 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 131.234 3.814 . . . . 0.0 121.022 -171.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.239 0 CA-C-N 121.494 1.952 . . . . 0.0 108.963 159.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.6 m -42.0 122.43 2.09 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.006 1.322 . . . . 0.0 110.786 165.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.598 ' H ' ' HB1' ' A' ' 33' ' ' ALA . 32.4 ttpt 68.41 92.29 0.08 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 127.86 2.464 . . . . 0.0 111.478 -166.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 t -58.73 140.71 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 160.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 147.06 36.08 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 36' ' ' VAL . 31.7 mt -141.59 129.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 71.5 mt-10 -128.59 128.03 43.43 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.14 69.56 1.16 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.669 1.988 . . . . 0.0 106.029 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -81.63 83.35 7.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.451 HG22 ' CB ' ' A' ' 57' ' ' PRO . 23.6 p -128.77 179.09 5.9 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.94 -1.1 . . . . 0.0 108.508 -166.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p 175.42 -63.81 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 CA-C-O 117.054 -1.45 . . . . 0.0 112.343 171.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.75 86.62 1.47 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.515 2.144 . . . . 0.0 111.882 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -166.19 149.97 7.62 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.683 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.3 m -69.76 168.58 16.64 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 158.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.26 46.16 0.7 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.232 2.621 . . . . 0.0 111.625 167.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -22.4 61.18 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.768 2.027 . . . . 0.0 113.769 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.4 m -133.32 149.83 73.54 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 167.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.85 72.8 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.922 2.415 . . . . 0.0 108.706 159.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.25 -80.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.804 1.642 . . . . 0.0 114.128 -158.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.05 -26.37 68.22 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.959 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -62.18 -47.74 83.15 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 117.23 -1.367 . . . . 0.0 110.231 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -49.09 69.51 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 120.412 1.46 . . . . 0.0 108.974 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 18.2 t -63.32 -34.07 64.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 117.662 -1.615 . . . . 0.0 110.342 -169.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.44 -45.37 75.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.532 170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -53.17 -48.22 68.19 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.98 1.718 . . . . 0.0 109.487 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.78 -54.24 47.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 129.191 2.996 . . . . 0.0 110.23 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.72 -38.89 45.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.758 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.36 -28.24 66.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 120.615 1.552 . . . . 0.0 110.655 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -57.19 -25.72 59.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.549 1.14 . . . . 0.0 112.587 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.01 -23.11 6.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.275 1.03 . . . . 0.0 111.895 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.8 mtp -133.93 75.61 66.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 127.277 2.231 . . . . 0.0 110.629 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.55 29.63 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.518 3.478 . . . . 0.0 114.178 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -178.31 -48.39 0.01 OUTLIER 'General case' 0 C--O 1.236 0.348 0 O-C-N 120.325 -1.485 . . . . 0.0 109.693 -164.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.598 ' HB1' ' H ' ' A' ' 2' ' ' LYS . . . -77.43 54.51 1.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.349 0.66 . . . . 0.0 110.518 169.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.02 136.31 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.36 138.05 51.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -142.98 127.0 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 124.172 0.989 . . . . 0.0 109.691 -168.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -127.61 110.97 13.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 167.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.74 106.5 9.6 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 166.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.3 90.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.94 108.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 161.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.7 t -44.35 110.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.324 1.85 . . . . 0.0 109.126 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 tpp -140.03 -67.68 0.43 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.9 86.54 2.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -139.42 148.53 56.89 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.59 137.92 67.0 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 N-CA-C 106.266 -2.244 . . . . 0.0 106.266 161.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -73.17 39.33 0.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.822 0.849 . . . . 0.0 110.672 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -31.23 70.2 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 120.792 -1.193 . . . . 0.0 112.609 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.36 -31.77 15.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.991 0.424 . . . . 0.0 111.551 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.9 mtt -65.75 -7.56 16.42 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.932 -1.105 . . . . 0.0 112.132 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -72.56 -30.46 64.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.411 1.084 . . . . 0.0 111.008 170.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.77 169.05 8.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.767 0.827 . . . . 0.0 110.306 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.45 -30.32 77.53 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.656 -1.636 . . . . 0.0 112.536 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -51.14 -66.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.803 1.802 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 31.5 mtt 59.08 -39.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.961 2.504 . . . . 0.0 114.719 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.21 99.97 0.21 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.92 1.688 . . . . 0.0 110.984 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.1 m -60.59 150.18 75.82 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 121.528 -0.732 . . . . 0.0 109.407 159.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.451 ' CB ' HG22 ' A' ' 9' ' ' THR . 98.5 Cg_endo -72.22 113.14 2.08 Favored 'Cis proline' 0 C--N 1.349 0.603 0 CA-C-N 120.666 1.273 . . . . 0.0 111.93 1.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 m -96.78 117.88 32.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.219 2.208 . . . . 0.0 106.294 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.01 119.04 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -167.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -102.05 131.25 50.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.466 HD13 ' HE3' ' A' ' 73' ' ' LYS . 16.7 pt -128.26 163.37 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 125.032 1.458 . . . . 0.0 108.717 168.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 t30 48.16 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 111.63 -159.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.93 -3.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.443 0 C-N-CA 128.155 2.788 . . . . 0.0 111.892 167.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -91.54 129.83 37.46 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.232 2.016 . . . . 0.0 111.7 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.27 140.5 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.612 0.765 . . . . 0.0 109.733 170.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.18 -178.17 6.55 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -164.61 115.58 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.79 81.02 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 119.532 1.06 . . . . 0.0 110.468 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 171.9 23.17 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.376 -1.284 . . . . 0.0 112.007 166.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.71 3.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 115.958 -1.973 . . . . 0.0 115.836 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.08 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.367 2.238 . . . . 0.0 111.047 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 p -134.95 -127.99 0.16 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.934 2.094 . . . . 0.0 108.435 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HE3' HD13 ' A' ' 61' ' ' ILE . 2.8 ttpt -91.91 20.62 5.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.208 -1.558 . . . . 0.0 114.923 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -41.98 -45.11 3.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.618 2.008 . . . . 0.0 113.299 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.23 -49.65 60.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.569 1.148 . . . . 0.0 113.302 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -85.37 -21.86 28.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.647 0.779 . . . . 0.0 111.299 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.03 -40.53 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 171.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.37 -29.05 65.7 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.471 -0.768 . . . . 0.0 112.455 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.599 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -77.53 -50.08 13.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 111.226 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 pt -60.44 -37.51 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.164 -0.96 . . . . 0.0 111.585 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -36.61 84.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.636 1.107 . . . . 0.0 113.237 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -21.47 45.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.44 1.473 . . . . 0.0 113.006 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.18 -73.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.126 1.771 . . . . 0.0 109.281 169.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.154 1.782 . . . . 0.0 107.268 -169.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.3 m 38.34 -123.84 0.28 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.256 2.222 . . . . 0.0 112.713 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? 27.72 73.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.976 2.51 . . . . 0.0 111.747 -165.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.77 101.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.74 160.37 32.73 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.811 0.815 . . . . 0.0 110.129 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 26' ' ' VAL . 3.0 mp -147.99 138.98 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 129.181 2.992 . . . . 0.0 105.135 167.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -135.7 146.87 48.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.56 82.98 2.06 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.785 1.234 . . . . 0.0 109.379 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.6 89.82 2.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.094 1.358 . . . . 0.0 108.5 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -135.69 179.69 6.18 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.856 -1.153 . . . . 0.0 113.279 -161.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 t 178.75 -56.92 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.385 2.274 . . . . 0.0 108.278 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.38 93.4 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.407 2.071 . . . . 0.0 111.29 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 ttp -151.62 93.1 1.83 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.182 1.793 . . . . 0.0 107.094 -168.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.8 m -131.48 -72.59 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 117.186 -1.388 . . . . 0.0 110.355 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.79 -46.2 5.36 Favored 'Trans proline' 0 C--N 1.353 0.77 0 CA-C-N 122.251 1.84 . . . . 0.0 110.95 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -78.31 63.78 3.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 t -56.63 -56.14 35.59 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.481 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.14 118.99 6.0 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-N 121.38 1.529 . . . . 0.0 109.314 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.52 -94.42 0.32 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB2' ' HD1' ' A' ' 38' ' ' TYR . . . -57.19 -25.29 58.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.264 174.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -56.61 -54.66 43.39 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.814 0.846 . . . . 0.0 111.755 171.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.6 mtt-85 -60.71 -45.21 95.11 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 118.659 0.663 . . . . 0.0 109.594 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.9 t -68.69 -34.58 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.563 -170.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.44 -32.57 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 121.133 1.788 . . . . 0.0 110.885 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -60.54 -53.68 54.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.815 1.189 . . . . 0.0 109.043 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.38 -36.97 77.33 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 122.915 0.486 . . . . 0.0 111.595 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 5' ' ' ILE . 59.2 t -74.7 -35.57 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.975 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.76 -28.7 70.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.642 1.564 . . . . 0.0 111.169 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -57.72 -22.23 45.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.56 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -112.55 -31.52 6.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.974 1.261 . . . . 0.0 112.069 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -145.14 85.84 7.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.549 1.939 . . . . 0.0 110.338 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.88 45.47 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 124.176 3.251 . . . . 0.0 110.913 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -178.0 -66.77 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.711 1.604 . . . . 0.0 109.035 -166.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.87 1.11 4.74 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.27 141.33 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.267 1.427 . . . . 0.0 108.988 171.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -137.31 130.06 30.22 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 164.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.63 92.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.815 1.246 . . . . 0.0 110.52 -159.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 104.33 16.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' HD1' ' HB2' ' A' ' 19' ' ' ALA . 31.0 t80 -75.61 121.75 22.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 159.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.09 92.41 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.7 161.72 14.53 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.745 -1.222 . . . . 0.0 109.948 170.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.25 138.3 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.5 mtp -178.59 -87.05 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.586 2.354 . . . . 0.0 105.665 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -68.17 -19.06 64.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.721 1.208 . . . . 0.0 111.983 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.08 56.13 17.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.394 1.878 . . . . 0.0 111.606 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.35 140.78 65.43 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.353 1.369 . . . . 0.0 109.934 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -61.76 -15.62 42.7 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.814 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -40.25 -45.37 2.06 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.378 1.471 . . . . 0.0 112.333 162.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.07 -46.01 8.0 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 168.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.2 mtp -68.57 -5.47 20.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.42 -26.27 63.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.378 1.071 . . . . 0.0 111.317 164.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -76.33 118.48 19.08 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.269 1.028 . . . . 0.0 110.243 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.59 -5.5 23.87 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.437 -1.201 . . . . 0.0 114.878 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 pt -68.44 -46.55 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.875 1.838 . . . . 0.0 109.603 170.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.3 mtt 47.08 -11.42 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.632 3.173 . . . . 0.0 117.447 -169.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.7 68.9 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.397 1.879 . . . . 0.0 115.735 -159.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.311 28.8 m 50.98 166.72 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 128.251 2.62 . . . . 0.0 113.625 -161.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -65.52 105.78 0.34 Allowed 'Cis proline' 0 C--N 1.356 0.948 0 CA-C-N 121.55 1.589 . . . . 0.0 109.99 -14.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 m -79.89 124.49 28.71 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.803 1.641 . . . . 0.0 107.066 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.7 mm -121.82 166.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 t -142.94 134.16 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.417 HG12 ' HZ1' ' A' ' 73' ' ' LYS . 37.1 pt -101.42 -157.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.745 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -23.23 -51.34 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.495 2.318 . . . . 0.0 114.91 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.22 -27.2 0.22 Allowed Glycine 0 CA--C 1.533 1.215 0 O-C-N 124.163 0.914 . . . . 0.0 112.106 158.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.55 140.59 29.6 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.684 1.742 . . . . 0.0 112.585 -163.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.71 147.64 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.173 2.189 . . . . 0.0 108.478 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -178.57 160.13 1.2 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.555 1.542 . . . . 0.0 109.401 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 146.89 52.51 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 159.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 mm -124.78 88.44 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.38 -165.16 51.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 121.664 0.591 . . . . 0.0 112.418 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -72.76 -22.84 0.54 Allowed Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 174.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 41.9 Cg_endo -65.65 177.17 2.96 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 123.67 2.346 . . . . 0.0 110.632 164.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.1 p -70.55 -159.77 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 159.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.417 ' HZ1' HG12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -77.29 23.26 0.2 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 119.199 -2.188 . . . . 0.0 112.746 -170.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -44.93 -37.92 4.31 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.84 2.456 . . . . 0.0 112.508 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.87 -66.47 0.38 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.481 1.112 . . . . 0.0 111.567 169.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.82 -23.31 64.25 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.647 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -39.8 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.568 1.531 . . . . 0.0 108.559 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -62.34 -7.46 4.39 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.05 -37.83 7.19 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.204 1.366 . . . . 0.0 112.376 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -42.78 73.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.569 1.077 . . . . 0.0 108.598 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -15.25 60.92 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.394 -1.441 . . . . 0.0 113.927 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -52.73 9.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.59 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -159.54 49.24 0.31 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.827 1.194 . . . . 0.0 112.307 174.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.426 0.0 OUTLIER . . . . . 0 C--O 1.245 0.845 0 C-N-CA 126.738 2.015 . . . . 0.0 113.667 -162.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 42.1 tpp . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.5 m 48.3 46.53 20.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.484 1.114 . . . . 0.0 112.083 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -142.04 156.65 45.43 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.764 0.826 . . . . 0.0 110.086 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.461 HG13 ' HA ' ' A' ' 62' ' ' ASN . 59.5 t -66.08 130.97 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.673 1.124 . . . . 0.0 108.507 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -106.2 147.04 29.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.261 -0.899 . . . . 0.0 109.224 170.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.567 HD13 ' HA ' ' A' ' 61' ' ' ILE . 4.4 mm -133.29 134.61 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -130.06 143.86 51.03 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.478 HD13 HD12 ' A' ' 59' ' ' ILE . 3.4 mm? -121.44 78.67 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 16.0 t80 -88.97 80.14 7.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 m -152.33 159.39 43.47 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.352 -1.468 . . . . 0.0 110.468 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 31.9 t -145.61 105.04 4.27 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 162.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.53 122.5 6.03 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.966 1.777 . . . . 0.0 110.715 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 46.8 ttm -91.84 91.48 7.93 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.4 m 113.18 -58.42 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.302 0 C-N-CA 131.055 3.742 . . . . 0.0 111.045 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.59 58.58 7.07 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.803 2.335 . . . . 0.0 110.999 -173.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -61.7 111.03 1.68 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.8 m -121.43 162.71 34.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 125.701 1.6 . . . . 0.0 108.119 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.34 -21.25 71.27 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.764 1.643 . . . . 0.0 113.856 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 43.08 -117.0 0.44 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.201 1.4 . . . . 0.0 110.389 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.59 -32.75 29.83 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 116.15 -1.881 . . . . 0.0 114.246 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -59.1 -59.07 6.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 121.457 1.935 . . . . 0.0 109.639 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -61.63 -50.26 73.27 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.495 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.4 -40.59 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 117.017 -1.468 . . . . 0.0 108.577 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.87 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 120.479 1.49 . . . . 0.0 109.657 171.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -58.69 -43.14 89.92 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.905 1.23 . . . . 0.0 110.653 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.28 -54.62 34.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.646 1.178 . . . . 0.0 110.653 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 HG11 ' A' ' 34' ' ' VAL . 34.5 m -71.6 -29.2 33.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.793 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.93 64.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.691 1.132 . . . . 0.0 110.125 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.77 -40.05 78.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.189 0.45 . . . . 0.0 110.078 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -76.56 -51.69 11.16 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.329 1.051 . . . . 0.0 111.909 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.4 mtt -141.38 82.94 13.93 Favored Pre-proline 0 C--N 1.333 -0.152 0 C-N-CA 127.517 2.327 . . . . 0.0 108.755 -167.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -68.85 8.81 0.52 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.205 1.937 . . . . 0.0 114.147 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.7 -40.69 0.13 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.551 1.141 . . . . 0.0 112.376 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -6.4 19.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.519 1.054 . . . . 0.0 111.812 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.53 HG11 HG23 ' A' ' 26' ' ' VAL . 1.5 t -80.66 144.72 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 119.496 1.044 . . . . 0.0 109.319 170.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 141.62 51.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.171 2.188 . . . . 0.0 105.182 165.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.35 129.04 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 124.019 0.928 . . . . 0.0 109.725 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -121.15 97.54 5.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -85.91 93.06 8.84 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.276 0.2 OUTLIER -116.27 92.42 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 123.056 1.408 . . . . 0.0 107.815 -170.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.06 124.15 20.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.967 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.79 117.45 5.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.59 -63.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -143.67 51.35 1.34 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -160.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -139.5 151.18 66.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.857 0.863 . . . . 0.0 111.101 -165.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.98 134.76 32.95 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.295 2.663 . . . . 0.0 111.852 -172.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -70.68 7.03 1.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.344 -0.848 . . . . 0.0 112.779 173.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.7 -31.63 17.03 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 126.079 1.752 . . . . 0.0 113.311 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -92.35 -41.48 10.33 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.616 0.644 . . . . 0.0 111.103 164.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.14 -0.75 3.56 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.83 -143.44 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.196 1.398 . . . . 0.0 109.662 159.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 67.6 -168.03 0.2 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.563 1.545 . . . . 0.0 111.725 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.87 162.76 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 158.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.293 1.5 tp 41.79 63.99 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 123.225 1.488 . . . . 0.0 112.563 -165.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtt -67.87 -22.33 65.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.687 163.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.02 0.84 4.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.906 1.282 . . . . 0.0 113.926 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 70.31 164.07 0.14 Allowed Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.406 1.482 . . . . 0.0 110.49 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.15 125.94 10.61 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.674 1.276 . . . . 0.0 111.474 -9.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.1 m -95.4 98.09 10.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.478 HD12 HD13 ' A' ' 7' ' ' LEU . 31.5 mm -119.48 120.4 63.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -167.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.63 127.95 47.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.567 ' HA ' HD13 ' A' ' 5' ' ' ILE . 8.9 pt -123.91 142.17 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.83 0.741 . . . . 0.0 109.885 169.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.461 ' HA ' HG13 ' A' ' 3' ' ' VAL . 18.5 t30 48.08 -42.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.288 3.035 . . . . 0.0 116.886 -159.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.96 -15.6 0.06 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 128.414 2.911 . . . . 0.0 111.255 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -91.06 160.61 15.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.413 1.606 . . . . 0.0 110.17 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.64 127.55 75.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.82 0.848 . . . . 0.0 109.209 -158.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -160.93 173.39 15.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.026 0.83 . . . . 0.0 111.015 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.92 155.51 48.94 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.782 1.633 . . . . 0.0 106.874 159.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.6 mm -141.06 136.17 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.01 -171.34 45.74 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.82 -30.97 0.64 Allowed Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 116.374 -1.774 . . . . 0.0 114.209 164.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -85.41 -166.54 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 CA-C-N 123.005 2.109 . . . . 0.0 110.53 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -63.33 175.63 0.95 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.054 0.941 . . . . 0.0 111.661 172.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HZ1' HG23 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -77.26 21.5 0.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.518 1.527 . . . . 0.0 113.771 -160.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -35.45 -40.8 0.16 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.312 2.245 . . . . 0.0 114.654 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.48 -64.76 0.72 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.714 1.606 . . . . 0.0 111.703 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -68.36 -28.15 66.87 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.042 0.537 . . . . 0.0 110.698 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.13 -34.65 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.25 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.45 -16.55 55.86 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.529 -1.357 . . . . 0.0 113.745 169.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -90.48 -47.81 7.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.351 1.432 . . . . 0.0 110.466 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.87 -24.84 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.024 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -64.01 -46.5 84.23 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.129 0.877 . . . . 0.0 111.282 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.85 -49.49 8.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -165.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 53.29 -58.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 129.128 2.971 . . . . 0.0 114.629 -165.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.479 1.912 . . . . 0.0 110.507 -169.574 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m -67.45 113.76 5.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.706 0.402 . . . . 0.0 110.285 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -144.05 126.21 15.57 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 168.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -105.39 103.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 158.17 35.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.446 HD13 HG22 ' A' ' 36' ' ' VAL . 4.8 mp -143.39 138.94 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 161.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -129.08 144.16 51.1 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 mt -138.37 89.62 2.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.404 1.082 . . . . 0.0 108.465 -170.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t80 -113.63 97.25 6.31 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.211 1.805 . . . . 0.0 108.917 -164.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t -178.91 -177.25 0.48 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.989 1.716 . . . . 0.0 106.626 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 t -158.23 69.71 3.86 Favored Pre-proline 0 CA--C 1.539 0.558 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 160.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.6 127.76 18.68 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.107 1.872 . . . . 0.0 109.26 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.6 ttt -55.88 105.89 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.765 1.226 . . . . 0.0 109.096 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.296 96.3 m 108.23 -76.11 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 131.352 3.861 . . . . 0.0 109.369 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.44 3.78 2.0 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 CA-C-N 123.346 2.231 . . . . 0.0 115.683 -172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.16 47.75 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.642 1.564 . . . . 0.0 113.396 163.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -138.46 -64.48 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 125.043 1.337 . . . . 0.0 109.629 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.85 -8.15 21.67 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.882 1.722 . . . . 0.0 114.235 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.73 -81.21 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.875 1.67 . . . . 0.0 113.496 -166.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.18 -25.35 68.04 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 117.491 -1.242 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -61.39 -59.29 5.5 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.203 0.91 . . . . 0.0 109.791 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -61.6 -43.15 99.39 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.762 -0.586 . . . . 0.0 111.005 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -66.36 -33.71 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.942 -173.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.24 -27.41 13.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 CA-C-N 120.368 1.44 . . . . 0.0 111.88 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -61.23 -57.58 11.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 120.202 1.365 . . . . 0.0 108.252 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -49.27 -66.18 0.44 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.328 1.851 . . . . 0.0 107.688 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.47 -27.95 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.686 1.13 . . . . 0.0 112.872 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 -26.35 68.01 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 120.829 1.649 . . . . 0.0 111.249 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -53.72 -48.98 69.09 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.221 0.919 . . . . 0.0 111.466 167.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.51 -51.77 47.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.587 0.63 . . . . 0.0 109.978 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.59 88.48 8.69 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 125.668 1.587 . . . . 0.0 109.367 -169.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.41 27.27 0.42 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.021 3.147 . . . . 0.0 110.95 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -151.67 -68.33 0.17 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.152 1.381 . . . . 0.0 108.62 -158.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.21 -5.03 28.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.16 139.44 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 119.175 0.898 . . . . 0.0 110.294 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.28 123.31 24.02 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 5' ' ' ILE . 33.6 t -117.02 140.02 41.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -116.97 100.6 7.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -77.57 115.68 17.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 160.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.266 0.2 OUTLIER -129.23 101.32 6.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.766 1.27 . . . . 0.0 107.876 177.406 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.1 129.03 38.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.244 1.418 . . . . 0.0 108.324 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.55 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -178.94 -72.26 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 128.458 2.703 . . . . 0.0 106.328 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.6 -41.8 59.81 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -58.86 142.79 84.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.061 0.944 . . . . 0.0 112.159 -167.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.01 136.45 32.37 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.911 1.741 . . . . 0.0 108.254 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.08 -12.88 2.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.542 1.537 . . . . 0.0 113.386 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -4.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.833 2.853 . . . . 0.0 118.468 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -91.42 -63.89 1.2 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 121.5 1.954 . . . . 0.0 107.546 158.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.435 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -40.83 -21.22 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 129.738 3.215 . . . . 0.0 115.254 174.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.91 -20.38 3.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.802 2.041 . . . . 0.0 114.84 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -52.58 175.39 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.019 2.928 . . . . 0.0 115.555 -164.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -43.42 127.41 5.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.822 1.201 . . . . 0.0 110.837 164.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.289 0.2 OUTLIER 60.12 -24.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 129.435 3.094 . . . . 0.0 115.895 -170.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.4 mtm 62.24 -73.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 128.628 2.771 . . . . 0.0 110.754 -172.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 36.27 -130.95 0.1 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.187 2.595 . . . . 0.0 110.965 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -179.32 154.28 0.74 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 128.937 2.895 . . . . 0.0 105.138 175.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.93 -179.87 8.81 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 119.483 0.851 . . . . 0.0 112.0 -14.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -128.69 127.19 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 168.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -129.56 163.71 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 65' ' ' VAL . 19.4 t -138.75 130.93 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 102.907 -2.998 . . . . 0.0 102.907 169.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.411 HG23 ' NZ ' ' A' ' 73' ' ' LYS . 41.0 pt -99.21 -161.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 117.005 -1.474 . . . . 0.0 108.9 168.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -20.17 -56.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.823 2.449 . . . . 0.0 114.308 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.68 -13.61 1.42 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.869 -0.962 . . . . 0.0 112.668 158.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -91.32 113.86 26.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.331 1.566 . . . . 0.0 113.186 -159.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 60' ' ' VAL . 57.5 t -58.42 135.35 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.421 1.489 . . . . 0.0 107.855 164.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 6.6 tt0 -178.57 169.33 1.74 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.862 2.065 . . . . 0.0 107.842 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -158.93 139.63 12.61 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 119.907 -1.745 . . . . 0.0 106.662 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.89 133.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -174.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 175.37 49.82 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.127 0.892 . . . . 0.0 111.966 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.21 -42.62 2.11 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.735 1.214 . . . . 0.0 112.825 164.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.12 -176.66 1.95 Allowed 'Trans proline' 0 C--N 1.355 0.878 0 CA-C-N 121.798 1.678 . . . . 0.0 109.354 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -62.85 -175.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.518 -0.739 . . . . 0.0 111.119 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HZ3' ' HB3' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -70.45 32.99 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.886 2.074 . . . . 0.0 114.64 -158.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.34 -34.63 64.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.236 -1.54 . . . . 0.0 112.017 -172.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.81 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.49 1.116 . . . . 0.0 111.7 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -82.51 -28.8 30.88 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.928 174.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -40.24 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 120.697 1.589 . . . . 0.0 109.97 -175.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -12.5 23.58 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.18 -37.28 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.718 2.007 . . . . 0.0 111.418 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 pt -56.29 -34.4 40.03 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 121.677 2.035 . . . . 0.0 110.251 173.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -53.81 -35.28 61.23 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -31.42 16.33 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 170.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.84 -66.32 0.4 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.834 1.253 . . . . 0.0 111.696 -169.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 C--O 1.255 1.343 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -178.294 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 58.0 mtp . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.8 p -151.73 169.95 20.95 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.104 0.562 . . . . 0.0 111.274 -164.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 108.86 104.61 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 131.046 3.738 . . . . 0.0 107.617 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 62' ' ' ASN . 11.0 t -65.12 130.06 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 168.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.14 141.5 33.94 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 165.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 26' ' ' VAL . 4.9 mp -138.43 85.38 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -172.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -93.71 128.67 40.04 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 169.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.653 HD13 HD12 ' A' ' 59' ' ' ILE . 4.2 mm? -100.21 87.12 3.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 164.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 48' ' ' ALA . 15.2 t80 -91.05 95.64 10.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.971 0.891 . . . . 0.0 108.65 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -178.47 172.1 1.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.192 1.797 . . . . 0.0 108.136 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 t -138.06 101.73 8.46 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 164.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.85 58.59 6.1 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.583 2.855 . . . . 0.0 110.914 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 39.9 ttm -62.42 -23.44 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.376 1.47 . . . . 0.0 111.835 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 14' ' ' PRO . 72.2 m -79.11 -73.05 0.12 Allowed Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 116.736 -1.602 . . . . 0.0 110.659 170.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 13' ' ' CYS . 43.3 Cg_endo -85.48 -9.85 7.89 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 CA-C-N 122.982 2.101 . . . . 0.0 115.699 -168.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 53.62 25.25 4.77 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 m -55.17 154.2 11.2 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.726 0.693 . . . . 0.0 112.336 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.37 57.22 3.44 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.429 3.42 . . . . 0.0 109.586 166.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.41 ' HB1' HG21 ' A' ' 72' ' ' THR . . . -52.92 -77.5 0.02 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.68 1.992 . . . . 0.0 111.994 -166.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.92 78.48 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 118.224 -0.893 . . . . 0.0 108.796 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -48.64 -46.08 39.41 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.278 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -68.04 -53.0 28.97 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 121.02 1.737 . . . . 0.0 111.085 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.72 -40.2 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.017 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HA ' HG22 ' A' ' 26' ' ' VAL . 6.7 m -73.98 -32.68 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 126.113 1.765 . . . . 0.0 112.637 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.64 -49.31 62.52 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.632 1.106 . . . . 0.0 108.139 164.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -76.98 -44.43 31.12 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.074 0.949 . . . . 0.0 110.531 -164.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG21 HG12 ' A' ' 5' ' ' ILE . 20.5 m -72.57 -26.44 24.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.95 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.87 -26.49 63.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.936 1.698 . . . . 0.0 110.328 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.24 -41.18 99.04 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.303 1.041 . . . . 0.0 109.878 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.7 -56.82 7.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.146 0.579 . . . . 0.0 110.63 171.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 62.0 mtt -146.86 86.83 6.48 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 125.355 1.462 . . . . 0.0 109.214 -159.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.25 41.4 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.437 2.758 . . . . 0.0 111.66 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -151.56 -66.36 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 127.198 2.199 . . . . 0.0 108.061 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 45.45 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.977 1.711 . . . . 0.0 111.775 -173.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.14 83.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.065 1.346 . . . . 0.0 109.928 -161.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -89.24 110.8 21.52 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.46 142.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.034 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -156.52 152.16 27.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.354 1.073 . . . . 0.0 112.068 158.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.58 90.57 4.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.386 2.274 . . . . 0.0 106.334 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.45 85.33 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.29 121.56 12.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 93.67 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 mmt -143.6 -52.99 0.35 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.94 1.696 . . . . 0.0 109.089 166.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 13.3 6.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.143 2.177 . . . . 0.0 110.845 -169.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.14 154.42 30.57 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.554 2.342 . . . . 0.0 115.594 -160.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.23 145.06 77.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.788 2.325 . . . . 0.0 110.592 170.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -66.33 -9.8 36.68 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.381 -0.824 . . . . 0.0 111.041 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HE3' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -61.0 -18.02 55.3 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -175.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' N ' ' HE3' ' A' ' 47' ' ' LYS . . . -92.24 -39.54 11.47 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 119.974 -1.704 . . . . 0.0 112.068 161.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.2 mtm -63.35 -12.98 34.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.121 -0.987 . . . . 0.0 112.543 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.14 -26.66 68.45 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.564 1.146 . . . . 0.0 110.902 168.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CD2' HG21 ' A' ' 65' ' ' VAL . 29.5 m-85 -66.6 114.65 5.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 108.953 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.69 8.14 3.48 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.576 1.39 . . . . 0.0 116.576 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -69.83 -52.59 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.937 1.869 . . . . 0.0 108.587 159.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . 0.279 0.1 OUTLIER 40.9 7.74 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.926 3.29 . . . . 0.0 117.815 -169.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -178.44 0.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 123.392 1.568 . . . . 0.0 109.354 159.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.04 158.56 48.33 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.194 -0.941 . . . . 0.0 108.922 -167.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB2' HD11 ' A' ' 59' ' ' ILE . 66.3 Cg_endo -70.21 128.76 13.6 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 -10.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -77.78 106.13 9.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.653 HD12 HD13 ' A' ' 7' ' ' LEU . 14.7 mm -118.93 121.54 67.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -111.81 111.28 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pp -101.07 167.75 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 169.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' A' ' 3' ' ' VAL . 37.7 m-80 30.33 -81.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.07 1.748 . . . . 0.0 114.501 -161.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.53 10.19 1.46 Allowed Glycine 0 CA--C 1.534 1.243 0 CA-C-N 120.241 1.382 . . . . 0.0 114.139 165.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -86.52 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.33 1.565 . . . . 0.0 113.358 -166.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' A' ' 51' ' ' TYR . 4.1 p 114.78 134.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.975 1 C-N-CA 133.766 4.826 . . . . 0.0 106.753 -163.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -178.72 167.08 1.73 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.738 2.415 . . . . 0.0 108.088 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.82 116.67 5.53 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.733 1.613 . . . . 0.0 107.831 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 150.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.51 172.36 47.7 Favored Glycine 0 CA--C 1.527 0.807 0 O-C-N 124.339 1.025 . . . . 0.0 111.248 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -83.98 -33.55 0.55 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.702 1.201 . . . . 0.0 111.459 158.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 85.9 Cg_endo -71.15 -165.75 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 121.636 1.62 . . . . 0.0 110.001 160.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.41 HG21 ' HB1' ' A' ' 18' ' ' ALA . 30.8 p -64.23 -172.47 0.07 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.525 0.73 . . . . 0.0 109.858 162.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -71.59 47.34 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.393 2.277 . . . . 0.0 114.529 -158.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -58.31 -45.36 88.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.577 1.951 . . . . 0.0 110.923 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.4 -39.86 61.4 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 112.867 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.94 -20.63 21.98 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.995 0.918 . . . . 0.0 110.476 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.92 -38.42 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.561 -1.337 . . . . 0.0 108.353 167.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.2 -0.64 10.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.444 0.698 . . . . 0.0 112.761 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.57 -51.11 3.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.592 1.557 . . . . 0.0 111.21 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pt -53.48 -40.51 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 119.967 1.258 . . . . 0.0 107.948 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -72.9 -29.09 62.87 Favored 'General case' 0 C--N 1.345 0.377 0 O-C-N 120.209 -1.557 . . . . 0.0 114.78 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.49 1.95 . . . . 0.0 109.291 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -71.64 11.01 0.55 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.994 1.318 . . . . 0.0 113.92 172.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.252 1.225 0 CA-C-N 120.151 1.341 . . . . 0.0 107.677 158.729 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 117.02 -1.467 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 m -66.15 143.69 57.12 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 122.227 2.285 . . . . 0.0 110.011 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -73.64 126.0 29.3 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.9 110.26 3.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -91.13 144.75 25.31 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.77 138.57 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -124.72 133.0 53.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.14 92.09 3.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.049 1.34 . . . . 0.0 109.118 -172.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -112.61 104.09 12.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.027 0.931 . . . . 0.0 109.857 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 t -178.57 170.92 1.59 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 108.65 170.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.9 t -165.95 47.71 0.16 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.603 1.161 . . . . 0.0 109.889 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.18 -64.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.816 2.344 . . . . 0.0 110.303 -161.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ttt -156.44 -115.72 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 159.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 3.4 m 50.74 -172.0 0.01 OUTLIER Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 119.135 0.88 . . . . 0.0 109.573 -159.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 13.8 Cg_endo -67.71 2.63 2.34 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.298 1.142 . . . . 0.0 113.679 166.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 69.28 -32.01 0.22 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 128.095 2.558 . . . . 0.0 113.428 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.2 m -56.88 -49.48 93.62 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.063 1.745 . . . . 0.0 114.24 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.82 88.63 1.05 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 N-CA-C 107.967 -1.59 . . . . 0.0 107.967 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 -100.21 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.44 51.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.58 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -51.4 -67.73 0.23 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.99 1.316 . . . . 0.0 111.466 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -65.17 -39.4 92.88 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.328 -0.858 . . . . 0.0 110.965 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 26' ' ' VAL . 51.5 t -65.05 -43.13 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.01 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 120.202 1.364 . . . . 0.0 110.227 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.83 -45.39 86.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 110.568 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -58.66 -60.44 3.82 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.925 1.29 . . . . 0.0 110.246 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 22' ' ' VAL . 1.2 p -73.75 -33.27 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.203 -176.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.49 70.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 121.032 1.742 . . . . 0.0 111.373 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -61.2 -13.07 15.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.25 -20.08 1.67 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.2 mtp -138.72 78.25 31.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 127.791 2.437 . . . . 0.0 107.304 168.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -70.9 25.28 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 125.29 3.994 . . . . 0.0 115.053 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -178.02 -45.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.11 -1.618 . . . . 0.0 110.488 -159.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.05 3.85 7.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.142 0.883 . . . . 0.0 111.639 169.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.1 136.92 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.129 0.972 . . . . 0.0 109.329 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -128.54 125.41 38.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 159.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.47 102.42 9.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.393 -2.076 . . . . 0.0 105.393 173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -92.05 130.66 37.74 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -112.79 104.64 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.94 1.696 . . . . 0.0 106.49 -168.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.69 67.22 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -58.8 144.14 45.02 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.581 0.705 . . . . 0.0 109.647 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.37 141.87 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.3 ttm -178.66 -70.01 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 128.394 2.677 . . . . 0.0 104.621 -173.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.27 0.941 . . . . 0.0 111.046 170.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t30 43.57 54.48 11.01 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.7 2.4 . . . . 0.0 112.513 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.5 151.49 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.087 1.858 . . . . 0.0 112.464 -169.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -63.95 -12.54 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -37.49 32.39 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 119.591 1.087 . . . . 0.0 113.755 -177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -37.78 12.61 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 165.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.7 mtp -65.78 -11.89 49.63 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.62 -22.83 64.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.623 1.169 . . . . 0.0 113.125 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -66.99 151.12 48.24 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.255 0.934 . . . . 0.0 112.498 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.07 -45.83 42.35 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 126.215 1.864 . . . . 0.0 112.487 -174.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.265 4.2 tt -133.37 83.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.516 1.15 . . . . 0.0 108.263 158.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -33.93 58.32 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.165 169.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 28.66 -116.67 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.829 2.452 . . . . 0.0 112.215 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -179.07 160.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 130.661 3.585 . . . . 0.0 105.673 164.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.21 119.28 5.37 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 CA-C-N 120.581 1.243 . . . . 0.0 110.124 -14.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 m -80.39 98.94 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.208 1.803 . . . . 0.0 108.077 -164.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 mm -109.48 151.79 11.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -121.3 141.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 162.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.505 HD13 ' HE3' ' A' ' 73' ' ' LYS . 36.6 pt -135.98 145.81 30.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.808 0.843 . . . . 0.0 109.857 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.17 -62.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.066 2.146 . . . . 0.0 110.89 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.42 -5.38 0.04 OUTLIER Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.932 2.206 . . . . 0.0 112.556 158.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.69 154.55 18.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.328 2.064 . . . . 0.0 116.177 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.2 m -105.12 131.78 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.3 1.44 . . . . 0.0 109.005 -161.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 21.5 tt0 -178.36 167.06 1.89 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.04 -1.038 . . . . 0.0 109.13 -165.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -162.02 125.72 3.14 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -170.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.61 109.07 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.69 -177.28 17.82 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.843 1.211 . . . . 0.0 110.337 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 71' ' ' PRO . . . -89.55 -32.79 0.38 Allowed Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 117.051 -1.452 . . . . 0.0 113.297 161.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 70' ' ' ALA . 86.8 Cg_endo -73.46 -170.98 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.847 1.695 . . . . 0.0 109.255 160.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.1 p -60.67 -176.22 0.05 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.755 1.622 . . . . 0.0 111.499 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HE3' HD13 ' A' ' 61' ' ' ILE . 6.4 ttpt -71.96 36.9 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.783 2.033 . . . . 0.0 113.142 -163.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -50.32 -44.81 54.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.492 1.917 . . . . 0.0 110.857 -164.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.67 65.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.779 1.631 . . . . 0.0 113.319 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.51 -26.94 19.51 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.0 0.52 . . . . 0.0 110.741 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . 0.266 22.4 t -61.81 -40.02 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 125.025 1.33 . . . . 0.0 108.294 175.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -60.0 -13.99 14.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.653 1.581 . . . . 0.0 112.542 170.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.39 -44.61 7.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 116.903 -1.522 . . . . 0.0 111.324 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.43 ' CG2' HD12 ' A' ' 61' ' ' ILE . 2.2 pt -56.0 -29.98 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.882 1.674 . . . . 0.0 112.599 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -51.93 -64.27 0.87 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.131 165.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -67.61 -59.74 3.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.058 -174.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 82' ' ' LYS . 2.6 mpt_? -161.11 101.3 1.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.398 1.879 . . . . 0.0 109.844 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.264 0 C-N-CA 129.778 3.231 . . . . 0.0 116.8 170.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 37.5 mtt . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t -148.12 -43.93 0.16 Allowed 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.636 -0.665 . . . . 0.0 110.616 174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt 57.65 91.76 0.04 OUTLIER 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.518 1.527 . . . . 0.0 111.859 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 62' ' ' ASN . 91.2 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -158.95 87.24 2.22 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.7 35.67 0.52 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.53 2.82 . . . . 0.0 112.287 -172.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.2 ttt 56.63 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.304 3.442 . . . . 0.0 114.893 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -78.15 -84.92 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.662 -1.637 . . . . 0.0 109.579 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.06 78.98 2.45 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.883 2.388 . . . . 0.0 111.188 -175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -129.2 28.53 5.25 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.544 1.138 . . . . 0.0 110.566 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 16.6 m -132.63 -57.55 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.799 1.24 . . . . 0.0 108.269 172.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 16' ' ' CYS . 87.7 Cg_endo -70.2 85.33 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.805 1.67 . . . . 0.0 109.027 164.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.01 116.59 16.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.98 86.96 4.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 39' ' ' ILE 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.447 ' CD2' HG21 ' A' ' 65' ' ' VAL . 21.2 m-85 -73.09 156.56 38.58 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.86 0.838 . . . . 0.0 111.618 -169.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 55' ' ' ALA . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' H ' HG13 ' A' ' 53' ' ' ILE . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.444 HG12 ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.814 ' HA ' HG13 ' A' ' 3' ' ' VAL . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.09 38.62 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.49 5.68 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.373 171.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.404 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.78 -40.87 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 120.41 1.459 . . . . 0.0 109.495 172.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -57.0 -23.17 44.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.928 0.785 . . . . 0.0 112.056 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -4.35 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 C--O 1.252 1.206 0 CA-C-N 120.062 1.301 . . . . 0.0 109.529 -176.681 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 62.6 mtt . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.0 p 153.06 -169.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.984 2.114 . . . . 0.0 107.273 -142.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt 14.46 80.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 128.997 2.919 . . . . 0.0 113.177 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.26 150.65 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.325 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -98.76 134.27 41.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.343 1.057 . . . . 0.0 109.032 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.9 149.61 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.14 146.26 42.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.47 96.64 4.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.111 0.965 . . . . 0.0 108.399 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -121.99 86.62 2.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 122.251 1.024 . . . . 0.0 110.385 -169.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 10' ' ' SER . 1.2 m -156.91 -157.51 0.7 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.451 1.9 . . . . 0.0 107.826 174.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.655 ' H ' HG22 ' A' ' 9' ' ' THR . 73.2 m 120.08 93.33 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.206 1 C-N-CA 133.345 4.658 . . . . 0.0 107.17 -175.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.97 -70.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 N-CA-C 107.269 -1.858 . . . . 0.0 107.269 159.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.3 ttt -162.68 -37.99 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 124.41 1.084 . . . . 0.0 109.008 163.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 m -51.73 -58.89 9.4 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 116.621 -1.657 . . . . 0.0 114.217 -171.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.12 -80.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 CA-C-N 122.042 1.765 . . . . 0.0 109.778 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 49.26 37.0 10.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.459 1.504 . . . . 0.0 113.585 165.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -172.03 -59.59 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.153 2.581 . . . . 0.0 108.886 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.16 -99.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.741 2.294 . . . . 0.0 110.764 -175.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.37 -92.71 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.186 1.794 . . . . 0.0 112.978 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.57 -29.36 36.92 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 124.933 1.293 . . . . 0.0 111.791 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.19 -43.44 87.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 119.67 1.123 . . . . 0.0 111.094 172.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -71.22 -42.51 68.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 119.332 0.969 . . . . 0.0 109.277 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 t -64.16 -44.05 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.549 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.64 -34.76 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 119.536 -1.977 . . . . 0.0 110.761 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.94 -51.19 70.34 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.88 0.872 . . . . 0.0 110.327 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.47 -61.72 2.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.527 1.931 . . . . 0.0 110.063 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -59.53 -44.96 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.3 67.27 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.548 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -58.46 -35.31 71.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.287 -1.34 . . . . 0.0 112.507 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -106.44 -38.13 6.29 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.469 1.94 . . . . 0.0 112.063 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.2 mtm -121.25 77.97 34.24 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 127.651 2.38 . . . . 0.0 107.037 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.92 11.62 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.941 3.761 . . . . 0.0 113.876 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.62 -59.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.611 1.565 . . . . 0.0 108.22 -159.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.93 50.6 0.47 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.16 2.584 . . . . 0.0 113.082 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.95 92.36 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.485 1.114 . . . . 0.0 109.78 -166.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -102.03 72.85 1.35 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.907 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -77.41 111.53 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.39 117.76 23.82 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -85.16 123.35 30.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 160.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 96.16 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 155.26 15.87 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.89 150.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.243 1.417 . . . . 0.0 112.922 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.415 ' C ' ' H ' ' A' ' 44' ' ' ASN 0.255 15.1 ptt? 54.35 -172.97 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.372 2.269 . . . . 0.0 111.496 -174.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 63.77 -17.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.899 2.08 . . . . 0.0 114.016 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 42' ' ' MET . 3.8 p-10 -68.65 149.75 97.86 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 127.804 2.442 . . . . 0.0 111.066 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.2 174.45 12.81 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.605 2.203 . . . . 0.0 108.859 160.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.69 0.45 4.21 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.089 -1.007 . . . . 0.0 113.449 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -48.03 -29.82 3.84 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -175.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.5 -53.13 4.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.352 0.524 . . . . 0.0 112.298 171.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.8 mtp -66.73 -7.56 21.85 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -171.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.99 -22.96 58.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.364 1.466 . . . . 0.0 113.372 166.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CD2' HG11 ' A' ' 65' ' ' VAL . 21.9 m-85 -64.91 154.66 36.73 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.777 0.831 . . . . 0.0 109.176 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -18.09 75.7 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.626 -0.672 . . . . 0.0 112.517 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.24 73.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 122.566 1.174 . . . . 0.0 108.802 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 93.9 mtp -73.76 24.9 0.07 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.932 0.893 . . . . 0.0 112.227 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.11 -45.74 71.93 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.102 1.361 . . . . 0.0 113.237 -164.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t 67.41 133.52 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.317 1.847 . . . . 0.0 109.137 -164.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.568 ' HB3' HG21 ' A' ' 9' ' ' THR . 24.5 Cg_endo -66.1 121.29 3.36 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.95 1.375 . . . . 0.0 111.243 -9.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.2 m -83.48 106.06 14.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.08 159.55 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.9 t -133.64 128.66 54.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 170.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.53 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -123.69 156.12 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 116.663 -1.637 . . . . 0.0 108.85 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 45.27 -67.25 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.767 2.427 . . . . 0.0 114.761 -167.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.69 -9.57 0.1 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.132 1.825 . . . . 0.0 113.112 160.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.62 125.31 35.6 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.367 2.083 . . . . 0.0 111.94 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 51' ' ' TYR . 16.0 t -72.03 140.25 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.43 1.492 . . . . 0.0 107.617 174.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -178.69 166.53 1.72 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.902 2.081 . . . . 0.0 107.905 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -126.17 152.84 45.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.177 1.791 . . . . 0.0 106.996 165.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 75' ' ' ALA . 7.0 mm -129.86 79.17 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 170.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.24 -164.49 36.75 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.799 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.3 1.5 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.99 -162.72 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 CA-C-N 123.517 2.292 . . . . 0.0 109.822 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.4 p -78.2 -150.6 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 O-C-N 119.751 -1.843 . . . . 0.0 107.65 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.53 ' HE3' ' CG1' ' A' ' 61' ' ' ILE . 3.5 tppt? -79.06 34.37 0.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.076 -2.265 . . . . 0.0 110.848 -174.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.303 29.7 mt-10 -62.08 -25.55 67.77 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -158.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -66.34 -42.21 88.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.775 1.17 . . . . 0.0 111.408 170.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -33.98 53.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.862 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.3 t -48.17 -50.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.846 1.659 . . . . 0.0 107.558 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.56 -10.9 13.56 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.24 -47.24 3.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.219 1.407 . . . . 0.0 112.097 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.2 pt -64.12 -33.09 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.414 1.461 . . . . 0.0 111.241 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -57.51 -24.78 57.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.028 1.286 . . . . 0.0 111.621 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.28 0.0 OUTLIER -91.4 -56.31 3.18 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 117.466 -1.254 . . . . 0.0 107.678 -171.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -110.44 -92.34 0.45 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.182 1.355 . . . . 0.0 110.401 167.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.358 0 C-N-CA 130.799 3.639 . . . . 0.0 104.254 -159.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.6 m -62.83 0.68 0.5 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -68.38 135.66 52.13 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 121.045 1.748 . . . . 0.0 107.352 168.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 62' ' ' ASN . 4.0 t -80.89 154.54 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.34 25.47 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -106.51 96.91 5.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -103.1 139.85 38.09 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -132.23 101.34 5.34 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 123.36 0.664 . . . . 0.0 109.857 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.63 82.51 1.63 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.347 2.259 . . . . 0.0 106.741 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -161.13 -179.37 7.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.926 1.29 . . . . 0.0 107.722 166.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p -136.8 92.95 14.15 Favored Pre-proline 0 C--O 1.235 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 167.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.98 -176.5 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.971 1.781 . . . . 0.0 108.878 170.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.85 85.0 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.492 1.917 . . . . 0.0 111.859 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 32.3 m 50.25 177.72 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.943 3.297 . . . . 0.0 113.09 -172.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 40.1 Cg_endo -64.04 1.22 1.63 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.78 1.653 . . . . 0.0 112.554 159.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -47.97 81.8 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 120.914 -1.116 . . . . 0.0 108.738 166.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.9 m -63.39 131.73 94.91 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 165.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -68.97 -46.13 1.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 120.846 1.03 . . . . 0.0 113.154 -171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.87 -104.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.116 1.766 . . . . 0.0 111.499 -169.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.01 68.31 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.879 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -38.14 -60.07 0.8 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.951 1.25 . . . . 0.0 111.271 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.78 -39.6 61.65 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.566 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -53.44 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.796 1.18 . . . . 0.0 108.089 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.4 t -51.66 -52.53 20.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 128.167 2.587 . . . . 0.0 109.889 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.5 -44.38 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.612 1.097 . . . . 0.0 111.059 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.68 -43.08 99.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.7 1.2 . . . . 0.0 111.062 -177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.681 ' CG2' HG11 ' A' ' 34' ' ' VAL . 31.1 m -78.58 -29.42 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.495 -0.753 . . . . 0.0 112.561 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.95 -25.21 60.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.329 1.052 . . . . 0.0 111.766 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.0 -24.43 58.16 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.79 -0.569 . . . . 0.0 110.526 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -89.5 -57.95 2.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.807 1.243 . . . . 0.0 110.088 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.505 ' HB2' HG23 ' A' ' 34' ' ' VAL . 41.6 mtm -129.63 89.04 47.95 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.495 1.118 . . . . 0.0 110.511 -171.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.76 34.21 0.52 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.375 3.383 . . . . 0.0 113.084 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -178.3 -51.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.984 1.314 . . . . 0.0 110.615 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.24 -24.63 66.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.406 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.681 HG11 ' CG2' ' A' ' 26' ' ' VAL . 51.5 t -72.12 98.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 164.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -83.69 135.71 34.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.551 1.941 . . . . 0.0 106.837 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.4 ' CG1' HG12 ' A' ' 34' ' ' VAL . 21.6 m -135.06 147.12 29.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 118.941 0.791 . . . . 0.0 112.571 -164.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -140.01 117.9 11.75 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.952 1.301 . . . . 0.0 108.043 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -99.84 84.43 2.9 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -90.68 75.38 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -60.51 92.05 0.02 OUTLIER 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.932 1.293 . . . . 0.0 109.457 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.255 9.6 p 39.25 -67.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 131.66 3.984 . . . . 0.0 116.346 -167.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.7 ttp -54.99 151.44 8.85 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.864 1.211 . . . . 0.0 112.931 -158.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 64.93 34.51 8.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.534 1.534 . . . . 0.0 109.52 -158.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -67.24 103.6 0.51 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 126.493 1.917 . . . . 0.0 110.771 -165.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 44' ' ' ASN . 6.8 Cg_endo -94.19 139.95 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.731 1.62 . . . . 0.0 111.474 -169.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -64.6 -7.01 8.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.608 -1.308 . . . . 0.0 112.392 170.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.93 -41.48 11.58 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.186 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.47 -27.89 17.16 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 172.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 20.0 mtt -63.25 -4.99 2.87 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.825 -1.172 . . . . 0.0 111.447 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -61.68 -25.68 67.55 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.237 1.415 . . . . 0.0 113.11 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.606 ' CE2' HG11 ' A' ' 65' ' ' VAL . 33.2 m-85 -80.74 -154.98 0.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.076 1.35 . . . . 0.0 110.821 -168.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.29 -170.12 0.71 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 158.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 54' ' ' MET 0.262 18.6 tt -31.05 -67.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.895 1.678 . . . . 0.0 113.275 -159.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.473 ' H ' HG23 ' A' ' 53' ' ' ILE . 14.1 mmt 36.99 35.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 128.263 2.625 . . . . 0.0 114.485 167.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.79 -68.49 0.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.94 171.13 6.78 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.745 1.618 . . . . 0.0 107.629 158.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.21 128.94 17.4 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 109.685 -0.929 . . . . 0.0 109.685 -20.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 m -106.45 114.3 28.33 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -164.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.511 HD11 HG22 ' A' ' 72' ' ' THR . 27.3 mm -132.3 124.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -159.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -97.08 128.06 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 168.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.8 pp -120.06 161.49 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.475 ' HA ' HG13 ' A' ' 3' ' ' VAL . 3.3 m120 45.69 -92.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.708 1.203 . . . . 0.0 111.306 -170.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.21 1.31 3.37 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.25 160.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.08 115.08 27.74 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.599 1.56 . . . . 0.0 111.503 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 51' ' ' TYR . 8.0 p -57.36 141.09 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.001 1.32 . . . . 0.0 109.843 159.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -178.7 -178.68 0.59 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 106.395 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -139.13 -36.48 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.77 1.228 . . . . 0.0 112.217 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . 0.274 31.9 mm 49.71 -74.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 127.398 2.279 . . . . 0.0 112.133 -160.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.92 -176.6 25.68 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.732 1.151 . . . . 0.0 114.142 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.25 -47.44 2.59 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.909 1.284 . . . . 0.0 108.7 158.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.76 174.97 4.89 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 CA-C-N 120.756 1.306 . . . . 0.0 108.826 158.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.511 HG22 HD11 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -63.22 178.5 0.51 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.551 -0.718 . . . . 0.0 112.068 178.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -68.05 64.84 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.393 1.877 . . . . 0.0 113.776 -159.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.282 -0.886 . . . . 0.0 111.816 -160.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.7 79.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.946 0.794 . . . . 0.0 110.726 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.6 -29.57 62.47 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.88 175.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.13 -46.56 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.818 1.645 . . . . 0.0 109.106 166.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -3.8 3.85 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.967 1.707 . . . . 0.0 112.538 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.46 -45.52 2.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.698 1.599 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 61' ' ' ILE . 3.7 pt -61.65 -23.66 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.998 1.272 . . . . 0.0 110.881 171.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -43.03 74.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.269 0.941 . . . . 0.0 111.857 169.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.272 0.4 OUTLIER -81.97 -53.74 5.88 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.334 0.515 . . . . 0.0 110.736 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -155.09 -77.22 0.1 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.243 0.733 1 C-N-CA 132.379 4.272 . . . . 0.0 104.902 167.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 37.5 mtt . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t -148.12 -43.93 0.16 Allowed 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.636 -0.665 . . . . 0.0 110.616 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt 57.65 91.76 0.04 OUTLIER 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.518 1.527 . . . . 0.0 111.859 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 62' ' ' ASN . 91.9 t -66.13 142.26 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 133.41 42.38 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 126.643 1.977 . . . . 0.0 106.337 169.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.41 82.01 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 -173.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -109.01 118.76 37.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -168.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.54 99.42 9.1 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.348 1.459 . . . . 0.0 107.124 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -110.83 96.42 6.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.678 1.191 . . . . 0.0 107.925 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 t -178.26 171.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.233 1.813 . . . . 0.0 106.75 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -158.95 87.24 2.22 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 160.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.7 35.67 0.52 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.53 2.82 . . . . 0.0 112.287 -172.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.2 ttt 56.63 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.304 3.442 . . . . 0.0 114.893 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -78.15 -84.92 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.662 -1.637 . . . . 0.0 109.579 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.06 78.98 2.45 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.883 2.388 . . . . 0.0 111.188 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -129.2 28.51 5.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.54 1.136 . . . . 0.0 110.586 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 16.6 m -132.63 -57.55 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.799 1.24 . . . . 0.0 108.269 172.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 16' ' ' CYS . 87.7 Cg_endo -70.2 85.33 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.805 1.67 . . . . 0.0 109.027 164.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 -91.72 0.08 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.81 -34.77 20.59 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.48 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -50.08 70.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.918 1.235 . . . . 0.0 111.654 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -69.77 -39.61 76.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.68 -31.74 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.054 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.9 p -72.96 -40.03 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.961 1.71 . . . . 0.0 110.514 173.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.85 -49.73 75.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.717 0.807 . . . . 0.0 109.561 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.24 -52.42 27.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.632 1.173 . . . . 0.0 111.33 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.89 -18.5 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.454 -1.404 . . . . 0.0 110.234 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.56 -26.96 37.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.723 1.601 . . . . 0.0 113.158 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -53.71 -48.53 69.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.89 1.223 . . . . 0.0 108.607 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -48.99 14.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.913 0.885 . . . . 0.0 110.764 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 44.1 mtt -140.73 78.71 20.32 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.95 1.3 . . . . 0.0 110.547 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.01 53.29 3.3 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.699 2.933 . . . . 0.0 110.789 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.67 -63.95 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.459 2.704 . . . . 0.0 106.406 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.62 2.11 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.496 1.918 . . . . 0.0 109.99 -170.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.19 84.77 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.287 1.435 . . . . 0.0 108.548 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.04 85.84 7.36 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 171.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -88.65 129.87 39.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 123.166 0.587 . . . . 0.0 111.065 177.4 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -133.03 116.53 16.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -94.94 86.96 4.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 39' ' ' ILE 0.269 0.2 OUTLIER -91.04 75.43 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.482 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.42 113.12 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.55 169.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.68 124.09 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 124.146 0.903 . . . . 0.0 110.6 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.4 mmm 135.34 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.7 1 C-N-CA 134.503 5.121 . . . . 0.0 104.837 -159.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 29.82 55.97 0.16 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.063 2.945 . . . . 0.0 115.373 159.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 153.97 30.63 Favored Pre-proline 0 C--O 1.234 0.252 0 O-C-N 120.851 -1.156 . . . . 0.0 110.053 173.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.32 173.79 12.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.183 1.922 . . . . 0.0 110.918 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.3 4.48 0.71 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -30.67 60.06 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 120.213 1.37 . . . . 0.0 114.694 -173.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -91.7 -31.12 15.94 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 168.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mtt -69.85 -16.52 63.27 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.605 1.162 . . . . 0.0 111.894 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -70.55 -18.37 62.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.937 1.295 . . . . 0.0 112.553 174.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.447 ' CD2' HG21 ' A' ' 65' ' ' VAL . 21.3 m-85 -73.04 156.55 38.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.861 0.839 . . . . 0.0 111.631 -169.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.8 121.02 16.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.676 1.131 . . . . 0.0 110.493 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 55' ' ' ALA . 18.3 pt 47.82 16.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 127.921 2.489 . . . . 0.0 113.881 -173.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 48.14 7.02 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.967 2.907 . . . . 0.0 116.113 -161.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' H ' HG13 ' A' ' 53' ' ' ILE . . . 40.4 46.57 2.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.702 2.001 . . . . 0.0 113.011 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.59 134.57 79.01 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 117.438 -1.268 . . . . 0.0 109.791 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.6 122.77 5.1 Favored 'Cis proline' 0 C--N 1.355 0.916 0 CA-C-N 121.632 1.619 . . . . 0.0 110.998 -4.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.8 m -82.78 120.64 25.88 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -168.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.6 155.17 34.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 120.675 1.579 . . . . 0.0 107.937 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.75 138.97 51.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 162.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.444 HG12 ' HE3' ' A' ' 73' ' ' LYS . 2.9 pp -134.29 159.44 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.115 2.566 . . . . 0.0 106.458 173.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.814 ' HA ' HG13 ' A' ' 3' ' ' VAL . 20.7 m120 37.99 -89.36 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.287 1.403 . . . . 0.0 111.734 -159.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.75 3.1 4.17 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 119.97 1.259 . . . . 0.0 113.704 163.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 116.24 26.98 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 128.665 2.786 . . . . 0.0 111.263 -167.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 51' ' ' TYR . 7.2 p -57.98 127.92 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -160.59 164.28 32.04 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 176.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.73 153.69 36.0 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 168.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm -135.01 82.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.96 -164.07 38.6 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.75 -31.47 5.62 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.443 -1.741 . . . . 0.0 115.36 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.76 168.92 22.71 Favored 'Trans proline' 0 C--N 1.354 0.831 0 CA-C-N 123.122 2.151 . . . . 0.0 110.618 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 p -65.03 -177.62 0.38 Allowed 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.525 -0.735 . . . . 0.0 109.525 163.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 ttpt -73.16 21.97 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -158.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.09 -40.27 58.03 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.599 1.545 . . . . 0.0 112.158 -175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.7 88.77 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.231 -0.918 . . . . 0.0 113.423 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.404 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.6 tm? -82.77 -22.3 34.36 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.75 -40.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.41 1.459 . . . . 0.0 109.518 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -56.99 -23.17 44.12 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.89 0.768 . . . . 0.0 112.056 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.41 -49.93 8.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.099 169.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.84 -38.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 121.374 1.897 . . . . 0.0 110.786 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -47.9 66.26 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.819 0.448 . . . . 0.0 111.917 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -21.23 59.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.205 0.912 . . . . 0.0 112.262 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -4.35 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.776 0.83 . . . . 0.0 112.05 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 C--O 1.252 1.206 0 CA-C-N 120.062 1.301 . . . . 0.0 109.529 -176.681 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.3 m -154.26 155.35 35.03 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.511 1.525 . . . . 0.0 107.066 155.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -139.96 157.89 44.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.471 1.032 . . . . 0.0 111.494 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 62' ' ' ASN . 2.4 t -97.38 160.33 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.859 1.264 . . . . 0.0 109.56 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 154.84 46.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 167.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.12 149.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 108.636 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -135.12 150.65 50.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.662 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.405 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 1.3 mm? -123.08 91.56 3.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.889 2.476 . . . . 0.0 106.678 167.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -94.67 82.25 3.93 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.4 p -140.43 169.87 16.86 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.093 -1.004 . . . . 0.0 109.792 -175.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 t -164.36 -59.45 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.355 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -59.64 133.68 53.02 Favored 'Trans proline' 0 C--N 1.353 0.778 0 N-CA-C 108.211 -1.496 . . . . 0.0 108.211 166.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.8 mtp -139.11 -171.29 3.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.027 2.131 . . . . 0.0 108.773 -170.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.272 85.5 m 119.33 -75.96 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.575 1 C-N-CA 132.134 4.174 . . . . 0.0 107.611 -175.502 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.35 -4.44 9.37 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.433 2.089 . . . . 0.0 113.744 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -141.13 56.12 1.55 Allowed 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 124.877 1.271 . . . . 0.0 109.381 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.9 m -56.52 -53.82 60.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.097 168.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.59 61.55 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.136 1.891 . . . . 0.0 110.643 177.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB1' ' CD1' ' A' ' 7' ' ' LEU . . . -68.83 -81.45 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.792 . . . . 0.0 111.617 -168.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.21 -19.43 45.37 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.372 -0.83 . . . . 0.0 112.003 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -65.03 -59.95 3.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.889 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -54.73 -45.39 74.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.18 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.24 -37.27 75.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 118.271 -1.372 . . . . 0.0 110.061 -174.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.251 3.3 p -67.36 -33.6 63.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 O-C-N 119.565 -1.96 . . . . 0.0 110.843 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.05 -53.84 53.09 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 120.928 1.694 . . . . 0.0 110.185 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.41 ' OE2' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -45.98 -60.69 2.12 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.98 2.512 . . . . 0.0 109.566 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.015 HG11 HG11 ' A' ' 34' ' ' VAL . 8.6 p -77.2 -40.58 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -25.91 64.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.8 -0.619 . . . . 0.0 110.241 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -38.39 -54.85 1.43 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.368 0.667 . . . . 0.0 111.009 165.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.28 -24.68 16.09 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.414 1.085 . . . . 0.0 112.797 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.531 ' CB ' HG23 ' A' ' 34' ' ' VAL . 46.7 mtt -144.74 78.61 12.77 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.271 1.028 . . . . 0.0 109.416 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.13 34.77 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.981 3.12 . . . . 0.0 113.054 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.97 -48.83 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.132 0.973 . . . . 0.0 109.294 -175.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.49 14.7 0.12 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.9 -1.048 . . . . 0.0 113.046 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.015 HG11 HG11 ' A' ' 26' ' ' VAL . 54.3 t -111.84 103.14 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 120.725 1.602 . . . . 0.0 107.488 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -76.76 96.59 4.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.76 153.29 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.547 0.612 . . . . 0.0 110.285 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.15 146.94 39.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.242 0.474 . . . . 0.0 110.409 158.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -107.74 69.92 0.76 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.744 2.418 . . . . 0.0 107.521 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.487 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -79.89 84.86 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 128.03 34.29 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 110.664 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -74.3 120.3 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.7 mmt -177.98 -74.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 -166.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -132.96 92.91 3.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -144.58 133.01 10.88 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.031 -0.985 . . . . 0.0 108.963 -159.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.03 152.01 74.32 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.125 1.883 . . . . 0.0 111.424 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -63.91 5.8 0.2 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -11.27 8.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 121.169 1.804 . . . . 0.0 115.363 -171.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.522 ' HA ' ' CE2' ' A' ' 51' ' ' TYR . . . -92.85 -33.57 14.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 122.969 2.622 . . . . 0.0 115.778 159.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtt -69.0 -6.84 30.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -64.09 -25.49 68.12 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.165 0.986 . . . . 0.0 111.664 163.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 48' ' ' ALA . 16.1 m-85 -84.13 153.44 23.71 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.664 0.786 . . . . 0.0 110.587 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.74 42.49 1.54 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.949 1.261 . . . . 0.0 113.111 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.454 HG13 ' H ' ' A' ' 55' ' ' ALA . 2.9 tp -138.87 -52.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.8 1.64 . . . . 0.0 108.243 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 32.2 mtt 58.51 -2.37 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.421 2.288 . . . . 0.0 115.782 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.454 ' H ' HG13 ' A' ' 53' ' ' ILE . . . -77.29 -161.06 0.2 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.65 1.98 . . . . 0.0 111.796 -175.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -155.58 159.36 31.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.388 2.275 . . . . 0.0 106.27 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.94 109.66 1.23 Allowed 'Cis proline' 0 C--N 1.35 0.617 0 CA-C-N 121.069 1.418 . . . . 0.0 110.829 -9.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -93.19 132.86 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.599 ' HB ' ' HE2' ' A' ' 73' ' ' LYS . 20.4 mm -134.91 146.32 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -168.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.7 t -114.63 121.09 66.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 170.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG23 ' HE3' ' A' ' 73' ' ' LYS . 2.7 pp -109.36 145.24 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 125.155 1.535 . . . . 0.0 108.082 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.436 ' HA ' HG13 ' A' ' 3' ' ' VAL . 23.7 t-20 57.97 -45.96 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.036 2.135 . . . . 0.0 115.749 -169.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.69 -11.67 0.3 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 130.326 3.822 . . . . 0.0 109.982 -168.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -91.51 124.15 35.46 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.316 2.247 . . . . 0.0 113.173 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 51' ' ' TYR . 12.3 p -75.18 149.92 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.573 0.749 . . . . 0.0 110.354 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -178.44 171.64 1.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.764 2.026 . . . . 0.0 108.471 173.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.33 139.03 40.58 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.365 1.066 . . . . 0.0 109.473 167.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 75' ' ' ALA . 7.9 mm -121.54 71.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 122.495 1.14 . . . . 0.0 108.315 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.04 -164.26 26.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 122.456 1.031 . . . . 0.0 113.431 160.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.62 6.02 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 116.273 -1.822 . . . . 0.0 115.801 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.13 -111.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 0 CA-C-N 123.122 2.151 . . . . 0.0 108.769 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.6 p -126.0 -116.99 0.27 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 121.561 1.982 . . . . 0.0 107.794 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.599 ' HE2' ' HB ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -92.11 14.84 14.85 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.075 1.75 . . . . 0.0 113.49 172.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -30.36 -50.49 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.021 2.601 . . . . 0.0 118.021 -163.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -67.93 -43.62 78.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.464 1.029 . . . . 0.0 111.766 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.99 -34.11 68.65 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.333 0.653 . . . . 0.0 109.969 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' OE2' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -48.65 -53.87 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.908 1.683 . . . . 0.0 108.37 171.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -67.62 -16.19 64.04 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.745 -0.597 . . . . 0.0 112.293 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.405 ' HA ' ' HE3' ' A' ' 82' ' ' LYS . . . -83.58 -49.19 9.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.311 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -60.44 -35.23 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 120.221 1.373 . . . . 0.0 109.885 174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.15 -19.69 47.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 117.368 -1.301 . . . . 0.0 113.542 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 79' ' ' ALA 0.255 0.0 OUTLIER -91.15 -67.5 0.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.545 1.52 . . . . 0.0 109.145 159.159 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 -142.17 -71.77 0.33 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.384 1.074 . . . . 0.0 108.876 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.735 0 C-N-CA 131.441 3.896 . . . . 0.0 103.884 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 42.3 mtt . . . . . 0 C--O 1.239 0.505 0 CA-C-O 121.661 0.743 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.6 m -167.75 151.0 6.0 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 129.939 3.296 . . . . 0.0 105.657 168.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -129.12 162.12 28.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.381 0.991 . . . . 0.0 111.476 170.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.34 133.23 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -124.47 117.31 24.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.088 0.858 . . . . 0.0 109.559 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.42 150.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 125.963 1.705 . . . . 0.0 107.681 -172.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -140.02 139.05 35.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 59' ' ' ILE . 3.6 mm? -114.21 78.18 1.13 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 174.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -80.26 88.38 5.51 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.673 1.225 . . . . 0.0 107.761 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.8 p -141.75 -149.22 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -166.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 41' ' ' VAL . 29.6 t 160.11 -65.81 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 128.857 2.863 . . . . 0.0 108.087 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -61.99 150.35 86.71 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 CA-C-N 120.721 1.293 . . . . 0.0 110.866 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.1 mtm -140.61 159.24 42.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.281 2.232 . . . . 0.0 107.523 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.6 m 141.84 -72.31 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.304 1 C-N-CA 131.906 4.082 . . . . 0.0 107.201 -168.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -67.53 -19.61 48.42 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.378 2.052 . . . . 0.0 112.044 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -133.03 162.4 31.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 160.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -115.65 -82.1 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 115.911 -1.995 . . . . 0.0 105.945 158.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.94 -22.33 37.85 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.497 3.464 . . . . 0.0 117.791 -161.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 44.18 -100.1 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.813 2.045 . . . . 0.0 112.344 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.85 72.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.538 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -61.01 -37.07 81.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.437 1.471 . . . . 0.0 111.413 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -66.53 -51.74 53.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.685 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.35 -32.06 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 118.487 -1.285 . . . . 0.0 110.187 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -63.86 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 117.703 -1.142 . . . . 0.0 108.768 165.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -58.93 -38.5 79.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.81 1.186 . . . . 0.0 111.048 -170.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.445 ' OE2' HG23 ' A' ' 77' ' ' VAL . 1.7 tp10 -60.75 -53.96 50.97 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 110.155 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.33 -39.35 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.63 68.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.56 1.544 . . . . 0.0 111.814 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -52.77 -39.88 62.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.918 0.887 . . . . 0.0 110.012 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -93.49 -46.93 7.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.899 1.28 . . . . 0.0 111.495 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.33 87.35 47.56 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 126.009 1.724 . . . . 0.0 108.099 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.59 13.0 0.48 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.889 2.393 . . . . 0.0 112.877 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -142.57 -55.02 0.42 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -162.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.23 48.46 1.49 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.611 -0.68 . . . . 0.0 110.991 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.36 83.43 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.563 1.145 . . . . 0.0 108.921 -164.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.38 128.88 35.52 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -146.59 97.15 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 125.551 1.54 . . . . 0.0 107.067 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -80.08 144.09 33.43 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 109.837 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -110.39 115.57 29.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . 0.258 0.2 OUTLIER -129.26 86.45 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -54.86 127.14 27.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 159.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' H ' ' HB2' ' A' ' 10' ' ' SER . 1.5 p -50.85 143.23 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.674 1.59 . . . . 0.0 112.075 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.7 ttt -142.19 -82.23 0.2 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 173.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.13 -2.82 26.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.478 1.111 . . . . 0.0 112.595 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.1 t30 35.83 57.76 2.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 127.432 2.293 . . . . 0.0 112.398 -168.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.74 137.22 37.99 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.182 1.255 . . . . 0.0 109.841 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -59.87 -20.71 58.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 116.32 -1.8 . . . . 0.0 112.182 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -37.34 -47.76 0.86 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 120.045 1.293 . . . . 0.0 112.332 171.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' A' ' 58' ' ' THR . . . -91.1 -33.47 15.45 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 117.233 2.309 . . . . 0.0 117.233 169.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.65 3.21 26.21 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.318 -0.864 . . . . 0.0 112.89 -172.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.27 -143.67 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.929 2.091 . . . . 0.0 109.51 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 65' ' ' VAL . 10.0 m-85 68.86 -167.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 0.0 111.192 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 5.74 81.92 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.067 0.842 . . . . 0.0 113.458 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 55' ' ' ALA . 0.4 OUTLIER -94.96 -59.58 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.958 1.303 . . . . 0.0 107.912 178.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 59.1 mtm 49.7 13.27 0.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.703 1.601 . . . . 0.0 114.818 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 53' ' ' ILE . . . -140.58 106.09 5.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.391 1.476 . . . . 0.0 109.638 -168.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 m -56.69 158.03 9.21 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.022 . . . . 0.0 111.596 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.33 112.71 1.76 Allowed 'Cis proline' 0 C--N 1.354 0.828 0 CA-C-N 121.024 1.401 . . . . 0.0 111.066 -0.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.459 HG21 ' HB1' ' A' ' 48' ' ' ALA . 21.6 m -86.94 110.67 20.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.232 1.413 . . . . 0.0 107.266 -169.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.543 HD12 HD13 ' A' ' 7' ' ' LEU . 13.2 mm -115.45 152.05 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -174.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.75 132.88 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 164.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.432 HG13 ' HE3' ' A' ' 73' ' ' LYS . 2.5 pp -122.48 153.69 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 161.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 47.35 -69.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 128.9 2.88 . . . . 0.0 113.259 -171.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.77 4.05 0.24 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 126.6 2.048 . . . . 0.0 113.78 162.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.95 120.25 31.81 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 126.753 2.021 . . . . 0.0 110.106 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 51' ' ' TYR . 7.2 p -72.82 133.7 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 118.799 0.727 . . . . 0.0 109.298 166.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 4.0 tp10 -161.56 163.05 30.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.244 1.817 . . . . 0.0 108.403 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -126.25 153.63 44.48 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 159.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 75' ' ' ALA . 1.6 mm -141.99 149.0 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.71 -167.13 30.13 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 122.291 0.939 . . . . 0.0 113.312 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.61 -34.18 0.98 Allowed Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 116.761 -1.59 . . . . 0.0 115.14 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.93 -109.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.282 1.851 . . . . 0.0 110.757 -164.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.3 p -114.72 -146.72 0.41 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 159.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HE3' HG13 ' A' ' 61' ' ' ILE . 4.8 ttpt -79.08 20.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.051 -1.656 . . . . 0.0 111.42 -169.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.838 ' HA ' HG22 ' A' ' 77' ' ' VAL . 9.1 mt-10 -61.62 -28.94 69.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -158.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HB3' HG21 ' A' ' 68' ' ' ILE . . . -48.98 -48.52 43.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.41 1.084 . . . . 0.0 112.422 165.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.72 -33.83 40.59 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 117.014 -1.47 . . . . 0.0 109.913 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.838 HG22 ' HA ' ' A' ' 74' ' ' GLU 0.291 2.6 m -68.29 -37.92 78.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 122.724 2.511 . . . . 0.0 110.961 -175.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -53.56 -19.54 3.95 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.245 2.218 . . . . 0.0 111.257 165.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.97 -46.0 7.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.788 166.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.0 pt -53.73 -28.99 17.13 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-N 122.266 2.303 . . . . 0.0 112.092 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -79.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.355 164.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -16.23 25.07 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -170.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.43 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -67.41 -10.35 50.44 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.378 173.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.245 0.855 0 CA-C-N 120.867 1.667 . . . . 0.0 108.707 170.51 . . . . . . . . 0 0 . 1 stop_ save_